data_1w1f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1w1f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -105.97 129.72 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.26 154.58 40.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 108.89 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 2.9 p -113.4 133.93 57.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.97 -1.081 . . . . 0.0 108.83 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -56.32 115.86 2.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.514 -0.741 . . . . 0.0 109.789 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 50.4 mt -88.37 -27.78 21.39 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -136.72 140.32 31.64 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.2 Cg_endo -60.97 141.47 94.6 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.762 2.308 . . . . 0.0 111.879 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.9 t80 -133.2 124.14 26.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.53 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -102.27 111.33 23.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.97 -1.081 . . . . 0.0 108.958 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -28.15 89.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.7 mt -94.63 -14.14 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.308 -1.113 . . . . 0.0 108.483 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.563 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.5 175.1 1.98 Allowed Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.563 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.1 Cg_endo -71.76 -34.34 9.05 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.511 2.14 . . . . 0.0 112.052 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 2.5 m-20 -112.09 -10.73 13.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 0.0 110.574 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.465 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 46.1 m-20 -60.34 116.22 4.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.915 -1.115 . . . . 0.0 109.752 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.634 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -78.67 134.96 37.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.907 -1.121 . . . . 0.0 108.45 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.609 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 1.6 p -83.54 136.6 34.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.354 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.8 p90 -139.41 147.94 42.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.288 -0.882 . . . . 0.0 108.739 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -108.51 140.02 42.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.072 -1.018 . . . . 0.0 109.497 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 30' ' ' LYS . 15.4 ptmt -42.21 152.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.23 -0.988 . . . . 0.0 108.36 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.55 -16.65 7.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -82.66 152.03 26.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.097 -1.237 . . . . 0.0 109.743 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 12.8 mtpt -105.79 145.99 30.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.435 -0.791 . . . . 0.0 109.962 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.511 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 5.9 mtm -138.2 154.21 49.13 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.718 0.77 . . . . 0.0 109.834 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 tttp -121.78 136.44 54.94 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 1.5 t -97.96 120.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.005 . . . . 0.0 110.075 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.516 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 2.2 mm? -86.34 -18.2 32.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 109.923 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -154.24 141.03 19.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.945 -1.097 . . . . 0.0 109.757 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.465 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 6.1 tt0 -108.64 135.18 50.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.145 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 74.2 m-70 -121.0 35.01 5.01 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.202 -0.936 . . . . 0.0 109.218 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.85 -110.0 3.94 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -85.76 -7.09 58.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -1.139 . . . . 0.0 109.857 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.56 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 27.3 m95 -129.99 141.86 50.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.071 -1.018 . . . . 0.0 109.786 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.579 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.98 167.68 21.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 109.569 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.573 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 13.1 tttp -110.8 118.84 37.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.38 -172.77 2.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 110.473 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 5.4 ttmt -140.83 150.24 43.03 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 53' ' ' LYS . 4.4 t -90.87 125.94 35.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.127 -0.983 . . . . 0.0 109.818 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -12.18 61.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.361 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.09 -55.29 4.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.694 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.71 8.07 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.351 -0.843 . . . . 0.0 109.281 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 49' ' ' SER . 21.4 mtmt 50.93 25.29 2.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.949 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 9.2 tttm -82.07 144.8 30.56 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.128 -0.982 . . . . 0.0 108.386 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 26.9 tt0 -120.84 145.62 47.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.014 -1.054 . . . . 0.0 109.456 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.634 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -164.79 -167.28 25.11 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.556 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.93 134.33 40.41 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.317 -1.108 . . . . 0.0 109.461 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 58' ' ' ILE . 10.9 pt -126.23 142.47 42.82 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.468 -0.77 . . . . 0.0 109.287 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 53.7 Cg_endo -75.62 157.55 40.13 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.854 1.703 . . . . 0.0 110.811 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.55 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 47.9 t -89.6 28.96 1.2 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.593 -1.317 . . . . 0.0 110.19 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -137.2 -0.35 2.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.079 -1.013 . . . . 0.0 109.664 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.519 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.7 m-85 -106.61 -25.72 11.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.229 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 15' ' ' ALA . 19.5 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.31 -0.869 . . . . 0.0 109.505 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.407 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 26.4 mm -109.54 132.87 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.524 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.34 155.6 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 108.957 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 12.7 p -112.79 134.46 55.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.306 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.68 118.83 5.67 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.482 -0.761 . . . . 0.0 110.103 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.453 HD13 ' C ' ' A' ' 63' ' ' VAL . 82.0 mt -91.51 -28.3 17.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -137.02 142.93 40.19 Favored Pre-proline 0 N--CA 1.486 1.352 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.9 Cg_endo -62.13 140.74 85.48 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.785 2.323 . . . . 0.0 111.575 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 34.2 t80 -132.04 123.6 27.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.576 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' ILE . 13.2 t0 -103.31 109.66 21.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.118 -0.989 . . . . 0.0 108.722 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.76 90.53 0.01 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.9 mt -88.44 -13.62 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -1.135 . . . . 0.0 108.403 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.581 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.63 177.99 1.06 Allowed Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.7 Cg_endo -73.59 -30.83 9.38 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.359 2.039 . . . . 0.0 111.955 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -112.59 -9.56 13.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.338 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 39.2 m-20 -60.91 116.29 4.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.952 -1.092 . . . . 0.0 109.899 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.695 ' CB ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -80.17 134.24 36.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 108.373 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.65 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.6 p -83.52 137.46 33.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 110.833 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.5 p90 -139.24 148.55 43.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 108.692 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -108.12 142.7 37.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.855 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.437 ' HE3' ' HD3' ' A' ' 18' ' ' PRO . 2.8 ptpt -44.19 151.82 0.22 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.29 -16.06 8.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.6 tm-20 -83.22 151.33 25.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.238 . . . . 0.0 109.67 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' N ' ' OE2' ' A' ' 33' ' ' GLU . 12.7 mttt -104.97 146.05 29.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.44 -0.787 . . . . 0.0 109.83 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.53 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 5.7 mtm -137.73 154.69 49.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.609 0.719 . . . . 0.0 109.662 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 20.2 tttt -118.36 133.73 55.64 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.533 HG22 ' CB ' ' A' ' 45' ' ' TRP . 1.4 p -103.78 119.08 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 109.433 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.53 -40.64 13.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.417 -0.802 . . . . 0.0 109.807 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 7.0 mp0 -129.81 137.08 50.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 109.687 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 4.9 mt-10 -111.11 146.4 36.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 7.8 m-70 -116.86 42.07 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.534 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.89 37.99 16.11 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 160.93 -47.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -1.12 . . . . 0.0 109.412 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.524 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 10.2 m95 -128.87 119.66 24.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.488 -0.757 . . . . 0.0 108.959 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.689 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -113.24 167.32 10.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.054 -1.029 . . . . 0.0 109.403 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 2.2 tttp -110.44 116.06 30.74 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.45 -172.29 2.16 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.415 -0.803 . . . . 0.0 110.417 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -144.04 154.44 43.24 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -94.55 126.87 40.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 0.0 110.195 -178.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.72 -11.87 60.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.153 -0.967 . . . . 0.0 109.359 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 tp -83.33 -55.73 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 109.728 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.12 10.04 28.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 48.25 24.63 0.71 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.428 -0.795 . . . . 0.0 110.111 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -81.42 144.0 31.72 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt-20 -120.52 149.1 42.95 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 109.392 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.695 ' HA2' ' CB ' ' A' ' 27' ' ' LEU . . . -169.01 -166.35 27.92 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.91 133.8 41.07 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.382 -1.069 . . . . 0.0 109.345 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 58' ' ' ILE . 17.8 pt -125.87 140.31 36.41 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 108.88 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.61 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 53.4 Cg_endo -75.05 159.15 41.51 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 121.694 1.596 . . . . 0.0 110.706 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.447 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 99.5 p -89.73 28.82 1.25 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.684 -1.26 . . . . 0.0 109.705 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -140.48 -1.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 109.999 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 8.4 m-85 -100.74 -26.6 13.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 0.0 110.07 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.471 HG13 ' CE ' ' A' ' 35' ' ' MET . 14.5 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.041 -1.037 . . . . 0.0 109.644 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.465 ' CD1' ' CD ' ' A' ' 36' ' ' LYS . 19.4 mm -106.02 129.96 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.162 -0.961 . . . . 0.0 109.561 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.57 156.31 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 8.1 p -114.04 134.45 56.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.027 -1.046 . . . . 0.0 108.807 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -55.85 115.36 2.34 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.545 -0.722 . . . . 0.0 109.849 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.433 HD13 ' C ' ' A' ' 63' ' ' VAL . 36.2 mt -88.02 -28.99 21.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -136.62 139.95 30.76 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.0 Cg_endo -60.76 141.39 94.78 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.857 2.372 . . . . 0.0 111.642 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.3 t80 -133.78 124.92 27.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 109.906 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.564 ' O ' ' C ' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -102.94 110.32 22.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.021 -1.049 . . . . 0.0 108.805 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.83 91.07 0.01 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.56 ' N ' ' O ' ' A' ' 20' ' ' ASP . 14.2 mt -91.76 -14.35 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.282 -1.128 . . . . 0.0 108.524 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.545 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.35 175.78 1.74 Allowed Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 50.7 Cg_endo -71.43 -31.67 13.57 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.4 2.067 . . . . 0.0 111.903 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.517 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.1 m-20 -112.0 -9.34 14.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 110.218 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -60.04 123.37 16.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.948 -1.095 . . . . 0.0 109.713 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.668 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -88.07 135.3 33.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.999 -1.063 . . . . 0.0 108.351 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.593 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 5.8 p -83.81 136.18 34.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.498 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.636 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.5 p90 -139.04 147.93 42.71 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 31' ' ' LYS . 4.5 ttmt -108.69 140.39 42.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.028 . . . . 0.0 109.551 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -42.79 152.01 0.11 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.92 -17.11 7.43 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -82.53 151.75 26.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.057 -1.261 . . . . 0.0 109.728 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -105.56 145.85 30.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.459 -0.776 . . . . 0.0 109.895 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.493 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 8.5 mtm -138.26 154.11 49.06 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.649 0.738 . . . . 0.0 109.669 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 4.2 ttpm? -119.72 134.33 55.27 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.581 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 1.5 t -96.84 119.9 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 110.14 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 mt -85.31 -20.41 30.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.366 -0.834 . . . . 0.0 110.011 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.24 141.2 20.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.902 -1.124 . . . . 0.0 109.763 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 2.9 tt0 -109.31 137.4 47.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.409 -0.807 . . . . 0.0 108.955 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.618 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 68.7 m-70 -123.43 36.25 4.68 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.208 -0.933 . . . . 0.0 109.197 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.85 -104.11 3.14 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.8 -8.82 48.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -1.088 . . . . 0.0 110.606 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.618 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 17.3 m95 -131.89 124.95 30.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.782 -1.199 . . . . 0.0 110.401 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.632 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.3 168.22 13.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.145 -0.972 . . . . 0.0 109.678 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.17 129.29 56.0 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -124.83 -172.21 2.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 110.537 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.545 ' CG ' ' HB3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -138.77 147.49 42.68 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' LYS . 8.4 t -88.26 124.92 34.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.04 -1.038 . . . . 0.0 109.491 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.2 -13.13 62.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 109.427 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.3 tp -80.65 -57.13 3.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.457 -0.777 . . . . 0.0 109.906 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.4 3.79 23.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 49' ' ' SER . 9.1 mttt 58.42 25.37 12.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.751 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 8.6 mmtp -78.13 142.05 38.31 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.545 ' HB3' ' CG ' ' A' ' 48' ' ' LYS . 10.0 pt-20 -121.59 139.9 52.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.033 -1.042 . . . . 0.0 109.511 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.668 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.11 -163.78 15.66 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.55 135.21 40.42 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.553 -0.969 . . . . 0.0 109.417 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.406 ' O ' HG13 ' A' ' 58' ' ' ILE . 18.4 pt -126.22 142.9 44.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.369 -0.832 . . . . 0.0 109.152 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.531 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 53.8 Cg_endo -75.93 157.42 38.87 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.877 1.718 . . . . 0.0 110.746 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 89.1 p -88.92 28.82 1.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.728 -1.232 . . . . 0.0 110.143 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -138.14 0.16 2.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.025 . . . . 0.0 109.741 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.531 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.5 m-85 -105.45 -26.3 11.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.097 -1.002 . . . . 0.0 109.4 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.486 HG13 ' CE ' ' A' ' 35' ' ' MET . 18.0 m . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.637 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.525 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.478 HD12 ' HG3' ' A' ' 36' ' ' LYS . 10.1 mm -107.25 130.39 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 109.356 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.32 153.34 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.274 -0.891 . . . . 0.0 108.928 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 8.7 p -112.41 133.61 57.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 118.841 -1.143 . . . . 0.0 109.168 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -58.18 118.71 5.76 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.494 -0.754 . . . . 0.0 110.285 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.82 -26.94 18.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -137.34 141.96 35.84 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.0 Cg_endo -62.57 141.49 86.37 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.716 2.277 . . . . 0.0 111.831 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.4 t80 -132.65 123.69 26.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 109.419 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -102.58 110.64 22.65 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.008 -1.058 . . . . 0.0 108.798 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.4 89.69 0.01 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' ASP . 6.2 mt -92.3 -14.27 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -1.163 . . . . 0.0 108.476 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.487 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -113.37 175.24 1.93 Allowed Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 52.9 Cg_endo -72.03 -32.85 10.44 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.414 2.076 . . . . 0.0 112.181 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.537 ' OD2' ' CE ' ' A' ' 46' ' ' LYS . 55.7 t0 -112.77 -10.38 13.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.123 -0.985 . . . . 0.0 110.611 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.463 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 44.5 m-20 -60.15 116.41 4.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.951 -1.093 . . . . 0.0 109.797 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.629 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -77.08 135.85 38.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.934 -1.104 . . . . 0.0 108.286 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.598 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 1.3 p -85.11 137.08 33.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -0.978 . . . . 0.0 110.423 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 12.3 p90 -140.4 148.81 41.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.0 108.701 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.485 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -108.19 140.62 41.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.027 -1.045 . . . . 0.0 109.428 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.01 152.44 0.11 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.59 -16.74 7.53 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -83.23 151.98 25.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -1.204 . . . . 0.0 109.659 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 13.4 mtmt -105.14 143.86 32.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.816 . . . . 0.0 110.093 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.564 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 6.7 mtm -136.91 154.71 50.39 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.619 0.723 . . . . 0.0 109.585 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 10.1 ttpt -121.26 136.12 55.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -103.12 119.72 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.487 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -85.64 -31.91 22.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 109.55 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -143.34 139.06 29.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.509 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.635 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tt0 -111.86 145.1 40.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.667 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 14.7 m-70 -114.68 43.25 1.97 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 109.523 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 48.13 40.53 21.34 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.584 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 158.7 -48.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.29 -1.123 . . . . 0.0 109.574 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.567 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 8.3 m95 -129.38 120.87 26.28 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.413 -0.804 . . . . 0.0 109.111 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.682 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.17 168.65 9.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.184 -0.948 . . . . 0.0 109.631 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.537 ' CE ' ' OD2' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -110.05 116.12 31.0 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.54 -174.84 2.56 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 110.498 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.5 ttmt -137.55 147.72 45.36 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.655 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -88.56 129.39 35.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.03 -1.044 . . . . 0.0 109.921 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.448 ' CD1' ' HB2' ' A' ' 34' ' ' LYS . 5.8 mt -68.76 -24.46 64.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.04 . . . . 0.0 109.835 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.6 tp -86.52 -42.36 13.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.966 . . . . 0.0 109.92 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 p -99.1 -16.78 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.376 -0.828 . . . . 0.0 109.16 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.655 ' N ' ' O ' ' A' ' 49' ' ' SER . 13.7 mttt 59.56 11.88 2.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.323 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -81.69 151.57 27.48 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 14.2 pt-20 -119.63 146.62 45.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.897 -1.127 . . . . 0.0 109.515 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.629 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -169.85 164.66 38.08 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -68.05 133.38 48.9 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.492 -1.005 . . . . 0.0 109.962 -179.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.406 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 7.5 pt -124.47 143.04 42.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.64 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.0 Cg_endo -73.69 153.57 48.79 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.543 1.495 . . . . 0.0 110.68 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.467 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 91.8 p -87.6 29.37 0.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.616 -1.302 . . . . 0.0 109.954 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -139.81 0.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 109.794 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.64 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 17.2 m-85 -102.06 -25.64 13.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.985 . . . . 0.0 110.198 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.488 HG12 ' HE2' ' A' ' 35' ' ' MET . 14.8 m . . . . . 0 N--CA 1.492 1.657 0 O-C-N 120.997 -1.064 . . . . 0.0 110.061 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.322 0.582 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' CD1' ' CG ' ' A' ' 36' ' ' LYS . 10.1 mm -108.0 132.44 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.275 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.49 156.66 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.933 . . . . 0.0 109.185 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 13.0 p -113.47 134.95 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.053 -1.029 . . . . 0.0 109.084 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.66 118.94 5.78 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.483 -0.761 . . . . 0.0 110.302 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.6 mt -91.19 -28.56 17.76 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -137.24 142.49 37.99 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.1 Cg_endo -61.13 140.88 91.77 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.783 2.322 . . . . 0.0 111.413 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.5 t80 -133.75 125.74 29.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.998 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -103.38 107.68 18.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.034 -1.041 . . . . 0.0 108.518 179.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.36 92.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.4 mt -79.32 -59.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.538 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -66.66 176.1 1.18 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.643 -0.661 . . . . 0.0 109.241 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.5 Cg_endo -71.73 -25.07 20.85 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.528 2.152 . . . . 0.0 111.938 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.2 t70 -112.65 -7.83 13.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.285 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.586 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -60.14 122.78 15.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.968 -1.082 . . . . 0.0 109.763 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.65 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -88.8 135.01 33.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.994 -1.066 . . . . 0.0 108.406 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.604 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 2.2 m -84.49 136.7 33.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.728 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.8 p90 -138.91 147.84 42.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 108.586 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.53 140.05 41.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.018 -1.051 . . . . 0.0 109.635 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.83 152.16 0.08 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.88 -15.7 7.85 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -83.34 152.46 25.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.087 -1.243 . . . . 0.0 109.838 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.478 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 30.6 ttmt -105.72 146.08 30.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 109.917 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.527 ' CE ' HG13 ' A' ' 63' ' ' VAL . 3.6 mtm -137.73 154.71 49.59 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.64 0.733 . . . . 0.0 109.919 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -117.86 132.65 56.4 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.453 HG22 ' CB ' ' A' ' 45' ' ' TRP . 1.5 p -103.82 119.41 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.961 . . . . 0.0 109.449 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.76 -45.87 9.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -0.86 . . . . 0.0 109.953 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 3.7 tt0 -122.97 136.14 54.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.621 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.583 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tt0 -111.74 143.8 42.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.558 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 24.7 m-70 -113.13 44.52 1.52 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.521 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 49.91 36.44 26.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 160.01 -45.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -1.175 . . . . 0.0 109.729 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.558 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 7.5 m95 -128.54 122.58 31.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.014 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -116.7 168.54 10.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.139 -0.976 . . . . 0.0 109.96 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.543 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 11.3 ttpt -109.41 117.61 34.47 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.32 -173.62 2.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.237 -0.915 . . . . 0.0 110.586 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.7 ttmt -139.01 148.59 43.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' LYS . 17.3 t -90.05 126.82 35.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.046 -1.034 . . . . 0.0 109.55 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.32 -11.32 60.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 109.424 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.7 tp -81.99 -57.43 3.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.719 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -108.99 7.97 26.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.372 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 49' ' ' SER . 19.2 mttt 53.95 25.76 5.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 109.897 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HG2' ' CD2' ' A' ' 27' ' ' LEU . 12.5 tttp -80.29 142.8 34.19 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 21.7 pt-20 -121.36 144.63 48.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.98 -1.075 . . . . 0.0 109.6 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.65 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -165.64 -164.24 20.7 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.49 132.99 41.51 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.374 -1.074 . . . . 0.0 109.633 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.525 HD12 ' CB ' ' A' ' 47' ' ' ALA . 11.2 pt -125.99 135.99 27.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 54.3 Cg_endo -77.95 166.23 25.3 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.591 1.527 . . . . 0.0 111.213 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.437 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 35.4 t -91.79 29.17 1.6 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.987 -1.071 . . . . 0.0 109.699 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -140.78 0.09 1.57 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.967 . . . . 0.0 109.719 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.52 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.3 m-85 -100.5 -28.72 12.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.079 -1.013 . . . . 0.0 109.664 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.527 HG13 ' CE ' ' A' ' 35' ' ' MET . 6.1 m . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 109.829 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.403 HD12 ' HD2' ' A' ' 36' ' ' LYS . 17.2 mm -106.74 132.01 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.357 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.82 157.23 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.28 -0.888 . . . . 0.0 109.269 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 6.4 p -113.55 134.63 55.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.077 -1.015 . . . . 0.0 108.552 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -56.24 115.81 2.68 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.69 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 9.8 mt -88.6 -28.15 20.88 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -136.74 141.02 33.66 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.6 Cg_endo -61.87 141.91 91.49 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.863 2.375 . . . . 0.0 111.82 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.6 t80 -133.55 124.41 26.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.84 . . . . 0.0 109.748 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -102.47 110.91 22.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.987 -1.071 . . . . 0.0 108.727 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.41 90.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.5 mt -93.52 -14.17 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -1.142 . . . . 0.0 108.591 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.565 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.66 175.91 1.68 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.565 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.2 Cg_endo -72.2 -33.31 9.48 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.46 2.106 . . . . 0.0 112.038 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.491 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 14.0 t0 -112.14 -10.04 13.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 110.366 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 34.1 m-20 -60.58 116.82 4.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.031 -1.043 . . . . 0.0 109.829 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.661 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -79.44 135.79 36.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.941 -1.1 . . . . 0.0 108.509 179.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.598 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 2.3 p -83.73 136.06 34.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 110.493 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.635 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.4 p90 -139.49 148.32 42.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.867 . . . . 0.0 108.826 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 31' ' ' LYS . 2.7 ttpt -108.77 140.61 41.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.94 -1.1 . . . . 0.0 109.572 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -42.86 152.7 0.1 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.29 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.19 -16.89 6.74 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.4 tp10 -83.12 152.86 25.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.035 -1.273 . . . . 0.0 109.801 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -105.38 145.42 30.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.473 -0.767 . . . . 0.0 109.662 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.571 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 6.6 mtm -137.16 154.17 50.29 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.71 0.767 . . . . 0.0 109.957 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.656 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 1.6 ttpm? -118.18 129.01 55.25 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.63 120.03 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 109.344 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.7 mp -86.65 -37.51 17.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 109.581 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -134.8 136.68 42.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.954 . . . . 0.0 109.653 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.63 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.3 tt0 -110.32 145.07 38.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.536 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 21.3 m-70 -111.81 46.23 1.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.122 -0.986 . . . . 0.0 109.584 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 50.57 32.06 23.26 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 161.19 -42.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.058 -1.26 . . . . 0.0 109.869 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CH2' ' HB3' ' A' ' 59' ' ' PRO . 50.4 m95 -127.2 122.0 32.85 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 108.908 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.648 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -118.82 168.76 10.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.079 -1.013 . . . . 0.0 109.726 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -108.85 121.15 44.48 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -125.7 146.68 49.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 110.983 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 1.7 ptpt -102.44 155.41 18.27 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 4.8 t -98.07 129.88 44.89 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.958 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.82 -12.55 61.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.2 tp -73.27 -62.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 109.714 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.9 -0.28 21.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.407 -0.808 . . . . 0.0 109.349 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 66.93 24.86 9.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -0.894 . . . . 0.0 109.892 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 5.6 mmtt -79.5 140.31 37.32 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 mt-10 -121.81 143.46 49.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.052 -1.03 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.661 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -166.39 -164.72 22.5 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.589 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -96.17 133.04 40.96 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.365 -1.08 . . . . 0.0 109.153 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 58' ' ' ILE . 33.2 pt -125.03 141.47 38.51 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.037 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.607 ' HB3' ' CH2' ' A' ' 44' ' ' TRP . 50.6 Cg_endo -72.24 152.56 55.95 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.927 1.751 . . . . 0.0 110.831 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.447 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 91.1 p -87.03 28.75 0.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.553 -1.342 . . . . 0.0 109.974 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -137.52 -4.09 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.832 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.562 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 5.2 m-85 -101.67 -24.2 14.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.947 -1.096 . . . . 0.0 109.068 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.531 HG13 ' CE ' ' A' ' 35' ' ' MET . 19.7 m . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 109.239 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.255 0.55 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.5 mm -106.2 130.9 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.304 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.76 155.99 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.249 -0.907 . . . . 0.0 109.135 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.2 p -113.89 134.88 55.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 120.932 -1.105 . . . . 0.0 108.735 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -57.83 115.98 3.17 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.527 -0.733 . . . . 0.0 109.951 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.2 mt -89.64 -27.39 20.2 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -137.89 140.98 31.06 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 39.4 Cg_endo -61.98 141.72 90.23 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.629 2.219 . . . . 0.0 111.516 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.638 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 38.3 t80 -133.54 124.67 27.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 109.982 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 5.4 m-20 -103.52 109.95 21.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 108.487 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.31 89.14 0.01 OUTLIER Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.3 mt -86.78 -13.46 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.225 -1.162 . . . . 0.0 108.544 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.558 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.91 176.77 1.37 Allowed Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.0 Cg_endo -73.05 -30.18 11.06 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.395 2.064 . . . . 0.0 111.949 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 24.1 t0 -113.2 -9.54 13.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 110.384 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 2.5 m-20 -59.83 122.19 13.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.928 -1.107 . . . . 0.0 109.83 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.642 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -82.9 136.81 34.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.985 -1.072 . . . . 0.0 108.231 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.598 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 39.5 p -86.41 137.36 32.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.079 -1.013 . . . . 0.0 110.623 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.638 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.2 p90 -140.29 149.23 42.54 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -108.77 141.14 41.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.996 -1.065 . . . . 0.0 109.615 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.73 151.83 0.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.083 -1.01 . . . . 0.0 108.386 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.37 -17.21 6.62 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -82.78 152.55 25.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.035 -1.273 . . . . 0.0 109.841 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.35 144.58 31.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.692 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.589 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -138.09 153.81 49.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.515 0.674 . . . . 0.0 109.666 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 5.2 ttmt -117.75 130.09 56.1 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.4 p -98.26 120.74 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.113 -0.992 . . . . 0.0 109.625 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.31 -48.82 7.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 0.0 109.827 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 24.8 tt0 -119.03 134.58 55.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.069 -1.019 . . . . 0.0 109.926 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.62 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.8 tt0 -110.54 144.53 39.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 29.7 m-70 -116.74 47.14 1.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 109.756 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.38 34.22 8.85 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.2 OUTLIER 161.08 -43.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -1.103 . . . . 0.0 109.872 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.562 ' CH2' ' HB3' ' A' ' 59' ' ' PRO . 39.2 m95 -127.16 120.78 29.63 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.62 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -117.04 168.29 10.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.029 -1.044 . . . . 0.0 109.555 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -109.53 122.83 48.3 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.7 -174.59 2.51 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 110.812 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -135.93 145.43 46.25 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -85.38 123.87 31.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.0 109.656 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.52 -9.24 53.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.09 -1.007 . . . . 0.0 109.429 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.0 tp -88.97 -53.46 4.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 109.717 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.42 7.01 24.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.842 . . . . 0.0 109.412 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 49' ' ' SER . 6.2 mmtp 52.39 26.24 4.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.926 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.12 142.29 32.38 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HG2' ' HB2' ' A' ' 48' ' ' LYS . 6.9 mt-10 -118.65 139.54 51.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.912 -1.118 . . . . 0.0 109.646 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.642 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.79 -162.3 11.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 4.5 m-85 -99.91 133.34 44.42 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.377 -1.073 . . . . 0.0 109.5 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 58' ' ' ILE . 18.0 pt -125.0 139.81 34.46 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.562 ' HB3' ' CH2' ' A' ' 44' ' ' TRP . 54.2 Cg_endo -77.42 162.47 30.74 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.712 1.608 . . . . 0.0 111.248 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.461 ' OG ' ' HZ2' ' A' ' 45' ' ' TRP . 41.9 t -91.77 30.06 1.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.797 -1.189 . . . . 0.0 109.794 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -137.81 -0.15 2.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.99 . . . . 0.0 109.743 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.534 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 8.7 m-85 -107.65 -26.91 10.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 108.932 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.589 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 12.2 m . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.452 -0.78 . . . . 0.0 109.284 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.563 HD11 ' CG ' ' A' ' 36' ' ' LYS . 13.2 mm -105.63 130.94 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.213 -0.929 . . . . 0.0 109.157 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.82 155.96 42.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.299 -0.875 . . . . 0.0 109.332 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 7.6 p -114.26 134.26 57.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.168 -0.957 . . . . 0.0 108.596 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -54.95 113.99 1.56 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.338 -0.851 . . . . 0.0 109.791 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 63' ' ' VAL . 47.5 mt -86.5 -29.58 22.63 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -136.35 139.95 31.21 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD3' ' HD3' ' A' ' 31' ' ' LYS . 38.4 Cg_endo -61.52 141.76 92.76 Favored 'Trans proline' 0 C--O 1.216 -0.584 0 C-N-CA 122.891 2.394 . . . . 0.0 111.82 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.643 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.7 t80 -134.02 125.35 27.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.755 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 22' ' ' ILE . 11.0 t70 -102.73 110.71 22.73 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.986 -1.071 . . . . 0.0 108.673 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.55 90.31 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.7 mt -92.72 -14.32 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -1.143 . . . . 0.0 108.662 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.544 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.89 174.95 2.06 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.544 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.4 Cg_endo -71.08 -32.72 12.78 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.425 2.083 . . . . 0.0 111.806 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -111.88 -9.67 14.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 110.284 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.01 123.27 16.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.905 -1.122 . . . . 0.0 109.796 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.668 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -86.38 135.56 33.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.94 -1.1 . . . . 0.0 108.286 179.207 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.601 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 0.9 OUTLIER -84.35 136.5 33.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 110.422 -178.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.643 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 9.4 p90 -139.74 148.39 42.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.922 . . . . 0.0 108.673 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.84 142.54 39.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.026 . . . . 0.0 109.588 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HD3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -44.43 152.01 0.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.019 -1.05 . . . . 0.0 108.325 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.4 -16.79 7.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -82.61 152.08 26.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.023 -1.281 . . . . 0.0 109.676 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -106.03 146.04 30.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.421 -0.799 . . . . 0.0 110.005 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.528 ' CE ' HG13 ' A' ' 63' ' ' VAL . 8.0 mtm -137.52 153.77 49.96 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.695 0.76 . . . . 0.0 109.838 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -116.41 130.1 56.58 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.598 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -96.44 119.99 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.936 -1.103 . . . . 0.0 110.113 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.44 -24.02 39.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.505 -0.747 . . . . 0.0 109.738 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -158.68 145.58 17.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.091 -1.006 . . . . 0.0 110.041 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.639 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 12.2 tt0 -111.42 143.06 42.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 0.0 109.392 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.571 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 84.6 m-70 -116.63 42.95 2.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.099 -1.001 . . . . 0.0 109.677 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.603 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.83 41.97 21.08 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.603 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 156.37 -48.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -1.079 . . . . 0.0 109.911 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.585 ' CZ2' ' HB3' ' A' ' 59' ' ' PRO . 13.4 m95 -126.65 122.99 36.56 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 109.017 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.65 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.17 166.28 12.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 109.841 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.13 123.45 50.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -122.51 -171.32 2.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.695 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 ttpm? -140.75 150.58 43.58 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -90.11 126.1 35.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.011 -1.055 . . . . 0.0 109.964 -179.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -14.5 63.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.005 . . . . 0.0 109.445 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.462 HD21 ' OE2' ' A' ' 33' ' ' GLU . 63.2 tp -85.06 -53.49 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.429 ' OG1' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -109.28 13.54 24.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.264 -0.898 . . . . 0.0 109.348 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' SER . 18.7 mttp 44.44 25.38 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.352 -0.843 . . . . 0.0 109.798 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.8 mtpm? -79.45 141.17 37.02 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.13 -0.981 . . . . 0.0 108.355 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 12.5 pt-20 -121.72 144.08 48.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.032 -1.043 . . . . 0.0 109.576 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.668 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -166.69 -163.54 20.64 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.62 134.42 40.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.576 -0.955 . . . . 0.0 109.371 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 58' ' ' ILE . 11.9 pt -125.96 142.22 41.75 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.098 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.585 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 49.7 Cg_endo -72.4 153.03 55.6 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.811 1.674 . . . . 0.0 110.638 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 80.7 p -86.25 29.45 0.75 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.546 -1.346 . . . . 0.0 109.969 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -138.27 0.61 2.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 0.0 109.736 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.56 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.5 m-85 -105.35 -25.51 12.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.009 . . . . 0.0 109.479 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.528 HG13 ' CE ' ' A' ' 35' ' ' MET . 18.8 m . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 1.6 m-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.288 0.566 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.6 mm -105.85 129.77 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.52 154.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.36 -0.838 . . . . 0.0 108.898 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 9.4 p -114.16 133.93 58.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 120.987 -1.07 . . . . 0.0 108.837 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -56.61 115.3 2.46 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.471 -0.768 . . . . 0.0 109.682 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.1 mt -88.4 -27.21 21.73 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -137.51 139.96 28.88 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 39.0 Cg_endo -61.87 142.24 92.64 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.652 2.234 . . . . 0.0 111.47 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.637 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 39.7 t80 -134.23 125.9 28.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 0.0 109.989 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' C ' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -103.22 110.67 22.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.061 -1.024 . . . . 0.0 108.751 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.573 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.68 91.92 0.01 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.5 mt -93.32 -13.01 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -1.117 . . . . 0.0 108.716 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.507 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -114.65 174.16 2.5 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 50.8 Cg_endo -71.02 -32.42 13.39 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.388 2.059 . . . . 0.0 112.046 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -112.2 -9.88 13.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.165 -0.96 . . . . 0.0 110.285 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -59.81 126.81 29.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.06 . . . . 0.0 109.857 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.688 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -87.53 137.07 32.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.59 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 3.0 m -87.48 137.98 31.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.637 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 7.7 p90 -141.08 150.14 42.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.85 . . . . 0.0 108.804 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -108.92 138.58 45.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.068 -1.02 . . . . 0.0 109.581 -179.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LYS . 4.1 ptpt -42.16 152.06 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.37 -17.54 7.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -82.1 150.47 27.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.146 -1.208 . . . . 0.0 109.673 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 12.7 mmtt -105.28 145.03 31.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.435 -0.79 . . . . 0.0 109.799 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.488 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 11.7 mtm -137.39 153.67 50.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.519 -0.738 . . . . 0.0 109.743 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.6 tttt -118.38 131.99 56.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.602 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -96.79 121.01 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.986 -1.071 . . . . 0.0 110.366 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.61 -36.49 26.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 109.041 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.588 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -128.01 131.56 49.19 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.539 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -112.94 98.81 7.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.975 . . . . 0.0 109.802 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 84.1 m-70 -75.86 -157.77 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.352 -1.468 . . . . 0.0 108.954 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . -105.49 43.88 1.58 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 2.2 mt-10 163.51 -40.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.141 -1.211 . . . . 0.0 109.115 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.467 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 7.0 m95 -132.39 123.58 27.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.386 -0.821 . . . . 0.0 109.871 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.632 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -115.54 168.58 9.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.396 -0.815 . . . . 0.0 109.807 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.74 121.29 44.96 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -120.17 -170.64 2.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.907 . . . . 0.0 110.631 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -142.04 150.75 41.68 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 53' ' ' LYS . 25.6 t -90.05 125.91 35.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 109.791 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -9.95 57.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 0.0 109.321 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.6 tp -82.76 -57.53 3.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.314 -0.867 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -109.32 2.22 20.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 109.378 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' SER . 19.5 mttt 61.99 26.68 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 109.845 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 7.4 mmtp -81.94 140.01 34.28 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.3 pm0 -121.29 144.16 48.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.996 -1.065 . . . . 0.0 109.834 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.688 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -171.49 166.66 39.71 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -66.92 135.09 53.29 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.362 -1.081 . . . . 0.0 109.763 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.475 HG23 ' CE1' ' A' ' 29' ' ' PHE . 2.6 pt -124.92 146.4 53.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.392 -0.818 . . . . 0.0 109.0 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 48.4 Cg_endo -71.95 146.85 48.2 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.98 1.787 . . . . 0.0 110.615 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 80.6 p -85.09 29.72 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.43 -1.419 . . . . 0.0 110.187 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -137.64 0.43 2.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.119 -0.988 . . . . 0.0 109.737 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.59 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 36.6 m-85 -107.54 -23.84 12.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.092 -1.005 . . . . 0.0 109.467 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 15' ' ' ALA . 29.3 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.431 ' HA ' HD11 ' A' ' 12' ' ' ILE . 27.0 mm -107.7 131.03 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.452 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.94 154.32 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.24 -0.912 . . . . 0.0 109.107 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.754 ' O ' HD21 ' A' ' 16' ' ' LEU . 12.9 p -116.16 135.17 57.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.075 -1.016 . . . . 0.0 109.001 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -58.95 118.74 6.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.645 -0.659 . . . . 0.0 110.843 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.754 HD21 ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -89.87 -26.4 20.51 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . 50.6 m-85 -138.26 141.77 32.97 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 40.2 Cg_endo -62.57 141.72 87.22 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.595 2.196 . . . . 0.0 111.474 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 42.8 t80 -133.84 125.39 28.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 0.0 109.8 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' ILE . 6.4 t70 -103.17 110.01 21.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.106 -0.996 . . . . 0.0 108.666 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.04 89.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.4 mp -88.33 -13.42 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.158 -1.201 . . . . 0.0 108.552 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.56 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -114.6 174.91 2.09 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 51.2 Cg_endo -71.38 -31.39 14.11 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.415 2.077 . . . . 0.0 111.906 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 9.4 t70 -112.54 -9.85 13.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.394 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -59.59 127.27 31.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.941 -1.099 . . . . 0.0 109.806 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.636 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -88.52 136.19 33.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.983 -1.073 . . . . 0.0 108.372 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.595 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 2.7 m -86.85 137.79 32.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.989 . . . . 0.0 110.452 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 10.0 p90 -141.37 150.34 42.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 0.0 108.802 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -108.53 137.62 46.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.052 -1.03 . . . . 0.0 109.303 -179.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.25 153.55 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.416 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.87 -17.52 4.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -82.2 154.46 25.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.042 -1.269 . . . . 0.0 109.703 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -106.32 142.93 35.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.592 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -137.67 153.71 49.79 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.497 0.665 . . . . 0.0 109.325 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.2 ptpt -118.34 131.68 56.31 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.381 -0.824 . . . . 0.0 108.818 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -100.65 120.25 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.337 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.56 -37.44 16.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 109.914 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -132.72 136.76 46.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.065 -1.022 . . . . 0.0 109.89 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.625 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.4 tt0 -111.21 146.41 36.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.556 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 36.0 m-70 -116.64 46.34 1.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.692 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 48.61 32.36 10.66 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 162.36 -42.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -1.199 . . . . 0.0 109.831 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.556 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 12.9 m95 -127.5 120.9 29.34 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.44 -0.788 . . . . 0.0 108.875 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.83 166.94 11.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.018 -1.051 . . . . 0.0 109.822 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HG2' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -109.66 121.16 44.58 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.12 -173.82 2.43 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 110.644 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -137.21 146.41 44.83 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -85.12 123.58 30.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.675 -179.231 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -8.76 49.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.088 -1.007 . . . . 0.0 109.308 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.95 -54.42 4.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 109.898 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -109.55 1.97 20.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' SER . 21.7 mmtm 59.71 26.66 15.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.227 -0.921 . . . . 0.0 109.744 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 5.1 ttmm -83.95 141.73 31.03 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 12.8 pt-20 -118.71 137.99 52.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.996 -1.065 . . . . 0.0 109.822 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.636 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -163.37 163.54 35.63 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -65.69 133.93 52.13 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.351 -1.087 . . . . 0.0 109.98 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.468 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 7.7 pt -123.43 144.05 42.99 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.701 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.6 Cg_endo -71.57 148.19 53.15 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.941 1.761 . . . . 0.0 110.786 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.492 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 89.3 p -86.14 29.5 0.74 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.481 -1.387 . . . . 0.0 110.241 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -136.99 -1.86 2.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.091 -1.006 . . . . 0.0 109.935 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.701 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 4.8 m-85 -106.64 -23.12 12.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 109.207 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.592 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 11.0 m . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.375 -0.828 . . . . 0.0 109.32 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.42 130.3 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.212 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.07 156.75 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.345 -0.847 . . . . 0.0 109.125 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 p -114.49 134.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.845 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -57.23 116.67 3.42 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.531 -0.73 . . . . 0.0 109.907 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.4 mt -89.27 -27.74 20.37 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -137.58 141.79 34.65 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.6 Cg_endo -61.83 141.41 89.98 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.731 2.287 . . . . 0.0 111.571 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 41.2 t80 -134.66 126.25 28.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 110.182 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 22' ' ' ILE . 12.1 t70 -102.0 107.87 19.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.054 -1.029 . . . . 0.0 108.282 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -31.06 90.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.7 mt -79.56 -59.91 2.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.494 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -65.34 173.75 1.73 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.609 -0.682 . . . . 0.0 109.401 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -71.53 -26.59 19.82 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.68 2.253 . . . . 0.0 112.29 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -113.23 -9.87 13.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.532 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.43 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 48.4 m-20 -59.69 121.78 12.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.915 -1.116 . . . . 0.0 109.782 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -83.39 135.78 34.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.965 -1.084 . . . . 0.0 108.405 179.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.608 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 3.2 m -85.23 136.41 33.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 110.362 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.5 p90 -139.77 148.71 42.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.302 -0.874 . . . . 0.0 108.709 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.52 141.21 40.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.963 -1.086 . . . . 0.0 109.557 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.63 152.23 0.16 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.37 -17.15 6.67 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 5.4 tp10 -82.45 152.64 26.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.051 -1.264 . . . . 0.0 109.77 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 7.0 mttm -105.88 145.22 31.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.918 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.522 ' CE ' HG13 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -138.42 154.11 48.88 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.553 -0.717 . . . . 0.0 109.647 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 5.4 tttp -120.62 136.48 54.8 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.58 HG13 ' CB ' ' A' ' 45' ' ' TRP . 3.3 t -98.4 119.14 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 109.797 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 2.3 mm? -88.11 -19.67 26.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.507 -0.746 . . . . 0.0 110.191 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' NE2' ' A' ' 41' ' ' HIS . 12.4 pt-20 -146.91 138.95 24.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.966 -1.084 . . . . 0.0 109.795 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.4 ' OE2' ' N ' ' A' ' 42' ' ' GLY . 2.5 tm-20 -108.65 135.38 49.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.403 -0.81 . . . . 0.0 109.125 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.515 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 44.1 m-70 -122.89 36.0 4.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.162 -0.961 . . . . 0.0 109.241 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 93.78 -108.57 3.69 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 60' ' ' SER . 0.4 OUTLIER -87.48 -7.13 57.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 110.01 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.577 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 10.6 m95 -130.21 143.01 50.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.015 -1.053 . . . . 0.0 109.827 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.58 ' CB ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -140.64 167.25 22.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.184 -0.948 . . . . 0.0 109.777 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.94 119.97 40.98 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.57 -172.13 2.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.515 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.1 tttm -138.93 147.86 42.83 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 53' ' ' LYS . 1.4 t -86.14 124.81 32.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 109.588 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -69.51 -10.97 60.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.963 . . . . 0.0 109.394 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.6 tp -86.17 -54.16 4.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -0.855 . . . . 0.0 109.893 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.3 2.0 22.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 109.306 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 49' ' ' SER . 4.8 mttp 57.53 24.73 10.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 110.319 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.5 ttmm -83.23 145.51 29.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 108.253 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -119.46 142.22 48.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.059 -1.025 . . . . 0.0 109.783 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.632 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -167.55 165.12 38.44 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -68.03 135.13 51.8 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.376 -1.073 . . . . 0.0 109.926 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.43 144.52 46.21 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.625 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.4 Cg_endo -71.95 149.03 52.51 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.028 1.819 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.58 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 46.4 t -86.98 28.76 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.44 -1.413 . . . . 0.0 110.269 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -136.9 -0.98 2.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.956 -1.09 . . . . 0.0 109.818 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.625 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 33.0 m-85 -106.35 -23.81 12.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.003 . . . . 0.0 109.184 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 15' ' ' ALA . 15.6 m . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.298 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 12' ' ' ILE . 29.7 mm -107.82 132.76 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.839 . . . . 0.0 109.33 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.467 HG22 HG22 ' A' ' 63' ' ' VAL . 1.6 m -130.31 155.7 41.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.127 -0.983 . . . . 0.0 109.26 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.2 p -113.25 134.6 55.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.107 -0.996 . . . . 0.0 108.775 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.03 117.52 4.07 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 110.131 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 68.7 mt -90.04 -28.21 19.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -137.71 142.93 38.39 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.8 Cg_endo -61.94 140.69 86.29 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.613 2.208 . . . . 0.0 111.419 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.0 t80 -133.78 125.98 29.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 0.0 109.921 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 22' ' ' ILE . 72.5 m-20 -102.86 107.36 18.18 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.954 -1.091 . . . . 0.0 108.385 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.13 90.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 20' ' ' ASP . 16.4 mt -78.77 -59.67 2.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.482 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -66.25 173.34 2.31 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.614 -0.679 . . . . 0.0 109.222 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 50.4 Cg_endo -70.82 -26.07 23.0 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.723 2.282 . . . . 0.0 112.349 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.7 OUTLIER -113.28 -9.4 13.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -0.927 . . . . 0.0 110.762 -178.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.49 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -60.69 116.48 4.43 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.799 -1.188 . . . . 0.0 109.882 -179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.648 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -77.66 135.63 38.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.981 -1.075 . . . . 0.0 108.408 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.603 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 3.5 m -85.54 137.13 33.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.627 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.8 p90 -139.36 148.04 42.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.289 -0.882 . . . . 0.0 108.718 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.6 141.09 39.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 109.475 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.479 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -43.11 151.21 0.15 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.141 -0.975 . . . . 0.0 108.438 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.36 -16.58 7.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 15' ' ' ALA . 7.5 tm-20 -82.71 151.93 26.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.138 -1.213 . . . . 0.0 109.722 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 37.7 mtpt -105.43 145.89 30.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.522 -0.736 . . . . 0.0 109.866 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.545 ' CE ' HG12 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -140.92 155.55 46.25 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.434 0.635 . . . . 0.0 109.427 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.563 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 4.2 tttm -122.55 139.48 53.86 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.537 HG22 ' CB ' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -104.43 119.7 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.195 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.7 -27.14 18.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 110.09 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -131.45 135.69 47.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.973 -1.079 . . . . 0.0 109.373 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -109.24 136.9 47.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.261 -0.899 . . . . 0.0 109.2 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.596 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 10.6 m-70 -122.47 37.35 4.41 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 108.947 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 -99.57 2.51 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -90.39 -10.39 44.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -1.113 . . . . 0.0 110.372 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.604 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 6.0 m95 -131.33 138.66 49.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.604 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -135.7 165.38 25.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.337 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.598 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 13.2 tttt -109.61 120.99 44.2 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 36' ' ' LYS . . . -115.76 -173.56 2.37 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.389 -0.819 . . . . 0.0 110.697 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.6 ttpt -137.31 146.92 45.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -85.71 125.09 32.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.001 -1.062 . . . . 0.0 109.687 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.91 -10.34 58.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 109.301 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.6 tp -88.4 -53.8 4.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.712 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.69 8.51 26.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 109.42 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' SER . 10.8 mttt 50.2 25.26 1.72 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.991 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.05 143.85 31.25 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -119.02 141.64 48.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 109.453 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.648 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.41 -166.42 21.15 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.63 132.92 41.78 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.416 -1.05 . . . . 0.0 109.419 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 58' ' ' ILE . 17.2 pt -125.14 141.1 37.61 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.625 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 51.9 Cg_endo -74.54 157.54 44.61 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 121.673 1.582 . . . . 0.0 110.942 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.486 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 89.2 p -90.31 29.43 1.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.636 -1.29 . . . . 0.0 109.908 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -140.7 -2.67 1.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.625 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 4.9 m-85 -102.23 -24.39 13.91 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.907 -1.121 . . . . 0.0 110.534 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.545 HG12 ' CE ' ' A' ' 35' ' ' MET . 10.5 m . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 0.0 109.97 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.465 ' HB3' HG22 ' A' ' 37' ' ' VAL . 13.0 t70 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.55 HD11 ' CG ' ' A' ' 36' ' ' LYS . 6.7 mm -105.55 130.6 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.77 155.97 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.055 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 p -113.69 135.12 54.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.081 -1.012 . . . . 0.0 108.532 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -57.16 114.38 2.13 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.509 -0.744 . . . . 0.0 109.81 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -88.48 -28.4 20.86 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -136.74 139.15 28.22 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.4 Cg_endo -61.62 142.28 94.0 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.758 2.305 . . . . 0.0 111.676 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.3 t80 -133.53 124.45 26.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 109.699 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -102.63 111.1 23.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.002 . . . . 0.0 108.521 179.239 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -25.66 88.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' ASP . 34.5 mt -88.99 -13.97 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -1.184 . . . . 0.0 108.636 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.562 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -115.13 175.85 1.73 Allowed Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 51.2 Cg_endo -71.93 -32.22 11.53 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.561 2.174 . . . . 0.0 111.697 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -112.34 -10.43 13.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 110.113 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.474 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -60.04 117.54 5.22 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.983 -1.073 . . . . 0.0 109.738 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.65 ' CB ' ' HA2' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -81.3 137.18 35.8 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.002 -1.061 . . . . 0.0 108.285 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.61 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 6.2 p -84.96 137.34 33.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.975 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.1 p90 -139.37 148.77 43.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 31' ' ' LYS . 2.3 ttmt -108.96 140.26 42.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.977 -1.077 . . . . 0.0 109.697 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' LYS . 1.5 ptmt -43.65 152.66 0.14 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.3 -17.93 5.88 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.0 tm-20 -82.23 153.15 26.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.031 -1.276 . . . . 0.0 109.643 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 144.63 32.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.437 -0.79 . . . . 0.0 109.78 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.488 ' HE2' HG13 ' A' ' 63' ' ' VAL . 1.1 mpp? -137.64 153.29 49.88 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.52 -0.737 . . . . 0.0 109.624 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.55 ' CG ' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -118.99 132.76 56.09 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.645 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -97.15 119.91 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.037 . . . . 0.0 109.794 -179.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mt -88.04 -22.38 24.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.462 -0.774 . . . . 0.0 110.317 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -146.4 138.81 25.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.798 -1.189 . . . . 0.0 109.771 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -108.76 137.0 47.41 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.412 -0.805 . . . . 0.0 109.13 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.552 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 16.0 m-70 -121.56 37.79 4.26 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.23 -0.919 . . . . 0.0 109.058 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.11 -106.08 3.34 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.78 -7.77 55.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -1.074 . . . . 0.0 110.008 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.595 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 29.6 m95 -129.25 139.48 51.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.0 109.777 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.645 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.72 167.34 22.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 109.759 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.561 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 12.2 tttt -110.66 123.51 50.14 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -118.78 -170.88 1.99 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 110.5 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 15.8 ttpt -140.87 150.28 43.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.2 t -88.6 125.51 34.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.058 -1.026 . . . . 0.0 109.783 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -10.75 59.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.184 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.2 tp -85.9 -54.34 4.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 109.847 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.68 8.39 24.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 49' ' ' SER . 53.5 mttp 51.99 26.74 3.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.733 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.0 OUTLIER -84.77 142.86 29.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 4.6 pt-20 -117.98 148.69 41.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.65 ' HA2' ' CB ' ' A' ' 27' ' ' LEU . . . -166.05 -167.4 26.63 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.94 132.91 42.24 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.354 -1.086 . . . . 0.0 109.151 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 58' ' ' ILE . 40.0 pt -124.92 140.99 37.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.547 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 51.5 Cg_endo -75.15 157.08 42.34 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.753 1.635 . . . . 0.0 110.837 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.539 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 48.1 t -88.6 29.85 0.96 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.609 -1.307 . . . . 0.0 109.836 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.492 ' OD1' ' C ' ' A' ' 60' ' ' SER . 6.0 m-20 -137.42 0.92 2.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 0.0 109.652 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.547 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 3.0 m-85 -108.19 -26.25 10.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.018 . . . . 0.0 109.286 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 15' ' ' ALA . 15.3 m . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.4 mm -107.3 131.04 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.554 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -130.56 156.75 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.28 -0.887 . . . . 0.0 108.994 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 p -112.47 134.32 55.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.939 -1.1 . . . . 0.0 109.001 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.35 118.2 4.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.443 -0.785 . . . . 0.0 110.281 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 25.5 mt -90.94 -29.11 17.63 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -137.16 143.05 40.27 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.5 Cg_endo -61.72 140.09 84.19 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.752 2.301 . . . . 0.0 111.552 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.634 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 39.2 t80 -134.05 126.37 30.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.957 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 22' ' ' ILE . 3.0 m-20 -103.22 107.39 18.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.942 -1.099 . . . . 0.0 108.516 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.04 91.42 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' ASP . 13.4 mm -79.29 -58.75 3.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.563 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -67.26 175.4 1.55 Allowed Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.563 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.4 Cg_endo -71.74 -25.47 20.38 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.637 2.225 . . . . 0.0 112.045 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 35.8 m-20 -112.65 -8.33 13.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.33 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.49 121.05 11.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.026 -1.046 . . . . 0.0 109.754 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.667 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -85.5 134.64 34.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.921 -1.112 . . . . 0.0 108.363 179.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.6 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 1.7 p -84.27 136.93 33.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.955 . . . . 0.0 110.635 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.634 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.6 p90 -139.01 147.34 42.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 11.6 mtpp -107.25 140.98 39.29 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.081 -1.012 . . . . 0.0 109.499 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -42.6 151.47 0.12 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.153 -0.967 . . . . 0.0 108.397 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.97 -16.03 7.59 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.9 tp10 -83.33 151.63 25.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.032 -1.275 . . . . 0.0 109.542 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 4.1 mttt -105.77 146.49 29.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.425 -0.797 . . . . 0.0 110.166 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.581 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 3.1 mtm -138.2 155.35 48.76 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.663 0.744 . . . . 0.0 109.557 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -123.0 138.86 54.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.419 HG22 ' CB ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -105.0 119.07 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 109.288 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.62 -26.91 16.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.998 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -132.0 135.82 46.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.002 -1.062 . . . . 0.0 109.294 -179.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.88 134.78 51.09 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.176 -0.952 . . . . 0.0 109.251 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.605 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 56.5 m-70 -120.61 34.85 5.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.309 -0.869 . . . . 0.0 109.009 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 -108.33 3.66 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' CD1' ' A' ' 44' ' ' TRP . 75.3 tt0 -85.15 -7.53 59.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -1.136 . . . . 0.0 109.987 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.611 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 21.4 m95 -132.28 140.13 48.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.948 -1.095 . . . . 0.0 110.315 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.611 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -136.54 166.53 23.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.463 -0.773 . . . . 0.0 109.186 179.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -108.73 117.36 33.97 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -112.03 -175.08 2.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.363 -0.836 . . . . 0.0 110.47 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 32.2 ttpt -139.13 148.17 42.88 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.9 t -88.89 124.94 34.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 0.0 109.672 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.499 ' CD1' ' HB2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -69.2 -11.77 61.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.058 -1.026 . . . . 0.0 109.281 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 tp -87.43 -53.57 4.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 0.0 109.769 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.538 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 1.8 t -108.99 14.63 23.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.355 -0.841 . . . . 0.0 109.351 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER 42.43 25.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HB3' HD22 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -80.99 142.67 33.19 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.033 -1.042 . . . . 0.0 108.416 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 18.9 tt0 -121.44 141.09 51.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.092 -1.005 . . . . 0.0 109.6 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.667 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -168.65 166.94 39.98 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -67.76 134.41 50.97 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.431 -1.041 . . . . 0.0 109.913 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.495 HD12 ' CB ' ' A' ' 47' ' ' ALA . 10.1 pt -124.64 142.28 40.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.678 ' CG ' ' CD1' ' A' ' 62' ' ' TYR . 50.1 Cg_endo -72.02 151.26 55.78 Favored 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 121.7 1.6 . . . . 0.0 110.918 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.503 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 98.9 p -87.67 28.09 1.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.55 -1.344 . . . . 0.0 109.983 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -140.27 -4.23 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.086 -1.009 . . . . 0.0 110.032 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.678 ' CD1' ' CG ' ' A' ' 59' ' ' PRO . 7.6 m-85 -98.7 -23.36 15.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.058 -1.026 . . . . 0.0 110.388 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.51 HG13 ' CE ' ' A' ' 35' ' ' MET . 17.5 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.179 . . . . 0.0 109.737 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.8 mm -105.37 131.13 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.253 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 63' ' ' VAL . 1.4 m -131.8 158.04 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.344 -0.848 . . . . 0.0 109.469 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -114.04 136.36 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.137 -0.977 . . . . 0.0 109.007 178.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 31' ' ' LYS . . . -57.39 117.13 3.81 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 109.631 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.462 HD13 ' C ' ' A' ' 63' ' ' VAL . 26.0 mt -90.39 -28.49 18.64 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -136.52 139.41 29.37 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 37.4 Cg_endo -59.73 141.25 96.58 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.925 2.416 . . . . 0.0 111.888 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.577 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 29.7 t80 -131.79 122.82 26.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.0 109.384 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 2.4 m-20 -102.57 110.92 23.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.116 -0.99 . . . . 0.0 108.858 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.97 89.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.3 mt -93.42 -14.98 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -1.131 . . . . 0.0 108.482 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.478 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -112.82 174.15 2.47 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 51.0 Cg_endo -70.65 -34.34 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.402 2.068 . . . . 0.0 112.022 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -111.41 -9.61 14.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.118 -0.989 . . . . 0.0 110.361 -179.43 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -60.29 120.62 10.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.975 -1.078 . . . . 0.0 109.772 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.641 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -84.54 135.64 34.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.999 -1.063 . . . . 0.0 108.336 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.6 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -84.3 136.51 33.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.584 -178.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 19' ' ' TYR . 13.9 p90 -140.29 149.1 42.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 108.754 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.535 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -107.68 136.78 46.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.909 -1.119 . . . . 0.0 109.392 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -38.87 154.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 72.5 -15.76 1.99 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -80.17 156.42 26.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.825 -1.397 . . . . 0.0 108.926 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -107.08 144.37 33.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 110.355 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.544 ' CE ' HG12 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -140.48 154.79 46.73 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.444 0.64 . . . . 0.0 109.298 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -122.24 139.86 53.28 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.632 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 1.3 t -99.87 119.22 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.015 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.23 -21.27 22.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.409 -0.807 . . . . 0.0 110.073 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 48.2 tt0 -144.51 138.12 27.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.932 -1.105 . . . . 0.0 109.787 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.37 133.27 52.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.329 -0.857 . . . . 0.0 109.0 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 77.9 m-70 -121.6 34.15 5.28 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.216 -0.928 . . . . 0.0 109.361 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.48 -110.53 4.04 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.36 -7.49 58.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -1.137 . . . . 0.0 109.892 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.572 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 m95 -130.65 142.55 50.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.985 -1.072 . . . . 0.0 109.908 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.632 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.85 168.16 20.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.287 -0.883 . . . . 0.0 109.766 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.578 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 7.9 tttm -110.88 117.38 33.23 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.03 -172.03 2.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 110.354 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 6.8 ttpm? -139.88 149.0 42.86 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -88.44 125.97 35.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.084 -1.01 . . . . 0.0 109.508 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.5 mt -69.98 -13.49 62.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.017 -1.052 . . . . 0.0 109.288 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.8 tp -82.92 -55.62 4.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.798 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.464 ' OG1' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.96 10.61 26.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.386 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.5 OUTLIER 49.72 25.43 1.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.88 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 13.4 mttp -79.47 142.54 35.76 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 6.5 pt-20 -120.99 143.4 49.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.074 -1.016 . . . . 0.0 109.391 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.641 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -165.63 -164.74 21.7 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.515 ' HB3' ' CZ3' ' A' ' 44' ' ' TRP . 1.7 m-85 -96.63 133.54 41.01 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.394 -1.062 . . . . 0.0 109.46 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.511 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 20.5 pt -125.64 140.31 36.18 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.588 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 54.5 Cg_endo -77.1 161.23 32.75 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 121.663 1.576 . . . . 0.0 110.963 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.593 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 41.8 t -90.88 29.33 1.37 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.677 -1.265 . . . . 0.0 109.872 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.411 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 23.5 t-20 -140.65 -0.1 1.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.588 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 9.8 m-85 -102.12 -26.86 13.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.057 -1.027 . . . . 0.0 110.151 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.544 HG12 ' CE ' ' A' ' 35' ' ' MET . 5.1 m . . . . . 0 N--CA 1.492 1.666 0 O-C-N 120.88 -1.137 . . . . 0.0 110.075 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.464 HD13 ' HB2' ' A' ' 36' ' ' LYS . 1.8 tp -109.83 134.1 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.412 ' HB ' HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -129.4 155.65 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.257 -0.902 . . . . 0.0 109.049 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 9.1 p -113.26 134.28 56.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.087 -1.008 . . . . 0.0 108.958 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -56.14 117.44 3.76 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.465 -0.772 . . . . 0.0 110.107 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 32.3 mt -89.1 -29.22 19.55 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -136.58 142.49 39.4 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.1 Cg_endo -60.73 140.03 88.61 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.747 2.298 . . . . 0.0 111.675 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 28.6 t80 -131.76 123.21 27.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 109.371 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -103.23 110.09 21.93 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 108.832 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.58 89.24 0.01 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.6 mt -90.75 -14.99 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.329 -1.101 . . . . 0.0 108.424 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.508 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.4 176.21 1.57 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.508 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -71.77 -32.94 10.91 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.422 2.081 . . . . 0.0 111.897 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 4.8 m-20 -111.46 -8.82 14.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.163 -0.961 . . . . 0.0 110.216 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.463 ' OD1' ' CZ ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -60.69 122.85 15.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.001 -1.062 . . . . 0.0 109.636 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.66 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -87.45 134.8 33.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.962 -1.086 . . . . 0.0 108.498 179.318 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.595 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -84.21 136.38 33.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.496 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.6 p90 -139.37 148.1 42.4 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -107.9 137.16 46.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.081 . . . . 0.0 109.437 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 30' ' ' LYS . 9.6 ptmm? -38.81 151.66 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.41 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.11 -16.77 8.38 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.143 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 1.8 mp0 -83.32 153.39 24.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.948 -1.325 . . . . 0.0 109.653 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 8.8 mtpt -105.43 146.33 29.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.413 -0.804 . . . . 0.0 109.958 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.499 ' CE ' HG13 ' A' ' 63' ' ' VAL . 4.9 mtm -138.68 155.18 48.49 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.699 0.761 . . . . 0.0 109.573 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.4 tppt? -123.05 138.75 54.6 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.438 HG22 ' CB ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -104.73 119.25 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.405 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -26.08 17.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.882 . . . . 0.0 109.989 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 68.5 mt-10 -133.04 135.51 45.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 109.155 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.438 ' OE2' ' N ' ' A' ' 42' ' ' GLY . 2.5 tm-20 -109.47 134.8 51.43 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.235 -0.916 . . . . 0.0 109.335 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.6 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 22.3 m-70 -119.95 36.02 4.66 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.252 -0.905 . . . . 0.0 108.86 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 92.63 -106.46 3.41 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -86.59 -8.32 57.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -1.165 . . . . 0.0 110.121 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.607 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 12.2 m95 -131.98 138.74 48.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.919 -1.113 . . . . 0.0 110.375 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.607 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -136.09 167.18 21.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.358 -0.839 . . . . 0.0 109.326 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.04 117.51 34.38 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -113.7 -173.1 2.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.379 -0.826 . . . . 0.0 110.677 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.5 ttmt -139.88 147.49 40.7 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.666 ' O ' ' N ' ' A' ' 53' ' ' LYS . 29.3 t -88.48 129.47 35.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 109.925 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.37 -27.47 66.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.052 . . . . 0.0 109.79 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.13 -41.82 16.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.181 -0.949 . . . . 0.0 109.947 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' ' 49' ' ' SER . 1.3 p -98.94 -18.35 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.354 -0.841 . . . . 0.0 109.371 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 49' ' ' SER . 14.0 mttt 60.65 11.21 2.98 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.334 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -80.21 150.76 29.99 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 8.6 pt-20 -120.53 143.52 48.53 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.9 -1.125 . . . . 0.0 109.695 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.66 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -167.15 165.6 38.68 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.01 134.88 51.43 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.441 -1.035 . . . . 0.0 110.109 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.531 HD12 ' CB ' ' A' ' 47' ' ' ALA . 6.9 pt -125.52 140.85 37.39 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.691 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 52.9 Cg_endo -74.42 157.04 45.52 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 121.62 1.547 . . . . 0.0 111.055 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -89.56 27.98 1.38 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.706 -1.246 . . . . 0.0 109.824 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -140.71 -1.82 1.41 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.841 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.691 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.4 m-85 -102.05 -25.96 13.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.118 -0.989 . . . . 0.0 110.276 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.499 HG13 ' CE ' ' A' ' 35' ' ' MET . 11.5 m . . . . . 0 N--CA 1.492 1.65 0 O-C-N 120.814 -1.179 . . . . 0.0 109.972 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 3.0 tp -109.4 132.75 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.453 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.38 154.32 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 108.861 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.3 p -113.01 134.02 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.267 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.47 119.36 6.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.603 -0.686 . . . . 0.0 110.303 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.455 HD13 ' C ' ' A' ' 63' ' ' VAL . 81.1 mt -91.51 -28.1 17.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -137.25 143.48 41.8 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.3 Cg_endo -61.47 140.03 85.3 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.62 2.213 . . . . 0.0 111.331 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.611 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 33.5 t80 -133.67 125.96 29.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.856 . . . . 0.0 110.051 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -103.25 106.76 17.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.016 -1.053 . . . . 0.0 108.371 178.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -29.63 92.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.0 mt -78.85 -59.01 3.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.354 -1.086 . . . . 0.0 108.099 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.566 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 3.6 m-70 -67.33 172.49 3.67 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 47.3 Cg_endo -68.83 -23.96 34.73 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.555 2.17 . . . . 0.0 112.108 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.544 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.1 m-20 -112.86 -7.48 13.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.151 -0.968 . . . . 0.0 110.284 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.509 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 13.3 m-20 -60.95 118.43 6.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.041 -1.037 . . . . 0.0 109.925 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.653 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -83.8 134.46 34.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.933 -1.104 . . . . 0.0 108.49 179.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.606 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 2.3 m -84.38 137.12 33.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.64 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' A' ' 19' ' ' TYR . 8.7 p90 -139.56 148.28 42.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.281 -0.887 . . . . 0.0 108.635 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 31' ' ' LYS . 4.6 ttpm? -107.28 139.73 41.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.965 -1.084 . . . . 0.0 109.479 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.66 152.3 0.07 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.73 -16.27 6.86 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -82.84 152.66 25.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.084 -1.244 . . . . 0.0 109.713 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 16.3 mttp -105.95 145.96 30.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.424 -0.798 . . . . 0.0 110.223 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.53 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 4.5 mtm -139.72 155.78 47.16 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.591 0.71 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.4 ttmm -120.67 137.61 54.37 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.411 ' CG2' ' CB ' ' A' ' 45' ' ' TRP . 1.6 p -104.35 120.12 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.707 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 1.6 mm? -88.52 -37.81 15.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.324 -0.86 . . . . 0.0 109.767 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 6.6 tp10 -128.43 136.25 50.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.104 -0.997 . . . . 0.0 109.732 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.601 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -110.83 142.4 42.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.603 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 68.2 m-70 -114.96 44.27 1.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.037 -1.039 . . . . 0.0 109.743 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 43' ' ' GLU . . . 52.81 27.52 28.76 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.401 -0.904 . . . . 0.0 110.881 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 42' ' ' GLY . 8.2 pt-20 164.04 -40.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.999 -1.295 . . . . 0.0 109.597 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.603 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 39.4 m95 -126.54 121.56 32.63 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.659 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -118.1 166.42 12.58 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.976 -1.077 . . . . 0.0 109.754 -179.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -109.45 122.61 47.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -118.69 -174.14 2.62 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 110.944 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 19.3 ttmt -139.09 148.68 43.62 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.3 t -90.45 124.92 35.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.971 -1.081 . . . . 0.0 109.852 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.48 -11.62 60.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.097 -1.002 . . . . 0.0 109.358 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.5 tp -83.87 -55.93 3.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 109.693 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.77 10.0 26.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.298 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' SER . 9.9 mtmt 49.93 25.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.366 -0.834 . . . . 0.0 109.834 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' HG2' ' CD2' ' A' ' 27' ' ' LEU . 2.9 tttt -80.35 142.52 34.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.089 -1.007 . . . . 0.0 108.317 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 13.2 pt-20 -122.05 142.95 49.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.042 -1.036 . . . . 0.0 109.637 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.653 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -164.14 -163.07 16.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 3.1 m-85 -97.79 133.62 42.05 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.466 -1.02 . . . . 0.0 109.491 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.524 HD12 ' CB ' ' A' ' 47' ' ' ALA . 12.7 pt -125.53 135.95 27.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.606 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 53.1 Cg_endo -75.35 164.21 33.14 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 121.637 1.558 . . . . 0.0 110.905 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.415 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 92.4 p -92.69 28.62 1.98 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.812 -1.18 . . . . 0.0 109.713 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -140.94 -1.71 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 109.915 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.606 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 9.4 m-85 -100.81 -27.89 13.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.044 -1.035 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.472 HG13 ' CE ' ' A' ' 35' ' ' MET . 11.6 m . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.029 -1.044 . . . . 0.0 109.534 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.8 mm -109.58 133.73 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.57 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.35 157.54 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.235 -0.916 . . . . 0.0 109.19 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 7.6 p -115.56 134.06 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.08 -1.013 . . . . 0.0 109.032 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -53.15 114.22 1.39 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.335 -0.853 . . . . 0.0 109.939 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.543 ' O ' ' CD ' ' A' ' 31' ' ' LYS . 27.8 mt -84.76 -30.0 25.03 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -137.49 140.88 31.67 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.586 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 37.6 Cg_endo -59.44 140.16 92.93 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.748 2.299 . . . . 0.0 111.649 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 33.3 t80 -134.27 125.76 28.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.836 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -102.13 107.94 19.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.892 -1.13 . . . . 0.0 108.571 179.003 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.11 89.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' ASP . 76.4 mt -80.94 -57.6 4.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.572 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 8.5 m80 -68.48 171.14 6.43 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 47.5 Cg_endo -68.18 -27.25 35.43 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.655 2.237 . . . . 0.0 112.246 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.575 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 23.6 t0 -111.8 -7.91 14.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.128 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -60.78 123.69 18.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.117 -0.989 . . . . 0.0 109.827 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.639 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -90.16 134.45 34.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.979 -1.075 . . . . 0.0 108.514 179.308 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.596 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -83.31 136.53 34.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.897 . . . . 0.0 110.605 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.3 p90 -138.86 147.07 41.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.339 -0.851 . . . . 0.0 108.721 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -108.87 146.81 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.831 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -46.51 151.39 0.56 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.918 -1.114 . . . . 0.0 108.545 179.231 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.3 -15.0 7.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -82.68 149.99 27.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.267 . . . . 0.0 109.683 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -105.98 144.94 31.99 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.711 0.767 . . . . 0.0 110.177 -179.307 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.574 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 4.7 mtm -137.79 155.23 49.26 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.588 0.708 . . . . 0.0 109.544 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 10.7 ttpp -118.85 136.06 54.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.32 118.77 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.21 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.56 -33.76 17.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -133.52 136.43 45.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 109.525 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.581 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.7 tt0 -111.05 144.92 39.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 44' ' ' TRP . 4.5 m-70 -115.95 43.88 2.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 0.0 109.765 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.86 35.48 12.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 160.56 -45.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -1.161 . . . . 0.0 109.759 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.579 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 11.9 m95 -127.56 122.44 33.24 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.369 -0.832 . . . . 0.0 109.087 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.682 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.37 166.03 12.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.14 -0.975 . . . . 0.0 109.605 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 123.22 49.17 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -120.23 -173.63 2.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 110.809 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 ttpt -138.8 148.93 44.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 53' ' ' LYS . 5.2 t -90.07 125.52 35.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.944 -1.097 . . . . 0.0 109.903 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.493 HD11 ' HD3' ' A' ' 34' ' ' LYS . 35.6 mt -69.5 -13.41 62.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 109.43 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.9 tp -82.64 -55.35 4.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.732 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.22 9.46 25.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 109.286 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.8 OUTLIER 50.67 25.93 2.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.848 . . . . 0.0 109.864 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -80.54 142.38 34.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.177 -0.952 . . . . 0.0 108.435 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -121.98 142.14 50.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.094 -1.004 . . . . 0.0 109.54 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.639 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.65 -164.66 18.17 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -97.42 134.14 41.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.523 -0.987 . . . . 0.0 109.291 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 58' ' ' ILE . 13.7 pt -126.49 137.8 31.1 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.562 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 52.2 Cg_endo -75.04 163.71 34.71 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 121.683 1.589 . . . . 0.0 110.675 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.7 p -92.21 29.26 1.69 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.72 -1.238 . . . . 0.0 109.906 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -138.92 -0.74 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.887 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.551 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.2 m-85 -106.16 -28.23 10.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 109.259 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.542 HG13 ' CE ' ' A' ' 35' ' ' MET . 22.0 m . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.317 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 36' ' ' LYS . 25.0 mm -105.86 129.56 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.972 . . . . 0.0 109.348 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.52 154.85 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.396 -0.815 . . . . 0.0 108.978 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 14.3 p -111.55 133.75 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.861 -1.149 . . . . 0.0 108.939 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.05 117.09 3.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.436 -0.79 . . . . 0.0 110.164 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.614 ' O ' ' CD ' ' A' ' 31' ' ' LYS . 14.5 mt -89.37 -28.08 20.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.8 140.17 28.79 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 37.6 Cg_endo -59.9 141.28 96.27 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.86 2.373 . . . . 0.0 111.49 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 34.5 t80 -132.83 123.92 27.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.727 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 22' ' ' ILE . 9.3 t70 -102.71 109.51 21.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.087 -1.008 . . . . 0.0 108.6 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.563 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.98 89.02 0.01 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.592 ' N ' ' O ' ' A' ' 20' ' ' ASP . 17.4 mt -88.36 -14.59 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.185 . . . . 0.0 108.318 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.551 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -114.13 176.67 1.4 Allowed Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.551 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.1 Cg_endo -72.43 -31.94 10.67 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.489 2.126 . . . . 0.0 112.085 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 17.7 m-20 -112.05 -9.59 13.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.354 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.41 122.24 14.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.918 -1.114 . . . . 0.0 109.778 -179.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.689 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -85.43 135.13 33.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.916 -1.115 . . . . 0.0 108.404 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.607 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 3.2 m -84.56 136.82 33.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.565 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 10.4 p90 -138.79 147.22 42.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.264 -0.898 . . . . 0.0 108.744 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 15.1 pttt -108.28 146.7 32.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.721 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.614 ' CD ' ' O ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -46.23 152.46 0.41 Allowed 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.868 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.68 -12.67 10.07 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.2 tm-20 -83.8 148.09 27.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.124 -1.221 . . . . 0.0 110.13 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -104.78 147.21 27.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -0.759 . . . . 0.0 109.714 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.497 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 8.7 mtm -139.42 155.28 47.72 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.667 0.746 . . . . 0.0 109.931 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -123.59 140.71 52.72 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.572 HG13 ' CB ' ' A' ' 45' ' ' TRP . 2.7 t -102.17 119.58 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.071 -1.018 . . . . 0.0 110.023 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.77 -21.64 23.7 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 0.0 109.811 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 4.3 mt-10 -148.33 139.05 22.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.97 -1.082 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.551 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 11.5 tt0 -109.74 135.44 50.66 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.299 -0.876 . . . . 0.0 109.166 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 63.3 m-70 -117.82 36.06 4.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.326 -0.859 . . . . 0.0 108.87 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.49 -110.14 3.95 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -84.74 -6.81 59.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -1.18 . . . . 0.0 109.865 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.572 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 23.4 m95 -130.89 143.16 50.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.058 -1.026 . . . . 0.0 109.97 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.586 ' CZ2' ' HB2' ' A' ' 60' ' ' SER . 0.0 OUTLIER -141.31 168.28 20.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.338 -0.851 . . . . 0.0 109.613 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.581 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 8.7 tttt -110.2 116.36 31.36 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.15 -172.31 2.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.407 -0.808 . . . . 0.0 110.307 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.4 ttpm? -142.33 151.27 41.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 109.305 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -92.23 126.5 37.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.054 -1.029 . . . . 0.0 109.695 -179.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.403 ' O ' ' NZ ' ' A' ' 53' ' ' LYS . 1.3 mt -70.19 -13.98 62.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.024 -1.048 . . . . 0.0 109.33 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 17.2 tp -75.96 -59.68 2.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -108.69 3.52 22.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 0.0 109.423 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 61.23 25.66 15.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.1 tptp -78.51 141.51 38.13 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.153 -0.967 . . . . 0.0 108.521 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 7.2 pt-20 -123.46 146.1 48.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.046 -1.034 . . . . 0.0 109.604 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.689 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -169.75 -164.87 26.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -95.77 134.16 39.04 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.446 -1.031 . . . . 0.0 109.53 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.46 HD12 ' HB1' ' A' ' 47' ' ' ALA . 11.2 pt -126.0 141.67 40.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.618 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 54.6 Cg_endo -75.71 156.97 39.97 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.839 1.693 . . . . 0.0 110.921 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 46.0 t -88.67 28.13 1.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.726 -1.234 . . . . 0.0 110.019 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -139.82 -1.96 1.57 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.138 -0.976 . . . . 0.0 109.819 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.618 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 5.9 m-85 -101.74 -25.38 13.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.385 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.453 HG12 ' HE2' ' A' ' 35' ' ' MET . 24.7 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.858 -1.151 . . . . 0.0 110.069 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.7 OUTLIER -104.9 128.65 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.501 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.44 155.51 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.3 p -112.84 133.77 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.943 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -58.48 118.66 5.84 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.476 -0.765 . . . . 0.0 110.385 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.448 HD13 ' C ' ' A' ' 63' ' ' VAL . 53.5 mt -92.02 -27.1 18.03 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -137.55 141.39 33.28 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.9 Cg_endo -62.2 141.43 88.11 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.648 2.232 . . . . 0.0 111.56 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 33.5 t80 -132.84 124.18 27.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.962 . . . . 0.0 109.671 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -103.37 110.32 22.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.069 -1.02 . . . . 0.0 108.796 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.96 89.52 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 20' ' ' ASP . 4.6 mt -90.1 -13.73 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -1.11 . . . . 0.0 108.359 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.533 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -114.01 174.56 2.27 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.533 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 50.9 Cg_endo -70.78 -32.48 14.26 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.409 2.073 . . . . 0.0 111.916 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.559 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 16.2 m-20 -112.02 -9.64 13.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 110.4 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -59.83 121.62 12.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.891 -1.131 . . . . 0.0 109.745 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.637 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -84.33 136.83 33.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 108.353 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.597 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 2.9 m -86.99 137.5 32.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 0.0 110.629 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.0 p90 -140.28 149.57 42.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -108.85 142.5 39.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 109.731 -179.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' LYS . 1.2 pttt -44.79 151.53 0.29 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.112 -0.993 . . . . 0.0 108.423 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.52 -16.43 7.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.575 ' CG ' ' CD2' ' A' ' 51' ' ' LEU . 10.0 tp10 -82.8 151.59 26.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.066 -1.255 . . . . 0.0 109.915 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 3.9 mttt -105.33 146.36 29.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.454 -0.779 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.542 ' SD ' ' CB ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -138.3 153.8 49.02 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.725 0.774 . . . . 0.0 110.132 -179.423 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HG2' HG13 ' A' ' 12' ' ' ILE . 2.8 mtpm? -122.62 138.3 54.63 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 t -88.32 155.38 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 118.48 -1.288 . . . . 0.0 109.292 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.529 ' O ' ' CG ' ' A' ' 39' ' ' GLU . 4.1 mt -122.61 -13.35 7.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.313 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.542 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 37.3 mt-10 -159.03 138.94 11.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.381 -0.824 . . . . 0.0 109.054 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 13.0 tt0 -106.18 132.8 51.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 41.6 m-70 -122.2 34.2 5.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.453 -0.779 . . . . 0.0 109.289 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.8 -113.53 4.61 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -83.26 -6.8 59.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -1.165 . . . . 0.0 109.601 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.587 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 32.1 m95 -130.35 148.08 52.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.431 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.587 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -146.69 172.01 14.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 110.072 179.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.609 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -111.7 128.41 56.07 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . . . -121.64 -173.29 2.6 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.128 -0.982 . . . . 0.0 110.509 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 26.7 ttpt -136.93 146.69 45.75 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -86.5 124.54 32.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 109.49 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.3 -10.07 52.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.057 -1.027 . . . . 0.0 109.404 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.575 ' CD2' ' CG ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -88.1 -53.16 4.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 109.991 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.505 HG23 ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.11 8.84 24.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.922 . . . . 0.0 109.584 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 50.73 26.64 2.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.302 -0.874 . . . . 0.0 109.752 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 11.3 tptt -84.4 142.06 30.4 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 23.4 pt-20 -117.48 139.53 50.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.979 -1.076 . . . . 0.0 109.638 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.637 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -156.58 -166.6 16.56 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -97.21 132.69 42.73 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 109.541 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.457 HD12 ' HB1' ' A' ' 47' ' ' ALA . 11.5 pt -124.78 141.47 38.2 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.595 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 55.1 Cg_endo -78.71 161.48 27.6 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.66 1.573 . . . . 0.0 111.199 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 32.9 t -90.86 30.01 1.26 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.837 -1.164 . . . . 0.0 109.701 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 60' ' ' SER . 6.8 m120 -141.19 -0.12 1.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.813 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.595 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 7.7 m-85 -102.72 -26.74 13.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 110.122 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.538 HG12 ' CE ' ' A' ' 35' ' ' MET . 6.4 m . . . . . 0 N--CA 1.491 1.618 0 O-C-N 120.965 -1.084 . . . . 0.0 110.003 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.303 0.573 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.21 114.83 3.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -102.93 151.02 22.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -1.127 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -105.97 129.72 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -129.26 154.58 40.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 108.89 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 66' ' ' LEU . 2.9 p -113.4 133.93 57.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.97 -1.081 . . . . 0.0 108.83 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -56.32 115.86 2.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.514 -0.741 . . . . 0.0 109.789 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 50.4 mt -88.37 -27.78 21.39 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -136.72 140.32 31.64 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.2 Cg_endo -60.97 141.47 94.6 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.762 2.308 . . . . 0.0 111.879 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.9 t80 -133.2 124.14 26.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.53 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -102.27 111.33 23.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.97 -1.081 . . . . 0.0 108.958 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -28.15 89.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.7 mt -94.63 -14.14 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.308 -1.113 . . . . 0.0 108.483 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.563 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.5 175.1 1.98 Allowed Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.563 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.1 Cg_endo -71.76 -34.34 9.05 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.511 2.14 . . . . 0.0 112.052 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 2.5 m-20 -112.09 -10.73 13.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 0.0 110.574 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.465 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 46.1 m-20 -60.34 116.22 4.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.915 -1.115 . . . . 0.0 109.752 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.634 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -78.67 134.96 37.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.907 -1.121 . . . . 0.0 108.45 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.609 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 1.6 p -83.54 136.6 34.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.354 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.8 p90 -139.41 147.94 42.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.288 -0.882 . . . . 0.0 108.739 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -108.51 140.02 42.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.072 -1.018 . . . . 0.0 109.497 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 30' ' ' LYS . 15.4 ptmt -42.21 152.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.23 -0.988 . . . . 0.0 108.36 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.55 -16.65 7.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -82.66 152.03 26.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.097 -1.237 . . . . 0.0 109.743 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 12.8 mtpt -105.79 145.99 30.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.435 -0.791 . . . . 0.0 109.962 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.511 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 5.9 mtm -138.2 154.21 49.13 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.718 0.77 . . . . 0.0 109.834 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 tttp -121.78 136.44 54.94 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 1.5 t -97.96 120.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.005 . . . . 0.0 110.075 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.516 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 2.2 mm? -86.34 -18.2 32.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 109.923 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -154.24 141.03 19.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.945 -1.097 . . . . 0.0 109.757 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.465 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 6.1 tt0 -108.64 135.18 50.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.145 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 74.2 m-70 -121.0 35.01 5.01 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.202 -0.936 . . . . 0.0 109.218 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.85 -110.0 3.94 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -85.76 -7.09 58.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -1.139 . . . . 0.0 109.857 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.56 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 27.3 m95 -129.99 141.86 50.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.071 -1.018 . . . . 0.0 109.786 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.579 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.98 167.68 21.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 109.569 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.573 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 13.1 tttp -110.8 118.84 37.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.38 -172.77 2.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 110.473 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 5.4 ttmt -140.83 150.24 43.03 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 53' ' ' LYS . 4.4 t -90.87 125.94 35.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.127 -0.983 . . . . 0.0 109.818 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -12.18 61.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.361 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.09 -55.29 4.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.694 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.71 8.07 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.351 -0.843 . . . . 0.0 109.281 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 49' ' ' SER . 21.4 mtmt 50.93 25.29 2.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.949 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 9.2 tttm -82.07 144.8 30.56 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.128 -0.982 . . . . 0.0 108.386 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 26.9 tt0 -120.84 145.62 47.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.014 -1.054 . . . . 0.0 109.456 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.634 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -164.79 -167.28 25.11 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.556 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.93 134.33 40.41 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.317 -1.108 . . . . 0.0 109.461 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 58' ' ' ILE . 10.9 pt -126.23 142.47 42.82 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.468 -0.77 . . . . 0.0 109.287 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 53.7 Cg_endo -75.62 157.55 40.13 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.854 1.703 . . . . 0.0 110.811 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.55 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 47.9 t -89.6 28.96 1.2 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.593 -1.317 . . . . 0.0 110.19 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -137.2 -0.35 2.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.079 -1.013 . . . . 0.0 109.664 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.519 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.7 m-85 -106.61 -25.72 11.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.229 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 15' ' ' ALA . 19.5 m -123.53 164.68 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -0.869 . . . . 0.0 109.505 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 13' ' ' VAL . . . -160.66 -165.47 1.41 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.088 -1.008 . . . . 0.0 109.752 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 66' ' ' LEU . 70.7 mttt -89.73 129.42 36.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.408 -0.808 . . . . 0.0 109.619 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.506 ' O ' ' CG1' ' A' ' 14' ' ' VAL . 2.7 tp 45.39 -171.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.55 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 66' ' ' LEU . 28.5 t-20 172.12 -87.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.477 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.5 m . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.477 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.06 -140.74 1.59 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.54 146.76 52.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -1.158 . . . . 0.0 109.481 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.407 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 26.4 mm -109.54 132.87 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.524 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.534 ' CG1' ' HB2' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -129.34 155.6 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 108.957 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 12.7 p -112.79 134.46 55.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.306 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.68 118.83 5.67 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.482 -0.761 . . . . 0.0 110.103 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.525 HD12 ' CB ' ' A' ' 64' ' ' ALA . 82.0 mt -91.51 -28.3 17.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -137.02 142.93 40.19 Favored Pre-proline 0 N--CA 1.486 1.352 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.9 Cg_endo -62.13 140.74 85.48 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.785 2.323 . . . . 0.0 111.575 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 34.2 t80 -132.04 123.6 27.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.576 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' ILE . 13.2 t0 -103.31 109.66 21.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.118 -0.989 . . . . 0.0 108.722 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.76 90.53 0.01 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.9 mt -88.44 -13.62 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -1.135 . . . . 0.0 108.403 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.581 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.63 177.99 1.06 Allowed Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.7 Cg_endo -73.59 -30.83 9.38 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.359 2.039 . . . . 0.0 111.955 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -112.59 -9.56 13.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.338 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 39.2 m-20 -60.91 116.29 4.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.952 -1.092 . . . . 0.0 109.899 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.695 ' CB ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -80.17 134.24 36.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 108.373 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.65 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.6 p -83.52 137.46 33.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 110.833 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.5 p90 -139.24 148.55 43.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 108.692 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -108.12 142.7 37.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.855 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.437 ' HE3' ' HD3' ' A' ' 18' ' ' PRO . 2.8 ptpt -44.19 151.82 0.22 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.29 -16.06 8.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.6 tm-20 -83.22 151.33 25.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.238 . . . . 0.0 109.67 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' N ' ' OE2' ' A' ' 33' ' ' GLU . 12.7 mttt -104.97 146.05 29.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.44 -0.787 . . . . 0.0 109.83 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.53 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 5.7 mtm -137.73 154.69 49.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.609 0.719 . . . . 0.0 109.662 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 20.2 tttt -118.36 133.73 55.64 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.533 HG22 ' CB ' ' A' ' 45' ' ' TRP . 1.4 p -103.78 119.08 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 109.433 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.53 -40.64 13.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.417 -0.802 . . . . 0.0 109.807 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 7.0 mp0 -129.81 137.08 50.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 109.687 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 4.9 mt-10 -111.11 146.4 36.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 7.8 m-70 -116.86 42.07 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.534 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.89 37.99 16.11 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 160.93 -47.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -1.12 . . . . 0.0 109.412 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.524 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 10.2 m95 -128.87 119.66 24.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.488 -0.757 . . . . 0.0 108.959 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.689 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -113.24 167.32 10.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.054 -1.029 . . . . 0.0 109.403 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 2.2 tttp -110.44 116.06 30.74 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.45 -172.29 2.16 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.415 -0.803 . . . . 0.0 110.417 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -144.04 154.44 43.24 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -94.55 126.87 40.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 0.0 110.195 -178.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.72 -11.87 60.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.153 -0.967 . . . . 0.0 109.359 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 tp -83.33 -55.73 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 109.728 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.12 10.04 28.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 48.25 24.63 0.71 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.428 -0.795 . . . . 0.0 110.111 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -81.42 144.0 31.72 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt-20 -120.52 149.1 42.95 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 109.392 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.695 ' HA2' ' CB ' ' A' ' 27' ' ' LEU . . . -169.01 -166.35 27.92 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.91 133.8 41.07 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.382 -1.069 . . . . 0.0 109.345 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 58' ' ' ILE . 17.8 pt -125.87 140.31 36.41 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 108.88 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.61 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 53.4 Cg_endo -75.05 159.15 41.51 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 121.694 1.596 . . . . 0.0 110.706 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.447 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 99.5 p -89.73 28.82 1.25 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.684 -1.26 . . . . 0.0 109.705 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -140.48 -1.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 109.999 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 8.4 m-85 -100.74 -26.6 13.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 0.0 110.07 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.471 HG13 ' CE ' ' A' ' 35' ' ' MET . 14.5 m -113.97 159.47 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.041 -1.037 . . . . 0.0 109.644 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.525 ' CB ' HD12 ' A' ' 16' ' ' LEU . . . -106.23 130.2 54.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.639 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.534 ' HB2' ' CG1' ' A' ' 13' ' ' VAL . 1.5 tmtt? -99.59 75.2 1.92 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.245 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.78 165.02 23.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.623 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -137.46 -163.16 1.39 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.273 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 68' ' ' THR . 5.0 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.514 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.9 85.27 0.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -134.26 154.41 51.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.326 -1.102 . . . . 0.0 109.207 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.465 ' CD1' ' CD ' ' A' ' 36' ' ' LYS . 19.4 mm -106.02 129.96 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.162 -0.961 . . . . 0.0 109.561 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.57 156.31 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 8.1 p -114.04 134.45 56.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.027 -1.046 . . . . 0.0 108.807 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -55.85 115.36 2.34 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.545 -0.722 . . . . 0.0 109.849 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.485 HD12 ' CB ' ' A' ' 64' ' ' ALA . 36.2 mt -88.02 -28.99 21.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -136.62 139.95 30.76 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.0 Cg_endo -60.76 141.39 94.78 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.857 2.372 . . . . 0.0 111.642 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.3 t80 -133.78 124.92 27.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 109.906 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.564 ' O ' ' C ' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -102.94 110.32 22.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.021 -1.049 . . . . 0.0 108.805 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.83 91.07 0.01 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.56 ' N ' ' O ' ' A' ' 20' ' ' ASP . 14.2 mt -91.76 -14.35 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.282 -1.128 . . . . 0.0 108.524 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.545 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.35 175.78 1.74 Allowed Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 50.7 Cg_endo -71.43 -31.67 13.57 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.4 2.067 . . . . 0.0 111.903 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.517 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.1 m-20 -112.0 -9.34 14.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 110.218 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -60.04 123.37 16.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.948 -1.095 . . . . 0.0 109.713 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.668 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -88.07 135.3 33.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.999 -1.063 . . . . 0.0 108.351 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.593 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 5.8 p -83.81 136.18 34.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.498 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.636 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.5 p90 -139.04 147.93 42.71 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 31' ' ' LYS . 4.5 ttmt -108.69 140.39 42.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.028 . . . . 0.0 109.551 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -42.79 152.01 0.11 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.92 -17.11 7.43 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -82.53 151.75 26.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.057 -1.261 . . . . 0.0 109.728 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -105.56 145.85 30.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.459 -0.776 . . . . 0.0 109.895 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.493 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 8.5 mtm -138.26 154.11 49.06 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.649 0.738 . . . . 0.0 109.669 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 4.2 ttpm? -119.72 134.33 55.27 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.581 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 1.5 t -96.84 119.9 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 110.14 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 mt -85.31 -20.41 30.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.366 -0.834 . . . . 0.0 110.011 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.24 141.2 20.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.902 -1.124 . . . . 0.0 109.763 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 2.9 tt0 -109.31 137.4 47.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.409 -0.807 . . . . 0.0 108.955 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.618 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 68.7 m-70 -123.43 36.25 4.68 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.208 -0.933 . . . . 0.0 109.197 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.85 -104.11 3.14 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.8 -8.82 48.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -1.088 . . . . 0.0 110.606 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.618 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 17.3 m95 -131.89 124.95 30.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.782 -1.199 . . . . 0.0 110.401 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.632 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.3 168.22 13.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.145 -0.972 . . . . 0.0 109.678 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.17 129.29 56.0 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -124.83 -172.21 2.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 110.537 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.545 ' CG ' ' HB3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -138.77 147.49 42.68 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' LYS . 8.4 t -88.26 124.92 34.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.04 -1.038 . . . . 0.0 109.491 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.2 -13.13 62.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 109.427 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.3 tp -80.65 -57.13 3.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.457 -0.777 . . . . 0.0 109.906 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.4 3.79 23.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 49' ' ' SER . 9.1 mttt 58.42 25.37 12.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.751 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 8.6 mmtp -78.13 142.05 38.31 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.545 ' HB3' ' CG ' ' A' ' 48' ' ' LYS . 10.0 pt-20 -121.59 139.9 52.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.033 -1.042 . . . . 0.0 109.511 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.668 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.11 -163.78 15.66 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.55 135.21 40.42 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.553 -0.969 . . . . 0.0 109.417 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.406 ' O ' HG13 ' A' ' 58' ' ' ILE . 18.4 pt -126.22 142.9 44.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.369 -0.832 . . . . 0.0 109.152 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.531 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 53.8 Cg_endo -75.93 157.42 38.87 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.877 1.718 . . . . 0.0 110.746 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 89.1 p -88.92 28.82 1.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.728 -1.232 . . . . 0.0 110.143 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -138.14 0.16 2.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.025 . . . . 0.0 109.741 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.531 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.5 m-85 -105.45 -26.3 11.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.097 -1.002 . . . . 0.0 109.4 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.486 HG13 ' CE ' ' A' ' 35' ' ' MET . 18.0 m -122.58 164.77 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.637 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.485 ' CB ' HD12 ' A' ' 16' ' ' LEU . . . -160.38 -166.03 1.57 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.89 119.31 35.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.385 -0.822 . . . . 0.0 109.574 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 67' ' ' ASN . 8.6 tt -53.59 138.63 33.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.422 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.515 ' N ' HD22 ' A' ' 66' ' ' LEU . 1.1 m-80 -134.41 178.45 6.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 0.0 109.635 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.44 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.13 7.63 10.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.525 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 0.7 OUTLIER -74.78 119.4 18.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -1.159 . . . . 0.0 109.463 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.478 HD12 ' HG3' ' A' ' 36' ' ' LYS . 10.1 mm -107.25 130.39 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 109.356 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -128.32 153.34 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.274 -0.891 . . . . 0.0 108.928 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 8.7 p -112.41 133.61 57.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 118.841 -1.143 . . . . 0.0 109.168 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -58.18 118.71 5.76 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.494 -0.754 . . . . 0.0 110.285 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.603 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 13.3 mt -91.82 -26.94 18.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -137.34 141.96 35.84 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.0 Cg_endo -62.57 141.49 86.37 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.716 2.277 . . . . 0.0 111.831 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.4 t80 -132.65 123.69 26.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 109.419 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -102.58 110.64 22.65 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.008 -1.058 . . . . 0.0 108.798 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.4 89.69 0.01 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' ASP . 6.2 mt -92.3 -14.27 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -1.163 . . . . 0.0 108.476 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.487 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -113.37 175.24 1.93 Allowed Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 52.9 Cg_endo -72.03 -32.85 10.44 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.414 2.076 . . . . 0.0 112.181 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.537 ' OD2' ' CE ' ' A' ' 46' ' ' LYS . 55.7 t0 -112.77 -10.38 13.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.123 -0.985 . . . . 0.0 110.611 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.463 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 44.5 m-20 -60.15 116.41 4.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.951 -1.093 . . . . 0.0 109.797 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.629 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -77.08 135.85 38.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.934 -1.104 . . . . 0.0 108.286 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.598 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 1.3 p -85.11 137.08 33.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -0.978 . . . . 0.0 110.423 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 12.3 p90 -140.4 148.81 41.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.0 108.701 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.485 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -108.19 140.62 41.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.027 -1.045 . . . . 0.0 109.428 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.01 152.44 0.11 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.59 -16.74 7.53 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -83.23 151.98 25.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -1.204 . . . . 0.0 109.659 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 13.4 mtmt -105.14 143.86 32.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.816 . . . . 0.0 110.093 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.564 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 6.7 mtm -136.91 154.71 50.39 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.619 0.723 . . . . 0.0 109.585 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 10.1 ttpt -121.26 136.12 55.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -103.12 119.72 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.487 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -85.64 -31.91 22.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 109.55 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -143.34 139.06 29.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.509 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.635 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tt0 -111.86 145.1 40.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.667 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 14.7 m-70 -114.68 43.25 1.97 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 109.523 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 48.13 40.53 21.34 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.584 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 158.7 -48.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.29 -1.123 . . . . 0.0 109.574 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.567 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 8.3 m95 -129.38 120.87 26.28 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.413 -0.804 . . . . 0.0 109.111 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.682 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.17 168.65 9.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.184 -0.948 . . . . 0.0 109.631 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.537 ' CE ' ' OD2' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -110.05 116.12 31.0 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.54 -174.84 2.56 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 110.498 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.5 ttmt -137.55 147.72 45.36 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.655 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -88.56 129.39 35.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.03 -1.044 . . . . 0.0 109.921 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.448 ' CD1' ' HB2' ' A' ' 34' ' ' LYS . 5.8 mt -68.76 -24.46 64.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.04 . . . . 0.0 109.835 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.6 tp -86.52 -42.36 13.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.966 . . . . 0.0 109.92 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 p -99.1 -16.78 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.376 -0.828 . . . . 0.0 109.16 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.655 ' N ' ' O ' ' A' ' 49' ' ' SER . 13.7 mttt 59.56 11.88 2.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.323 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -81.69 151.57 27.48 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 14.2 pt-20 -119.63 146.62 45.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.897 -1.127 . . . . 0.0 109.515 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.629 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -169.85 164.66 38.08 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -68.05 133.38 48.9 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.492 -1.005 . . . . 0.0 109.962 -179.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.406 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 7.5 pt -124.47 143.04 42.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.64 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.0 Cg_endo -73.69 153.57 48.79 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.543 1.495 . . . . 0.0 110.68 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.467 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 91.8 p -87.6 29.37 0.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.616 -1.302 . . . . 0.0 109.954 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -139.81 0.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 109.794 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.64 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 17.2 m-85 -102.06 -25.64 13.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.985 . . . . 0.0 110.198 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.488 HG12 ' HE2' ' A' ' 35' ' ' MET . 14.8 m -117.03 162.66 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.997 -1.064 . . . . 0.0 110.061 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.603 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -108.59 133.73 52.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.749 . . . . 0.0 109.412 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.55 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -95.25 90.35 5.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.903 -1.123 . . . . 0.0 109.328 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 tp -67.02 80.95 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.321 -0.862 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.87 22.6 6.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.409 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.477 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.7 144.98 10.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 175.75 153.47 0.16 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 109.475 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' CD1' ' CG ' ' A' ' 36' ' ' LYS . 10.1 mm -108.0 132.44 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.275 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.503 HG13 ' CA ' ' A' ' 65' ' ' LYS . 0.9 OUTLIER -130.49 156.66 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.933 . . . . 0.0 109.185 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 13.0 p -113.47 134.95 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.053 -1.029 . . . . 0.0 109.084 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.66 118.94 5.78 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.483 -0.761 . . . . 0.0 110.302 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.592 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 12.6 mt -91.19 -28.56 17.76 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -137.24 142.49 37.99 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.1 Cg_endo -61.13 140.88 91.77 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.783 2.322 . . . . 0.0 111.413 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.5 t80 -133.75 125.74 29.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.998 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -103.38 107.68 18.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.034 -1.041 . . . . 0.0 108.518 179.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.36 92.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.4 mt -79.32 -59.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.538 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -66.66 176.1 1.18 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.643 -0.661 . . . . 0.0 109.241 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.5 Cg_endo -71.73 -25.07 20.85 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.528 2.152 . . . . 0.0 111.938 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.2 t70 -112.65 -7.83 13.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.285 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.586 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -60.14 122.78 15.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.968 -1.082 . . . . 0.0 109.763 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.65 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -88.8 135.01 33.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.994 -1.066 . . . . 0.0 108.406 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.604 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 2.2 m -84.49 136.7 33.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.728 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.8 p90 -138.91 147.84 42.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 108.586 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.53 140.05 41.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.018 -1.051 . . . . 0.0 109.635 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.83 152.16 0.08 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.88 -15.7 7.85 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -83.34 152.46 25.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.087 -1.243 . . . . 0.0 109.838 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.478 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 30.6 ttmt -105.72 146.08 30.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 109.917 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.527 ' CE ' HG13 ' A' ' 63' ' ' VAL . 3.6 mtm -137.73 154.71 49.59 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.64 0.733 . . . . 0.0 109.919 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -117.86 132.65 56.4 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.453 HG22 ' CB ' ' A' ' 45' ' ' TRP . 1.5 p -103.82 119.41 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.961 . . . . 0.0 109.449 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.76 -45.87 9.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -0.86 . . . . 0.0 109.953 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 3.7 tt0 -122.97 136.14 54.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.621 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.583 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tt0 -111.74 143.8 42.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.558 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 24.7 m-70 -113.13 44.52 1.52 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.521 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 49.91 36.44 26.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 160.01 -45.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -1.175 . . . . 0.0 109.729 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.558 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 7.5 m95 -128.54 122.58 31.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.014 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -116.7 168.54 10.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.139 -0.976 . . . . 0.0 109.96 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.543 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 11.3 ttpt -109.41 117.61 34.47 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.32 -173.62 2.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.237 -0.915 . . . . 0.0 110.586 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.7 ttmt -139.01 148.59 43.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 53' ' ' LYS . 17.3 t -90.05 126.82 35.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.046 -1.034 . . . . 0.0 109.55 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.32 -11.32 60.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 109.424 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.7 tp -81.99 -57.43 3.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.719 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -108.99 7.97 26.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.372 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 49' ' ' SER . 19.2 mttt 53.95 25.76 5.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 109.897 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HG2' ' CD2' ' A' ' 27' ' ' LEU . 12.5 tttp -80.29 142.8 34.19 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 21.7 pt-20 -121.36 144.63 48.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.98 -1.075 . . . . 0.0 109.6 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.65 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -165.64 -164.24 20.7 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.49 132.99 41.51 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.374 -1.074 . . . . 0.0 109.633 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.525 HD12 ' CB ' ' A' ' 47' ' ' ALA . 11.2 pt -125.99 135.99 27.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 54.3 Cg_endo -77.95 166.23 25.3 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.591 1.527 . . . . 0.0 111.213 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.437 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 35.4 t -91.79 29.17 1.6 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.987 -1.071 . . . . 0.0 109.699 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -140.78 0.09 1.57 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.967 . . . . 0.0 109.719 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.52 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.3 m-85 -100.5 -28.72 12.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.079 -1.013 . . . . 0.0 109.664 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.527 HG13 ' CE ' ' A' ' 35' ' ' MET . 6.1 m -115.39 160.1 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 109.829 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.592 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -106.36 130.22 54.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.507 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.503 ' CA ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -97.47 85.84 3.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.086 -1.009 . . . . 0.0 109.435 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.33 133.24 56.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.643 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -87.76 175.5 7.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.92 . . . . 0.0 109.426 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.335 0.588 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.75 -174.14 17.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.1 152.36 36.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -1.162 . . . . 0.0 109.504 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.403 HD12 ' HD2' ' A' ' 36' ' ' LYS . 17.2 mm -106.74 132.01 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.357 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -131.82 157.23 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.28 -0.888 . . . . 0.0 109.269 -179.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.526 HG13 ' CA ' ' A' ' 66' ' ' LEU . 6.4 p -113.55 134.63 55.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.077 -1.015 . . . . 0.0 108.552 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -56.24 115.81 2.68 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.69 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 9.8 mt -88.6 -28.15 20.88 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -136.74 141.02 33.66 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.6 Cg_endo -61.87 141.91 91.49 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.863 2.375 . . . . 0.0 111.82 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.6 t80 -133.55 124.41 26.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.84 . . . . 0.0 109.748 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -102.47 110.91 22.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.987 -1.071 . . . . 0.0 108.727 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.41 90.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.5 mt -93.52 -14.17 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -1.142 . . . . 0.0 108.591 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.565 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.66 175.91 1.68 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.565 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.2 Cg_endo -72.2 -33.31 9.48 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.46 2.106 . . . . 0.0 112.038 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.491 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 14.0 t0 -112.14 -10.04 13.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 110.366 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 34.1 m-20 -60.58 116.82 4.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.031 -1.043 . . . . 0.0 109.829 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.661 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -79.44 135.79 36.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.941 -1.1 . . . . 0.0 108.509 179.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.598 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 2.3 p -83.73 136.06 34.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 110.493 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.635 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.4 p90 -139.49 148.32 42.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.867 . . . . 0.0 108.826 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 31' ' ' LYS . 2.7 ttpt -108.77 140.61 41.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.94 -1.1 . . . . 0.0 109.572 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -42.86 152.7 0.1 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.29 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.19 -16.89 6.74 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.4 tp10 -83.12 152.86 25.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.035 -1.273 . . . . 0.0 109.801 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -105.38 145.42 30.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.473 -0.767 . . . . 0.0 109.662 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.571 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 6.6 mtm -137.16 154.17 50.29 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.71 0.767 . . . . 0.0 109.957 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.656 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 1.6 ttpm? -118.18 129.01 55.25 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.63 120.03 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 109.344 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.7 mp -86.65 -37.51 17.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 109.581 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -134.8 136.68 42.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.954 . . . . 0.0 109.653 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.63 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.3 tt0 -110.32 145.07 38.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.536 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 21.3 m-70 -111.81 46.23 1.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.122 -0.986 . . . . 0.0 109.584 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 50.57 32.06 23.26 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 161.19 -42.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.058 -1.26 . . . . 0.0 109.869 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CH2' ' HB3' ' A' ' 59' ' ' PRO . 50.4 m95 -127.2 122.0 32.85 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 108.908 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.648 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -118.82 168.76 10.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.079 -1.013 . . . . 0.0 109.726 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -108.85 121.15 44.48 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -125.7 146.68 49.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 110.983 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 1.7 ptpt -102.44 155.41 18.27 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 4.8 t -98.07 129.88 44.89 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.958 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.82 -12.55 61.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.2 tp -73.27 -62.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 109.714 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.9 -0.28 21.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.407 -0.808 . . . . 0.0 109.349 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 66.93 24.86 9.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -0.894 . . . . 0.0 109.892 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 5.6 mmtt -79.5 140.31 37.32 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 mt-10 -121.81 143.46 49.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.052 -1.03 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.661 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -166.39 -164.72 22.5 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.589 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -96.17 133.04 40.96 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.365 -1.08 . . . . 0.0 109.153 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 58' ' ' ILE . 33.2 pt -125.03 141.47 38.51 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.037 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.607 ' HB3' ' CH2' ' A' ' 44' ' ' TRP . 50.6 Cg_endo -72.24 152.56 55.95 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.927 1.751 . . . . 0.0 110.831 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.447 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 91.1 p -87.03 28.75 0.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.553 -1.342 . . . . 0.0 109.974 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -137.52 -4.09 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.832 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.562 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 5.2 m-85 -101.67 -24.2 14.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.947 -1.096 . . . . 0.0 109.068 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.531 HG13 ' CE ' ' A' ' 35' ' ' MET . 19.7 m -124.25 157.3 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 109.239 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 13' ' ' VAL . . . -151.57 -166.58 2.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.997 . . . . 0.0 109.543 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -98.3 64.47 1.61 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.458 -0.776 . . . . 0.0 109.415 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.526 ' CA ' HG13 ' A' ' 14' ' ' VAL . 0.9 OUTLIER 41.46 85.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.349 -0.844 . . . . 0.0 109.488 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -51.71 151.44 3.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.553 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -155.65 -159.78 9.56 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER 163.84 137.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -1.179 . . . . 0.0 109.57 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.5 mm -106.2 130.9 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.304 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -130.76 155.99 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.249 -0.907 . . . . 0.0 109.135 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.435 HG13 ' HG ' ' A' ' 66' ' ' LEU . 12.2 p -113.89 134.88 55.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 120.932 -1.105 . . . . 0.0 108.735 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -57.83 115.98 3.17 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.527 -0.733 . . . . 0.0 109.951 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.43 HD12 ' HB3' ' A' ' 64' ' ' ALA . 52.2 mt -89.64 -27.39 20.2 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -137.89 140.98 31.06 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 39.4 Cg_endo -61.98 141.72 90.23 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.629 2.219 . . . . 0.0 111.516 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.638 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 38.3 t80 -133.54 124.67 27.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 109.982 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 5.4 m-20 -103.52 109.95 21.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 108.487 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.31 89.14 0.01 OUTLIER Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.3 mt -86.78 -13.46 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.225 -1.162 . . . . 0.0 108.544 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.558 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.91 176.77 1.37 Allowed Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.0 Cg_endo -73.05 -30.18 11.06 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.395 2.064 . . . . 0.0 111.949 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 24.1 t0 -113.2 -9.54 13.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 110.384 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 2.5 m-20 -59.83 122.19 13.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.928 -1.107 . . . . 0.0 109.83 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.642 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -82.9 136.81 34.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.985 -1.072 . . . . 0.0 108.231 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.598 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 39.5 p -86.41 137.36 32.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.079 -1.013 . . . . 0.0 110.623 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.638 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.2 p90 -140.29 149.23 42.54 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -108.77 141.14 41.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.996 -1.065 . . . . 0.0 109.615 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.73 151.83 0.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.083 -1.01 . . . . 0.0 108.386 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.37 -17.21 6.62 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -82.78 152.55 25.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.035 -1.273 . . . . 0.0 109.841 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.35 144.58 31.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.692 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.589 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -138.09 153.81 49.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.515 0.674 . . . . 0.0 109.666 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 5.2 ttmt -117.75 130.09 56.1 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.4 p -98.26 120.74 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.113 -0.992 . . . . 0.0 109.625 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.31 -48.82 7.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 0.0 109.827 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 24.8 tt0 -119.03 134.58 55.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.069 -1.019 . . . . 0.0 109.926 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.62 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.8 tt0 -110.54 144.53 39.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 29.7 m-70 -116.74 47.14 1.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 109.756 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.38 34.22 8.85 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.2 OUTLIER 161.08 -43.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -1.103 . . . . 0.0 109.872 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.562 ' CH2' ' HB3' ' A' ' 59' ' ' PRO . 39.2 m95 -127.16 120.78 29.63 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.62 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -117.04 168.29 10.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.029 -1.044 . . . . 0.0 109.555 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -109.53 122.83 48.3 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.7 -174.59 2.51 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 110.812 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -135.93 145.43 46.25 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -85.38 123.87 31.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.0 109.656 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.52 -9.24 53.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.09 -1.007 . . . . 0.0 109.429 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.0 tp -88.97 -53.46 4.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 109.717 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.42 7.01 24.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.842 . . . . 0.0 109.412 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 49' ' ' SER . 6.2 mmtp 52.39 26.24 4.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.926 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.12 142.29 32.38 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HG2' ' HB2' ' A' ' 48' ' ' LYS . 6.9 mt-10 -118.65 139.54 51.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.912 -1.118 . . . . 0.0 109.646 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.642 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.79 -162.3 11.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 4.5 m-85 -99.91 133.34 44.42 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.377 -1.073 . . . . 0.0 109.5 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 58' ' ' ILE . 18.0 pt -125.0 139.81 34.46 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.562 ' HB3' ' CH2' ' A' ' 44' ' ' TRP . 54.2 Cg_endo -77.42 162.47 30.74 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.712 1.608 . . . . 0.0 111.248 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.461 ' OG ' ' HZ2' ' A' ' 45' ' ' TRP . 41.9 t -91.77 30.06 1.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.797 -1.189 . . . . 0.0 109.794 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -137.81 -0.15 2.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.99 . . . . 0.0 109.743 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.534 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 8.7 m-85 -107.65 -26.91 10.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 108.932 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.589 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 12.2 m -123.98 161.12 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.452 -0.78 . . . . 0.0 109.284 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 13' ' ' VAL . . . -156.07 -166.25 2.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.993 . . . . 0.0 109.798 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -99.48 113.99 26.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.471 -0.768 . . . . 0.0 109.525 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.435 ' HG ' HG13 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -63.45 102.17 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.466 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 m120 55.38 -172.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.93 . . . . 0.0 109.473 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 68' ' ' THR . 2.7 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.428 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.357 0.598 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.41 -96.64 0.16 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.91 159.64 26.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -1.127 . . . . 0.0 109.375 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.563 HD11 ' CG ' ' A' ' 36' ' ' LYS . 13.2 mm -105.63 130.94 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.213 -0.929 . . . . 0.0 109.157 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -130.82 155.96 42.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.299 -0.875 . . . . 0.0 109.332 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 7.6 p -114.26 134.26 57.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.168 -0.957 . . . . 0.0 108.596 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -54.95 113.99 1.56 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.338 -0.851 . . . . 0.0 109.791 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.508 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 47.5 mt -86.5 -29.58 22.63 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -136.35 139.95 31.21 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD3' ' HD3' ' A' ' 31' ' ' LYS . 38.4 Cg_endo -61.52 141.76 92.76 Favored 'Trans proline' 0 C--O 1.216 -0.584 0 C-N-CA 122.891 2.394 . . . . 0.0 111.82 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.643 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.7 t80 -134.02 125.35 27.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.755 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 22' ' ' ILE . 11.0 t70 -102.73 110.71 22.73 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.986 -1.071 . . . . 0.0 108.673 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.55 90.31 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.7 mt -92.72 -14.32 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -1.143 . . . . 0.0 108.662 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.544 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.89 174.95 2.06 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.544 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.4 Cg_endo -71.08 -32.72 12.78 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.425 2.083 . . . . 0.0 111.806 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -111.88 -9.67 14.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 110.284 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.01 123.27 16.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.905 -1.122 . . . . 0.0 109.796 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.668 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -86.38 135.56 33.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.94 -1.1 . . . . 0.0 108.286 179.207 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.601 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 0.9 OUTLIER -84.35 136.5 33.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 110.422 -178.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.643 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 9.4 p90 -139.74 148.39 42.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.922 . . . . 0.0 108.673 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.84 142.54 39.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.026 . . . . 0.0 109.588 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HD3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -44.43 152.01 0.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.019 -1.05 . . . . 0.0 108.325 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.4 -16.79 7.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -82.61 152.08 26.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.023 -1.281 . . . . 0.0 109.676 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -106.03 146.04 30.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.421 -0.799 . . . . 0.0 110.005 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.528 ' CE ' HG13 ' A' ' 63' ' ' VAL . 8.0 mtm -137.52 153.77 49.96 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.695 0.76 . . . . 0.0 109.838 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -116.41 130.1 56.58 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.598 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -96.44 119.99 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.936 -1.103 . . . . 0.0 110.113 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.44 -24.02 39.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.505 -0.747 . . . . 0.0 109.738 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -158.68 145.58 17.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.091 -1.006 . . . . 0.0 110.041 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.639 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 12.2 tt0 -111.42 143.06 42.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 0.0 109.392 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.571 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 84.6 m-70 -116.63 42.95 2.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.099 -1.001 . . . . 0.0 109.677 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.603 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.83 41.97 21.08 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.603 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 156.37 -48.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -1.079 . . . . 0.0 109.911 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.585 ' CZ2' ' HB3' ' A' ' 59' ' ' PRO . 13.4 m95 -126.65 122.99 36.56 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 109.017 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.65 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.17 166.28 12.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 109.841 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.13 123.45 50.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -122.51 -171.32 2.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.695 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 ttpm? -140.75 150.58 43.58 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -90.11 126.1 35.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.011 -1.055 . . . . 0.0 109.964 -179.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -14.5 63.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.005 . . . . 0.0 109.445 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.462 HD21 ' OE2' ' A' ' 33' ' ' GLU . 63.2 tp -85.06 -53.49 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.429 ' OG1' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -109.28 13.54 24.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.264 -0.898 . . . . 0.0 109.348 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' SER . 18.7 mttp 44.44 25.38 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.352 -0.843 . . . . 0.0 109.798 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.8 mtpm? -79.45 141.17 37.02 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.13 -0.981 . . . . 0.0 108.355 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 12.5 pt-20 -121.72 144.08 48.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.032 -1.043 . . . . 0.0 109.576 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.668 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -166.69 -163.54 20.64 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.62 134.42 40.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.576 -0.955 . . . . 0.0 109.371 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 58' ' ' ILE . 11.9 pt -125.96 142.22 41.75 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.098 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.585 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 49.7 Cg_endo -72.4 153.03 55.6 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.811 1.674 . . . . 0.0 110.638 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 80.7 p -86.25 29.45 0.75 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.546 -1.346 . . . . 0.0 109.969 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -138.27 0.61 2.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 0.0 109.736 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.56 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.5 m-85 -105.35 -25.51 12.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.009 . . . . 0.0 109.479 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.528 HG13 ' CE ' ' A' ' 35' ' ' MET . 18.8 m -123.16 160.68 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.508 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -157.25 -165.3 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 109.587 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -79.88 135.55 36.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -0.797 . . . . 0.0 109.512 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . 1.2 tp -73.64 116.03 13.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.44 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -134.05 6.36 3.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.3 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.47 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 10' ' ' GLY . 25.7 mt-30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 9' ' ' GLN . . . 57.75 110.68 0.01 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 1.6 m-20 -111.98 155.4 23.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -1.129 . . . . 0.0 109.491 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.6 mm -105.85 129.77 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.6 OUTLIER -129.52 154.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.36 -0.838 . . . . 0.0 108.898 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.517 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 9.4 p -114.16 133.93 58.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 120.987 -1.07 . . . . 0.0 108.837 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -56.61 115.3 2.46 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.471 -0.768 . . . . 0.0 109.682 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.516 HD13 ' CB ' ' A' ' 64' ' ' ALA . 56.1 mt -88.4 -27.21 21.73 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -137.51 139.96 28.88 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 39.0 Cg_endo -61.87 142.24 92.64 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.652 2.234 . . . . 0.0 111.47 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.637 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 39.7 t80 -134.23 125.9 28.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 0.0 109.989 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' C ' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -103.22 110.67 22.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.061 -1.024 . . . . 0.0 108.751 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.573 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.68 91.92 0.01 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.5 mt -93.32 -13.01 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -1.117 . . . . 0.0 108.716 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.507 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -114.65 174.16 2.5 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 50.8 Cg_endo -71.02 -32.42 13.39 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.388 2.059 . . . . 0.0 112.046 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -112.2 -9.88 13.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.165 -0.96 . . . . 0.0 110.285 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -59.81 126.81 29.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.06 . . . . 0.0 109.857 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.688 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -87.53 137.07 32.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.59 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 3.0 m -87.48 137.98 31.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.637 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 7.7 p90 -141.08 150.14 42.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.85 . . . . 0.0 108.804 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -108.92 138.58 45.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.068 -1.02 . . . . 0.0 109.581 -179.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LYS . 4.1 ptpt -42.16 152.06 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.37 -17.54 7.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -82.1 150.47 27.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.146 -1.208 . . . . 0.0 109.673 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 12.7 mmtt -105.28 145.03 31.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.435 -0.79 . . . . 0.0 109.799 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.488 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 11.7 mtm -137.39 153.67 50.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.519 -0.738 . . . . 0.0 109.743 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.6 tttt -118.38 131.99 56.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.602 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -96.79 121.01 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.986 -1.071 . . . . 0.0 110.366 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.61 -36.49 26.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 109.041 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.588 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -128.01 131.56 49.19 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.539 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -112.94 98.81 7.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.975 . . . . 0.0 109.802 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 84.1 m-70 -75.86 -157.77 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.352 -1.468 . . . . 0.0 108.954 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . -105.49 43.88 1.58 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 2.2 mt-10 163.51 -40.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.141 -1.211 . . . . 0.0 109.115 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.467 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 7.0 m95 -132.39 123.58 27.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.386 -0.821 . . . . 0.0 109.871 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.632 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -115.54 168.58 9.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.396 -0.815 . . . . 0.0 109.807 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.74 121.29 44.96 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -120.17 -170.64 2.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.907 . . . . 0.0 110.631 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -142.04 150.75 41.68 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 53' ' ' LYS . 25.6 t -90.05 125.91 35.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 109.791 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -9.95 57.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 0.0 109.321 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.6 tp -82.76 -57.53 3.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.314 -0.867 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -109.32 2.22 20.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 109.378 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' SER . 19.5 mttt 61.99 26.68 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 109.845 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 7.4 mmtp -81.94 140.01 34.28 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.3 pm0 -121.29 144.16 48.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.996 -1.065 . . . . 0.0 109.834 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.688 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -171.49 166.66 39.71 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -66.92 135.09 53.29 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.362 -1.081 . . . . 0.0 109.763 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.475 HG23 ' CE1' ' A' ' 29' ' ' PHE . 2.6 pt -124.92 146.4 53.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.392 -0.818 . . . . 0.0 109.0 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 48.4 Cg_endo -71.95 146.85 48.2 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.98 1.787 . . . . 0.0 110.615 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 80.6 p -85.09 29.72 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.43 -1.419 . . . . 0.0 110.187 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -137.64 0.43 2.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.119 -0.988 . . . . 0.0 109.737 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.59 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 36.6 m-85 -107.54 -23.84 12.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.092 -1.005 . . . . 0.0 109.467 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 15' ' ' ALA . 29.3 m -124.7 159.31 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.516 ' CB ' HD13 ' A' ' 16' ' ' LEU . . . -154.33 -166.31 2.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.633 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -102.49 127.75 49.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.428 -0.795 . . . . 0.0 109.556 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' HB2' ' CG1' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -127.88 96.71 4.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.481 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -95.61 -168.73 1.83 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.507 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.515 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 9' ' ' GLN . . . -60.31 -117.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.96 141.02 0.09 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -1.182 . . . . 0.0 109.445 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.431 ' HA ' HD11 ' A' ' 12' ' ' ILE . 27.0 mm -107.7 131.03 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.452 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -129.94 154.32 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.24 -0.912 . . . . 0.0 109.107 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.754 ' O ' HD21 ' A' ' 16' ' ' LEU . 12.9 p -116.16 135.17 57.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.075 -1.016 . . . . 0.0 109.001 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -58.95 118.74 6.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.645 -0.659 . . . . 0.0 110.843 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.754 HD21 ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -89.87 -26.4 20.51 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . 50.6 m-85 -138.26 141.77 32.97 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 40.2 Cg_endo -62.57 141.72 87.22 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.595 2.196 . . . . 0.0 111.474 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 42.8 t80 -133.84 125.39 28.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 0.0 109.8 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' ILE . 6.4 t70 -103.17 110.01 21.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.106 -0.996 . . . . 0.0 108.666 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.04 89.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.4 mp -88.33 -13.42 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.158 -1.201 . . . . 0.0 108.552 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.56 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -114.6 174.91 2.09 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 51.2 Cg_endo -71.38 -31.39 14.11 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.415 2.077 . . . . 0.0 111.906 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 9.4 t70 -112.54 -9.85 13.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.394 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -59.59 127.27 31.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.941 -1.099 . . . . 0.0 109.806 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.636 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -88.52 136.19 33.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.983 -1.073 . . . . 0.0 108.372 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.595 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 2.7 m -86.85 137.79 32.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.989 . . . . 0.0 110.452 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 10.0 p90 -141.37 150.34 42.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 0.0 108.802 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -108.53 137.62 46.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.052 -1.03 . . . . 0.0 109.303 -179.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.25 153.55 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.416 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.87 -17.52 4.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -82.2 154.46 25.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.042 -1.269 . . . . 0.0 109.703 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -106.32 142.93 35.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.592 ' CE ' ' CG1' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -137.67 153.71 49.79 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.497 0.665 . . . . 0.0 109.325 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.2 ptpt -118.34 131.68 56.31 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.381 -0.824 . . . . 0.0 108.818 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -100.65 120.25 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.337 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.56 -37.44 16.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 109.914 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -132.72 136.76 46.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.065 -1.022 . . . . 0.0 109.89 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.625 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.4 tt0 -111.21 146.41 36.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.556 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 36.0 m-70 -116.64 46.34 1.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.692 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 48.61 32.36 10.66 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 162.36 -42.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -1.199 . . . . 0.0 109.831 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.556 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 12.9 m95 -127.5 120.9 29.34 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.44 -0.788 . . . . 0.0 108.875 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.83 166.94 11.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.018 -1.051 . . . . 0.0 109.822 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HG2' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -109.66 121.16 44.58 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.12 -173.82 2.43 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 110.644 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -137.21 146.41 44.83 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -85.12 123.58 30.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.675 -179.231 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -8.76 49.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.088 -1.007 . . . . 0.0 109.308 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.95 -54.42 4.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 109.898 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -109.55 1.97 20.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' SER . 21.7 mmtm 59.71 26.66 15.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.227 -0.921 . . . . 0.0 109.744 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 5.1 ttmm -83.95 141.73 31.03 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 12.8 pt-20 -118.71 137.99 52.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.996 -1.065 . . . . 0.0 109.822 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.636 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -163.37 163.54 35.63 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -65.69 133.93 52.13 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.351 -1.087 . . . . 0.0 109.98 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.468 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 7.7 pt -123.43 144.05 42.99 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.701 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.6 Cg_endo -71.57 148.19 53.15 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.941 1.761 . . . . 0.0 110.786 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.492 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 89.3 p -86.14 29.5 0.74 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.481 -1.387 . . . . 0.0 110.241 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -136.99 -1.86 2.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.091 -1.006 . . . . 0.0 109.935 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.701 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 4.8 m-85 -106.64 -23.12 12.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 109.207 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.592 ' CG1' ' CE ' ' A' ' 35' ' ' MET . 11.0 m -123.75 157.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.375 -0.828 . . . . 0.0 109.32 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 13' ' ' VAL . . . -153.36 -166.13 2.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.982 . . . . 0.0 109.532 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.83 111.53 24.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.377 -0.827 . . . . 0.0 109.556 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.527 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 3.5 mm? 46.66 -166.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.462 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -178.98 153.13 0.61 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 0.0 109.515 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.64 146.46 18.76 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -136.09 163.94 29.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -1.163 . . . . 0.0 109.425 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.42 130.3 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.212 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 1.1 m -131.07 156.75 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.345 -0.847 . . . . 0.0 109.125 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 p -114.49 134.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.845 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -57.23 116.67 3.42 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.531 -0.73 . . . . 0.0 109.907 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.4 mt -89.27 -27.74 20.37 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -137.58 141.79 34.65 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.6 Cg_endo -61.83 141.41 89.98 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.731 2.287 . . . . 0.0 111.571 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 41.2 t80 -134.66 126.25 28.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 110.182 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 22' ' ' ILE . 12.1 t70 -102.0 107.87 19.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.054 -1.029 . . . . 0.0 108.282 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -31.06 90.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.7 mt -79.56 -59.91 2.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.494 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -65.34 173.75 1.73 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.609 -0.682 . . . . 0.0 109.401 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -71.53 -26.59 19.82 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.68 2.253 . . . . 0.0 112.29 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -113.23 -9.87 13.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.532 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.43 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 48.4 m-20 -59.69 121.78 12.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.915 -1.116 . . . . 0.0 109.782 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -83.39 135.78 34.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.965 -1.084 . . . . 0.0 108.405 179.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.608 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 3.2 m -85.23 136.41 33.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 110.362 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.5 p90 -139.77 148.71 42.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.302 -0.874 . . . . 0.0 108.709 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.52 141.21 40.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.963 -1.086 . . . . 0.0 109.557 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.63 152.23 0.16 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.37 -17.15 6.67 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 5.4 tp10 -82.45 152.64 26.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.051 -1.264 . . . . 0.0 109.77 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 7.0 mttm -105.88 145.22 31.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.918 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.522 ' CE ' HG13 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -138.42 154.11 48.88 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.553 -0.717 . . . . 0.0 109.647 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 5.4 tttp -120.62 136.48 54.8 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.58 HG13 ' CB ' ' A' ' 45' ' ' TRP . 3.3 t -98.4 119.14 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 109.797 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 2.3 mm? -88.11 -19.67 26.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.507 -0.746 . . . . 0.0 110.191 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' NE2' ' A' ' 41' ' ' HIS . 12.4 pt-20 -146.91 138.95 24.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.966 -1.084 . . . . 0.0 109.795 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.4 ' OE2' ' N ' ' A' ' 42' ' ' GLY . 2.5 tm-20 -108.65 135.38 49.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.403 -0.81 . . . . 0.0 109.125 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.515 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 44.1 m-70 -122.89 36.0 4.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.162 -0.961 . . . . 0.0 109.241 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 93.78 -108.57 3.69 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 60' ' ' SER . 0.4 OUTLIER -87.48 -7.13 57.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 110.01 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.577 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 10.6 m95 -130.21 143.01 50.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.015 -1.053 . . . . 0.0 109.827 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.58 ' CB ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -140.64 167.25 22.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.184 -0.948 . . . . 0.0 109.777 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.94 119.97 40.98 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.57 -172.13 2.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.515 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.1 tttm -138.93 147.86 42.83 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 53' ' ' LYS . 1.4 t -86.14 124.81 32.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 109.588 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -69.51 -10.97 60.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.963 . . . . 0.0 109.394 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.6 tp -86.17 -54.16 4.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -0.855 . . . . 0.0 109.893 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.3 2.0 22.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 109.306 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 49' ' ' SER . 4.8 mttp 57.53 24.73 10.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 110.319 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.5 ttmm -83.23 145.51 29.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 108.253 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -119.46 142.22 48.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.059 -1.025 . . . . 0.0 109.783 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.632 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -167.55 165.12 38.44 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -68.03 135.13 51.8 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.376 -1.073 . . . . 0.0 109.926 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.43 144.52 46.21 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.625 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.4 Cg_endo -71.95 149.03 52.51 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.028 1.819 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.58 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 46.4 t -86.98 28.76 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.44 -1.413 . . . . 0.0 110.269 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -136.9 -0.98 2.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.956 -1.09 . . . . 0.0 109.818 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.625 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 33.0 m-85 -106.35 -23.81 12.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.003 . . . . 0.0 109.184 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 15' ' ' ALA . 15.6 m -123.91 157.13 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.298 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 13' ' ' VAL . . . -151.77 -166.96 2.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.701 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -98.93 135.2 40.7 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.774 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -107.98 125.7 51.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -0.845 . . . . 0.0 109.318 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 66' ' ' LEU . 15.0 t30 -42.71 115.91 0.79 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.568 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.469 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.35 151.1 20.04 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.58 155.72 20.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.214 -1.168 . . . . 0.0 109.496 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 12' ' ' ILE . 29.7 mm -107.82 132.76 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.839 . . . . 0.0 109.33 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.551 ' CG1' ' HA ' ' A' ' 65' ' ' LYS . 1.6 m -130.31 155.7 41.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.127 -0.983 . . . . 0.0 109.26 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.2 p -113.25 134.6 55.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.107 -0.996 . . . . 0.0 108.775 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.03 117.52 4.07 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 110.131 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.54 ' CG ' ' HB1' ' A' ' 64' ' ' ALA . 68.7 mt -90.04 -28.21 19.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -137.71 142.93 38.39 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.8 Cg_endo -61.94 140.69 86.29 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.613 2.208 . . . . 0.0 111.419 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.0 t80 -133.78 125.98 29.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 0.0 109.921 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 22' ' ' ILE . 72.5 m-20 -102.86 107.36 18.18 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.954 -1.091 . . . . 0.0 108.385 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.13 90.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 20' ' ' ASP . 16.4 mt -78.77 -59.67 2.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.482 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -66.25 173.34 2.31 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.614 -0.679 . . . . 0.0 109.222 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 50.4 Cg_endo -70.82 -26.07 23.0 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.723 2.282 . . . . 0.0 112.349 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.7 OUTLIER -113.28 -9.4 13.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -0.927 . . . . 0.0 110.762 -178.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.49 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -60.69 116.48 4.43 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.799 -1.188 . . . . 0.0 109.882 -179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.648 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -77.66 135.63 38.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.981 -1.075 . . . . 0.0 108.408 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.603 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 3.5 m -85.54 137.13 33.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.627 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.8 p90 -139.36 148.04 42.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.289 -0.882 . . . . 0.0 108.718 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.6 141.09 39.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 109.475 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.479 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -43.11 151.21 0.15 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.141 -0.975 . . . . 0.0 108.438 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.36 -16.58 7.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 15' ' ' ALA . 7.5 tm-20 -82.71 151.93 26.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.138 -1.213 . . . . 0.0 109.722 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 37.7 mtpt -105.43 145.89 30.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.522 -0.736 . . . . 0.0 109.866 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.545 ' CE ' HG12 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -140.92 155.55 46.25 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.434 0.635 . . . . 0.0 109.427 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.563 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 4.2 tttm -122.55 139.48 53.86 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.537 HG22 ' CB ' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -104.43 119.7 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.195 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.7 -27.14 18.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 110.09 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -131.45 135.69 47.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.973 -1.079 . . . . 0.0 109.373 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -109.24 136.9 47.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.261 -0.899 . . . . 0.0 109.2 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.596 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 10.6 m-70 -122.47 37.35 4.41 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 108.947 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 -99.57 2.51 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -90.39 -10.39 44.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -1.113 . . . . 0.0 110.372 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.604 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 6.0 m95 -131.33 138.66 49.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.604 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -135.7 165.38 25.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.337 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.598 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 13.2 tttt -109.61 120.99 44.2 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 36' ' ' LYS . . . -115.76 -173.56 2.37 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.389 -0.819 . . . . 0.0 110.697 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.6 ttpt -137.31 146.92 45.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -85.71 125.09 32.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.001 -1.062 . . . . 0.0 109.687 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.91 -10.34 58.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 109.301 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.6 tp -88.4 -53.8 4.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.712 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.69 8.51 26.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 109.42 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' SER . 10.8 mttt 50.2 25.26 1.72 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.991 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.05 143.85 31.25 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -119.02 141.64 48.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 109.453 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.648 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.41 -166.42 21.15 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.63 132.92 41.78 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.416 -1.05 . . . . 0.0 109.419 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 58' ' ' ILE . 17.2 pt -125.14 141.1 37.61 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.625 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 51.9 Cg_endo -74.54 157.54 44.61 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 121.673 1.582 . . . . 0.0 110.942 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.486 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 89.2 p -90.31 29.43 1.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.636 -1.29 . . . . 0.0 109.908 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -140.7 -2.67 1.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.625 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 4.9 m-85 -102.23 -24.39 13.91 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.907 -1.121 . . . . 0.0 110.534 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.545 HG12 ' CE ' ' A' ' 35' ' ' MET . 10.5 m -111.16 155.5 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 0.0 109.97 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.54 ' HB1' ' CG ' ' A' ' 16' ' ' LEU . . . -102.78 129.44 49.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.452 -0.78 . . . . 0.0 109.561 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.551 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 13.9 ptpt -80.03 134.48 36.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.967 -1.083 . . . . 0.0 109.391 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mp 63.33 -91.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.49 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 174.17 110.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.431 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.494 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.296 0.57 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.63 81.14 0.23 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.465 ' HB3' HG22 ' A' ' 37' ' ' VAL . 13.0 t70 -127.21 122.32 33.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.338 -1.095 . . . . 0.0 109.28 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.55 HD11 ' CG ' ' A' ' 36' ' ' LYS . 6.7 mm -105.55 130.6 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -130.77 155.97 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.055 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 66' ' ' LEU . 14.3 p -113.69 135.12 54.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.081 -1.012 . . . . 0.0 108.532 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' HA ' HG13 ' A' ' 63' ' ' VAL . . . -57.16 114.38 2.13 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.509 -0.744 . . . . 0.0 109.81 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.509 ' CD1' ' HB1' ' A' ' 64' ' ' ALA . 49.9 mt -88.48 -28.4 20.86 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -136.74 139.15 28.22 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.4 Cg_endo -61.62 142.28 94.0 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.758 2.305 . . . . 0.0 111.676 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.3 t80 -133.53 124.45 26.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 109.699 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -102.63 111.1 23.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.002 . . . . 0.0 108.521 179.239 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -25.66 88.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' ASP . 34.5 mt -88.99 -13.97 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -1.184 . . . . 0.0 108.636 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.562 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -115.13 175.85 1.73 Allowed Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 51.2 Cg_endo -71.93 -32.22 11.53 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.561 2.174 . . . . 0.0 111.697 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -112.34 -10.43 13.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 110.113 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.474 ' OD2' ' OH ' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -60.04 117.54 5.22 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.983 -1.073 . . . . 0.0 109.738 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.65 ' CB ' ' HA2' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -81.3 137.18 35.8 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.002 -1.061 . . . . 0.0 108.285 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.61 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 6.2 p -84.96 137.34 33.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.975 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.1 p90 -139.37 148.77 43.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 31' ' ' LYS . 2.3 ttmt -108.96 140.26 42.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.977 -1.077 . . . . 0.0 109.697 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' LYS . 1.5 ptmt -43.65 152.66 0.14 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.3 -17.93 5.88 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.0 tm-20 -82.23 153.15 26.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.031 -1.276 . . . . 0.0 109.643 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 144.63 32.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.437 -0.79 . . . . 0.0 109.78 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.488 ' HE2' HG13 ' A' ' 63' ' ' VAL . 1.1 mpp? -137.64 153.29 49.88 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.52 -0.737 . . . . 0.0 109.624 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.55 ' CG ' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -118.99 132.76 56.09 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.645 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -97.15 119.91 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.037 . . . . 0.0 109.794 -179.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mt -88.04 -22.38 24.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.462 -0.774 . . . . 0.0 110.317 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -146.4 138.81 25.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.798 -1.189 . . . . 0.0 109.771 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -108.76 137.0 47.41 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.412 -0.805 . . . . 0.0 109.13 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.552 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 16.0 m-70 -121.56 37.79 4.26 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.23 -0.919 . . . . 0.0 109.058 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.11 -106.08 3.34 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.78 -7.77 55.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -1.074 . . . . 0.0 110.008 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.595 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 29.6 m95 -129.25 139.48 51.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.0 109.777 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.645 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.72 167.34 22.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 109.759 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.561 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 12.2 tttt -110.66 123.51 50.14 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -118.78 -170.88 1.99 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 110.5 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 15.8 ttpt -140.87 150.28 43.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.2 t -88.6 125.51 34.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.058 -1.026 . . . . 0.0 109.783 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -10.75 59.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.184 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.2 tp -85.9 -54.34 4.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 109.847 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.68 8.39 24.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 49' ' ' SER . 53.5 mttp 51.99 26.74 3.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.733 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.0 OUTLIER -84.77 142.86 29.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 4.6 pt-20 -117.98 148.69 41.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.65 ' HA2' ' CB ' ' A' ' 27' ' ' LEU . . . -166.05 -167.4 26.63 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.94 132.91 42.24 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.354 -1.086 . . . . 0.0 109.151 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 58' ' ' ILE . 40.0 pt -124.92 140.99 37.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.547 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 51.5 Cg_endo -75.15 157.08 42.34 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.753 1.635 . . . . 0.0 110.837 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.539 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 48.1 t -88.6 29.85 0.96 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.609 -1.307 . . . . 0.0 109.836 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.492 ' OD1' ' C ' ' A' ' 60' ' ' SER . 6.0 m-20 -137.42 0.92 2.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 0.0 109.652 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.547 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 3.0 m-85 -108.19 -26.25 10.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.018 . . . . 0.0 109.286 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 15' ' ' ALA . 15.3 m -124.22 161.06 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 16' ' ' LEU . . . -155.41 -166.59 2.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 109.776 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.36 87.95 2.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.522 -0.736 . . . . 0.0 109.484 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.467 ' HB3' HG13 ' A' ' 14' ' ' VAL . 12.6 tp -137.83 119.93 15.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.42 41.68 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.452 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.335 0.588 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 11' ' ' ASP . . . -105.03 177.17 23.14 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -158.32 158.9 35.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -1.101 . . . . 0.0 109.395 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.4 mm -107.3 131.04 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.554 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.531 ' CG1' ' HG2' ' A' ' 65' ' ' LYS . 1.0 OUTLIER -130.56 156.75 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.28 -0.887 . . . . 0.0 108.994 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 p -112.47 134.32 55.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.939 -1.1 . . . . 0.0 109.001 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.35 118.2 4.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.443 -0.785 . . . . 0.0 110.281 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 64' ' ' ALA . 25.5 mt -90.94 -29.11 17.63 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -137.16 143.05 40.27 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.5 Cg_endo -61.72 140.09 84.19 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.752 2.301 . . . . 0.0 111.552 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.634 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 39.2 t80 -134.05 126.37 30.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.957 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 22' ' ' ILE . 3.0 m-20 -103.22 107.39 18.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.942 -1.099 . . . . 0.0 108.516 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.04 91.42 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' ASP . 13.4 mm -79.29 -58.75 3.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.563 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -67.26 175.4 1.55 Allowed Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.563 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.4 Cg_endo -71.74 -25.47 20.38 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.637 2.225 . . . . 0.0 112.045 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 35.8 m-20 -112.65 -8.33 13.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.33 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.49 121.05 11.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.026 -1.046 . . . . 0.0 109.754 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.667 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -85.5 134.64 34.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.921 -1.112 . . . . 0.0 108.363 179.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.6 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 1.7 p -84.27 136.93 33.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.955 . . . . 0.0 110.635 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.634 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.6 p90 -139.01 147.34 42.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 11.6 mtpp -107.25 140.98 39.29 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.081 -1.012 . . . . 0.0 109.499 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -42.6 151.47 0.12 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.153 -0.967 . . . . 0.0 108.397 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.97 -16.03 7.59 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.9 tp10 -83.33 151.63 25.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.032 -1.275 . . . . 0.0 109.542 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 4.1 mttt -105.77 146.49 29.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.425 -0.797 . . . . 0.0 110.166 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.581 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 3.1 mtm -138.2 155.35 48.76 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.663 0.744 . . . . 0.0 109.557 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -123.0 138.86 54.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.419 HG22 ' CB ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -105.0 119.07 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 109.288 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.62 -26.91 16.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.998 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -132.0 135.82 46.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.002 -1.062 . . . . 0.0 109.294 -179.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.88 134.78 51.09 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.176 -0.952 . . . . 0.0 109.251 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.605 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 56.5 m-70 -120.61 34.85 5.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.309 -0.869 . . . . 0.0 109.009 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 -108.33 3.66 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' CD1' ' A' ' 44' ' ' TRP . 75.3 tt0 -85.15 -7.53 59.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -1.136 . . . . 0.0 109.987 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.611 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 21.4 m95 -132.28 140.13 48.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.948 -1.095 . . . . 0.0 110.315 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.611 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -136.54 166.53 23.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.463 -0.773 . . . . 0.0 109.186 179.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -108.73 117.36 33.97 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -112.03 -175.08 2.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.363 -0.836 . . . . 0.0 110.47 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 32.2 ttpt -139.13 148.17 42.88 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.9 t -88.89 124.94 34.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 0.0 109.672 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.499 ' CD1' ' HB2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -69.2 -11.77 61.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.058 -1.026 . . . . 0.0 109.281 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 tp -87.43 -53.57 4.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 0.0 109.769 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.538 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 1.8 t -108.99 14.63 23.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.355 -0.841 . . . . 0.0 109.351 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER 42.43 25.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HB3' HD22 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -80.99 142.67 33.19 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.033 -1.042 . . . . 0.0 108.416 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 18.9 tt0 -121.44 141.09 51.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.092 -1.005 . . . . 0.0 109.6 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.667 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -168.65 166.94 39.98 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -67.76 134.41 50.97 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.431 -1.041 . . . . 0.0 109.913 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.495 HD12 ' CB ' ' A' ' 47' ' ' ALA . 10.1 pt -124.64 142.28 40.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.678 ' CG ' ' CD1' ' A' ' 62' ' ' TYR . 50.1 Cg_endo -72.02 151.26 55.78 Favored 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 121.7 1.6 . . . . 0.0 110.918 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.503 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 98.9 p -87.67 28.09 1.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.55 -1.344 . . . . 0.0 109.983 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -140.27 -4.23 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.086 -1.009 . . . . 0.0 110.032 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.678 ' CD1' ' CG ' ' A' ' 59' ' ' PRO . 7.6 m-85 -98.7 -23.36 15.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.058 -1.026 . . . . 0.0 110.388 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.51 HG13 ' CE ' ' A' ' 35' ' ' MET . 17.5 m -110.42 156.69 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.179 . . . . 0.0 109.737 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.53 ' N ' HD13 ' A' ' 16' ' ' LEU . . . -104.6 128.21 52.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 109.734 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.531 ' HG2' ' CG1' ' A' ' 13' ' ' VAL . 2.7 mtpt -82.47 79.42 8.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -0.978 . . . . 0.0 109.254 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.515 ' CB ' ' O ' ' A' ' 65' ' ' LYS . 1.1 tm? 77.99 -71.99 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.361 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 68' ' ' THR . 6.5 p30 -145.8 -39.4 0.23 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.562 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.505 ' N ' ' OD1' ' A' ' 67' ' ' ASN . 6.7 t . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.481 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.33 0.586 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.0 -159.4 9.14 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.55 136.91 48.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -1.186 . . . . 0.0 109.308 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.8 mm -105.37 131.13 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.253 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.55 ' CG1' ' HB3' ' A' ' 65' ' ' LYS . 1.4 m -131.8 158.04 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.344 -0.848 . . . . 0.0 109.469 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -114.04 136.36 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.137 -0.977 . . . . 0.0 109.007 178.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 31' ' ' LYS . . . -57.39 117.13 3.81 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 109.631 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.587 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 26.0 mt -90.39 -28.49 18.64 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -136.52 139.41 29.37 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 37.4 Cg_endo -59.73 141.25 96.58 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.925 2.416 . . . . 0.0 111.888 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.577 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 29.7 t80 -131.79 122.82 26.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.0 109.384 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 2.4 m-20 -102.57 110.92 23.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.116 -0.99 . . . . 0.0 108.858 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.97 89.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.3 mt -93.42 -14.98 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -1.131 . . . . 0.0 108.482 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.478 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -112.82 174.15 2.47 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 51.0 Cg_endo -70.65 -34.34 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.402 2.068 . . . . 0.0 112.022 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -111.41 -9.61 14.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.118 -0.989 . . . . 0.0 110.361 -179.43 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -60.29 120.62 10.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.975 -1.078 . . . . 0.0 109.772 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.641 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -84.54 135.64 34.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.999 -1.063 . . . . 0.0 108.336 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.6 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -84.3 136.51 33.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.584 -178.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 19' ' ' TYR . 13.9 p90 -140.29 149.1 42.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 108.754 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.535 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -107.68 136.78 46.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.909 -1.119 . . . . 0.0 109.392 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -38.87 154.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 72.5 -15.76 1.99 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -80.17 156.42 26.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.825 -1.397 . . . . 0.0 108.926 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -107.08 144.37 33.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 110.355 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.544 ' CE ' HG12 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -140.48 154.79 46.73 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.444 0.64 . . . . 0.0 109.298 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -122.24 139.86 53.28 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.632 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 1.3 t -99.87 119.22 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.015 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.23 -21.27 22.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.409 -0.807 . . . . 0.0 110.073 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 48.2 tt0 -144.51 138.12 27.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.932 -1.105 . . . . 0.0 109.787 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.37 133.27 52.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.329 -0.857 . . . . 0.0 109.0 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 77.9 m-70 -121.6 34.15 5.28 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.216 -0.928 . . . . 0.0 109.361 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.48 -110.53 4.04 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.36 -7.49 58.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -1.137 . . . . 0.0 109.892 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.572 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 m95 -130.65 142.55 50.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.985 -1.072 . . . . 0.0 109.908 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.632 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.85 168.16 20.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.287 -0.883 . . . . 0.0 109.766 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.578 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 7.9 tttm -110.88 117.38 33.23 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.03 -172.03 2.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 110.354 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 6.8 ttpm? -139.88 149.0 42.86 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -88.44 125.97 35.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.084 -1.01 . . . . 0.0 109.508 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.5 mt -69.98 -13.49 62.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.017 -1.052 . . . . 0.0 109.288 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.8 tp -82.92 -55.62 4.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.798 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.464 ' OG1' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.96 10.61 26.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.386 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.5 OUTLIER 49.72 25.43 1.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.88 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 13.4 mttp -79.47 142.54 35.76 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 6.5 pt-20 -120.99 143.4 49.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.074 -1.016 . . . . 0.0 109.391 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.641 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -165.63 -164.74 21.7 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.515 ' HB3' ' CZ3' ' A' ' 44' ' ' TRP . 1.7 m-85 -96.63 133.54 41.01 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.394 -1.062 . . . . 0.0 109.46 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.511 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 20.5 pt -125.64 140.31 36.18 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.588 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 54.5 Cg_endo -77.1 161.23 32.75 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 121.663 1.576 . . . . 0.0 110.963 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.593 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 41.8 t -90.88 29.33 1.37 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.677 -1.265 . . . . 0.0 109.872 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.411 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 23.5 t-20 -140.65 -0.1 1.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.588 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 9.8 m-85 -102.12 -26.86 13.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.057 -1.027 . . . . 0.0 110.151 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.544 HG12 ' CE ' ' A' ' 35' ' ' MET . 5.1 m -113.76 163.3 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.88 -1.137 . . . . 0.0 110.075 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.587 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -109.69 130.47 55.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 109.379 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.55 ' HB3' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.4 130.7 43.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.043 -1.035 . . . . 0.0 109.423 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -132.83 102.94 5.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.892 . . . . 0.0 109.445 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 66' ' ' LEU . 7.0 t-20 179.62 151.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.895 . . . . 0.0 109.455 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.462 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.43 119.71 3.45 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.8 155.48 42.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -1.129 . . . . 0.0 109.381 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.464 HD13 ' HB2' ' A' ' 36' ' ' LYS . 1.8 tp -109.83 134.1 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.508 HG13 ' CA ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -129.4 155.65 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.257 -0.902 . . . . 0.0 109.049 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 9.1 p -113.26 134.28 56.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.087 -1.008 . . . . 0.0 108.958 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -56.14 117.44 3.76 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.465 -0.772 . . . . 0.0 110.107 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.575 HD13 ' CB ' ' A' ' 64' ' ' ALA . 32.3 mt -89.1 -29.22 19.55 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -136.58 142.49 39.4 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.1 Cg_endo -60.73 140.03 88.61 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.747 2.298 . . . . 0.0 111.675 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 28.6 t80 -131.76 123.21 27.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 109.371 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -103.23 110.09 21.93 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 108.832 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.58 89.24 0.01 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.6 mt -90.75 -14.99 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.329 -1.101 . . . . 0.0 108.424 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.508 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.4 176.21 1.57 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.508 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -71.77 -32.94 10.91 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.422 2.081 . . . . 0.0 111.897 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 4.8 m-20 -111.46 -8.82 14.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.163 -0.961 . . . . 0.0 110.216 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.463 ' OD1' ' CZ ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -60.69 122.85 15.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.001 -1.062 . . . . 0.0 109.636 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.66 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -87.45 134.8 33.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.962 -1.086 . . . . 0.0 108.498 179.318 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.595 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -84.21 136.38 33.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.496 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.6 p90 -139.37 148.1 42.4 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -107.9 137.16 46.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.081 . . . . 0.0 109.437 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 30' ' ' LYS . 9.6 ptmm? -38.81 151.66 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.41 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.11 -16.77 8.38 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.143 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 1.8 mp0 -83.32 153.39 24.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.948 -1.325 . . . . 0.0 109.653 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 8.8 mtpt -105.43 146.33 29.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.413 -0.804 . . . . 0.0 109.958 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.499 ' CE ' HG13 ' A' ' 63' ' ' VAL . 4.9 mtm -138.68 155.18 48.49 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.699 0.761 . . . . 0.0 109.573 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.4 tppt? -123.05 138.75 54.6 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.438 HG22 ' CB ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -104.73 119.25 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.405 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -26.08 17.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.882 . . . . 0.0 109.989 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 68.5 mt-10 -133.04 135.51 45.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 109.155 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.438 ' OE2' ' N ' ' A' ' 42' ' ' GLY . 2.5 tm-20 -109.47 134.8 51.43 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.235 -0.916 . . . . 0.0 109.335 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.6 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 22.3 m-70 -119.95 36.02 4.66 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.252 -0.905 . . . . 0.0 108.86 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 92.63 -106.46 3.41 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -86.59 -8.32 57.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -1.165 . . . . 0.0 110.121 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.607 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 12.2 m95 -131.98 138.74 48.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.919 -1.113 . . . . 0.0 110.375 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.607 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -136.09 167.18 21.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.358 -0.839 . . . . 0.0 109.326 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.04 117.51 34.38 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -113.7 -173.1 2.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.379 -0.826 . . . . 0.0 110.677 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.5 ttmt -139.88 147.49 40.7 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.666 ' O ' ' N ' ' A' ' 53' ' ' LYS . 29.3 t -88.48 129.47 35.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 109.925 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.37 -27.47 66.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.052 . . . . 0.0 109.79 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.13 -41.82 16.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.181 -0.949 . . . . 0.0 109.947 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' ' 49' ' ' SER . 1.3 p -98.94 -18.35 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.354 -0.841 . . . . 0.0 109.371 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 49' ' ' SER . 14.0 mttt 60.65 11.21 2.98 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.334 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -80.21 150.76 29.99 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 8.6 pt-20 -120.53 143.52 48.53 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.9 -1.125 . . . . 0.0 109.695 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.66 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -167.15 165.6 38.68 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.01 134.88 51.43 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.441 -1.035 . . . . 0.0 110.109 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.531 HD12 ' CB ' ' A' ' 47' ' ' ALA . 6.9 pt -125.52 140.85 37.39 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.691 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 52.9 Cg_endo -74.42 157.04 45.52 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 121.62 1.547 . . . . 0.0 111.055 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -89.56 27.98 1.38 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.706 -1.246 . . . . 0.0 109.824 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -140.71 -1.82 1.41 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.841 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.691 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.4 m-85 -102.05 -25.96 13.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.118 -0.989 . . . . 0.0 110.276 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.499 HG13 ' CE ' ' A' ' 35' ' ' MET . 11.5 m -108.79 172.0 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.814 -1.179 . . . . 0.0 109.972 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.575 ' CB ' HD13 ' A' ' 16' ' ' LEU . . . -119.99 126.54 51.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.789 . . . . 0.0 109.595 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.508 ' CA ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -92.08 52.57 2.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.129 -0.982 . . . . 0.0 109.305 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.44 66.63 0.46 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 t30 57.23 167.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.488 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.37 100.68 0.37 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.6 129.75 40.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -1.115 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 3.0 tp -109.4 132.75 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.453 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.534 ' CG1' ' HB2' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -128.38 154.32 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 108.861 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.3 p -113.01 134.02 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.267 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.47 119.36 6.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.603 -0.686 . . . . 0.0 110.303 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.544 HD13 ' CA ' ' A' ' 64' ' ' ALA . 81.1 mt -91.51 -28.1 17.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -137.25 143.48 41.8 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.3 Cg_endo -61.47 140.03 85.3 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.62 2.213 . . . . 0.0 111.331 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.611 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 33.5 t80 -133.67 125.96 29.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.856 . . . . 0.0 110.051 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -103.25 106.76 17.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.016 -1.053 . . . . 0.0 108.371 178.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -29.63 92.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.0 mt -78.85 -59.01 3.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.354 -1.086 . . . . 0.0 108.099 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.566 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 3.6 m-70 -67.33 172.49 3.67 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 47.3 Cg_endo -68.83 -23.96 34.73 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.555 2.17 . . . . 0.0 112.108 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.544 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.1 m-20 -112.86 -7.48 13.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.151 -0.968 . . . . 0.0 110.284 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.509 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 13.3 m-20 -60.95 118.43 6.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.041 -1.037 . . . . 0.0 109.925 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.653 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -83.8 134.46 34.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.933 -1.104 . . . . 0.0 108.49 179.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.606 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 2.3 m -84.38 137.12 33.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.64 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' A' ' 19' ' ' TYR . 8.7 p90 -139.56 148.28 42.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.281 -0.887 . . . . 0.0 108.635 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 31' ' ' LYS . 4.6 ttpm? -107.28 139.73 41.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.965 -1.084 . . . . 0.0 109.479 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.66 152.3 0.07 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.73 -16.27 6.86 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -82.84 152.66 25.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.084 -1.244 . . . . 0.0 109.713 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 16.3 mttp -105.95 145.96 30.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.424 -0.798 . . . . 0.0 110.223 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.53 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 4.5 mtm -139.72 155.78 47.16 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.591 0.71 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.4 ttmm -120.67 137.61 54.37 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.411 ' CG2' ' CB ' ' A' ' 45' ' ' TRP . 1.6 p -104.35 120.12 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.707 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 1.6 mm? -88.52 -37.81 15.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.324 -0.86 . . . . 0.0 109.767 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 6.6 tp10 -128.43 136.25 50.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.104 -0.997 . . . . 0.0 109.732 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.601 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -110.83 142.4 42.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.603 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 68.2 m-70 -114.96 44.27 1.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.037 -1.039 . . . . 0.0 109.743 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 43' ' ' GLU . . . 52.81 27.52 28.76 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.401 -0.904 . . . . 0.0 110.881 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 42' ' ' GLY . 8.2 pt-20 164.04 -40.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.999 -1.295 . . . . 0.0 109.597 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.603 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 39.4 m95 -126.54 121.56 32.63 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.659 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -118.1 166.42 12.58 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.976 -1.077 . . . . 0.0 109.754 -179.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -109.45 122.61 47.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -118.69 -174.14 2.62 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 110.944 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 19.3 ttmt -139.09 148.68 43.62 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.3 t -90.45 124.92 35.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.971 -1.081 . . . . 0.0 109.852 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.48 -11.62 60.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.097 -1.002 . . . . 0.0 109.358 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.5 tp -83.87 -55.93 3.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 109.693 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.77 10.0 26.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.298 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' SER . 9.9 mtmt 49.93 25.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.366 -0.834 . . . . 0.0 109.834 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' HG2' ' CD2' ' A' ' 27' ' ' LEU . 2.9 tttt -80.35 142.52 34.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.089 -1.007 . . . . 0.0 108.317 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 13.2 pt-20 -122.05 142.95 49.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.042 -1.036 . . . . 0.0 109.637 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.653 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -164.14 -163.07 16.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 3.1 m-85 -97.79 133.62 42.05 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.466 -1.02 . . . . 0.0 109.491 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.524 HD12 ' CB ' ' A' ' 47' ' ' ALA . 12.7 pt -125.53 135.95 27.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.606 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 53.1 Cg_endo -75.35 164.21 33.14 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 121.637 1.558 . . . . 0.0 110.905 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.415 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 92.4 p -92.69 28.62 1.98 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.812 -1.18 . . . . 0.0 109.713 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -140.94 -1.71 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 109.915 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.606 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 9.4 m-85 -100.81 -27.89 13.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.044 -1.035 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.472 HG13 ' CE ' ' A' ' 35' ' ' MET . 11.6 m -113.61 163.07 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.029 -1.044 . . . . 0.0 109.534 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.544 ' CA ' HD13 ' A' ' 16' ' ' LEU . . . -109.8 129.8 55.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.744 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.534 ' HB2' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -105.53 102.14 11.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 109.393 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.94 115.93 22.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 109.456 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.49 41.25 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.955 . . . . 0.0 109.498 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.425 ' OXT' HG21 ' A' ' 68' ' ' THR . 32.3 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.352 0.596 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.44 -114.87 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.94 160.35 2.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -1.148 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.8 mm -109.58 133.73 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.57 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -131.35 157.54 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.235 -0.916 . . . . 0.0 109.19 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 7.6 p -115.56 134.06 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.08 -1.013 . . . . 0.0 109.032 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -53.15 114.22 1.39 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.335 -0.853 . . . . 0.0 109.939 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.543 ' O ' ' CD ' ' A' ' 31' ' ' LYS . 27.8 mt -84.76 -30.0 25.03 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -137.49 140.88 31.67 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.586 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 37.6 Cg_endo -59.44 140.16 92.93 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.748 2.299 . . . . 0.0 111.649 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 33.3 t80 -134.27 125.76 28.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.836 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -102.13 107.94 19.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.892 -1.13 . . . . 0.0 108.571 179.003 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.11 89.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' ASP . 76.4 mt -80.94 -57.6 4.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.572 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 8.5 m80 -68.48 171.14 6.43 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 47.5 Cg_endo -68.18 -27.25 35.43 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.655 2.237 . . . . 0.0 112.246 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.575 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 23.6 t0 -111.8 -7.91 14.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.128 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -60.78 123.69 18.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.117 -0.989 . . . . 0.0 109.827 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.639 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -90.16 134.45 34.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.979 -1.075 . . . . 0.0 108.514 179.308 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.596 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -83.31 136.53 34.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.897 . . . . 0.0 110.605 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.3 p90 -138.86 147.07 41.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.339 -0.851 . . . . 0.0 108.721 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -108.87 146.81 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.831 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -46.51 151.39 0.56 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.918 -1.114 . . . . 0.0 108.545 179.231 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.3 -15.0 7.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -82.68 149.99 27.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.267 . . . . 0.0 109.683 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -105.98 144.94 31.99 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.711 0.767 . . . . 0.0 110.177 -179.307 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.574 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 4.7 mtm -137.79 155.23 49.26 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.588 0.708 . . . . 0.0 109.544 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 10.7 ttpp -118.85 136.06 54.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.32 118.77 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.21 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.56 -33.76 17.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -133.52 136.43 45.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 109.525 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.581 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.7 tt0 -111.05 144.92 39.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 44' ' ' TRP . 4.5 m-70 -115.95 43.88 2.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 0.0 109.765 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.86 35.48 12.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 160.56 -45.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -1.161 . . . . 0.0 109.759 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.579 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 11.9 m95 -127.56 122.44 33.24 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.369 -0.832 . . . . 0.0 109.087 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.682 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.37 166.03 12.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.14 -0.975 . . . . 0.0 109.605 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 123.22 49.17 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -120.23 -173.63 2.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 110.809 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 ttpt -138.8 148.93 44.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 53' ' ' LYS . 5.2 t -90.07 125.52 35.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.944 -1.097 . . . . 0.0 109.903 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.493 HD11 ' HD3' ' A' ' 34' ' ' LYS . 35.6 mt -69.5 -13.41 62.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 109.43 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.9 tp -82.64 -55.35 4.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.732 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.22 9.46 25.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 109.286 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.8 OUTLIER 50.67 25.93 2.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.848 . . . . 0.0 109.864 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -80.54 142.38 34.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.177 -0.952 . . . . 0.0 108.435 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -121.98 142.14 50.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.094 -1.004 . . . . 0.0 109.54 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.639 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.65 -164.66 18.17 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -97.42 134.14 41.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.523 -0.987 . . . . 0.0 109.291 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 58' ' ' ILE . 13.7 pt -126.49 137.8 31.1 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.562 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 52.2 Cg_endo -75.04 163.71 34.71 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 121.683 1.589 . . . . 0.0 110.675 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.7 p -92.21 29.26 1.69 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.72 -1.238 . . . . 0.0 109.906 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -138.92 -0.74 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.887 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.551 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.2 m-85 -106.16 -28.23 10.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 109.259 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.542 HG13 ' CE ' ' A' ' 35' ' ' MET . 22.0 m -122.02 158.05 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.317 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.534 ' CB ' HD12 ' A' ' 16' ' ' LEU . . . -155.35 -165.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.657 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -82.45 142.95 31.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.518 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . 7.8 tt -87.55 147.76 25.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.423 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -140.7 -89.67 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.539 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 37' ' ' VAL . . . 99.26 108.09 2.85 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -121.8 152.57 39.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 109.399 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 36' ' ' LYS . 25.0 mm -105.86 129.56 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.972 . . . . 0.0 109.348 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.597 ' CG1' ' HA ' ' A' ' 65' ' ' LYS . 0.5 OUTLIER -129.52 154.85 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.396 -0.815 . . . . 0.0 108.978 -179.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 14.3 p -111.55 133.75 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.861 -1.149 . . . . 0.0 108.939 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.05 117.09 3.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.436 -0.79 . . . . 0.0 110.164 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.614 ' O ' ' CD ' ' A' ' 31' ' ' LYS . 14.5 mt -89.37 -28.08 20.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.8 140.17 28.79 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 37.6 Cg_endo -59.9 141.28 96.27 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.86 2.373 . . . . 0.0 111.49 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 34.5 t80 -132.83 123.92 27.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.727 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 22' ' ' ILE . 9.3 t70 -102.71 109.51 21.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.087 -1.008 . . . . 0.0 108.6 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.563 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.98 89.02 0.01 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.592 ' N ' ' O ' ' A' ' 20' ' ' ASP . 17.4 mt -88.36 -14.59 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.185 . . . . 0.0 108.318 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.551 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -114.13 176.67 1.4 Allowed Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.551 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.1 Cg_endo -72.43 -31.94 10.67 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.489 2.126 . . . . 0.0 112.085 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 17.7 m-20 -112.05 -9.59 13.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.354 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.41 122.24 14.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.918 -1.114 . . . . 0.0 109.778 -179.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.689 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -85.43 135.13 33.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.916 -1.115 . . . . 0.0 108.404 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.607 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 3.2 m -84.56 136.82 33.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.565 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 10.4 p90 -138.79 147.22 42.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.264 -0.898 . . . . 0.0 108.744 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 15.1 pttt -108.28 146.7 32.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.721 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.614 ' CD ' ' O ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -46.23 152.46 0.41 Allowed 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.868 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.68 -12.67 10.07 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.2 tm-20 -83.8 148.09 27.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.124 -1.221 . . . . 0.0 110.13 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -104.78 147.21 27.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -0.759 . . . . 0.0 109.714 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.497 ' HE3' ' CG ' ' A' ' 29' ' ' PHE . 8.7 mtm -139.42 155.28 47.72 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.667 0.746 . . . . 0.0 109.931 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -123.59 140.71 52.72 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.572 HG13 ' CB ' ' A' ' 45' ' ' TRP . 2.7 t -102.17 119.58 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.071 -1.018 . . . . 0.0 110.023 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.77 -21.64 23.7 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 0.0 109.811 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 4.3 mt-10 -148.33 139.05 22.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.97 -1.082 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.551 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 11.5 tt0 -109.74 135.44 50.66 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.299 -0.876 . . . . 0.0 109.166 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 63.3 m-70 -117.82 36.06 4.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.326 -0.859 . . . . 0.0 108.87 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.49 -110.14 3.95 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -84.74 -6.81 59.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -1.18 . . . . 0.0 109.865 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.572 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 23.4 m95 -130.89 143.16 50.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.058 -1.026 . . . . 0.0 109.97 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.586 ' CZ2' ' HB2' ' A' ' 60' ' ' SER . 0.0 OUTLIER -141.31 168.28 20.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.338 -0.851 . . . . 0.0 109.613 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.581 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 8.7 tttt -110.2 116.36 31.36 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.15 -172.31 2.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.407 -0.808 . . . . 0.0 110.307 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.4 ttpm? -142.33 151.27 41.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 109.305 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -92.23 126.5 37.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.054 -1.029 . . . . 0.0 109.695 -179.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.403 ' O ' ' NZ ' ' A' ' 53' ' ' LYS . 1.3 mt -70.19 -13.98 62.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.024 -1.048 . . . . 0.0 109.33 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 17.2 tp -75.96 -59.68 2.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -108.69 3.52 22.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 0.0 109.423 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 61.23 25.66 15.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.1 tptp -78.51 141.51 38.13 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.153 -0.967 . . . . 0.0 108.521 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 7.2 pt-20 -123.46 146.1 48.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.046 -1.034 . . . . 0.0 109.604 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.689 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -169.75 -164.87 26.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -95.77 134.16 39.04 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.446 -1.031 . . . . 0.0 109.53 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.46 HD12 ' HB1' ' A' ' 47' ' ' ALA . 11.2 pt -126.0 141.67 40.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.618 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 54.6 Cg_endo -75.71 156.97 39.97 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.839 1.693 . . . . 0.0 110.921 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 46.0 t -88.67 28.13 1.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.726 -1.234 . . . . 0.0 110.019 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -139.82 -1.96 1.57 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.138 -0.976 . . . . 0.0 109.819 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.618 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 5.9 m-85 -101.74 -25.38 13.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.385 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.453 HG12 ' HE2' ' A' ' 35' ' ' MET . 24.7 m -113.0 161.42 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.858 -1.151 . . . . 0.0 110.069 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.564 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -108.51 131.7 54.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.444 -0.785 . . . . 0.0 109.62 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.597 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.1 OUTLIER -84.95 101.47 12.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.999 -1.063 . . . . 0.0 109.533 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.21 163.68 3.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 109.439 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -115.76 -179.47 3.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.879 . . . . 0.0 109.415 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.49 -179.943 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.43 36.52 0.12 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -85.51 141.22 30.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -1.151 . . . . 0.0 109.429 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.7 OUTLIER -104.9 128.65 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.501 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -130.44 155.51 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.3 p -112.84 133.77 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.943 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -58.48 118.66 5.84 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.476 -0.765 . . . . 0.0 110.385 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.592 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 53.5 mt -92.02 -27.1 18.03 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -137.55 141.39 33.28 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.9 Cg_endo -62.2 141.43 88.11 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.648 2.232 . . . . 0.0 111.56 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 33.5 t80 -132.84 124.18 27.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.962 . . . . 0.0 109.671 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -103.37 110.32 22.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.069 -1.02 . . . . 0.0 108.796 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.96 89.52 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 20' ' ' ASP . 4.6 mt -90.1 -13.73 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -1.11 . . . . 0.0 108.359 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.533 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -114.01 174.56 2.27 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.533 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 50.9 Cg_endo -70.78 -32.48 14.26 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.409 2.073 . . . . 0.0 111.916 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.559 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 16.2 m-20 -112.02 -9.64 13.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 110.4 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -59.83 121.62 12.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.891 -1.131 . . . . 0.0 109.745 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.637 ' HB2' ' N ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -84.33 136.83 33.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 108.353 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.597 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 2.9 m -86.99 137.5 32.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 0.0 110.629 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.0 p90 -140.28 149.57 42.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -108.85 142.5 39.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 109.731 -179.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' LYS . 1.2 pttt -44.79 151.53 0.29 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.112 -0.993 . . . . 0.0 108.423 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.52 -16.43 7.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.575 ' CG ' ' CD2' ' A' ' 51' ' ' LEU . 10.0 tp10 -82.8 151.59 26.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.066 -1.255 . . . . 0.0 109.915 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 3.9 mttt -105.33 146.36 29.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.454 -0.779 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.542 ' SD ' ' CB ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -138.3 153.8 49.02 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.725 0.774 . . . . 0.0 110.132 -179.423 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HG2' HG13 ' A' ' 12' ' ' ILE . 2.8 mtpm? -122.62 138.3 54.63 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 t -88.32 155.38 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 118.48 -1.288 . . . . 0.0 109.292 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.529 ' O ' ' CG ' ' A' ' 39' ' ' GLU . 4.1 mt -122.61 -13.35 7.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.313 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.542 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 37.3 mt-10 -159.03 138.94 11.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.381 -0.824 . . . . 0.0 109.054 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 13.0 tt0 -106.18 132.8 51.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 41.6 m-70 -122.2 34.2 5.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.453 -0.779 . . . . 0.0 109.289 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.8 -113.53 4.61 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -83.26 -6.8 59.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -1.165 . . . . 0.0 109.601 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.587 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 32.1 m95 -130.35 148.08 52.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.431 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.587 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -146.69 172.01 14.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 110.072 179.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.609 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -111.7 128.41 56.07 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . . . -121.64 -173.29 2.6 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.128 -0.982 . . . . 0.0 110.509 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 26.7 ttpt -136.93 146.69 45.75 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -86.5 124.54 32.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 109.49 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.3 -10.07 52.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.057 -1.027 . . . . 0.0 109.404 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.575 ' CD2' ' CG ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -88.1 -53.16 4.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 109.991 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.505 HG23 ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.11 8.84 24.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.922 . . . . 0.0 109.584 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 50.73 26.64 2.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.302 -0.874 . . . . 0.0 109.752 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 11.3 tptt -84.4 142.06 30.4 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 23.4 pt-20 -117.48 139.53 50.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.979 -1.076 . . . . 0.0 109.638 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.637 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -156.58 -166.6 16.56 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -97.21 132.69 42.73 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 109.541 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.457 HD12 ' HB1' ' A' ' 47' ' ' ALA . 11.5 pt -124.78 141.47 38.2 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.595 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 55.1 Cg_endo -78.71 161.48 27.6 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.66 1.573 . . . . 0.0 111.199 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 32.9 t -90.86 30.01 1.26 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.837 -1.164 . . . . 0.0 109.701 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 60' ' ' SER . 6.8 m120 -141.19 -0.12 1.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.813 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.595 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 7.7 m-85 -102.72 -26.74 13.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 110.122 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.538 HG12 ' CE ' ' A' ' 35' ' ' MET . 6.4 m -114.73 163.92 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.965 -1.084 . . . . 0.0 110.003 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.592 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -109.22 129.49 55.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 109.312 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -91.18 120.56 32.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.118 -0.989 . . . . 0.0 109.38 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.46 104.73 1.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 0.0 109.516 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -119.96 116.27 25.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.925 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.44 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -105.97 129.72 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.26 154.58 40.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 108.89 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 2.9 p -113.4 133.93 57.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.97 -1.081 . . . . 0.0 108.83 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.655 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -56.32 115.86 2.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.514 -0.741 . . . . 0.0 109.789 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 50.4 mt -88.37 -27.78 21.39 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -136.72 140.32 31.64 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.97 141.47 94.6 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.762 2.308 . . . . 0.0 111.879 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.9 t80 -133.2 124.14 26.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.53 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -102.27 111.33 23.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.97 -1.081 . . . . 0.0 108.958 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -28.15 89.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.7 mt -94.63 -14.14 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.308 -1.113 . . . . 0.0 108.483 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.587 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.5 175.1 1.98 Allowed Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.1 Cg_endo -71.76 -34.34 9.05 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.511 2.14 . . . . 0.0 112.052 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 2.5 m-20 -112.09 -10.73 13.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 0.0 110.574 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 46.1 m-20 -60.34 116.22 4.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.915 -1.115 . . . . 0.0 109.752 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.125 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -78.67 134.96 37.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.907 -1.121 . . . . 0.0 108.45 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.125 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.6 p -83.54 136.6 34.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.354 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.8 p90 -139.41 147.94 42.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.288 -0.882 . . . . 0.0 108.739 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -108.51 140.02 42.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.072 -1.018 . . . . 0.0 109.497 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 30' ' ' LYS . 15.4 ptmt -42.21 152.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.23 -0.988 . . . . 0.0 108.36 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.55 -16.65 7.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -82.66 152.03 26.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.097 -1.237 . . . . 0.0 109.743 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 12.8 mtpt -105.79 145.99 30.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.435 -0.791 . . . . 0.0 109.962 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.617 ' CE ' HG11 ' A' ' 63' ' ' VAL . 5.9 mtm -138.2 154.21 49.13 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.718 0.77 . . . . 0.0 109.834 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 tttp -121.78 136.44 54.94 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.645 HG11 ' CB ' ' A' ' 45' ' ' TRP . 1.5 t -97.96 120.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.005 . . . . 0.0 110.075 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.777 ' N ' HD22 ' A' ' 38' ' ' LEU . 2.2 mm? -86.34 -18.2 32.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 109.923 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -154.24 141.03 19.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.945 -1.097 . . . . 0.0 109.757 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 6.1 tt0 -108.64 135.18 50.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.145 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 74.2 m-70 -121.0 35.01 5.01 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.202 -0.936 . . . . 0.0 109.218 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.85 -110.0 3.94 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -85.76 -7.09 58.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -1.139 . . . . 0.0 109.857 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.577 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 27.3 m95 -129.99 141.86 50.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.071 -1.018 . . . . 0.0 109.786 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.645 ' CB ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.98 167.68 21.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 109.569 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.573 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 13.1 tttp -110.8 118.84 37.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.38 -172.77 2.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 110.473 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 5.4 ttmt -140.83 150.24 43.03 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 53' ' ' LYS . 4.4 t -90.87 125.94 35.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.127 -0.983 . . . . 0.0 109.818 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -12.18 61.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.361 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.09 -55.29 4.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.694 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.71 8.07 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.351 -0.843 . . . . 0.0 109.281 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 49' ' ' SER . 21.4 mtmt 50.93 25.29 2.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.949 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 9.2 tttm -82.07 144.8 30.56 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.128 -0.982 . . . . 0.0 108.386 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 26.9 tt0 -120.84 145.62 47.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.014 -1.054 . . . . 0.0 109.456 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.665 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -164.79 -167.28 25.11 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.93 134.33 40.41 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.317 -1.108 . . . . 0.0 109.461 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 HG21 ' A' ' 63' ' ' VAL . 10.9 pt -126.23 142.47 42.82 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.468 -0.77 . . . . 0.0 109.287 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.527 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 53.7 Cg_endo -75.62 157.55 40.13 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.854 1.703 . . . . 0.0 110.811 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.55 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 47.9 t -89.6 28.96 1.2 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.593 -1.317 . . . . 0.0 110.19 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.2 -0.35 2.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.079 -1.013 . . . . 0.0 109.664 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.527 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.7 m-85 -106.61 -25.72 11.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.229 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.7 HG21 HD12 ' A' ' 58' ' ' ILE . 19.5 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.31 -0.869 . . . . 0.0 109.505 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.743 HD13 ' HG3' ' A' ' 36' ' ' LYS . 26.4 mm -109.54 132.87 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.524 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.34 155.6 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 108.957 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 12.7 p -112.79 134.46 55.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.306 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.68 118.83 5.67 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.482 -0.761 . . . . 0.0 110.103 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 82.0 mt -91.51 -28.3 17.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -137.02 142.93 40.19 Favored Pre-proline 0 N--CA 1.486 1.352 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HD3' ' HE3' ' A' ' 31' ' ' LYS . 38.9 Cg_endo -62.13 140.74 85.48 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.785 2.323 . . . . 0.0 111.575 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.633 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 34.2 t80 -132.04 123.6 27.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.576 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' ILE . 13.2 t0 -103.31 109.66 21.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.118 -0.989 . . . . 0.0 108.722 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.76 90.53 0.01 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.9 mt -88.44 -13.62 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -1.135 . . . . 0.0 108.403 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.606 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.63 177.99 1.06 Allowed Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.7 Cg_endo -73.59 -30.83 9.38 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.359 2.039 . . . . 0.0 111.955 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -112.59 -9.56 13.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.338 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.453 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 39.2 m-20 -60.91 116.29 4.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.952 -1.092 . . . . 0.0 109.899 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.112 HD22 ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -80.17 134.24 36.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 108.373 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.112 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.6 p -83.52 137.46 33.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 110.833 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.633 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.5 p90 -139.24 148.55 43.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 108.692 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.12 142.7 37.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.855 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.462 ' HE3' ' HD3' ' A' ' 18' ' ' PRO . 2.8 ptpt -44.19 151.82 0.22 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.29 -16.06 8.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 2.6 tm-20 -83.22 151.33 25.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.238 . . . . 0.0 109.67 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 12.7 mttt -104.97 146.05 29.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.44 -0.787 . . . . 0.0 109.83 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.597 ' CE ' HG11 ' A' ' 63' ' ' VAL . 5.7 mtm -137.73 154.69 49.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.609 0.719 . . . . 0.0 109.662 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.743 ' HG3' HD13 ' A' ' 12' ' ' ILE . 20.2 tttt -118.36 133.73 55.64 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.583 HG21 ' HG3' ' A' ' 40' ' ' GLU . 1.4 p -103.78 119.08 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 109.433 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.796 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -88.53 -40.64 13.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.417 -0.802 . . . . 0.0 109.807 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 7.0 mp0 -129.81 137.08 50.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 109.687 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 4.9 mt-10 -111.11 146.4 36.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 2.5 m80 -116.86 42.07 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.534 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.89 37.99 16.11 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 160.93 -47.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -1.12 . . . . 0.0 109.412 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.511 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 10.2 m95 -128.87 119.66 24.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.488 -0.757 . . . . 0.0 108.959 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -113.24 167.32 10.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.054 -1.029 . . . . 0.0 109.403 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.796 ' O ' HD12 ' A' ' 38' ' ' LEU . 2.2 tttp -110.44 116.06 30.74 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 36' ' ' LYS . . . -116.45 -172.29 2.16 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.415 -0.803 . . . . 0.0 110.417 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -144.04 154.44 43.24 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -94.55 126.87 40.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 0.0 110.195 -178.72 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.72 -11.87 60.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.153 -0.967 . . . . 0.0 109.359 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 tp -83.33 -55.73 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 109.728 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.12 10.04 28.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 48.25 24.63 0.71 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.428 -0.795 . . . . 0.0 110.111 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -81.42 144.0 31.72 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt-20 -120.52 149.1 42.95 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 109.392 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.687 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -169.01 -166.35 27.92 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.437 ' HE1' ' CE1' ' A' ' 41' ' ' HIS . 1.8 m-85 -96.91 133.8 41.07 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.382 -1.069 . . . . 0.0 109.345 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 58' ' ' ILE . 17.8 pt -125.87 140.31 36.41 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 108.88 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.628 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 53.4 Cg_endo -75.05 159.15 41.51 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 121.694 1.596 . . . . 0.0 110.706 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.447 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 99.5 p -89.73 28.82 1.25 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.684 -1.26 . . . . 0.0 109.705 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -140.48 -1.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 109.999 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.628 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 8.4 m-85 -100.74 -26.6 13.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 0.0 110.07 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.597 HG11 ' CE ' ' A' ' 35' ' ' MET . 14.5 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.041 -1.037 . . . . 0.0 109.644 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.762 HD13 ' HG3' ' A' ' 36' ' ' LYS . 19.4 mm -106.02 129.96 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.162 -0.961 . . . . 0.0 109.561 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.57 156.31 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 8.1 p -114.04 134.45 56.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.027 -1.046 . . . . 0.0 108.807 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.577 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -55.85 115.36 2.34 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.545 -0.722 . . . . 0.0 109.849 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.2 mt -88.02 -28.99 21.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -136.62 139.95 30.76 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.0 Cg_endo -60.76 141.39 94.78 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.857 2.372 . . . . 0.0 111.642 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.3 t80 -133.78 124.92 27.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 109.906 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.564 ' O ' ' C ' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -102.94 110.32 22.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.021 -1.049 . . . . 0.0 108.805 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.83 91.07 0.01 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.56 ' N ' ' O ' ' A' ' 20' ' ' ASP . 14.2 mt -91.76 -14.35 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.282 -1.128 . . . . 0.0 108.524 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.569 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.35 175.78 1.74 Allowed Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 50.7 Cg_endo -71.43 -31.67 13.57 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.4 2.067 . . . . 0.0 111.903 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.517 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.1 m-20 -112.0 -9.34 14.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 110.218 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -60.04 123.37 16.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.948 -1.095 . . . . 0.0 109.713 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.103 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -88.07 135.3 33.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.999 -1.063 . . . . 0.0 108.351 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.103 ' N ' HD22 ' A' ' 27' ' ' LEU . 5.8 p -83.81 136.18 34.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.498 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.5 p90 -139.04 147.93 42.71 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 31' ' ' LYS . 4.5 ttmt -108.69 140.39 42.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.028 . . . . 0.0 109.551 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -42.79 152.01 0.11 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.92 -17.11 7.43 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -82.53 151.75 26.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.057 -1.261 . . . . 0.0 109.728 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -105.56 145.85 30.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.459 -0.776 . . . . 0.0 109.895 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.611 ' CE ' HG11 ' A' ' 63' ' ' VAL . 8.5 mtm -138.26 154.11 49.06 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.649 0.738 . . . . 0.0 109.669 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.762 ' HG3' HD13 ' A' ' 12' ' ' ILE . 4.2 ttpm? -119.72 134.33 55.27 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.63 HG11 ' CB ' ' A' ' 45' ' ' TRP . 1.5 t -96.84 119.9 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 110.14 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 mt -85.31 -20.41 30.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.366 -0.834 . . . . 0.0 110.011 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.24 141.2 20.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.902 -1.124 . . . . 0.0 109.763 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 2.9 tt0 -109.31 137.4 47.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.409 -0.807 . . . . 0.0 108.955 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.609 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 68.7 m-70 -123.43 36.25 4.68 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.208 -0.933 . . . . 0.0 109.197 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.85 -104.11 3.14 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.8 -8.82 48.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -1.088 . . . . 0.0 110.606 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.609 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 17.3 m95 -131.89 124.95 30.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.782 -1.199 . . . . 0.0 110.401 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.632 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.3 168.22 13.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.145 -0.972 . . . . 0.0 109.678 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.17 129.29 56.0 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -124.83 -172.21 2.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 110.537 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.561 ' CG ' ' HB3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -138.77 147.49 42.68 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' LYS . 8.4 t -88.26 124.92 34.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.04 -1.038 . . . . 0.0 109.491 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.2 -13.13 62.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 109.427 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.3 tp -80.65 -57.13 3.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.457 -0.777 . . . . 0.0 109.906 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.4 3.79 23.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 49' ' ' SER . 9.1 mttt 58.42 25.37 12.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.751 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 8.6 mmtp -78.13 142.05 38.31 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.561 ' HB3' ' CG ' ' A' ' 48' ' ' LYS . 10.0 pt-20 -121.59 139.9 52.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.033 -1.042 . . . . 0.0 109.511 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.698 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.11 -163.78 15.66 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.55 135.21 40.42 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.553 -0.969 . . . . 0.0 109.417 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.638 HD12 HG21 ' A' ' 63' ' ' VAL . 18.4 pt -126.22 142.9 44.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.369 -0.832 . . . . 0.0 109.152 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.547 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 53.8 Cg_endo -75.93 157.42 38.87 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.877 1.718 . . . . 0.0 110.746 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 89.1 p -88.92 28.82 1.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.728 -1.232 . . . . 0.0 110.143 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -138.14 0.16 2.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.025 . . . . 0.0 109.741 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.547 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.5 m-85 -105.45 -26.3 11.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.097 -1.002 . . . . 0.0 109.4 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.638 HG21 HD12 ' A' ' 58' ' ' ILE . 18.0 m . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.637 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.582 ' CB ' HG13 ' A' ' 37' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.537 HD11 ' HD3' ' A' ' 36' ' ' LYS . 10.1 mm -107.25 130.39 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 109.356 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.32 153.34 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.274 -0.891 . . . . 0.0 108.928 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 8.7 p -112.41 133.61 57.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 118.841 -1.143 . . . . 0.0 109.168 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -58.18 118.71 5.76 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.494 -0.754 . . . . 0.0 110.285 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.428 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 13.3 mt -91.82 -26.94 18.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -137.34 141.96 35.84 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.0 Cg_endo -62.57 141.49 86.37 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.716 2.277 . . . . 0.0 111.831 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.4 t80 -132.65 123.69 26.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 109.419 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -102.58 110.64 22.65 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.008 -1.058 . . . . 0.0 108.798 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.4 89.69 0.01 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' ASP . 6.2 mt -92.3 -14.27 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -1.163 . . . . 0.0 108.476 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.505 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -113.37 175.24 1.93 Allowed Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 52.9 Cg_endo -72.03 -32.85 10.44 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.414 2.076 . . . . 0.0 112.181 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.537 ' OD2' ' CE ' ' A' ' 46' ' ' LYS . 55.7 t0 -112.77 -10.38 13.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.123 -0.985 . . . . 0.0 110.611 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 44.5 m-20 -60.15 116.41 4.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.951 -1.093 . . . . 0.0 109.797 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.107 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.08 135.85 38.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.934 -1.104 . . . . 0.0 108.286 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.107 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.3 p -85.11 137.08 33.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -0.978 . . . . 0.0 110.423 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.635 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 12.3 p90 -140.4 148.81 41.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.0 108.701 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -108.19 140.62 41.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.027 -1.045 . . . . 0.0 109.428 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.01 152.44 0.11 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.59 -16.74 7.53 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -83.23 151.98 25.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -1.204 . . . . 0.0 109.659 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.697 ' HB2' HD12 ' A' ' 50' ' ' LEU . 13.4 mtmt -105.14 143.86 32.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.816 . . . . 0.0 110.093 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.726 ' CE ' HG11 ' A' ' 63' ' ' VAL . 6.7 mtm -136.91 154.71 50.39 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.619 0.723 . . . . 0.0 109.585 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 10.1 ttpt -121.26 136.12 55.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 ' CB ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -103.12 119.72 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.487 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.822 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -85.64 -31.91 22.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 109.55 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -143.34 139.06 29.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.509 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.635 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tt0 -111.86 145.1 40.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.667 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 11.6 m80 -114.68 43.25 1.97 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 109.523 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 48.13 40.53 21.34 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.584 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 158.7 -48.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.29 -1.123 . . . . 0.0 109.574 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 8.3 m95 -129.38 120.87 26.28 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.413 -0.804 . . . . 0.0 109.111 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.682 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.17 168.65 9.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.184 -0.948 . . . . 0.0 109.631 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.822 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -110.05 116.12 31.0 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.54 -174.84 2.56 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 110.498 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.5 ttmt -137.55 147.72 45.36 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.655 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -88.56 129.39 35.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.03 -1.044 . . . . 0.0 109.921 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.697 HD12 ' HB2' ' A' ' 34' ' ' LYS . 5.8 mt -68.76 -24.46 64.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.04 . . . . 0.0 109.835 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.6 tp -86.52 -42.36 13.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.966 . . . . 0.0 109.92 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 49' ' ' SER . 1.2 p -99.1 -16.78 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.376 -0.828 . . . . 0.0 109.16 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.655 ' N ' ' O ' ' A' ' 49' ' ' SER . 13.7 mttt 59.56 11.88 2.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.323 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -81.69 151.57 27.48 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 14.2 pt-20 -119.63 146.62 45.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.897 -1.127 . . . . 0.0 109.515 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.659 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -169.85 164.66 38.08 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.591 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -68.05 133.38 48.9 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.492 -1.005 . . . . 0.0 109.962 -179.433 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.5 pt -124.47 143.04 42.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.0 Cg_endo -73.69 153.57 48.79 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.543 1.495 . . . . 0.0 110.68 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.467 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 91.8 p -87.6 29.37 0.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.616 -1.302 . . . . 0.0 109.954 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -139.81 0.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 109.794 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.649 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 17.2 m-85 -102.06 -25.64 13.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.985 . . . . 0.0 110.198 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.726 HG11 ' CE ' ' A' ' 35' ' ' MET . 14.8 m . . . . . 0 N--CA 1.492 1.657 0 O-C-N 120.997 -1.064 . . . . 0.0 110.061 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.322 0.582 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.874 HD13 ' HG2' ' A' ' 36' ' ' LYS . 10.1 mm -108.0 132.44 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.275 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.49 156.66 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.933 . . . . 0.0 109.185 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 13.0 p -113.47 134.95 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.053 -1.029 . . . . 0.0 109.084 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.66 118.94 5.78 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.483 -0.761 . . . . 0.0 110.302 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 12.6 mt -91.19 -28.56 17.76 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -137.24 142.49 37.99 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.1 Cg_endo -61.13 140.88 91.77 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.783 2.322 . . . . 0.0 111.413 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.5 t80 -133.75 125.74 29.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.998 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -103.38 107.68 18.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.034 -1.041 . . . . 0.0 108.518 179.052 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 26' ' ' ASP . . . -30.36 92.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.4 mt -79.32 -59.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -66.66 176.1 1.18 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.643 -0.661 . . . . 0.0 109.241 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.5 Cg_endo -71.73 -25.07 20.85 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.528 2.152 . . . . 0.0 111.938 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.2 t70 -112.65 -7.83 13.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.285 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.586 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -60.14 122.78 15.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.968 -1.082 . . . . 0.0 109.763 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.118 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -88.8 135.01 33.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.994 -1.066 . . . . 0.0 108.406 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.118 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.2 m -84.49 136.7 33.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.728 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.653 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.8 p90 -138.91 147.84 42.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 108.586 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.53 140.05 41.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.018 -1.051 . . . . 0.0 109.635 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.83 152.16 0.08 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.88 -15.7 7.85 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -83.34 152.46 25.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.087 -1.243 . . . . 0.0 109.838 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.478 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 30.6 ttmt -105.72 146.08 30.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 109.917 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.695 ' CE ' HG11 ' A' ' 63' ' ' VAL . 3.6 mtm -137.73 154.71 49.59 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.64 0.733 . . . . 0.0 109.919 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.874 ' HG2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -117.86 132.65 56.4 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 p -103.82 119.41 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.961 . . . . 0.0 109.449 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -89.76 -45.87 9.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -0.86 . . . . 0.0 109.953 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 3.7 tt0 -122.97 136.14 54.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.621 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.583 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tt0 -111.74 143.8 42.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.542 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 28.3 m80 -113.13 44.52 1.52 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.521 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 49.91 36.44 26.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 160.01 -45.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -1.175 . . . . 0.0 109.729 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.542 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 7.5 m95 -128.54 122.58 31.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.014 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -116.7 168.54 10.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.139 -0.976 . . . . 0.0 109.96 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.803 ' O ' HD12 ' A' ' 38' ' ' LEU . 11.3 ttpt -109.41 117.61 34.47 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.32 -173.62 2.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.237 -0.915 . . . . 0.0 110.586 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.7 ttmt -139.01 148.59 43.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 17.3 t -90.05 126.82 35.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.046 -1.034 . . . . 0.0 109.55 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.409 HD13 ' HD2' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -70.32 -11.32 60.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 109.424 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.7 tp -81.99 -57.43 3.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.719 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 54' ' ' LYS . 4.6 t -108.99 7.97 26.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.372 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 49' ' ' SER . 19.2 mttt 53.95 25.76 5.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 109.897 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 1.048 ' HG2' HD23 ' A' ' 27' ' ' LEU . 12.5 tttp -80.29 142.8 34.19 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 21.7 pt-20 -121.36 144.63 48.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.98 -1.075 . . . . 0.0 109.6 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.683 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -165.64 -164.24 20.7 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.49 132.99 41.51 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.374 -1.074 . . . . 0.0 109.633 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 58' ' ' ILE . 11.2 pt -125.99 135.99 27.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.527 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 54.3 Cg_endo -77.95 166.23 25.3 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.591 1.527 . . . . 0.0 111.213 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.511 ' HG ' ' HZ2' ' A' ' 45' ' ' TRP . 35.4 t -91.79 29.17 1.6 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.987 -1.071 . . . . 0.0 109.699 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -140.78 0.09 1.57 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.967 . . . . 0.0 109.719 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.527 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.3 m-85 -100.5 -28.72 12.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.079 -1.013 . . . . 0.0 109.664 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.695 HG11 ' CE ' ' A' ' 35' ' ' MET . 6.1 m . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 109.829 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.692 HD13 ' HG3' ' A' ' 36' ' ' LYS . 17.2 mm -106.74 132.01 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.357 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.82 157.23 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.28 -0.888 . . . . 0.0 109.269 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 6.4 p -113.55 134.63 55.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.077 -1.015 . . . . 0.0 108.552 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.663 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -56.24 115.81 2.68 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.69 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 9.8 mt -88.6 -28.15 20.88 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -136.74 141.02 33.66 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.6 Cg_endo -61.87 141.91 91.49 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.863 2.375 . . . . 0.0 111.82 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.6 t80 -133.55 124.41 26.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.84 . . . . 0.0 109.748 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -102.47 110.91 22.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.987 -1.071 . . . . 0.0 108.727 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.41 90.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.5 mt -93.52 -14.17 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -1.142 . . . . 0.0 108.591 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.66 175.91 1.68 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.2 Cg_endo -72.2 -33.31 9.48 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.46 2.106 . . . . 0.0 112.038 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.491 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 14.0 t0 -112.14 -10.04 13.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 110.366 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 34.1 m-20 -60.58 116.82 4.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.031 -1.043 . . . . 0.0 109.829 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.109 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -79.44 135.79 36.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.941 -1.1 . . . . 0.0 108.509 179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.109 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.3 p -83.73 136.06 34.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 110.493 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.4 p90 -139.49 148.32 42.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.867 . . . . 0.0 108.826 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 31' ' ' LYS . 2.7 ttpt -108.77 140.61 41.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.94 -1.1 . . . . 0.0 109.572 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -42.86 152.7 0.1 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.29 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.19 -16.89 6.74 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.4 tp10 -83.12 152.86 25.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.035 -1.273 . . . . 0.0 109.801 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -105.38 145.42 30.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.473 -0.767 . . . . 0.0 109.662 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.728 ' CE ' HG11 ' A' ' 63' ' ' VAL . 6.6 mtm -137.16 154.17 50.29 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.71 0.767 . . . . 0.0 109.957 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.692 ' HG3' HD13 ' A' ' 12' ' ' ILE . 1.6 ttpm? -118.18 129.01 55.25 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.63 120.03 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 109.344 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.704 ' H ' HD12 ' A' ' 38' ' ' LEU . 1.7 mp -86.65 -37.51 17.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 109.581 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -134.8 136.68 42.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.954 . . . . 0.0 109.653 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.63 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.3 tt0 -110.32 145.07 38.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 22.6 m80 -111.81 46.23 1.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.122 -0.986 . . . . 0.0 109.584 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 50.57 32.06 23.26 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 161.19 -42.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.058 -1.26 . . . . 0.0 109.869 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.614 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 50.4 m95 -127.2 122.0 32.85 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 108.908 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.648 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -118.82 168.76 10.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.079 -1.013 . . . . 0.0 109.726 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -108.85 121.15 44.48 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -125.7 146.68 49.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 110.983 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 1.7 ptpt -102.44 155.41 18.27 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 4.8 t -98.07 129.88 44.89 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.958 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.82 -12.55 61.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.2 tp -73.27 -62.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 109.714 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.9 -0.28 21.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.407 -0.808 . . . . 0.0 109.349 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 66.93 24.86 9.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -0.894 . . . . 0.0 109.892 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 5.6 mmtt -79.5 140.31 37.32 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 mt-10 -121.81 143.46 49.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.052 -1.03 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.694 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -166.39 -164.72 22.5 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.614 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -96.17 133.04 40.96 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.365 -1.08 . . . . 0.0 109.153 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.818 HD12 HG21 ' A' ' 63' ' ' VAL . 33.2 pt -125.03 141.47 38.51 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.037 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.612 ' HB3' ' CH2' ' A' ' 44' ' ' TRP . 50.6 Cg_endo -72.24 152.56 55.95 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.927 1.751 . . . . 0.0 110.831 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 91.1 p -87.03 28.75 0.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.553 -1.342 . . . . 0.0 109.974 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -137.52 -4.09 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.832 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.575 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 5.2 m-85 -101.67 -24.2 14.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.947 -1.096 . . . . 0.0 109.068 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.818 HG21 HD12 ' A' ' 58' ' ' ILE . 19.7 m . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 109.239 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.255 0.55 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.5 mm -106.2 130.9 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.304 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.76 155.99 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.249 -0.907 . . . . 0.0 109.135 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 12.2 p -113.89 134.88 55.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 120.932 -1.105 . . . . 0.0 108.735 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.49 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -57.83 115.98 3.17 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.527 -0.733 . . . . 0.0 109.951 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.2 mt -89.64 -27.39 20.2 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -137.89 140.98 31.06 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 39.4 Cg_endo -61.98 141.72 90.23 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.629 2.219 . . . . 0.0 111.516 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 38.3 t80 -133.54 124.67 27.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 109.982 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 5.4 m-20 -103.52 109.95 21.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 108.487 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.31 89.14 0.01 OUTLIER Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.3 mt -86.78 -13.46 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.225 -1.162 . . . . 0.0 108.544 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.587 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.91 176.77 1.37 Allowed Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.0 Cg_endo -73.05 -30.18 11.06 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.395 2.064 . . . . 0.0 111.949 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 24.1 t0 -113.2 -9.54 13.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 110.384 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 2.5 m-20 -59.83 122.19 13.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.928 -1.107 . . . . 0.0 109.83 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.104 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -82.9 136.81 34.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.985 -1.072 . . . . 0.0 108.231 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.104 ' N ' HD22 ' A' ' 27' ' ' LEU . 39.5 p -86.41 137.36 32.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.079 -1.013 . . . . 0.0 110.623 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.2 p90 -140.29 149.23 42.54 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -108.77 141.14 41.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.996 -1.065 . . . . 0.0 109.615 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.73 151.83 0.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.083 -1.01 . . . . 0.0 108.386 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.37 -17.21 6.62 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -82.78 152.55 25.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.035 -1.273 . . . . 0.0 109.841 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -105.35 144.58 31.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.692 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.795 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -138.09 153.81 49.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.515 0.674 . . . . 0.0 109.666 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 5.2 ttmt -117.75 130.09 56.1 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.4 p -98.26 120.74 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.113 -0.992 . . . . 0.0 109.625 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.31 -48.82 7.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 0.0 109.827 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 24.8 tt0 -119.03 134.58 55.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.069 -1.019 . . . . 0.0 109.926 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.62 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.8 tt0 -110.54 144.53 39.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 36.3 m80 -116.74 47.14 1.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 109.756 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.38 34.22 8.85 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.2 OUTLIER 161.08 -43.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -1.103 . . . . 0.0 109.872 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.563 ' CH2' ' HB3' ' A' ' 59' ' ' PRO . 39.2 m95 -127.16 120.78 29.63 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.62 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -117.04 168.29 10.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.029 -1.044 . . . . 0.0 109.555 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -109.53 122.83 48.3 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.7 -174.59 2.51 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 110.812 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -135.93 145.43 46.25 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -85.38 123.87 31.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.0 109.656 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.52 -9.24 53.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.09 -1.007 . . . . 0.0 109.429 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.0 tp -88.97 -53.46 4.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 109.717 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -109.42 7.01 24.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.842 . . . . 0.0 109.412 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 49' ' ' SER . 6.2 mmtp 52.39 26.24 4.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.926 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.12 142.29 32.38 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 6.9 mt-10 -118.65 139.54 51.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.912 -1.118 . . . . 0.0 109.646 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.671 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.79 -162.3 11.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 4.5 m-85 -99.91 133.34 44.42 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.377 -1.073 . . . . 0.0 109.5 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.682 HD12 HG21 ' A' ' 63' ' ' VAL . 18.0 pt -125.0 139.81 34.46 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.563 ' HB3' ' CH2' ' A' ' 44' ' ' TRP . 54.2 Cg_endo -77.42 162.47 30.74 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.712 1.608 . . . . 0.0 111.248 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.582 ' HG ' ' HZ2' ' A' ' 45' ' ' TRP . 41.9 t -91.77 30.06 1.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.797 -1.189 . . . . 0.0 109.794 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -137.81 -0.15 2.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.99 . . . . 0.0 109.743 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.546 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 8.7 m-85 -107.65 -26.91 10.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 108.932 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.795 HG11 ' CE ' ' A' ' 35' ' ' MET . 12.2 m . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.452 -0.78 . . . . 0.0 109.284 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.607 HD12 ' CG ' ' A' ' 36' ' ' LYS . 13.2 mm -105.63 130.94 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.213 -0.929 . . . . 0.0 109.157 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.82 155.96 42.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.299 -0.875 . . . . 0.0 109.332 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 7.6 p -114.26 134.26 57.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.168 -0.957 . . . . 0.0 108.596 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -54.95 113.99 1.56 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.338 -0.851 . . . . 0.0 109.791 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.5 mt -86.5 -29.58 22.63 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -136.35 139.95 31.21 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 38.4 Cg_endo -61.52 141.76 92.76 Favored 'Trans proline' 0 C--O 1.216 -0.584 0 C-N-CA 122.891 2.394 . . . . 0.0 111.82 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.7 t80 -134.02 125.35 27.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.755 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 22' ' ' ILE . 11.0 t70 -102.73 110.71 22.73 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.986 -1.071 . . . . 0.0 108.673 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.55 90.31 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.7 mt -92.72 -14.32 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -1.143 . . . . 0.0 108.662 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.57 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -113.89 174.95 2.06 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.57 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.4 Cg_endo -71.08 -32.72 12.78 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.425 2.083 . . . . 0.0 111.806 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -111.88 -9.67 14.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 110.284 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.01 123.27 16.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.905 -1.122 . . . . 0.0 109.796 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.114 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -86.38 135.56 33.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.94 -1.1 . . . . 0.0 108.286 179.207 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.114 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -84.35 136.5 33.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 110.422 -178.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 9.4 p90 -139.74 148.39 42.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.922 . . . . 0.0 108.673 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.84 142.54 39.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.026 . . . . 0.0 109.588 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -44.43 152.01 0.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.019 -1.05 . . . . 0.0 108.325 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.4 -16.79 7.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -82.61 152.08 26.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.023 -1.281 . . . . 0.0 109.676 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -106.03 146.04 30.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.421 -0.799 . . . . 0.0 110.005 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.731 ' CE ' HG11 ' A' ' 63' ' ' VAL . 8.0 mtm -137.52 153.77 49.96 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.695 0.76 . . . . 0.0 109.838 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.607 ' CG ' HD12 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -116.41 130.1 56.58 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.628 HG11 ' CB ' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -96.44 119.99 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.936 -1.103 . . . . 0.0 110.113 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.44 -24.02 39.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.505 -0.747 . . . . 0.0 109.738 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -158.68 145.58 17.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.091 -1.006 . . . . 0.0 110.041 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.65 ' HG3' ' CG ' ' A' ' 45' ' ' TRP . 12.2 tt0 -111.42 143.06 42.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 0.0 109.392 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 75.1 m80 -116.63 42.95 2.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.099 -1.001 . . . . 0.0 109.677 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.603 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.83 41.97 21.08 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.603 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 156.37 -48.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -1.079 . . . . 0.0 109.911 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 59' ' ' PRO . 13.4 m95 -126.65 122.99 36.56 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 109.017 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.65 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.17 166.28 12.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 109.841 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.13 123.45 50.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -122.51 -171.32 2.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.695 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 ttpm? -140.75 150.58 43.58 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -90.11 126.1 35.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.011 -1.055 . . . . 0.0 109.964 -179.116 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -14.5 63.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.005 . . . . 0.0 109.445 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 tp -85.06 -53.49 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -109.28 13.54 24.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.264 -0.898 . . . . 0.0 109.348 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' SER . 18.7 mttp 44.44 25.38 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.352 -0.843 . . . . 0.0 109.798 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.8 mtpm? -79.45 141.17 37.02 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.13 -0.981 . . . . 0.0 108.355 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 12.5 pt-20 -121.72 144.08 48.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.032 -1.043 . . . . 0.0 109.576 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.697 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -166.69 -163.54 20.64 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.62 134.42 40.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.576 -0.955 . . . . 0.0 109.371 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.621 HD12 HG21 ' A' ' 63' ' ' VAL . 11.9 pt -125.96 142.22 41.75 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.098 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 49.7 Cg_endo -72.4 153.03 55.6 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.811 1.674 . . . . 0.0 110.638 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 80.7 p -86.25 29.45 0.75 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.546 -1.346 . . . . 0.0 109.969 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -138.27 0.61 2.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 0.0 109.736 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.567 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.5 m-85 -105.35 -25.51 12.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.009 . . . . 0.0 109.479 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.731 HG11 ' CE ' ' A' ' 35' ' ' MET . 18.8 m . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 1.6 m-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.288 0.566 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.6 mm -105.85 129.77 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.52 154.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.36 -0.838 . . . . 0.0 108.898 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.524 HG23 ' HG2' ' A' ' 34' ' ' LYS . 9.4 p -114.16 133.93 58.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 120.987 -1.07 . . . . 0.0 108.837 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.685 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -56.61 115.3 2.46 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.471 -0.768 . . . . 0.0 109.682 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.1 mt -88.4 -27.21 21.73 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -137.51 139.96 28.88 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 39.0 Cg_endo -61.87 142.24 92.64 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.652 2.234 . . . . 0.0 111.47 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 39.7 t80 -134.23 125.9 28.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 0.0 109.989 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' C ' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -103.22 110.67 22.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.061 -1.024 . . . . 0.0 108.751 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.573 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.68 91.92 0.01 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.5 mt -93.32 -13.01 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -1.117 . . . . 0.0 108.716 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 26' ' ' ASP . 1.7 m-70 -114.65 174.16 2.5 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 50.8 Cg_endo -71.02 -32.42 13.39 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.388 2.059 . . . . 0.0 112.046 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -112.2 -9.88 13.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.165 -0.96 . . . . 0.0 110.285 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -59.81 126.81 29.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.06 . . . . 0.0 109.857 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.09 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -87.53 137.07 32.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.09 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.0 m -87.48 137.98 31.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 7.7 p90 -141.08 150.14 42.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.85 . . . . 0.0 108.804 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -108.92 138.58 45.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.068 -1.02 . . . . 0.0 109.581 -179.352 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LYS . 4.1 ptpt -42.16 152.06 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.37 -17.54 7.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -82.1 150.47 27.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.146 -1.208 . . . . 0.0 109.673 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HG2' HG23 ' A' ' 14' ' ' VAL . 12.7 mmtt -105.28 145.03 31.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.435 -0.79 . . . . 0.0 109.799 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.745 ' CE ' HG11 ' A' ' 63' ' ' VAL . 11.7 mtm -137.39 153.67 50.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.519 -0.738 . . . . 0.0 109.743 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.6 tttt -118.38 131.99 56.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.631 HG11 ' CB ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -96.79 121.01 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.986 -1.071 . . . . 0.0 110.366 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.61 -36.49 26.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 109.041 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -128.01 131.56 49.19 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -112.94 98.81 7.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.975 . . . . 0.0 109.802 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 74.0 m80 -75.86 -157.77 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.352 -1.468 . . . . 0.0 108.954 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . -105.49 43.88 1.58 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 2.2 mt-10 163.51 -40.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.141 -1.211 . . . . 0.0 109.115 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.463 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 7.0 m95 -132.39 123.58 27.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.386 -0.821 . . . . 0.0 109.871 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.647 ' CZ2' ' HB2' ' A' ' 60' ' ' SER . 0.1 OUTLIER -115.54 168.58 9.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.396 -0.815 . . . . 0.0 109.807 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -110.74 121.29 44.96 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -120.17 -170.64 2.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.907 . . . . 0.0 110.631 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -142.04 150.75 41.68 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 53' ' ' LYS . 25.6 t -90.05 125.91 35.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 109.791 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -9.95 57.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 0.0 109.321 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 51' ' ' LEU . 15.6 tp -82.76 -57.53 3.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.314 -0.867 . . . . 0.0 109.812 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -109.32 2.22 20.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 109.378 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' SER . 19.5 mttt 61.99 26.68 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 109.845 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 7.4 mmtp -81.94 140.01 34.28 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.3 pm0 -121.29 144.16 48.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.996 -1.065 . . . . 0.0 109.834 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.721 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -171.49 166.66 39.71 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 10.2 m-85 -66.92 135.09 53.29 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.362 -1.081 . . . . 0.0 109.763 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.472 HG22 ' CE1' ' A' ' 29' ' ' PHE . 2.6 pt -124.92 146.4 53.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.392 -0.818 . . . . 0.0 109.0 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 48.4 Cg_endo -71.95 146.85 48.2 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.98 1.787 . . . . 0.0 110.615 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.647 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 80.6 p -85.09 29.72 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.43 -1.419 . . . . 0.0 110.187 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -137.64 0.43 2.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.119 -0.988 . . . . 0.0 109.737 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.609 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 36.6 m-85 -107.54 -23.84 12.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.092 -1.005 . . . . 0.0 109.467 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.745 HG11 ' CE ' ' A' ' 35' ' ' MET . 29.3 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.0 mm -107.7 131.03 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.419 HG11 ' HZ3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -129.94 154.32 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.24 -0.912 . . . . 0.0 109.107 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.772 ' O ' HD23 ' A' ' 16' ' ' LEU . 12.9 p -116.16 135.17 57.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.075 -1.016 . . . . 0.0 109.001 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -58.95 118.74 6.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.645 -0.659 . . . . 0.0 110.843 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.772 HD23 ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -89.87 -26.4 20.51 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.508 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . 50.6 m-85 -138.26 141.77 32.97 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 40.2 Cg_endo -62.57 141.72 87.22 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.595 2.196 . . . . 0.0 111.474 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 42.8 t80 -133.84 125.39 28.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 0.0 109.8 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' ILE . 6.4 t70 -103.17 110.01 21.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.106 -0.996 . . . . 0.0 108.666 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.04 89.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.4 mp -88.33 -13.42 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.158 -1.201 . . . . 0.0 108.552 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.506 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -114.6 174.91 2.09 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 51.2 Cg_endo -71.38 -31.39 14.11 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.415 2.077 . . . . 0.0 111.906 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 9.4 t70 -112.54 -9.85 13.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.394 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.477 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -59.59 127.27 31.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.941 -1.099 . . . . 0.0 109.806 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.101 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -88.52 136.19 33.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.983 -1.073 . . . . 0.0 108.372 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.101 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.7 m -86.85 137.79 32.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.989 . . . . 0.0 110.452 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.663 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 10.0 p90 -141.37 150.34 42.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 0.0 108.802 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -108.53 137.62 46.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.052 -1.03 . . . . 0.0 109.303 -179.562 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.25 153.55 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.416 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.87 -17.52 4.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -82.2 154.46 25.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.042 -1.269 . . . . 0.0 109.703 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -106.32 142.93 35.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.768 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -137.67 153.71 49.79 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.497 0.665 . . . . 0.0 109.325 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.2 ptpt -118.34 131.68 56.31 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.381 -0.824 . . . . 0.0 108.818 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -100.65 120.25 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.337 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.56 -37.44 16.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 109.914 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -132.72 136.76 46.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.065 -1.022 . . . . 0.0 109.89 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.625 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.4 tt0 -111.21 146.41 36.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.547 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 45.2 m80 -116.64 46.34 1.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.692 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 48.61 32.36 10.66 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 162.36 -42.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -1.199 . . . . 0.0 109.831 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.547 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 12.9 m95 -127.5 120.9 29.34 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.44 -0.788 . . . . 0.0 108.875 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.83 166.94 11.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.018 -1.051 . . . . 0.0 109.822 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.469 ' HG2' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -109.66 121.16 44.58 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.12 -173.82 2.43 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 110.644 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -137.21 146.41 44.83 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -85.12 123.58 30.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.675 -179.231 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -8.76 49.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.088 -1.007 . . . . 0.0 109.308 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.95 -54.42 4.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 109.898 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -109.55 1.97 20.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' SER . 21.7 mmtm 59.71 26.66 15.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.227 -0.921 . . . . 0.0 109.744 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HD2' HD23 ' A' ' 27' ' ' LEU . 5.1 ttmm -83.95 141.73 31.03 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 12.8 pt-20 -118.71 137.99 52.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.996 -1.065 . . . . 0.0 109.822 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.661 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -163.37 163.54 35.63 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.436 ' HE1' ' CE1' ' A' ' 41' ' ' HIS . 18.6 m-85 -65.69 133.93 52.13 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.351 -1.087 . . . . 0.0 109.98 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.627 HD12 HG21 ' A' ' 63' ' ' VAL . 7.7 pt -123.43 144.05 42.99 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.729 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.6 Cg_endo -71.57 148.19 53.15 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.941 1.761 . . . . 0.0 110.786 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 89.3 p -86.14 29.5 0.74 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.481 -1.387 . . . . 0.0 110.241 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -136.99 -1.86 2.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.091 -1.006 . . . . 0.0 109.935 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.729 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 4.8 m-85 -106.64 -23.12 12.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 109.207 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.768 HG11 ' CE ' ' A' ' 35' ' ' MET . 11.0 m . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.375 -0.828 . . . . 0.0 109.32 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 12' ' ' ILE . 19.8 mm -105.42 130.3 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.212 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.07 156.75 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.345 -0.847 . . . . 0.0 109.125 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 p -114.49 134.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.845 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.605 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -57.23 116.67 3.42 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.531 -0.73 . . . . 0.0 109.907 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.4 mt -89.27 -27.74 20.37 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -137.58 141.79 34.65 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.6 Cg_endo -61.83 141.41 89.98 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.731 2.287 . . . . 0.0 111.571 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.649 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 41.2 t80 -134.66 126.25 28.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 110.182 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 22' ' ' ILE . 12.1 t70 -102.0 107.87 19.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.054 -1.029 . . . . 0.0 108.282 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -31.06 90.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.7 mt -79.56 -59.91 2.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.506 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -65.34 173.75 1.73 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.609 -0.682 . . . . 0.0 109.401 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -71.53 -26.59 19.82 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.68 2.253 . . . . 0.0 112.29 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -113.23 -9.87 13.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.532 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.446 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 48.4 m-20 -59.69 121.78 12.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.915 -1.116 . . . . 0.0 109.782 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.12 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -83.39 135.78 34.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.965 -1.084 . . . . 0.0 108.405 179.372 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.12 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.2 m -85.23 136.41 33.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 110.362 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.5 p90 -139.77 148.71 42.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.302 -0.874 . . . . 0.0 108.709 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.52 141.21 40.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.963 -1.086 . . . . 0.0 109.557 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.63 152.23 0.16 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.37 -17.15 6.67 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 5.4 tp10 -82.45 152.64 26.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.051 -1.264 . . . . 0.0 109.77 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 7.0 mttm -105.88 145.22 31.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.918 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.755 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -138.42 154.11 48.88 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.553 -0.717 . . . . 0.0 109.647 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.691 ' HD3' HD11 ' A' ' 38' ' ' LEU . 5.4 tttp -120.62 136.48 54.8 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.658 HG11 ' CB ' ' A' ' 45' ' ' TRP . 3.3 t -98.4 119.14 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 109.797 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 38' ' ' LEU . 2.3 mm? -88.11 -19.67 26.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.507 -0.746 . . . . 0.0 110.191 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' NE2' ' A' ' 41' ' ' HIS . 12.4 pt-20 -146.91 138.95 24.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.966 -1.084 . . . . 0.0 109.795 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.4 ' OE2' ' N ' ' A' ' 42' ' ' GLY . 2.5 tm-20 -108.65 135.38 49.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.403 -0.81 . . . . 0.0 109.125 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 44.1 m-70 -122.89 36.0 4.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.162 -0.961 . . . . 0.0 109.241 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 93.78 -108.57 3.69 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 60' ' ' SER . 0.4 OUTLIER -87.48 -7.13 57.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 110.01 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.577 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 10.6 m95 -130.21 143.01 50.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.015 -1.053 . . . . 0.0 109.827 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.658 ' CB ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -140.64 167.25 22.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.184 -0.948 . . . . 0.0 109.777 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.94 119.97 40.98 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.57 -172.13 2.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.515 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.1 tttm -138.93 147.86 42.83 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 53' ' ' LYS . 1.4 t -86.14 124.81 32.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 109.588 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -69.51 -10.97 60.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.963 . . . . 0.0 109.394 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.6 tp -86.17 -54.16 4.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -0.855 . . . . 0.0 109.893 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.3 2.0 22.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 109.306 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 49' ' ' SER . 4.8 mttp 57.53 24.73 10.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 110.319 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.5 ttmm -83.23 145.51 29.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 108.253 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -119.46 142.22 48.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.059 -1.025 . . . . 0.0 109.783 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.657 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -167.55 165.12 38.44 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -68.03 135.13 51.8 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.376 -1.073 . . . . 0.0 109.926 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.658 HD12 HG21 ' A' ' 63' ' ' VAL . 10.4 pt -124.43 144.52 46.21 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.64 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.4 Cg_endo -71.95 149.03 52.51 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.028 1.819 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.58 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 46.4 t -86.98 28.76 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.44 -1.413 . . . . 0.0 110.269 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -136.9 -0.98 2.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.956 -1.09 . . . . 0.0 109.818 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.64 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 33.0 m-85 -106.35 -23.81 12.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.003 . . . . 0.0 109.184 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.755 HG11 ' CE ' ' A' ' 35' ' ' MET . 15.6 m . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.298 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.446 HD11 ' HE2' ' A' ' 36' ' ' LYS . 29.7 mm -107.82 132.76 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.839 . . . . 0.0 109.33 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 m -130.31 155.7 41.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.127 -0.983 . . . . 0.0 109.26 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.2 p -113.25 134.6 55.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.107 -0.996 . . . . 0.0 108.775 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.03 117.52 4.07 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 110.131 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 68.7 mt -90.04 -28.21 19.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -137.71 142.93 38.39 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.8 Cg_endo -61.94 140.69 86.29 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.613 2.208 . . . . 0.0 111.419 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.0 t80 -133.78 125.98 29.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 0.0 109.921 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 22' ' ' ILE . 72.5 m-20 -102.86 107.36 18.18 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.954 -1.091 . . . . 0.0 108.385 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.13 90.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 20' ' ' ASP . 16.4 mt -78.77 -59.67 2.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.49 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER -66.25 173.34 2.31 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.614 -0.679 . . . . 0.0 109.222 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 50.4 Cg_endo -70.82 -26.07 23.0 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.723 2.282 . . . . 0.0 112.349 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.7 OUTLIER -113.28 -9.4 13.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -0.927 . . . . 0.0 110.762 -178.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.6 OUTLIER -60.69 116.48 4.43 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.799 -1.188 . . . . 0.0 109.882 -179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.113 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.66 135.63 38.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.981 -1.075 . . . . 0.0 108.408 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.113 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.5 m -85.54 137.13 33.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.627 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.8 p90 -139.36 148.04 42.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.289 -0.882 . . . . 0.0 108.718 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.6 141.09 39.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 109.475 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.479 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -43.11 151.21 0.15 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.141 -0.975 . . . . 0.0 108.438 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.36 -16.58 7.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 15' ' ' ALA . 7.5 tm-20 -82.71 151.93 26.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.138 -1.213 . . . . 0.0 109.722 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 37.7 mtpt -105.43 145.89 30.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.522 -0.736 . . . . 0.0 109.866 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.662 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -140.92 155.55 46.25 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.434 0.635 . . . . 0.0 109.427 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.609 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 4.2 tttm -122.55 139.48 53.86 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -104.43 119.7 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.195 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.7 -27.14 18.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 110.09 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -131.45 135.69 47.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.973 -1.079 . . . . 0.0 109.373 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -109.24 136.9 47.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.261 -0.899 . . . . 0.0 109.2 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.583 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 10.6 m-70 -122.47 37.35 4.41 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 108.947 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 -99.57 2.51 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -90.39 -10.39 44.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -1.113 . . . . 0.0 110.372 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.604 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 6.0 m95 -131.33 138.66 49.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.604 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -135.7 165.38 25.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.337 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.598 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 13.2 tttt -109.61 120.99 44.2 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 36' ' ' LYS . . . -115.76 -173.56 2.37 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.389 -0.819 . . . . 0.0 110.697 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.6 ttpt -137.31 146.92 45.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -85.71 125.09 32.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.001 -1.062 . . . . 0.0 109.687 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.91 -10.34 58.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 109.301 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.6 tp -88.4 -53.8 4.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.712 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.69 8.51 26.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 109.42 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' SER . 10.8 mttt 50.2 25.26 1.72 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.991 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.05 143.85 31.25 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.15 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -119.02 141.64 48.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 109.453 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.678 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.41 -166.42 21.15 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.439 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -96.63 132.92 41.78 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.416 -1.05 . . . . 0.0 109.419 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 58' ' ' ILE . 17.2 pt -125.14 141.1 37.61 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.644 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 51.9 Cg_endo -74.54 157.54 44.61 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 121.673 1.582 . . . . 0.0 110.942 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.486 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 89.2 p -90.31 29.43 1.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.636 -1.29 . . . . 0.0 109.908 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -140.7 -2.67 1.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.644 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 4.9 m-85 -102.23 -24.39 13.91 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.907 -1.121 . . . . 0.0 110.534 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.662 HG11 ' CE ' ' A' ' 35' ' ' MET . 10.5 m . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 0.0 109.97 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.494 ' C ' HD13 ' A' ' 12' ' ' ILE . 13.0 t70 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.723 HD12 ' CG ' ' A' ' 36' ' ' LYS . 6.7 mm -105.55 130.6 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.77 155.97 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.055 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 p -113.69 135.12 54.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.081 -1.012 . . . . 0.0 108.532 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -57.16 114.38 2.13 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.509 -0.744 . . . . 0.0 109.81 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -88.48 -28.4 20.86 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -136.74 139.15 28.22 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 38.4 Cg_endo -61.62 142.28 94.0 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.758 2.305 . . . . 0.0 111.676 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.3 t80 -133.53 124.45 26.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 109.699 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -102.63 111.1 23.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.002 . . . . 0.0 108.521 179.239 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -25.66 88.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' ASP . 34.5 mt -88.99 -13.97 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -1.184 . . . . 0.0 108.636 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.555 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -115.13 175.85 1.73 Allowed Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.555 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.2 Cg_endo -71.93 -32.22 11.53 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.561 2.174 . . . . 0.0 111.697 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -112.34 -10.43 13.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 110.113 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.474 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -60.04 117.54 5.22 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.983 -1.073 . . . . 0.0 109.738 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.117 HD22 ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -81.3 137.18 35.8 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.002 -1.061 . . . . 0.0 108.285 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.117 ' N ' HD22 ' A' ' 27' ' ' LEU . 6.2 p -84.96 137.34 33.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.975 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.1 p90 -139.37 148.77 43.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 2.3 ttmt -108.96 140.26 42.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.977 -1.077 . . . . 0.0 109.697 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' LYS . 1.5 ptmt -43.65 152.66 0.14 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.3 -17.93 5.88 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 6.0 tm-20 -82.23 153.15 26.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.031 -1.276 . . . . 0.0 109.643 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 144.63 32.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.437 -0.79 . . . . 0.0 109.78 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.684 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.1 mpp? -137.64 153.29 49.88 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.52 -0.737 . . . . 0.0 109.624 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.723 ' CG ' HD12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -118.99 132.76 56.09 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.72 HG11 ' HB2' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -97.15 119.91 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.037 . . . . 0.0 109.794 -179.616 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mt -88.04 -22.38 24.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.462 -0.774 . . . . 0.0 110.317 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -146.4 138.81 25.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.798 -1.189 . . . . 0.0 109.771 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -108.76 137.0 47.41 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.412 -0.805 . . . . 0.0 109.13 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.546 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 11.9 m80 -121.56 37.79 4.26 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.23 -0.919 . . . . 0.0 109.058 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.11 -106.08 3.34 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.78 -7.77 55.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -1.074 . . . . 0.0 110.008 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.595 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 29.6 m95 -129.25 139.48 51.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.0 109.777 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.72 ' HB2' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.72 167.34 22.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 109.759 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.561 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 12.2 tttt -110.66 123.51 50.14 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -118.78 -170.88 1.99 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 110.5 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 15.8 ttpt -140.87 150.28 43.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.2 t -88.6 125.51 34.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.058 -1.026 . . . . 0.0 109.783 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -10.75 59.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.184 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.2 tp -85.9 -54.34 4.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 109.847 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.68 8.39 24.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 49' ' ' SER . 53.5 mttp 51.99 26.74 3.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.733 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.0 OUTLIER -84.77 142.86 29.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 4.6 pt-20 -117.98 148.69 41.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.64 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -166.05 -167.4 26.63 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.94 132.91 42.24 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.354 -1.086 . . . . 0.0 109.151 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.787 HD12 HG21 ' A' ' 63' ' ' VAL . 40.0 pt -124.92 140.99 37.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.556 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 51.5 Cg_endo -75.15 157.08 42.34 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.753 1.635 . . . . 0.0 110.837 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.539 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 48.1 t -88.6 29.85 0.96 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.609 -1.307 . . . . 0.0 109.836 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.492 ' OD1' ' C ' ' A' ' 60' ' ' SER . 6.0 m-20 -137.42 0.92 2.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 0.0 109.652 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.556 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 3.0 m-85 -108.19 -26.25 10.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.018 . . . . 0.0 109.286 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.787 HG21 HD12 ' A' ' 58' ' ' ILE . 15.3 m . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 12' ' ' ILE . 18.4 mm -107.3 131.04 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.554 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.56 156.75 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.28 -0.887 . . . . 0.0 108.994 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 p -112.47 134.32 55.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.939 -1.1 . . . . 0.0 109.001 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.35 118.2 4.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.443 -0.785 . . . . 0.0 110.281 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 25.5 mt -90.94 -29.11 17.63 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -137.16 143.05 40.27 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.5 Cg_endo -61.72 140.09 84.19 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.752 2.301 . . . . 0.0 111.552 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 39.2 t80 -134.05 126.37 30.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.957 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 22' ' ' ILE . 3.0 m-20 -103.22 107.39 18.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.942 -1.099 . . . . 0.0 108.516 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.04 91.42 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' ASP . 13.4 mm -79.29 -58.75 3.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.588 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -67.26 175.4 1.55 Allowed Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.4 Cg_endo -71.74 -25.47 20.38 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.637 2.225 . . . . 0.0 112.045 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 35.8 m-20 -112.65 -8.33 13.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.33 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.49 121.05 11.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.026 -1.046 . . . . 0.0 109.754 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.116 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -85.5 134.64 34.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.921 -1.112 . . . . 0.0 108.363 179.262 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.116 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.7 p -84.27 136.93 33.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.955 . . . . 0.0 110.635 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.6 p90 -139.01 147.34 42.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 11.6 mtpp -107.25 140.98 39.29 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.081 -1.012 . . . . 0.0 109.499 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -42.6 151.47 0.12 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.153 -0.967 . . . . 0.0 108.397 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.97 -16.03 7.59 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.9 tp10 -83.33 151.63 25.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.032 -1.275 . . . . 0.0 109.542 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 4.1 mttt -105.77 146.49 29.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.425 -0.797 . . . . 0.0 110.166 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.555 ' HE3' HG11 ' A' ' 63' ' ' VAL . 3.1 mtm -138.2 155.35 48.76 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.663 0.744 . . . . 0.0 109.557 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -123.0 138.86 54.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.0 119.07 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 109.288 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.62 -26.91 16.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.998 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -132.0 135.82 46.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.002 -1.062 . . . . 0.0 109.294 -179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.88 134.78 51.09 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.176 -0.952 . . . . 0.0 109.251 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.608 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 56.5 m-70 -120.61 34.85 5.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.309 -0.869 . . . . 0.0 109.009 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 -108.33 3.66 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 75.3 tt0 -85.15 -7.53 59.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -1.136 . . . . 0.0 109.987 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.611 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 21.4 m95 -132.28 140.13 48.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.948 -1.095 . . . . 0.0 110.315 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.611 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -136.54 166.53 23.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.463 -0.773 . . . . 0.0 109.186 179.086 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -108.73 117.36 33.97 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -112.03 -175.08 2.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.363 -0.836 . . . . 0.0 110.47 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 32.2 ttpt -139.13 148.17 42.88 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.9 t -88.89 124.94 34.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 0.0 109.672 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -69.2 -11.77 61.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.058 -1.026 . . . . 0.0 109.281 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 tp -87.43 -53.57 4.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 0.0 109.769 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.533 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 1.8 t -108.99 14.63 23.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.355 -0.841 . . . . 0.0 109.351 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER 42.43 25.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -80.99 142.67 33.19 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.033 -1.042 . . . . 0.0 108.416 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 18.9 tt0 -121.44 141.09 51.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.092 -1.005 . . . . 0.0 109.6 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.699 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -168.65 166.94 39.98 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -67.76 134.41 50.97 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.431 -1.041 . . . . 0.0 109.913 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.64 142.28 40.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.678 ' CG ' ' CD1' ' A' ' 62' ' ' TYR . 50.1 Cg_endo -72.02 151.26 55.78 Favored 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 121.7 1.6 . . . . 0.0 110.918 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.503 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 98.9 p -87.67 28.09 1.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.55 -1.344 . . . . 0.0 109.983 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -140.27 -4.23 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.086 -1.009 . . . . 0.0 110.032 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.678 ' CD1' ' CG ' ' A' ' 59' ' ' PRO . 7.6 m-85 -98.7 -23.36 15.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.058 -1.026 . . . . 0.0 110.388 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.555 HG11 ' HE3' ' A' ' 35' ' ' MET . 17.5 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.179 . . . . 0.0 109.737 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.615 HD13 ' HG2' ' A' ' 36' ' ' LYS . 34.8 mm -105.37 131.13 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.253 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.8 158.04 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.344 -0.848 . . . . 0.0 109.469 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.04 136.36 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.137 -0.977 . . . . 0.0 109.007 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 31' ' ' LYS . . . -57.39 117.13 3.81 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 109.631 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 mt -90.39 -28.49 18.64 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -136.52 139.41 29.37 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 37.4 Cg_endo -59.73 141.25 96.58 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.925 2.416 . . . . 0.0 111.888 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.599 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 29.7 t80 -131.79 122.82 26.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.0 109.384 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 2.4 m-20 -102.57 110.92 23.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.116 -0.99 . . . . 0.0 108.858 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.97 89.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.3 mt -93.42 -14.98 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -1.131 . . . . 0.0 108.482 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -112.82 174.15 2.47 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 51.0 Cg_endo -70.65 -34.34 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.402 2.068 . . . . 0.0 112.022 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -111.41 -9.61 14.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.118 -0.989 . . . . 0.0 110.361 -179.43 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -60.29 120.62 10.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.975 -1.078 . . . . 0.0 109.772 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.113 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -84.54 135.64 34.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.999 -1.063 . . . . 0.0 108.336 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.113 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -84.3 136.51 33.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.584 -178.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 19' ' ' TYR . 13.9 p90 -140.29 149.1 42.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 108.754 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.535 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -107.68 136.78 46.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.909 -1.119 . . . . 0.0 109.392 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -38.87 154.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 72.5 -15.76 1.99 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.9 OUTLIER -80.17 156.42 26.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.825 -1.397 . . . . 0.0 108.926 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -107.08 144.37 33.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 110.355 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.641 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -140.48 154.79 46.73 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.444 0.64 . . . . 0.0 109.298 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.615 ' HG2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -122.24 139.86 53.28 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.66 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 1.3 t -99.87 119.22 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.015 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -90.23 -21.27 22.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.409 -0.807 . . . . 0.0 110.073 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 48.2 tt0 -144.51 138.12 27.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.932 -1.105 . . . . 0.0 109.787 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.37 133.27 52.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.329 -0.857 . . . . 0.0 109.0 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.522 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 77.9 m-70 -121.6 34.15 5.28 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.216 -0.928 . . . . 0.0 109.361 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.48 -110.53 4.04 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.36 -7.49 58.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -1.137 . . . . 0.0 109.892 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.572 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 m95 -130.65 142.55 50.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.985 -1.072 . . . . 0.0 109.908 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.66 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.85 168.16 20.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.287 -0.883 . . . . 0.0 109.766 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.628 ' O ' HD12 ' A' ' 38' ' ' LEU . 7.9 tttm -110.88 117.38 33.23 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.03 -172.03 2.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 110.354 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 6.8 ttpm? -139.88 149.0 42.86 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -88.44 125.97 35.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.084 -1.01 . . . . 0.0 109.508 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.5 mt -69.98 -13.49 62.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.017 -1.052 . . . . 0.0 109.288 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.8 tp -82.92 -55.62 4.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.798 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.468 ' OG1' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.96 10.61 26.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.386 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.5 OUTLIER 49.72 25.43 1.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.88 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.577 ' HB3' HD23 ' A' ' 27' ' ' LEU . 13.4 mttp -79.47 142.54 35.76 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 6.5 pt-20 -120.99 143.4 49.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.074 -1.016 . . . . 0.0 109.391 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.669 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -165.63 -164.74 21.7 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HB3' ' CZ3' ' A' ' 44' ' ' TRP . 1.7 m-85 -96.63 133.54 41.01 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.394 -1.062 . . . . 0.0 109.46 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 58' ' ' ILE . 20.5 pt -125.64 140.31 36.18 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.607 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 54.5 Cg_endo -77.1 161.23 32.75 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 121.663 1.576 . . . . 0.0 110.963 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.593 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 41.8 t -90.88 29.33 1.37 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.677 -1.265 . . . . 0.0 109.872 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 23.5 t-20 -140.65 -0.1 1.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.607 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 9.8 m-85 -102.12 -26.86 13.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.057 -1.027 . . . . 0.0 110.151 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.641 HG11 ' CE ' ' A' ' 35' ' ' MET . 5.1 m . . . . . 0 N--CA 1.492 1.666 0 O-C-N 120.88 -1.137 . . . . 0.0 110.075 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.699 HD12 ' HD3' ' A' ' 36' ' ' LYS . 1.8 tp -109.83 134.1 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.4 155.65 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.257 -0.902 . . . . 0.0 109.049 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 9.1 p -113.26 134.28 56.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.087 -1.008 . . . . 0.0 108.958 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -56.14 117.44 3.76 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.465 -0.772 . . . . 0.0 110.107 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 63' ' ' VAL . 32.3 mt -89.1 -29.22 19.55 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -136.58 142.49 39.4 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.1 Cg_endo -60.73 140.03 88.61 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.747 2.298 . . . . 0.0 111.675 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 28.6 t80 -131.76 123.21 27.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 109.371 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -103.23 110.09 21.93 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 108.832 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.58 89.24 0.01 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.6 mt -90.75 -14.99 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.329 -1.101 . . . . 0.0 108.424 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.4 176.21 1.57 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -71.77 -32.94 10.91 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.422 2.081 . . . . 0.0 111.897 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 4.8 m-20 -111.46 -8.82 14.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.163 -0.961 . . . . 0.0 110.216 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.463 ' OD1' ' CZ ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -60.69 122.85 15.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.001 -1.062 . . . . 0.0 109.636 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.108 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -87.45 134.8 33.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.962 -1.086 . . . . 0.0 108.498 179.318 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.108 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -84.21 136.38 33.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.496 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.663 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.6 p90 -139.37 148.1 42.4 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -107.9 137.16 46.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.081 . . . . 0.0 109.437 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 30' ' ' LYS . 9.6 ptmm? -38.81 151.66 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.41 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.11 -16.77 8.38 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.143 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 1.8 mp0 -83.32 153.39 24.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.948 -1.325 . . . . 0.0 109.653 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 8.8 mtpt -105.43 146.33 29.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.413 -0.804 . . . . 0.0 109.958 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.601 ' HE3' HG11 ' A' ' 63' ' ' VAL . 4.9 mtm -138.68 155.18 48.49 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.699 0.761 . . . . 0.0 109.573 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.699 ' HD3' HD12 ' A' ' 12' ' ' ILE . 3.4 tppt? -123.05 138.75 54.6 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.43 ' N ' ' HG3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -104.73 119.25 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.405 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -26.08 17.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.882 . . . . 0.0 109.989 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 68.5 mt-10 -133.04 135.51 45.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 109.155 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.433 ' OE2' ' N ' ' A' ' 42' ' ' GLY . 2.5 tm-20 -109.47 134.8 51.43 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.235 -0.916 . . . . 0.0 109.335 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.596 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 25.8 m80 -119.95 36.02 4.66 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.252 -0.905 . . . . 0.0 108.86 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.433 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 92.63 -106.46 3.41 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -86.59 -8.32 57.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -1.165 . . . . 0.0 110.121 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.607 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 12.2 m95 -131.98 138.74 48.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.919 -1.113 . . . . 0.0 110.375 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.607 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -136.09 167.18 21.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.358 -0.839 . . . . 0.0 109.326 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -109.04 117.51 34.38 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.766 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -113.7 -173.1 2.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.379 -0.826 . . . . 0.0 110.677 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.5 ttmt -139.88 147.49 40.7 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.666 ' O ' ' N ' ' A' ' 53' ' ' LYS . 29.3 t -88.48 129.47 35.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 109.925 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.37 -27.47 66.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.052 . . . . 0.0 109.79 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.13 -41.82 16.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.181 -0.949 . . . . 0.0 109.947 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.495 ' OG1' ' HB3' ' A' ' 49' ' ' SER . 1.3 p -98.94 -18.35 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.354 -0.841 . . . . 0.0 109.371 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 49' ' ' SER . 14.0 mttt 60.65 11.21 2.98 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.334 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -80.21 150.76 29.99 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.597 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 8.6 pt-20 -120.53 143.52 48.53 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.9 -1.125 . . . . 0.0 109.695 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.69 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -167.15 165.6 38.68 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 1.8 m-85 -68.01 134.88 51.43 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.441 -1.035 . . . . 0.0 110.109 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 6.9 pt -125.52 140.85 37.39 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.703 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 52.9 Cg_endo -74.42 157.04 45.52 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 121.62 1.547 . . . . 0.0 111.055 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -89.56 27.98 1.38 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.706 -1.246 . . . . 0.0 109.824 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -140.71 -1.82 1.41 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.841 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.703 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.4 m-85 -102.05 -25.96 13.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.118 -0.989 . . . . 0.0 110.276 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.601 HG11 ' HE3' ' A' ' 35' ' ' MET . 11.5 m . . . . . 0 N--CA 1.492 1.65 0 O-C-N 120.814 -1.179 . . . . 0.0 109.972 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 3.0 tp -109.4 132.75 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.453 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.521 HG11 ' HZ3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -128.38 154.32 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 108.861 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.3 p -113.01 134.02 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.267 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.47 119.36 6.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.603 -0.686 . . . . 0.0 110.303 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.1 mt -91.51 -28.1 17.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -137.25 143.48 41.8 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.3 Cg_endo -61.47 140.03 85.3 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.62 2.213 . . . . 0.0 111.331 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.636 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 33.5 t80 -133.67 125.96 29.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.856 . . . . 0.0 110.051 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -103.25 106.76 17.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.016 -1.053 . . . . 0.0 108.371 178.748 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -29.63 92.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.0 mt -78.85 -59.01 3.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.354 -1.086 . . . . 0.0 108.099 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 3.6 m-70 -67.33 172.49 3.67 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 47.3 Cg_endo -68.83 -23.96 34.73 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.555 2.17 . . . . 0.0 112.108 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.544 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.1 m-20 -112.86 -7.48 13.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.151 -0.968 . . . . 0.0 110.284 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.517 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 13.3 m-20 -60.95 118.43 6.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.041 -1.037 . . . . 0.0 109.925 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.122 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -83.8 134.46 34.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.933 -1.104 . . . . 0.0 108.49 179.218 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.122 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.3 m -84.38 137.12 33.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.64 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 19' ' ' TYR . 8.7 p90 -139.56 148.28 42.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.281 -0.887 . . . . 0.0 108.635 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 31' ' ' LYS . 4.6 ttpm? -107.28 139.73 41.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.965 -1.084 . . . . 0.0 109.479 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.66 152.3 0.07 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.73 -16.27 6.86 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -82.84 152.66 25.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.084 -1.244 . . . . 0.0 109.713 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 16.3 mttp -105.95 145.96 30.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.424 -0.798 . . . . 0.0 110.223 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 63' ' ' VAL . 4.5 mtm -139.72 155.78 47.16 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.591 0.71 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.4 ttmm -120.67 137.61 54.37 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.411 ' CG2' ' CB ' ' A' ' 45' ' ' TRP . 1.6 p -104.35 120.12 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.707 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.745 ' N ' HD22 ' A' ' 38' ' ' LEU . 1.6 mm? -88.52 -37.81 15.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.324 -0.86 . . . . 0.0 109.767 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 6.6 tp10 -128.43 136.25 50.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.104 -0.997 . . . . 0.0 109.732 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.627 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -110.83 142.4 42.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.59 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 73.9 m80 -114.96 44.27 1.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.037 -1.039 . . . . 0.0 109.743 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 52.81 27.52 28.76 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.401 -0.904 . . . . 0.0 110.881 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 41' ' ' HIS . 8.2 pt-20 164.04 -40.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.999 -1.295 . . . . 0.0 109.597 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.59 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 39.4 m95 -126.54 121.56 32.63 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.659 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -118.1 166.42 12.58 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.976 -1.077 . . . . 0.0 109.754 -179.51 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -109.45 122.61 47.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.733 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -118.69 -174.14 2.62 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 110.944 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 19.3 ttmt -139.09 148.68 43.62 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.3 t -90.45 124.92 35.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.971 -1.081 . . . . 0.0 109.852 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.48 -11.62 60.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.097 -1.002 . . . . 0.0 109.358 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.5 tp -83.87 -55.93 3.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 109.693 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.77 10.0 26.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.298 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' SER . 9.9 mtmt 49.93 25.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.366 -0.834 . . . . 0.0 109.834 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 1.026 ' HG2' HD23 ' A' ' 27' ' ' LEU . 2.9 tttt -80.35 142.52 34.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.089 -1.007 . . . . 0.0 108.317 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 13.2 pt-20 -122.05 142.95 49.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.042 -1.036 . . . . 0.0 109.637 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.685 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -164.14 -163.07 16.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 3.1 m-85 -97.79 133.62 42.05 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.466 -1.02 . . . . 0.0 109.491 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 12.7 pt -125.53 135.95 27.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.624 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 53.1 Cg_endo -75.35 164.21 33.14 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 121.637 1.558 . . . . 0.0 110.905 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.415 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 92.4 p -92.69 28.62 1.98 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.812 -1.18 . . . . 0.0 109.713 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -140.94 -1.71 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 109.915 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.624 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 9.4 m-85 -100.81 -27.89 13.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.044 -1.035 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.541 HG11 ' CE ' ' A' ' 35' ' ' MET . 11.6 m . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.029 -1.044 . . . . 0.0 109.534 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.409 ' HA ' HD13 ' A' ' 12' ' ' ILE . 26.8 mm -109.58 133.73 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.57 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.35 157.54 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.235 -0.916 . . . . 0.0 109.19 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 7.6 p -115.56 134.06 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.08 -1.013 . . . . 0.0 109.032 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.702 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -53.15 114.22 1.39 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.335 -0.853 . . . . 0.0 109.939 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.543 ' O ' ' CD ' ' A' ' 31' ' ' LYS . 27.8 mt -84.76 -30.0 25.03 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -137.49 140.88 31.67 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.638 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 37.6 Cg_endo -59.44 140.16 92.93 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.748 2.299 . . . . 0.0 111.649 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 33.3 t80 -134.27 125.76 28.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.836 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -102.13 107.94 19.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.892 -1.13 . . . . 0.0 108.571 179.003 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.11 89.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' ASP . 76.4 mt -80.94 -57.6 4.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.568 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 8.5 m80 -68.48 171.14 6.43 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 47.5 Cg_endo -68.18 -27.25 35.43 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.655 2.237 . . . . 0.0 112.246 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.575 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 23.6 t0 -111.8 -7.91 14.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.128 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -60.78 123.69 18.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.117 -0.989 . . . . 0.0 109.827 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.112 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -90.16 134.45 34.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.979 -1.075 . . . . 0.0 108.514 179.308 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.112 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -83.31 136.53 34.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.897 . . . . 0.0 110.605 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.3 p90 -138.86 147.07 41.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.339 -0.851 . . . . 0.0 108.721 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -108.87 146.81 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.831 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.638 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -46.51 151.39 0.56 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.918 -1.114 . . . . 0.0 108.545 179.231 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.3 -15.0 7.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -82.68 149.99 27.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.267 . . . . 0.0 109.683 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -105.98 144.94 31.99 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.711 0.767 . . . . 0.0 110.177 -179.307 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.722 ' CE ' HG11 ' A' ' 63' ' ' VAL . 4.7 mtm -137.79 155.23 49.26 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.588 0.708 . . . . 0.0 109.544 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 10.7 ttpp -118.85 136.06 54.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.32 118.77 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.21 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.48 ' H ' HD12 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -88.56 -33.76 17.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -133.52 136.43 45.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 109.525 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.575 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.7 tt0 -111.05 144.92 39.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.549 ' CD2' ' HZ ' ' A' ' 57' ' ' PHE . 1.0 OUTLIER -115.95 43.88 2.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 0.0 109.765 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.86 35.48 12.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 160.56 -45.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -1.161 . . . . 0.0 109.759 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.602 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 11.9 m95 -127.56 122.44 33.24 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.369 -0.832 . . . . 0.0 109.087 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.682 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.37 166.03 12.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.14 -0.975 . . . . 0.0 109.605 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -109.81 123.22 49.17 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.67 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -120.23 -173.63 2.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 110.809 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 ttpt -138.8 148.93 44.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 53' ' ' LYS . 5.2 t -90.07 125.52 35.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.944 -1.097 . . . . 0.0 109.903 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.6 mt -69.5 -13.41 62.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 109.43 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.9 tp -82.64 -55.35 4.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.732 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.22 9.46 25.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 109.286 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.8 OUTLIER 50.67 25.93 2.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.848 . . . . 0.0 109.864 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -80.54 142.38 34.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.177 -0.952 . . . . 0.0 108.435 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -121.98 142.14 50.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.094 -1.004 . . . . 0.0 109.54 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.672 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.65 -164.66 18.17 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -97.42 134.14 41.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.523 -0.987 . . . . 0.0 109.291 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.681 HD12 HG21 ' A' ' 63' ' ' VAL . 13.7 pt -126.49 137.8 31.1 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 52.2 Cg_endo -75.04 163.71 34.71 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 121.683 1.589 . . . . 0.0 110.675 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.7 p -92.21 29.26 1.69 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.72 -1.238 . . . . 0.0 109.906 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -138.92 -0.74 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.887 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.561 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.2 m-85 -106.16 -28.23 10.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 109.259 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.722 HG11 ' CE ' ' A' ' 35' ' ' MET . 22.0 m . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.317 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 36' ' ' LYS . 25.0 mm -105.86 129.56 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.972 . . . . 0.0 109.348 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.52 154.85 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.396 -0.815 . . . . 0.0 108.978 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 14.3 p -111.55 133.75 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.861 -1.149 . . . . 0.0 108.939 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -57.05 117.09 3.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.436 -0.79 . . . . 0.0 110.164 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.614 ' O ' ' CD ' ' A' ' 31' ' ' LYS . 14.5 mt -89.37 -28.08 20.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.8 140.17 28.79 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 37.6 Cg_endo -59.9 141.28 96.27 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.86 2.373 . . . . 0.0 111.49 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.646 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 34.5 t80 -132.83 123.92 27.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.727 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 22' ' ' ILE . 9.3 t70 -102.71 109.51 21.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.087 -1.008 . . . . 0.0 108.6 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.563 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.98 89.02 0.01 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.592 ' N ' ' O ' ' A' ' 20' ' ' ASP . 17.4 mt -88.36 -14.59 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.185 . . . . 0.0 108.318 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -114.13 176.67 1.4 Allowed Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.1 Cg_endo -72.43 -31.94 10.67 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.489 2.126 . . . . 0.0 112.085 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 17.7 m-20 -112.05 -9.59 13.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.354 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.41 122.24 14.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.918 -1.114 . . . . 0.0 109.778 -179.466 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.12 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -85.43 135.13 33.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.916 -1.115 . . . . 0.0 108.404 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.12 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.2 m -84.56 136.82 33.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.565 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.646 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 10.4 p90 -138.79 147.22 42.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.264 -0.898 . . . . 0.0 108.744 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 15.1 pttt -108.28 146.7 32.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.721 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.614 ' CD ' ' O ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -46.23 152.46 0.41 Allowed 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.868 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.68 -12.67 10.07 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.2 tm-20 -83.8 148.09 27.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.124 -1.221 . . . . 0.0 110.13 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -104.78 147.21 27.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -0.759 . . . . 0.0 109.714 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.565 ' CE ' HG11 ' A' ' 63' ' ' VAL . 8.7 mtm -139.42 155.28 47.72 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.667 0.746 . . . . 0.0 109.931 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -123.59 140.71 52.72 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.596 HG11 ' CB ' ' A' ' 45' ' ' TRP . 2.7 t -102.17 119.58 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.071 -1.018 . . . . 0.0 110.023 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -88.77 -21.64 23.7 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 0.0 109.811 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 4.3 mt-10 -148.33 139.05 22.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.97 -1.082 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.577 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 11.5 tt0 -109.74 135.44 50.66 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.299 -0.876 . . . . 0.0 109.166 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 63.3 m-70 -117.82 36.06 4.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.326 -0.859 . . . . 0.0 108.87 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.49 -110.14 3.95 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -84.74 -6.81 59.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -1.18 . . . . 0.0 109.865 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.572 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 23.4 m95 -130.89 143.16 50.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.058 -1.026 . . . . 0.0 109.97 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.596 ' CB ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -141.31 168.28 20.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.338 -0.851 . . . . 0.0 109.613 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.602 ' O ' HD12 ' A' ' 38' ' ' LEU . 8.7 tttt -110.2 116.36 31.36 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.15 -172.31 2.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.407 -0.808 . . . . 0.0 110.307 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.4 ttpm? -142.33 151.27 41.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 109.305 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -92.23 126.5 37.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.054 -1.029 . . . . 0.0 109.695 -179.376 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 mt -70.19 -13.98 62.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.024 -1.048 . . . . 0.0 109.33 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 51' ' ' LEU . 17.2 tp -75.96 -59.68 2.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -108.69 3.52 22.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 0.0 109.423 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.545 ' CD ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 61.23 25.66 15.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.752 ' HG2' HD23 ' A' ' 27' ' ' LEU . 1.1 tptp -78.51 141.51 38.13 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.153 -0.967 . . . . 0.0 108.521 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 7.2 pt-20 -123.46 146.1 48.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.046 -1.034 . . . . 0.0 109.604 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.723 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -169.75 -164.87 26.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -95.77 134.16 39.04 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.446 -1.031 . . . . 0.0 109.53 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 pt -126.0 141.67 40.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.631 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 54.6 Cg_endo -75.71 156.97 39.97 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.839 1.693 . . . . 0.0 110.921 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.584 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 46.0 t -88.67 28.13 1.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.726 -1.234 . . . . 0.0 110.019 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -139.82 -1.96 1.57 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.138 -0.976 . . . . 0.0 109.819 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.631 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 5.9 m-85 -101.74 -25.38 13.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.385 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.565 HG11 ' CE ' ' A' ' 35' ' ' MET . 24.7 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.858 -1.151 . . . . 0.0 110.069 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.487 ' C ' HD12 ' A' ' 12' ' ' ILE . 10.4 t70 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.7 OUTLIER -104.9 128.65 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.501 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.44 155.51 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.3 p -112.84 133.77 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.943 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -58.48 118.66 5.84 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.476 -0.765 . . . . 0.0 110.385 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.5 mt -92.02 -27.1 18.03 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -137.55 141.39 33.28 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.9 Cg_endo -62.2 141.43 88.11 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.648 2.232 . . . . 0.0 111.56 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.649 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 33.5 t80 -132.84 124.18 27.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.962 . . . . 0.0 109.671 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -103.37 110.32 22.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.069 -1.02 . . . . 0.0 108.796 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.96 89.52 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 20' ' ' ASP . 4.6 mt -90.1 -13.73 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -1.11 . . . . 0.0 108.359 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 1.3 m-70 -114.01 174.56 2.27 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 50.9 Cg_endo -70.78 -32.48 14.26 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.409 2.073 . . . . 0.0 111.916 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.559 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 16.2 m-20 -112.02 -9.64 13.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 110.4 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -59.83 121.62 12.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.891 -1.131 . . . . 0.0 109.745 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.1 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -84.33 136.83 33.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 108.353 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 1.1 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.9 m -86.99 137.5 32.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 0.0 110.629 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.0 p90 -140.28 149.57 42.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -108.85 142.5 39.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 109.731 -179.167 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' LYS . 1.2 pttt -44.79 151.53 0.29 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.112 -0.993 . . . . 0.0 108.423 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.52 -16.43 7.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.575 ' CG ' ' CD2' ' A' ' 51' ' ' LEU . 10.0 tp10 -82.8 151.59 26.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.066 -1.255 . . . . 0.0 109.915 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 3.9 mttt -105.33 146.36 29.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.454 -0.779 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.677 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -138.3 153.8 49.02 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.725 0.774 . . . . 0.0 110.132 -179.423 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG2' HG13 ' A' ' 12' ' ' ILE . 2.8 mtpm? -122.62 138.3 54.63 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 t -88.32 155.38 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 118.48 -1.288 . . . . 0.0 109.292 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.529 ' O ' ' CG ' ' A' ' 39' ' ' GLU . 4.1 mt -122.61 -13.35 7.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.313 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 37.3 mt-10 -159.03 138.94 11.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.381 -0.824 . . . . 0.0 109.054 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 13.0 tt0 -106.18 132.8 51.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 41.6 m-70 -122.2 34.2 5.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.453 -0.779 . . . . 0.0 109.289 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.8 -113.53 4.61 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -83.26 -6.8 59.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -1.165 . . . . 0.0 109.601 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.587 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 32.1 m95 -130.35 148.08 52.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.431 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.587 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -146.69 172.01 14.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 110.072 179.648 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.609 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -111.7 128.41 56.07 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . . . -121.64 -173.29 2.6 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.128 -0.982 . . . . 0.0 110.509 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 26.7 ttpt -136.93 146.69 45.75 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -86.5 124.54 32.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 109.49 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.3 -10.07 52.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.057 -1.027 . . . . 0.0 109.404 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.575 ' CD2' ' CG ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -88.1 -53.16 4.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 109.991 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.543 HG22 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.11 8.84 24.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.922 . . . . 0.0 109.584 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 50.73 26.64 2.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.302 -0.874 . . . . 0.0 109.752 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 11.3 tptt -84.4 142.06 30.4 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 23.4 pt-20 -117.48 139.53 50.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.979 -1.076 . . . . 0.0 109.638 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.664 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -156.58 -166.6 16.56 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.408 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 5.5 m-85 -97.21 132.69 42.73 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 109.541 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.418 HG22 ' CE1' ' A' ' 29' ' ' PHE . 11.5 pt -124.78 141.47 38.2 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.615 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 55.1 Cg_endo -78.71 161.48 27.6 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.66 1.573 . . . . 0.0 111.199 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 32.9 t -90.86 30.01 1.26 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.837 -1.164 . . . . 0.0 109.701 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -141.19 -0.12 1.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.813 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.615 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 7.7 m-85 -102.72 -26.74 13.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 110.122 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.677 HG11 ' CE ' ' A' ' 35' ' ' MET . 6.4 m . . . . . 0 N--CA 1.491 1.618 0 O-C-N 120.965 -1.084 . . . . 0.0 110.003 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.303 0.573 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.21 114.83 3.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -102.93 151.02 22.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -1.127 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -105.97 129.72 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -129.26 154.58 40.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 108.89 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 2.9 p -113.4 133.93 57.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.97 -1.081 . . . . 0.0 108.83 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.655 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -56.32 115.86 2.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.514 -0.741 . . . . 0.0 109.789 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.899 HD11 ' HB3' ' A' ' 64' ' ' ALA . 50.4 mt -88.37 -27.78 21.39 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -136.72 140.32 31.64 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.97 141.47 94.6 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.762 2.308 . . . . 0.0 111.879 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.9 t80 -133.2 124.14 26.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.53 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -102.27 111.33 23.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.97 -1.081 . . . . 0.0 108.958 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -28.15 89.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.7 mt -94.63 -14.14 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.308 -1.113 . . . . 0.0 108.483 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.587 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.5 175.1 1.98 Allowed Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.1 Cg_endo -71.76 -34.34 9.05 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.511 2.14 . . . . 0.0 112.052 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 2.5 m-20 -112.09 -10.73 13.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 0.0 110.574 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 46.1 m-20 -60.34 116.22 4.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.915 -1.115 . . . . 0.0 109.752 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.125 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -78.67 134.96 37.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.907 -1.121 . . . . 0.0 108.45 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.125 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.6 p -83.54 136.6 34.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.354 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.8 p90 -139.41 147.94 42.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.288 -0.882 . . . . 0.0 108.739 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -108.51 140.02 42.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.072 -1.018 . . . . 0.0 109.497 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 30' ' ' LYS . 15.4 ptmt -42.21 152.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.23 -0.988 . . . . 0.0 108.36 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.55 -16.65 7.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -82.66 152.03 26.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.097 -1.237 . . . . 0.0 109.743 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 12.8 mtpt -105.79 145.99 30.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.435 -0.791 . . . . 0.0 109.962 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.617 ' CE ' HG11 ' A' ' 63' ' ' VAL . 5.9 mtm -138.2 154.21 49.13 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.718 0.77 . . . . 0.0 109.834 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 tttp -121.78 136.44 54.94 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.645 HG11 ' CB ' ' A' ' 45' ' ' TRP . 1.5 t -97.96 120.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.005 . . . . 0.0 110.075 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.777 ' N ' HD22 ' A' ' 38' ' ' LEU . 2.2 mm? -86.34 -18.2 32.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 109.923 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -154.24 141.03 19.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.945 -1.097 . . . . 0.0 109.757 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 6.1 tt0 -108.64 135.18 50.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.145 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 74.2 m-70 -121.0 35.01 5.01 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.202 -0.936 . . . . 0.0 109.218 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.85 -110.0 3.94 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -85.76 -7.09 58.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -1.139 . . . . 0.0 109.857 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.577 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 27.3 m95 -129.99 141.86 50.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.071 -1.018 . . . . 0.0 109.786 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.645 ' CB ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.98 167.68 21.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 109.569 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.573 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 13.1 tttp -110.8 118.84 37.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.38 -172.77 2.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 110.473 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 5.4 ttmt -140.83 150.24 43.03 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 53' ' ' LYS . 4.4 t -90.87 125.94 35.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.127 -0.983 . . . . 0.0 109.818 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -12.18 61.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.361 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.09 -55.29 4.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.694 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.71 8.07 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.351 -0.843 . . . . 0.0 109.281 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 49' ' ' SER . 21.4 mtmt 50.93 25.29 2.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.949 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 9.2 tttm -82.07 144.8 30.56 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.128 -0.982 . . . . 0.0 108.386 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 26.9 tt0 -120.84 145.62 47.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.014 -1.054 . . . . 0.0 109.456 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.665 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -164.79 -167.28 25.11 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.93 134.33 40.41 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.317 -1.108 . . . . 0.0 109.461 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 HG21 ' A' ' 63' ' ' VAL . 10.9 pt -126.23 142.47 42.82 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.468 -0.77 . . . . 0.0 109.287 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.527 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 53.7 Cg_endo -75.62 157.55 40.13 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.854 1.703 . . . . 0.0 110.811 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.55 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 47.9 t -89.6 28.96 1.2 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.593 -1.317 . . . . 0.0 110.19 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.2 -0.35 2.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.079 -1.013 . . . . 0.0 109.664 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.527 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.7 m-85 -106.61 -25.72 11.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.229 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.7 HG21 HD12 ' A' ' 58' ' ' ILE . 19.5 m -123.53 164.68 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -0.869 . . . . 0.0 109.505 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.899 ' HB3' HD11 ' A' ' 16' ' ' LEU . . . -160.66 -165.47 1.41 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.088 -1.008 . . . . 0.0 109.752 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 66' ' ' LEU . 70.7 mttt -89.73 129.42 36.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.408 -0.808 . . . . 0.0 109.619 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.509 ' C ' HG11 ' A' ' 14' ' ' VAL . 2.7 tp 45.39 -171.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.55 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.719 ' ND2' HD23 ' A' ' 16' ' ' LEU . 28.5 t-20 172.12 -87.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.477 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.5 m . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.477 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.06 -140.74 1.59 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.54 146.76 52.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -1.158 . . . . 0.0 109.481 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.743 HD13 ' HG3' ' A' ' 36' ' ' LYS . 26.4 mm -109.54 132.87 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.524 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.888 HG12 ' CA ' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -129.34 155.6 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 108.957 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 12.7 p -112.79 134.46 55.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.306 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.68 118.83 5.67 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.482 -0.761 . . . . 0.0 110.103 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 64' ' ' ALA . 82.0 mt -91.51 -28.3 17.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -137.02 142.93 40.19 Favored Pre-proline 0 N--CA 1.486 1.352 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HD3' ' HE3' ' A' ' 31' ' ' LYS . 38.9 Cg_endo -62.13 140.74 85.48 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.785 2.323 . . . . 0.0 111.575 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.633 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 34.2 t80 -132.04 123.6 27.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.576 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' ILE . 13.2 t0 -103.31 109.66 21.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.118 -0.989 . . . . 0.0 108.722 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.76 90.53 0.01 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.9 mt -88.44 -13.62 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -1.135 . . . . 0.0 108.403 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.606 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.63 177.99 1.06 Allowed Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.7 Cg_endo -73.59 -30.83 9.38 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.359 2.039 . . . . 0.0 111.955 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -112.59 -9.56 13.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.338 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.453 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 39.2 m-20 -60.91 116.29 4.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.952 -1.092 . . . . 0.0 109.899 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.112 HD22 ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -80.17 134.24 36.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 108.373 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.112 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.6 p -83.52 137.46 33.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 110.833 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.633 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.5 p90 -139.24 148.55 43.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 108.692 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.12 142.7 37.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.855 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.462 ' HE3' ' HD3' ' A' ' 18' ' ' PRO . 2.8 ptpt -44.19 151.82 0.22 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.29 -16.06 8.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 2.6 tm-20 -83.22 151.33 25.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.238 . . . . 0.0 109.67 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 12.7 mttt -104.97 146.05 29.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.44 -0.787 . . . . 0.0 109.83 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.597 ' CE ' HG11 ' A' ' 63' ' ' VAL . 5.7 mtm -137.73 154.69 49.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.609 0.719 . . . . 0.0 109.662 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.743 ' HG3' HD13 ' A' ' 12' ' ' ILE . 20.2 tttt -118.36 133.73 55.64 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.583 HG21 ' HG3' ' A' ' 40' ' ' GLU . 1.4 p -103.78 119.08 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 109.433 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.796 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -88.53 -40.64 13.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.417 -0.802 . . . . 0.0 109.807 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 7.0 mp0 -129.81 137.08 50.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 109.687 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 4.9 mt-10 -111.11 146.4 36.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 2.5 m80 -116.86 42.07 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.534 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.89 37.99 16.11 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 160.93 -47.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -1.12 . . . . 0.0 109.412 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.511 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 10.2 m95 -128.87 119.66 24.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.488 -0.757 . . . . 0.0 108.959 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -113.24 167.32 10.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.054 -1.029 . . . . 0.0 109.403 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.796 ' O ' HD12 ' A' ' 38' ' ' LEU . 2.2 tttp -110.44 116.06 30.74 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 36' ' ' LYS . . . -116.45 -172.29 2.16 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.415 -0.803 . . . . 0.0 110.417 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -144.04 154.44 43.24 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -94.55 126.87 40.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 0.0 110.195 -178.72 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.72 -11.87 60.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.153 -0.967 . . . . 0.0 109.359 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 tp -83.33 -55.73 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 109.728 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.12 10.04 28.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 48.25 24.63 0.71 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.428 -0.795 . . . . 0.0 110.111 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -81.42 144.0 31.72 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt-20 -120.52 149.1 42.95 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 109.392 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.687 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -169.01 -166.35 27.92 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.437 ' HE1' ' CE1' ' A' ' 41' ' ' HIS . 1.8 m-85 -96.91 133.8 41.07 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.382 -1.069 . . . . 0.0 109.345 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 58' ' ' ILE . 17.8 pt -125.87 140.31 36.41 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 108.88 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.628 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 53.4 Cg_endo -75.05 159.15 41.51 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 121.694 1.596 . . . . 0.0 110.706 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.447 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 99.5 p -89.73 28.82 1.25 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.684 -1.26 . . . . 0.0 109.705 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -140.48 -1.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 109.999 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.628 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 8.4 m-85 -100.74 -26.6 13.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 0.0 110.07 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.597 HG11 ' CE ' ' A' ' 35' ' ' MET . 14.5 m -113.97 159.47 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.041 -1.037 . . . . 0.0 109.644 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -106.23 130.2 54.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.639 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.888 ' CA ' HG12 ' A' ' 13' ' ' VAL . 1.5 tmtt? -99.59 75.2 1.92 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.245 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.78 165.02 23.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.623 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -137.46 -163.16 1.39 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.273 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.452 ' O ' ' OG1' ' A' ' 68' ' ' THR . 5.0 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.514 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.9 85.27 0.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -134.26 154.41 51.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.326 -1.102 . . . . 0.0 109.207 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.762 HD13 ' HG3' ' A' ' 36' ' ' LYS . 19.4 mm -106.02 129.96 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.162 -0.961 . . . . 0.0 109.561 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.57 156.31 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 8.1 p -114.04 134.45 56.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.027 -1.046 . . . . 0.0 108.807 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.577 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -55.85 115.36 2.34 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.545 -0.722 . . . . 0.0 109.849 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.935 HD11 ' CB ' ' A' ' 64' ' ' ALA . 36.2 mt -88.02 -28.99 21.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -136.62 139.95 30.76 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.0 Cg_endo -60.76 141.39 94.78 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.857 2.372 . . . . 0.0 111.642 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.3 t80 -133.78 124.92 27.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 109.906 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.564 ' O ' ' C ' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -102.94 110.32 22.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.021 -1.049 . . . . 0.0 108.805 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.83 91.07 0.01 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.56 ' N ' ' O ' ' A' ' 20' ' ' ASP . 14.2 mt -91.76 -14.35 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.282 -1.128 . . . . 0.0 108.524 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.569 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.35 175.78 1.74 Allowed Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 50.7 Cg_endo -71.43 -31.67 13.57 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.4 2.067 . . . . 0.0 111.903 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.517 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.1 m-20 -112.0 -9.34 14.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 110.218 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -60.04 123.37 16.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.948 -1.095 . . . . 0.0 109.713 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.103 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -88.07 135.3 33.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.999 -1.063 . . . . 0.0 108.351 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.103 ' N ' HD22 ' A' ' 27' ' ' LEU . 5.8 p -83.81 136.18 34.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.498 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.5 p90 -139.04 147.93 42.71 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 31' ' ' LYS . 4.5 ttmt -108.69 140.39 42.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.028 . . . . 0.0 109.551 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -42.79 152.01 0.11 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.92 -17.11 7.43 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -82.53 151.75 26.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.057 -1.261 . . . . 0.0 109.728 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -105.56 145.85 30.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.459 -0.776 . . . . 0.0 109.895 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.611 ' CE ' HG11 ' A' ' 63' ' ' VAL . 8.5 mtm -138.26 154.11 49.06 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.649 0.738 . . . . 0.0 109.669 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.762 ' HG3' HD13 ' A' ' 12' ' ' ILE . 4.2 ttpm? -119.72 134.33 55.27 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.63 HG11 ' CB ' ' A' ' 45' ' ' TRP . 1.5 t -96.84 119.9 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 110.14 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 mt -85.31 -20.41 30.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.366 -0.834 . . . . 0.0 110.011 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.24 141.2 20.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.902 -1.124 . . . . 0.0 109.763 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 2.9 tt0 -109.31 137.4 47.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.409 -0.807 . . . . 0.0 108.955 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.609 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 68.7 m-70 -123.43 36.25 4.68 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.208 -0.933 . . . . 0.0 109.197 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.85 -104.11 3.14 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.8 -8.82 48.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -1.088 . . . . 0.0 110.606 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.609 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 17.3 m95 -131.89 124.95 30.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.782 -1.199 . . . . 0.0 110.401 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.632 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.3 168.22 13.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.145 -0.972 . . . . 0.0 109.678 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.17 129.29 56.0 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -124.83 -172.21 2.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 110.537 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.561 ' CG ' ' HB3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -138.77 147.49 42.68 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' LYS . 8.4 t -88.26 124.92 34.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.04 -1.038 . . . . 0.0 109.491 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.2 -13.13 62.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 109.427 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.3 tp -80.65 -57.13 3.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.457 -0.777 . . . . 0.0 109.906 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.4 3.79 23.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 49' ' ' SER . 9.1 mttt 58.42 25.37 12.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.751 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 8.6 mmtp -78.13 142.05 38.31 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.561 ' HB3' ' CG ' ' A' ' 48' ' ' LYS . 10.0 pt-20 -121.59 139.9 52.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.033 -1.042 . . . . 0.0 109.511 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.698 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.11 -163.78 15.66 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.55 135.21 40.42 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.553 -0.969 . . . . 0.0 109.417 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.638 HD12 HG21 ' A' ' 63' ' ' VAL . 18.4 pt -126.22 142.9 44.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.369 -0.832 . . . . 0.0 109.152 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.547 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 53.8 Cg_endo -75.93 157.42 38.87 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.877 1.718 . . . . 0.0 110.746 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 89.1 p -88.92 28.82 1.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.728 -1.232 . . . . 0.0 110.143 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -138.14 0.16 2.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.025 . . . . 0.0 109.741 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.547 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.5 m-85 -105.45 -26.3 11.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.097 -1.002 . . . . 0.0 109.4 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.638 HG21 HD12 ' A' ' 58' ' ' ILE . 18.0 m -122.58 164.77 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.637 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.935 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -160.38 -166.03 1.57 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.89 119.31 35.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.385 -0.822 . . . . 0.0 109.574 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 67' ' ' ASN . 8.6 tt -53.59 138.63 33.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.422 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.697 ' N ' HD23 ' A' ' 66' ' ' LEU . 1.1 m-80 -134.41 178.45 6.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 0.0 109.635 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.44 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.13 7.63 10.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.582 ' CB ' HG13 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -74.78 119.4 18.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -1.159 . . . . 0.0 109.463 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.537 HD11 ' HD3' ' A' ' 36' ' ' LYS . 10.1 mm -107.25 130.39 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 109.356 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.942 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -128.32 153.34 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.274 -0.891 . . . . 0.0 108.928 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 8.7 p -112.41 133.61 57.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 118.841 -1.143 . . . . 0.0 109.168 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -58.18 118.71 5.76 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.494 -0.754 . . . . 0.0 110.285 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.098 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 13.3 mt -91.82 -26.94 18.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -137.34 141.96 35.84 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.0 Cg_endo -62.57 141.49 86.37 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.716 2.277 . . . . 0.0 111.831 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.4 t80 -132.65 123.69 26.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 109.419 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -102.58 110.64 22.65 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.008 -1.058 . . . . 0.0 108.798 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.4 89.69 0.01 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' ASP . 6.2 mt -92.3 -14.27 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -1.163 . . . . 0.0 108.476 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.505 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -113.37 175.24 1.93 Allowed Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 52.9 Cg_endo -72.03 -32.85 10.44 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.414 2.076 . . . . 0.0 112.181 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.537 ' OD2' ' CE ' ' A' ' 46' ' ' LYS . 55.7 t0 -112.77 -10.38 13.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.123 -0.985 . . . . 0.0 110.611 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 44.5 m-20 -60.15 116.41 4.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.951 -1.093 . . . . 0.0 109.797 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.107 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.08 135.85 38.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.934 -1.104 . . . . 0.0 108.286 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.107 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.3 p -85.11 137.08 33.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -0.978 . . . . 0.0 110.423 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.635 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 12.3 p90 -140.4 148.81 41.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.0 108.701 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -108.19 140.62 41.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.027 -1.045 . . . . 0.0 109.428 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.01 152.44 0.11 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.59 -16.74 7.53 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -83.23 151.98 25.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -1.204 . . . . 0.0 109.659 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.697 ' HB2' HD12 ' A' ' 50' ' ' LEU . 13.4 mtmt -105.14 143.86 32.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.816 . . . . 0.0 110.093 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.726 ' CE ' HG11 ' A' ' 63' ' ' VAL . 6.7 mtm -136.91 154.71 50.39 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.619 0.723 . . . . 0.0 109.585 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 10.1 ttpt -121.26 136.12 55.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 ' CB ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -103.12 119.72 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.487 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.822 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -85.64 -31.91 22.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 109.55 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -143.34 139.06 29.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.509 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.635 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tt0 -111.86 145.1 40.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.667 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 11.6 m80 -114.68 43.25 1.97 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 109.523 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 48.13 40.53 21.34 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.584 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 158.7 -48.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.29 -1.123 . . . . 0.0 109.574 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 8.3 m95 -129.38 120.87 26.28 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.413 -0.804 . . . . 0.0 109.111 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.682 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.17 168.65 9.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.184 -0.948 . . . . 0.0 109.631 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.822 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -110.05 116.12 31.0 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.54 -174.84 2.56 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 110.498 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.5 ttmt -137.55 147.72 45.36 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.655 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -88.56 129.39 35.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.03 -1.044 . . . . 0.0 109.921 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.697 HD12 ' HB2' ' A' ' 34' ' ' LYS . 5.8 mt -68.76 -24.46 64.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.04 . . . . 0.0 109.835 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.6 tp -86.52 -42.36 13.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.966 . . . . 0.0 109.92 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 49' ' ' SER . 1.2 p -99.1 -16.78 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.376 -0.828 . . . . 0.0 109.16 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.655 ' N ' ' O ' ' A' ' 49' ' ' SER . 13.7 mttt 59.56 11.88 2.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.323 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -81.69 151.57 27.48 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 14.2 pt-20 -119.63 146.62 45.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.897 -1.127 . . . . 0.0 109.515 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.659 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -169.85 164.66 38.08 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.591 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -68.05 133.38 48.9 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.492 -1.005 . . . . 0.0 109.962 -179.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.5 pt -124.47 143.04 42.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.0 Cg_endo -73.69 153.57 48.79 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.543 1.495 . . . . 0.0 110.68 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.467 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 91.8 p -87.6 29.37 0.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.616 -1.302 . . . . 0.0 109.954 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -139.81 0.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 109.794 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.649 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 17.2 m-85 -102.06 -25.64 13.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.985 . . . . 0.0 110.198 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.726 HG11 ' CE ' ' A' ' 35' ' ' MET . 14.8 m -117.03 162.66 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.997 -1.064 . . . . 0.0 110.061 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.098 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -108.59 133.73 52.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.749 . . . . 0.0 109.412 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.942 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -95.25 90.35 5.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.903 -1.123 . . . . 0.0 109.328 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 tp -67.02 80.95 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.321 -0.862 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.87 22.6 6.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.409 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.477 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.7 144.98 10.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 175.75 153.47 0.16 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 109.475 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.874 HD13 ' HG2' ' A' ' 36' ' ' LYS . 10.1 mm -108.0 132.44 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.275 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.835 HG12 ' CA ' ' A' ' 65' ' ' LYS . 0.9 OUTLIER -130.49 156.66 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.933 . . . . 0.0 109.185 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 13.0 p -113.47 134.95 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.053 -1.029 . . . . 0.0 109.084 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.66 118.94 5.78 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.483 -0.761 . . . . 0.0 110.302 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.054 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 12.6 mt -91.19 -28.56 17.76 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -137.24 142.49 37.99 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.1 Cg_endo -61.13 140.88 91.77 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.783 2.322 . . . . 0.0 111.413 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.5 t80 -133.75 125.74 29.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.998 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -103.38 107.68 18.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.034 -1.041 . . . . 0.0 108.518 179.052 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 26' ' ' ASP . . . -30.36 92.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.4 mt -79.32 -59.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -66.66 176.1 1.18 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.643 -0.661 . . . . 0.0 109.241 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.5 Cg_endo -71.73 -25.07 20.85 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.528 2.152 . . . . 0.0 111.938 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.2 t70 -112.65 -7.83 13.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.285 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.586 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -60.14 122.78 15.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.968 -1.082 . . . . 0.0 109.763 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.118 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -88.8 135.01 33.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.994 -1.066 . . . . 0.0 108.406 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.118 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.2 m -84.49 136.7 33.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.728 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.653 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.8 p90 -138.91 147.84 42.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 108.586 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.53 140.05 41.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.018 -1.051 . . . . 0.0 109.635 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.83 152.16 0.08 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.88 -15.7 7.85 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -83.34 152.46 25.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.087 -1.243 . . . . 0.0 109.838 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.478 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 30.6 ttmt -105.72 146.08 30.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 109.917 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.695 ' CE ' HG11 ' A' ' 63' ' ' VAL . 3.6 mtm -137.73 154.71 49.59 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.64 0.733 . . . . 0.0 109.919 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.874 ' HG2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -117.86 132.65 56.4 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 p -103.82 119.41 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.961 . . . . 0.0 109.449 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -89.76 -45.87 9.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -0.86 . . . . 0.0 109.953 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 3.7 tt0 -122.97 136.14 54.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.621 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.583 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tt0 -111.74 143.8 42.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.542 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 28.3 m80 -113.13 44.52 1.52 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.521 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 49.91 36.44 26.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 160.01 -45.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -1.175 . . . . 0.0 109.729 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.542 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 7.5 m95 -128.54 122.58 31.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.014 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -116.7 168.54 10.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.139 -0.976 . . . . 0.0 109.96 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.803 ' O ' HD12 ' A' ' 38' ' ' LEU . 11.3 ttpt -109.41 117.61 34.47 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.32 -173.62 2.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.237 -0.915 . . . . 0.0 110.586 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.7 ttmt -139.01 148.59 43.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 17.3 t -90.05 126.82 35.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.046 -1.034 . . . . 0.0 109.55 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.409 HD13 ' HD2' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -70.32 -11.32 60.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 109.424 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.7 tp -81.99 -57.43 3.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.719 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 54' ' ' LYS . 4.6 t -108.99 7.97 26.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.372 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 49' ' ' SER . 19.2 mttt 53.95 25.76 5.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 109.897 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 1.048 ' HG2' HD23 ' A' ' 27' ' ' LEU . 12.5 tttp -80.29 142.8 34.19 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 21.7 pt-20 -121.36 144.63 48.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.98 -1.075 . . . . 0.0 109.6 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.683 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -165.64 -164.24 20.7 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.49 132.99 41.51 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.374 -1.074 . . . . 0.0 109.633 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 58' ' ' ILE . 11.2 pt -125.99 135.99 27.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.527 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 54.3 Cg_endo -77.95 166.23 25.3 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.591 1.527 . . . . 0.0 111.213 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.511 ' HG ' ' HZ2' ' A' ' 45' ' ' TRP . 35.4 t -91.79 29.17 1.6 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.987 -1.071 . . . . 0.0 109.699 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -140.78 0.09 1.57 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.967 . . . . 0.0 109.719 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.527 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.3 m-85 -100.5 -28.72 12.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.079 -1.013 . . . . 0.0 109.664 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.695 HG11 ' CE ' ' A' ' 35' ' ' MET . 6.1 m -115.39 160.1 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 109.829 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.054 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -106.36 130.22 54.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.507 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.835 ' CA ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -97.47 85.84 3.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.086 -1.009 . . . . 0.0 109.435 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.33 133.24 56.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.643 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -87.76 175.5 7.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.92 . . . . 0.0 109.426 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.335 0.588 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.75 -174.14 17.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.1 152.36 36.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -1.162 . . . . 0.0 109.504 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.692 HD13 ' HG3' ' A' ' 36' ' ' LYS . 17.2 mm -106.74 132.01 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.357 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.548 HG12 ' C ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -131.82 157.23 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.28 -0.888 . . . . 0.0 109.269 -179.452 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 66' ' ' LEU . 6.4 p -113.55 134.63 55.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.077 -1.015 . . . . 0.0 108.552 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.663 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -56.24 115.81 2.68 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.69 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 64' ' ' ALA . 9.8 mt -88.6 -28.15 20.88 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -136.74 141.02 33.66 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.6 Cg_endo -61.87 141.91 91.49 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.863 2.375 . . . . 0.0 111.82 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.6 t80 -133.55 124.41 26.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.84 . . . . 0.0 109.748 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -102.47 110.91 22.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.987 -1.071 . . . . 0.0 108.727 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.41 90.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.5 mt -93.52 -14.17 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -1.142 . . . . 0.0 108.591 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.66 175.91 1.68 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.2 Cg_endo -72.2 -33.31 9.48 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.46 2.106 . . . . 0.0 112.038 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.491 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 14.0 t0 -112.14 -10.04 13.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 110.366 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 34.1 m-20 -60.58 116.82 4.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.031 -1.043 . . . . 0.0 109.829 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.109 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -79.44 135.79 36.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.941 -1.1 . . . . 0.0 108.509 179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.109 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.3 p -83.73 136.06 34.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 110.493 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.4 p90 -139.49 148.32 42.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.867 . . . . 0.0 108.826 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 31' ' ' LYS . 2.7 ttpt -108.77 140.61 41.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.94 -1.1 . . . . 0.0 109.572 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -42.86 152.7 0.1 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.29 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.19 -16.89 6.74 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.4 tp10 -83.12 152.86 25.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.035 -1.273 . . . . 0.0 109.801 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -105.38 145.42 30.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.473 -0.767 . . . . 0.0 109.662 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.728 ' CE ' HG11 ' A' ' 63' ' ' VAL . 6.6 mtm -137.16 154.17 50.29 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.71 0.767 . . . . 0.0 109.957 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.692 ' HG3' HD13 ' A' ' 12' ' ' ILE . 1.6 ttpm? -118.18 129.01 55.25 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.63 120.03 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 109.344 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.704 ' H ' HD12 ' A' ' 38' ' ' LEU . 1.7 mp -86.65 -37.51 17.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 109.581 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -134.8 136.68 42.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.954 . . . . 0.0 109.653 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.63 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.3 tt0 -110.32 145.07 38.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 22.6 m80 -111.81 46.23 1.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.122 -0.986 . . . . 0.0 109.584 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 50.57 32.06 23.26 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 161.19 -42.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.058 -1.26 . . . . 0.0 109.869 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.614 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 50.4 m95 -127.2 122.0 32.85 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 108.908 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.648 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -118.82 168.76 10.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.079 -1.013 . . . . 0.0 109.726 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -108.85 121.15 44.48 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -125.7 146.68 49.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 110.983 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 1.7 ptpt -102.44 155.41 18.27 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 4.8 t -98.07 129.88 44.89 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.958 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.82 -12.55 61.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.2 tp -73.27 -62.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 109.714 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.9 -0.28 21.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.407 -0.808 . . . . 0.0 109.349 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 66.93 24.86 9.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -0.894 . . . . 0.0 109.892 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 5.6 mmtt -79.5 140.31 37.32 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 mt-10 -121.81 143.46 49.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.052 -1.03 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.694 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -166.39 -164.72 22.5 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.614 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -96.17 133.04 40.96 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.365 -1.08 . . . . 0.0 109.153 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.818 HD12 HG21 ' A' ' 63' ' ' VAL . 33.2 pt -125.03 141.47 38.51 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.037 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.612 ' HB3' ' CH2' ' A' ' 44' ' ' TRP . 50.6 Cg_endo -72.24 152.56 55.95 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.927 1.751 . . . . 0.0 110.831 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 91.1 p -87.03 28.75 0.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.553 -1.342 . . . . 0.0 109.974 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -137.52 -4.09 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.832 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.575 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 5.2 m-85 -101.67 -24.2 14.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.947 -1.096 . . . . 0.0 109.068 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.818 HG21 HD12 ' A' ' 58' ' ' ILE . 19.7 m -124.25 157.3 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 109.239 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.616 ' HB3' HD11 ' A' ' 16' ' ' LEU . . . -151.57 -166.58 2.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.997 . . . . 0.0 109.543 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -98.3 64.47 1.61 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.458 -0.776 . . . . 0.0 109.415 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.761 ' H ' HG12 ' A' ' 14' ' ' VAL . 0.9 OUTLIER 41.46 85.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.349 -0.844 . . . . 0.0 109.488 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -51.71 151.44 3.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.553 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -155.65 -159.78 9.56 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER 163.84 137.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -1.179 . . . . 0.0 109.57 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.5 mm -106.2 130.9 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.304 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -130.76 155.99 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.249 -0.907 . . . . 0.0 109.135 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.432 HG11 ' HG ' ' A' ' 66' ' ' LEU . 12.2 p -113.89 134.88 55.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 120.932 -1.105 . . . . 0.0 108.735 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.49 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -57.83 115.98 3.17 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.527 -0.733 . . . . 0.0 109.951 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' ' 64' ' ' ALA . 52.2 mt -89.64 -27.39 20.2 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -137.89 140.98 31.06 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 39.4 Cg_endo -61.98 141.72 90.23 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.629 2.219 . . . . 0.0 111.516 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 38.3 t80 -133.54 124.67 27.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 109.982 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 5.4 m-20 -103.52 109.95 21.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 108.487 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.31 89.14 0.01 OUTLIER Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.3 mt -86.78 -13.46 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.225 -1.162 . . . . 0.0 108.544 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.587 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.91 176.77 1.37 Allowed Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.0 Cg_endo -73.05 -30.18 11.06 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.395 2.064 . . . . 0.0 111.949 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 24.1 t0 -113.2 -9.54 13.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 110.384 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 2.5 m-20 -59.83 122.19 13.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.928 -1.107 . . . . 0.0 109.83 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.104 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -82.9 136.81 34.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.985 -1.072 . . . . 0.0 108.231 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.104 ' N ' HD22 ' A' ' 27' ' ' LEU . 39.5 p -86.41 137.36 32.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.079 -1.013 . . . . 0.0 110.623 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.2 p90 -140.29 149.23 42.54 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -108.77 141.14 41.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.996 -1.065 . . . . 0.0 109.615 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.73 151.83 0.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.083 -1.01 . . . . 0.0 108.386 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.37 -17.21 6.62 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -82.78 152.55 25.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.035 -1.273 . . . . 0.0 109.841 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -105.35 144.58 31.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.692 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.795 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -138.09 153.81 49.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.515 0.674 . . . . 0.0 109.666 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 5.2 ttmt -117.75 130.09 56.1 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.4 p -98.26 120.74 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.113 -0.992 . . . . 0.0 109.625 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.31 -48.82 7.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 0.0 109.827 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 24.8 tt0 -119.03 134.58 55.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.069 -1.019 . . . . 0.0 109.926 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.62 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.8 tt0 -110.54 144.53 39.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 36.3 m80 -116.74 47.14 1.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 109.756 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.38 34.22 8.85 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.2 OUTLIER 161.08 -43.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -1.103 . . . . 0.0 109.872 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.563 ' CH2' ' HB3' ' A' ' 59' ' ' PRO . 39.2 m95 -127.16 120.78 29.63 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.62 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -117.04 168.29 10.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.029 -1.044 . . . . 0.0 109.555 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -109.53 122.83 48.3 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.7 -174.59 2.51 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 110.812 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -135.93 145.43 46.25 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -85.38 123.87 31.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.0 109.656 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.52 -9.24 53.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.09 -1.007 . . . . 0.0 109.429 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.0 tp -88.97 -53.46 4.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 109.717 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -109.42 7.01 24.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.842 . . . . 0.0 109.412 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 49' ' ' SER . 6.2 mmtp 52.39 26.24 4.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.926 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.12 142.29 32.38 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 6.9 mt-10 -118.65 139.54 51.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.912 -1.118 . . . . 0.0 109.646 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.671 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.79 -162.3 11.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 4.5 m-85 -99.91 133.34 44.42 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.377 -1.073 . . . . 0.0 109.5 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.682 HD12 HG21 ' A' ' 63' ' ' VAL . 18.0 pt -125.0 139.81 34.46 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.563 ' HB3' ' CH2' ' A' ' 44' ' ' TRP . 54.2 Cg_endo -77.42 162.47 30.74 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.712 1.608 . . . . 0.0 111.248 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.582 ' HG ' ' HZ2' ' A' ' 45' ' ' TRP . 41.9 t -91.77 30.06 1.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.797 -1.189 . . . . 0.0 109.794 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -137.81 -0.15 2.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.99 . . . . 0.0 109.743 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.546 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 8.7 m-85 -107.65 -26.91 10.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 108.932 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.795 HG11 ' CE ' ' A' ' 35' ' ' MET . 12.2 m -123.98 161.12 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.452 -0.78 . . . . 0.0 109.284 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 16' ' ' LEU . . . -156.07 -166.25 2.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.993 . . . . 0.0 109.798 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -99.48 113.99 26.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.471 -0.768 . . . . 0.0 109.525 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HG ' HG11 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -63.45 102.17 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.466 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 m120 55.38 -172.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.93 . . . . 0.0 109.473 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 68' ' ' THR . 2.7 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.428 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.357 0.598 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.41 -96.64 0.16 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.91 159.64 26.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -1.127 . . . . 0.0 109.375 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.607 HD12 ' CG ' ' A' ' 36' ' ' LYS . 13.2 mm -105.63 130.94 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.213 -0.929 . . . . 0.0 109.157 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -130.82 155.96 42.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.299 -0.875 . . . . 0.0 109.332 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.687 HG21 HD12 ' A' ' 66' ' ' LEU . 7.6 p -114.26 134.26 57.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.168 -0.957 . . . . 0.0 108.596 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -54.95 113.99 1.56 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.338 -0.851 . . . . 0.0 109.791 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.025 HD11 ' HB3' ' A' ' 64' ' ' ALA . 47.5 mt -86.5 -29.58 22.63 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -136.35 139.95 31.21 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 38.4 Cg_endo -61.52 141.76 92.76 Favored 'Trans proline' 0 C--O 1.216 -0.584 0 C-N-CA 122.891 2.394 . . . . 0.0 111.82 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.7 t80 -134.02 125.35 27.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.755 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 22' ' ' ILE . 11.0 t70 -102.73 110.71 22.73 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.986 -1.071 . . . . 0.0 108.673 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.55 90.31 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.7 mt -92.72 -14.32 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -1.143 . . . . 0.0 108.662 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.57 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -113.89 174.95 2.06 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.57 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.4 Cg_endo -71.08 -32.72 12.78 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.425 2.083 . . . . 0.0 111.806 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -111.88 -9.67 14.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 110.284 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.01 123.27 16.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.905 -1.122 . . . . 0.0 109.796 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.114 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -86.38 135.56 33.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.94 -1.1 . . . . 0.0 108.286 179.207 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.114 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -84.35 136.5 33.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 110.422 -178.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 9.4 p90 -139.74 148.39 42.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.922 . . . . 0.0 108.673 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.84 142.54 39.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.026 . . . . 0.0 109.588 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -44.43 152.01 0.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.019 -1.05 . . . . 0.0 108.325 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.4 -16.79 7.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -82.61 152.08 26.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.023 -1.281 . . . . 0.0 109.676 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -106.03 146.04 30.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.421 -0.799 . . . . 0.0 110.005 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.731 ' CE ' HG11 ' A' ' 63' ' ' VAL . 8.0 mtm -137.52 153.77 49.96 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.695 0.76 . . . . 0.0 109.838 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.607 ' CG ' HD12 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -116.41 130.1 56.58 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.628 HG11 ' CB ' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -96.44 119.99 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.936 -1.103 . . . . 0.0 110.113 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.44 -24.02 39.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.505 -0.747 . . . . 0.0 109.738 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -158.68 145.58 17.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.091 -1.006 . . . . 0.0 110.041 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.65 ' HG3' ' CG ' ' A' ' 45' ' ' TRP . 12.2 tt0 -111.42 143.06 42.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 0.0 109.392 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 75.1 m80 -116.63 42.95 2.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.099 -1.001 . . . . 0.0 109.677 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.603 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.83 41.97 21.08 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.603 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 156.37 -48.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -1.079 . . . . 0.0 109.911 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 59' ' ' PRO . 13.4 m95 -126.65 122.99 36.56 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 109.017 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.65 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.17 166.28 12.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 109.841 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.13 123.45 50.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -122.51 -171.32 2.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.695 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 ttpm? -140.75 150.58 43.58 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -90.11 126.1 35.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.011 -1.055 . . . . 0.0 109.964 -179.116 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -14.5 63.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.005 . . . . 0.0 109.445 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 tp -85.06 -53.49 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -109.28 13.54 24.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.264 -0.898 . . . . 0.0 109.348 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' SER . 18.7 mttp 44.44 25.38 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.352 -0.843 . . . . 0.0 109.798 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.8 mtpm? -79.45 141.17 37.02 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.13 -0.981 . . . . 0.0 108.355 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 12.5 pt-20 -121.72 144.08 48.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.032 -1.043 . . . . 0.0 109.576 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.697 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -166.69 -163.54 20.64 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.62 134.42 40.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.576 -0.955 . . . . 0.0 109.371 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.621 HD12 HG21 ' A' ' 63' ' ' VAL . 11.9 pt -125.96 142.22 41.75 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.098 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 49.7 Cg_endo -72.4 153.03 55.6 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.811 1.674 . . . . 0.0 110.638 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 80.7 p -86.25 29.45 0.75 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.546 -1.346 . . . . 0.0 109.969 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -138.27 0.61 2.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 0.0 109.736 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.567 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.5 m-85 -105.35 -25.51 12.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.009 . . . . 0.0 109.479 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.731 HG11 ' CE ' ' A' ' 35' ' ' MET . 18.8 m -123.16 160.68 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.025 ' HB3' HD11 ' A' ' 16' ' ' LEU . . . -157.25 -165.3 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 109.587 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -79.88 135.55 36.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -0.797 . . . . 0.0 109.512 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.687 HD12 HG21 ' A' ' 14' ' ' VAL . 1.2 tp -73.64 116.03 13.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.44 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -134.05 6.36 3.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.3 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.47 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 10' ' ' GLY . 79.5 mt-30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 9' ' ' GLN . . . 57.75 110.68 0.01 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 1.6 m-20 -111.98 155.4 23.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -1.129 . . . . 0.0 109.491 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.6 mm -105.85 129.77 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.6 OUTLIER -129.52 154.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.36 -0.838 . . . . 0.0 108.898 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 66' ' ' LEU . 9.4 p -114.16 133.93 58.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 120.987 -1.07 . . . . 0.0 108.837 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.685 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -56.61 115.3 2.46 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.471 -0.768 . . . . 0.0 109.682 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.862 HD11 ' HB3' ' A' ' 64' ' ' ALA . 56.1 mt -88.4 -27.21 21.73 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -137.51 139.96 28.88 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 39.0 Cg_endo -61.87 142.24 92.64 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.652 2.234 . . . . 0.0 111.47 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 39.7 t80 -134.23 125.9 28.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 0.0 109.989 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' C ' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -103.22 110.67 22.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.061 -1.024 . . . . 0.0 108.751 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.573 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.68 91.92 0.01 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.5 mt -93.32 -13.01 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -1.117 . . . . 0.0 108.716 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 26' ' ' ASP . 1.7 m-70 -114.65 174.16 2.5 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 50.8 Cg_endo -71.02 -32.42 13.39 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.388 2.059 . . . . 0.0 112.046 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -112.2 -9.88 13.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.165 -0.96 . . . . 0.0 110.285 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -59.81 126.81 29.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.06 . . . . 0.0 109.857 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.09 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -87.53 137.07 32.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.09 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.0 m -87.48 137.98 31.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 7.7 p90 -141.08 150.14 42.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.85 . . . . 0.0 108.804 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -108.92 138.58 45.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.068 -1.02 . . . . 0.0 109.581 -179.352 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LYS . 4.1 ptpt -42.16 152.06 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.37 -17.54 7.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -82.1 150.47 27.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.146 -1.208 . . . . 0.0 109.673 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HG2' HG23 ' A' ' 14' ' ' VAL . 12.7 mmtt -105.28 145.03 31.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.435 -0.79 . . . . 0.0 109.799 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.745 ' CE ' HG11 ' A' ' 63' ' ' VAL . 11.7 mtm -137.39 153.67 50.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.519 -0.738 . . . . 0.0 109.743 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.6 tttt -118.38 131.99 56.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.631 HG11 ' CB ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -96.79 121.01 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.986 -1.071 . . . . 0.0 110.366 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.61 -36.49 26.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 109.041 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -128.01 131.56 49.19 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -112.94 98.81 7.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.975 . . . . 0.0 109.802 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 74.0 m80 -75.86 -157.77 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.352 -1.468 . . . . 0.0 108.954 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . -105.49 43.88 1.58 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 2.2 mt-10 163.51 -40.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.141 -1.211 . . . . 0.0 109.115 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.463 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 7.0 m95 -132.39 123.58 27.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.386 -0.821 . . . . 0.0 109.871 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.647 ' CZ2' ' HB2' ' A' ' 60' ' ' SER . 0.1 OUTLIER -115.54 168.58 9.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.396 -0.815 . . . . 0.0 109.807 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -110.74 121.29 44.96 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -120.17 -170.64 2.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.907 . . . . 0.0 110.631 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -142.04 150.75 41.68 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 53' ' ' LYS . 25.6 t -90.05 125.91 35.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 109.791 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -9.95 57.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 0.0 109.321 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 51' ' ' LEU . 15.6 tp -82.76 -57.53 3.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.314 -0.867 . . . . 0.0 109.812 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -109.32 2.22 20.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 109.378 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' SER . 19.5 mttt 61.99 26.68 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 109.845 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 7.4 mmtp -81.94 140.01 34.28 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.3 pm0 -121.29 144.16 48.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.996 -1.065 . . . . 0.0 109.834 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.721 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -171.49 166.66 39.71 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 10.2 m-85 -66.92 135.09 53.29 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.362 -1.081 . . . . 0.0 109.763 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.472 HG22 ' CE1' ' A' ' 29' ' ' PHE . 2.6 pt -124.92 146.4 53.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.392 -0.818 . . . . 0.0 109.0 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 48.4 Cg_endo -71.95 146.85 48.2 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.98 1.787 . . . . 0.0 110.615 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.647 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 80.6 p -85.09 29.72 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.43 -1.419 . . . . 0.0 110.187 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -137.64 0.43 2.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.119 -0.988 . . . . 0.0 109.737 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.609 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 36.6 m-85 -107.54 -23.84 12.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.092 -1.005 . . . . 0.0 109.467 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.745 HG11 ' CE ' ' A' ' 35' ' ' MET . 29.3 m -124.7 159.31 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.862 ' HB3' HD11 ' A' ' 16' ' ' LEU . . . -154.33 -166.31 2.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.633 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -102.49 127.75 49.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.428 -0.795 . . . . 0.0 109.556 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.555 ' HB2' HG11 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -127.88 96.71 4.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.481 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -95.61 -168.73 1.83 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.507 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.411 ' OXT' HG22 ' A' ' 68' ' ' THR . 4.9 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.515 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 9' ' ' GLN . . . -60.31 -117.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.96 141.02 0.09 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -1.182 . . . . 0.0 109.445 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.0 mm -107.7 131.03 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -129.94 154.32 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.24 -0.912 . . . . 0.0 109.107 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.772 ' O ' HD23 ' A' ' 16' ' ' LEU . 12.9 p -116.16 135.17 57.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.075 -1.016 . . . . 0.0 109.001 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -58.95 118.74 6.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.645 -0.659 . . . . 0.0 110.843 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.772 HD23 ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -89.87 -26.4 20.51 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.508 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . 50.6 m-85 -138.26 141.77 32.97 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 40.2 Cg_endo -62.57 141.72 87.22 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.595 2.196 . . . . 0.0 111.474 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 42.8 t80 -133.84 125.39 28.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 0.0 109.8 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' ILE . 6.4 t70 -103.17 110.01 21.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.106 -0.996 . . . . 0.0 108.666 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.04 89.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.4 mp -88.33 -13.42 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.158 -1.201 . . . . 0.0 108.552 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.506 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -114.6 174.91 2.09 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 51.2 Cg_endo -71.38 -31.39 14.11 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.415 2.077 . . . . 0.0 111.906 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 9.4 t70 -112.54 -9.85 13.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.394 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -59.59 127.27 31.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.941 -1.099 . . . . 0.0 109.806 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.101 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -88.52 136.19 33.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.983 -1.073 . . . . 0.0 108.372 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.101 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.7 m -86.85 137.79 32.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.989 . . . . 0.0 110.452 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.663 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 10.0 p90 -141.37 150.34 42.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 0.0 108.802 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -108.53 137.62 46.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.052 -1.03 . . . . 0.0 109.303 -179.562 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.25 153.55 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.416 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.87 -17.52 4.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -82.2 154.46 25.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.042 -1.269 . . . . 0.0 109.703 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -106.32 142.93 35.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.768 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -137.67 153.71 49.79 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.497 0.665 . . . . 0.0 109.325 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.2 ptpt -118.34 131.68 56.31 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.381 -0.824 . . . . 0.0 108.818 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -100.65 120.25 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.337 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.56 -37.44 16.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 109.914 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -132.72 136.76 46.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.065 -1.022 . . . . 0.0 109.89 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.625 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.4 tt0 -111.21 146.41 36.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.547 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 45.2 m80 -116.64 46.34 1.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.692 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 48.61 32.36 10.66 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 162.36 -42.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -1.199 . . . . 0.0 109.831 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.547 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 12.9 m95 -127.5 120.9 29.34 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.44 -0.788 . . . . 0.0 108.875 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.83 166.94 11.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.018 -1.051 . . . . 0.0 109.822 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.469 ' HG2' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -109.66 121.16 44.58 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.12 -173.82 2.43 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 110.644 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -137.21 146.41 44.83 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -85.12 123.58 30.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.675 -179.231 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -8.76 49.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.088 -1.007 . . . . 0.0 109.308 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.95 -54.42 4.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 109.898 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -109.55 1.97 20.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' SER . 21.7 mmtm 59.71 26.66 15.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.227 -0.921 . . . . 0.0 109.744 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HD2' HD23 ' A' ' 27' ' ' LEU . 5.1 ttmm -83.95 141.73 31.03 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 12.8 pt-20 -118.71 137.99 52.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.996 -1.065 . . . . 0.0 109.822 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.661 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -163.37 163.54 35.63 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.436 ' HE1' ' CE1' ' A' ' 41' ' ' HIS . 18.6 m-85 -65.69 133.93 52.13 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.351 -1.087 . . . . 0.0 109.98 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.627 HD12 HG21 ' A' ' 63' ' ' VAL . 7.7 pt -123.43 144.05 42.99 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.729 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.6 Cg_endo -71.57 148.19 53.15 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.941 1.761 . . . . 0.0 110.786 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 89.3 p -86.14 29.5 0.74 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.481 -1.387 . . . . 0.0 110.241 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -136.99 -1.86 2.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.091 -1.006 . . . . 0.0 109.935 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.729 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 4.8 m-85 -106.64 -23.12 12.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 109.207 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.768 HG11 ' CE ' ' A' ' 35' ' ' MET . 11.0 m -123.75 157.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.375 -0.828 . . . . 0.0 109.32 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 13' ' ' VAL . . . -153.36 -166.13 2.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.982 . . . . 0.0 109.532 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.83 111.53 24.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.377 -0.827 . . . . 0.0 109.556 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 66' ' ' LEU . 3.5 mm? 46.66 -166.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.462 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -178.98 153.13 0.61 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 0.0 109.515 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.64 146.46 18.76 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -136.09 163.94 29.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -1.163 . . . . 0.0 109.425 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 12' ' ' ILE . 19.8 mm -105.42 130.3 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.212 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 1.1 m -131.07 156.75 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.345 -0.847 . . . . 0.0 109.125 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.543 HG11 ' HB2' ' A' ' 66' ' ' LEU . 6.6 p -114.49 134.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.845 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.605 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -57.23 116.67 3.42 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.531 -0.73 . . . . 0.0 109.907 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.723 HD11 ' CB ' ' A' ' 64' ' ' ALA . 20.4 mt -89.27 -27.74 20.37 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -137.58 141.79 34.65 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.6 Cg_endo -61.83 141.41 89.98 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.731 2.287 . . . . 0.0 111.571 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.649 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 41.2 t80 -134.66 126.25 28.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 110.182 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 22' ' ' ILE . 12.1 t70 -102.0 107.87 19.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.054 -1.029 . . . . 0.0 108.282 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -31.06 90.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.7 mt -79.56 -59.91 2.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.506 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -65.34 173.75 1.73 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.609 -0.682 . . . . 0.0 109.401 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -71.53 -26.59 19.82 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.68 2.253 . . . . 0.0 112.29 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -113.23 -9.87 13.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.532 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.446 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 48.4 m-20 -59.69 121.78 12.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.915 -1.116 . . . . 0.0 109.782 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.12 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -83.39 135.78 34.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.965 -1.084 . . . . 0.0 108.405 179.372 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.12 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.2 m -85.23 136.41 33.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 110.362 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.5 p90 -139.77 148.71 42.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.302 -0.874 . . . . 0.0 108.709 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.52 141.21 40.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.963 -1.086 . . . . 0.0 109.557 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.63 152.23 0.16 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.37 -17.15 6.67 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 5.4 tp10 -82.45 152.64 26.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.051 -1.264 . . . . 0.0 109.77 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 7.0 mttm -105.88 145.22 31.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.918 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.755 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -138.42 154.11 48.88 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.553 -0.717 . . . . 0.0 109.647 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.691 ' HD3' HD11 ' A' ' 38' ' ' LEU . 5.4 tttp -120.62 136.48 54.8 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.658 HG11 ' CB ' ' A' ' 45' ' ' TRP . 3.3 t -98.4 119.14 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 109.797 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 38' ' ' LEU . 2.3 mm? -88.11 -19.67 26.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.507 -0.746 . . . . 0.0 110.191 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' NE2' ' A' ' 41' ' ' HIS . 12.4 pt-20 -146.91 138.95 24.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.966 -1.084 . . . . 0.0 109.795 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.4 ' OE2' ' N ' ' A' ' 42' ' ' GLY . 2.5 tm-20 -108.65 135.38 49.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.403 -0.81 . . . . 0.0 109.125 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 44.1 m-70 -122.89 36.0 4.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.162 -0.961 . . . . 0.0 109.241 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 93.78 -108.57 3.69 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 60' ' ' SER . 0.4 OUTLIER -87.48 -7.13 57.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 110.01 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.577 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 10.6 m95 -130.21 143.01 50.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.015 -1.053 . . . . 0.0 109.827 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.658 ' CB ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -140.64 167.25 22.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.184 -0.948 . . . . 0.0 109.777 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.94 119.97 40.98 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.57 -172.13 2.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.515 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.1 tttm -138.93 147.86 42.83 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 53' ' ' LYS . 1.4 t -86.14 124.81 32.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 109.588 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -69.51 -10.97 60.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.963 . . . . 0.0 109.394 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.6 tp -86.17 -54.16 4.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -0.855 . . . . 0.0 109.893 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.3 2.0 22.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 109.306 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 49' ' ' SER . 4.8 mttp 57.53 24.73 10.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 110.319 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.5 ttmm -83.23 145.51 29.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 108.253 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -119.46 142.22 48.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.059 -1.025 . . . . 0.0 109.783 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.657 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -167.55 165.12 38.44 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -68.03 135.13 51.8 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.376 -1.073 . . . . 0.0 109.926 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.658 HD12 HG21 ' A' ' 63' ' ' VAL . 10.4 pt -124.43 144.52 46.21 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.64 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.4 Cg_endo -71.95 149.03 52.51 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.028 1.819 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.58 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 46.4 t -86.98 28.76 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.44 -1.413 . . . . 0.0 110.269 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -136.9 -0.98 2.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.956 -1.09 . . . . 0.0 109.818 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.64 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 33.0 m-85 -106.35 -23.81 12.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.003 . . . . 0.0 109.184 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.755 HG11 ' CE ' ' A' ' 35' ' ' MET . 15.6 m -123.91 157.13 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.298 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.723 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -151.77 -166.96 2.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.701 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -98.93 135.2 40.7 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.774 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.617 HD23 HG23 ' A' ' 68' ' ' THR . 0.5 OUTLIER -107.98 125.7 51.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -0.845 . . . . 0.0 109.318 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 66' ' ' LEU . 15.0 t30 -42.71 115.91 0.79 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.568 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.617 HG23 HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.469 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.35 151.1 20.04 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.58 155.72 20.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.214 -1.168 . . . . 0.0 109.496 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.446 HD11 ' HE2' ' A' ' 36' ' ' LYS . 29.7 mm -107.82 132.76 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.839 . . . . 0.0 109.33 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.877 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.6 m -130.31 155.7 41.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.127 -0.983 . . . . 0.0 109.26 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.532 ' CG1' ' HB3' ' A' ' 64' ' ' ALA . 11.2 p -113.25 134.6 55.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.107 -0.996 . . . . 0.0 108.775 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.03 117.52 4.07 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 110.131 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.935 HD11 ' HB2' ' A' ' 64' ' ' ALA . 68.7 mt -90.04 -28.21 19.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -137.71 142.93 38.39 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.8 Cg_endo -61.94 140.69 86.29 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.613 2.208 . . . . 0.0 111.419 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.0 t80 -133.78 125.98 29.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 0.0 109.921 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 22' ' ' ILE . 72.5 m-20 -102.86 107.36 18.18 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.954 -1.091 . . . . 0.0 108.385 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.13 90.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 20' ' ' ASP . 16.4 mt -78.77 -59.67 2.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.49 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER -66.25 173.34 2.31 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.614 -0.679 . . . . 0.0 109.222 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 50.4 Cg_endo -70.82 -26.07 23.0 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.723 2.282 . . . . 0.0 112.349 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.7 OUTLIER -113.28 -9.4 13.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -0.927 . . . . 0.0 110.762 -178.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.6 OUTLIER -60.69 116.48 4.43 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.799 -1.188 . . . . 0.0 109.882 -179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.113 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.66 135.63 38.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.981 -1.075 . . . . 0.0 108.408 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.113 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.5 m -85.54 137.13 33.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.627 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.8 p90 -139.36 148.04 42.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.289 -0.882 . . . . 0.0 108.718 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.6 141.09 39.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 109.475 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.479 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -43.11 151.21 0.15 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.141 -0.975 . . . . 0.0 108.438 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.36 -16.58 7.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 15' ' ' ALA . 7.5 tm-20 -82.71 151.93 26.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.138 -1.213 . . . . 0.0 109.722 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 37.7 mtpt -105.43 145.89 30.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.522 -0.736 . . . . 0.0 109.866 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.662 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -140.92 155.55 46.25 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.434 0.635 . . . . 0.0 109.427 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.609 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 4.2 tttm -122.55 139.48 53.86 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -104.43 119.7 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.195 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.7 -27.14 18.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 110.09 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -131.45 135.69 47.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.973 -1.079 . . . . 0.0 109.373 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -109.24 136.9 47.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.261 -0.899 . . . . 0.0 109.2 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.583 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 10.6 m-70 -122.47 37.35 4.41 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 108.947 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 -99.57 2.51 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -90.39 -10.39 44.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -1.113 . . . . 0.0 110.372 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.604 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 6.0 m95 -131.33 138.66 49.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.604 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -135.7 165.38 25.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.337 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.598 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 13.2 tttt -109.61 120.99 44.2 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 36' ' ' LYS . . . -115.76 -173.56 2.37 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.389 -0.819 . . . . 0.0 110.697 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.6 ttpt -137.31 146.92 45.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -85.71 125.09 32.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.001 -1.062 . . . . 0.0 109.687 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.91 -10.34 58.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 109.301 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.6 tp -88.4 -53.8 4.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.712 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.69 8.51 26.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 109.42 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' SER . 10.8 mttt 50.2 25.26 1.72 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.991 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.05 143.85 31.25 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.15 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -119.02 141.64 48.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 109.453 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.678 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.41 -166.42 21.15 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.439 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -96.63 132.92 41.78 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.416 -1.05 . . . . 0.0 109.419 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 58' ' ' ILE . 17.2 pt -125.14 141.1 37.61 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.644 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 51.9 Cg_endo -74.54 157.54 44.61 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 121.673 1.582 . . . . 0.0 110.942 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.486 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 89.2 p -90.31 29.43 1.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.636 -1.29 . . . . 0.0 109.908 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -140.7 -2.67 1.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.644 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 4.9 m-85 -102.23 -24.39 13.91 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.907 -1.121 . . . . 0.0 110.534 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.662 HG11 ' CE ' ' A' ' 35' ' ' MET . 10.5 m -111.16 155.5 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 0.0 109.97 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.935 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -102.78 129.44 49.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.452 -0.78 . . . . 0.0 109.561 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.877 ' HA ' HG12 ' A' ' 13' ' ' VAL . 13.9 ptpt -80.03 134.48 36.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.967 -1.083 . . . . 0.0 109.391 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mp 63.33 -91.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.49 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 174.17 110.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.431 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.494 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.296 0.57 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.63 81.14 0.23 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.494 ' C ' HD13 ' A' ' 12' ' ' ILE . 13.0 t70 -127.21 122.32 33.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.338 -1.095 . . . . 0.0 109.28 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.723 HD12 ' CG ' ' A' ' 36' ' ' LYS . 6.7 mm -105.55 130.6 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -130.77 155.97 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.055 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.446 HG11 ' HB3' ' A' ' 66' ' ' LEU . 14.3 p -113.69 135.12 54.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.081 -1.012 . . . . 0.0 108.532 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -57.16 114.38 2.13 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.509 -0.744 . . . . 0.0 109.81 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.869 HD11 ' CB ' ' A' ' 64' ' ' ALA . 49.9 mt -88.48 -28.4 20.86 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -136.74 139.15 28.22 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 38.4 Cg_endo -61.62 142.28 94.0 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.758 2.305 . . . . 0.0 111.676 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.3 t80 -133.53 124.45 26.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 109.699 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -102.63 111.1 23.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.002 . . . . 0.0 108.521 179.239 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -25.66 88.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' ASP . 34.5 mt -88.99 -13.97 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -1.184 . . . . 0.0 108.636 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.555 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -115.13 175.85 1.73 Allowed Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.555 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.2 Cg_endo -71.93 -32.22 11.53 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.561 2.174 . . . . 0.0 111.697 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -112.34 -10.43 13.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 110.113 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.474 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -60.04 117.54 5.22 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.983 -1.073 . . . . 0.0 109.738 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.117 HD22 ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -81.3 137.18 35.8 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.002 -1.061 . . . . 0.0 108.285 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.117 ' N ' HD22 ' A' ' 27' ' ' LEU . 6.2 p -84.96 137.34 33.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.975 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.1 p90 -139.37 148.77 43.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 2.3 ttmt -108.96 140.26 42.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.977 -1.077 . . . . 0.0 109.697 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' LYS . 1.5 ptmt -43.65 152.66 0.14 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.3 -17.93 5.88 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 6.0 tm-20 -82.23 153.15 26.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.031 -1.276 . . . . 0.0 109.643 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 144.63 32.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.437 -0.79 . . . . 0.0 109.78 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.684 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.1 mpp? -137.64 153.29 49.88 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.52 -0.737 . . . . 0.0 109.624 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.723 ' CG ' HD12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -118.99 132.76 56.09 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.72 HG11 ' HB2' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -97.15 119.91 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.037 . . . . 0.0 109.794 -179.616 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mt -88.04 -22.38 24.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.462 -0.774 . . . . 0.0 110.317 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -146.4 138.81 25.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.798 -1.189 . . . . 0.0 109.771 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -108.76 137.0 47.41 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.412 -0.805 . . . . 0.0 109.13 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.546 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 11.9 m80 -121.56 37.79 4.26 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.23 -0.919 . . . . 0.0 109.058 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.11 -106.08 3.34 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.78 -7.77 55.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -1.074 . . . . 0.0 110.008 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.595 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 29.6 m95 -129.25 139.48 51.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.0 109.777 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.72 ' HB2' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.72 167.34 22.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 109.759 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.561 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 12.2 tttt -110.66 123.51 50.14 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -118.78 -170.88 1.99 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 110.5 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 15.8 ttpt -140.87 150.28 43.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.2 t -88.6 125.51 34.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.058 -1.026 . . . . 0.0 109.783 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -10.75 59.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.184 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.2 tp -85.9 -54.34 4.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 109.847 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.68 8.39 24.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 49' ' ' SER . 53.5 mttp 51.99 26.74 3.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.733 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.0 OUTLIER -84.77 142.86 29.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 4.6 pt-20 -117.98 148.69 41.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.64 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -166.05 -167.4 26.63 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.94 132.91 42.24 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.354 -1.086 . . . . 0.0 109.151 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.787 HD12 HG21 ' A' ' 63' ' ' VAL . 40.0 pt -124.92 140.99 37.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.556 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 51.5 Cg_endo -75.15 157.08 42.34 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.753 1.635 . . . . 0.0 110.837 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.539 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 48.1 t -88.6 29.85 0.96 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.609 -1.307 . . . . 0.0 109.836 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.492 ' OD1' ' C ' ' A' ' 60' ' ' SER . 6.0 m-20 -137.42 0.92 2.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 0.0 109.652 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.556 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 3.0 m-85 -108.19 -26.25 10.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.018 . . . . 0.0 109.286 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.787 HG21 HD12 ' A' ' 58' ' ' ILE . 15.3 m -124.22 161.06 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.869 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -155.41 -166.59 2.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 109.776 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.36 87.95 2.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.522 -0.736 . . . . 0.0 109.484 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HA ' HD12 ' A' ' 66' ' ' LEU . 12.6 tp -137.83 119.93 15.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.42 41.68 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.452 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.335 0.588 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 11' ' ' ASP . . . -105.03 177.17 23.14 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -158.32 158.9 35.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -1.101 . . . . 0.0 109.395 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 12' ' ' ILE . 18.4 mm -107.3 131.04 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.554 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.867 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.0 OUTLIER -130.56 156.75 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.28 -0.887 . . . . 0.0 108.994 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 p -112.47 134.32 55.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.939 -1.1 . . . . 0.0 109.001 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.35 118.2 4.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.443 -0.785 . . . . 0.0 110.281 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.081 HD11 ' HB2' ' A' ' 64' ' ' ALA . 25.5 mt -90.94 -29.11 17.63 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -137.16 143.05 40.27 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.5 Cg_endo -61.72 140.09 84.19 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.752 2.301 . . . . 0.0 111.552 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 39.2 t80 -134.05 126.37 30.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.957 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 22' ' ' ILE . 3.0 m-20 -103.22 107.39 18.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.942 -1.099 . . . . 0.0 108.516 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.04 91.42 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' ASP . 13.4 mm -79.29 -58.75 3.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.588 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -67.26 175.4 1.55 Allowed Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.4 Cg_endo -71.74 -25.47 20.38 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.637 2.225 . . . . 0.0 112.045 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 35.8 m-20 -112.65 -8.33 13.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.33 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.49 121.05 11.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.026 -1.046 . . . . 0.0 109.754 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.116 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -85.5 134.64 34.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.921 -1.112 . . . . 0.0 108.363 179.262 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.116 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.7 p -84.27 136.93 33.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.955 . . . . 0.0 110.635 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.6 p90 -139.01 147.34 42.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 11.6 mtpp -107.25 140.98 39.29 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.081 -1.012 . . . . 0.0 109.499 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -42.6 151.47 0.12 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.153 -0.967 . . . . 0.0 108.397 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.97 -16.03 7.59 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.9 tp10 -83.33 151.63 25.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.032 -1.275 . . . . 0.0 109.542 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 4.1 mttt -105.77 146.49 29.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.425 -0.797 . . . . 0.0 110.166 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.555 ' HE3' HG11 ' A' ' 63' ' ' VAL . 3.1 mtm -138.2 155.35 48.76 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.663 0.744 . . . . 0.0 109.557 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -123.0 138.86 54.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.0 119.07 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 109.288 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.62 -26.91 16.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.998 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -132.0 135.82 46.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.002 -1.062 . . . . 0.0 109.294 -179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.88 134.78 51.09 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.176 -0.952 . . . . 0.0 109.251 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.608 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 56.5 m-70 -120.61 34.85 5.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.309 -0.869 . . . . 0.0 109.009 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 -108.33 3.66 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 75.3 tt0 -85.15 -7.53 59.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -1.136 . . . . 0.0 109.987 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.611 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 21.4 m95 -132.28 140.13 48.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.948 -1.095 . . . . 0.0 110.315 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.611 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -136.54 166.53 23.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.463 -0.773 . . . . 0.0 109.186 179.086 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -108.73 117.36 33.97 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -112.03 -175.08 2.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.363 -0.836 . . . . 0.0 110.47 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 32.2 ttpt -139.13 148.17 42.88 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.9 t -88.89 124.94 34.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 0.0 109.672 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -69.2 -11.77 61.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.058 -1.026 . . . . 0.0 109.281 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 tp -87.43 -53.57 4.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 0.0 109.769 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.533 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 1.8 t -108.99 14.63 23.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.355 -0.841 . . . . 0.0 109.351 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER 42.43 25.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -80.99 142.67 33.19 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.033 -1.042 . . . . 0.0 108.416 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 18.9 tt0 -121.44 141.09 51.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.092 -1.005 . . . . 0.0 109.6 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.699 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -168.65 166.94 39.98 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -67.76 134.41 50.97 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.431 -1.041 . . . . 0.0 109.913 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.64 142.28 40.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.678 ' CG ' ' CD1' ' A' ' 62' ' ' TYR . 50.1 Cg_endo -72.02 151.26 55.78 Favored 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 121.7 1.6 . . . . 0.0 110.918 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.503 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 98.9 p -87.67 28.09 1.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.55 -1.344 . . . . 0.0 109.983 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -140.27 -4.23 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.086 -1.009 . . . . 0.0 110.032 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.678 ' CD1' ' CG ' ' A' ' 59' ' ' PRO . 7.6 m-85 -98.7 -23.36 15.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.058 -1.026 . . . . 0.0 110.388 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.555 HG11 ' HE3' ' A' ' 35' ' ' MET . 17.5 m -110.42 156.69 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.179 . . . . 0.0 109.737 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.081 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -104.6 128.21 52.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 109.734 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.867 ' HA ' HG12 ' A' ' 13' ' ' VAL . 2.7 mtpt -82.47 79.42 8.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -0.978 . . . . 0.0 109.254 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.672 HD12 ' ND2' ' A' ' 67' ' ' ASN . 1.1 tm? 77.99 -71.99 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.361 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.672 ' ND2' HD12 ' A' ' 66' ' ' LEU . 6.5 p30 -145.8 -39.4 0.23 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.562 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 68' ' ' THR . 6.7 t . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.481 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.33 0.586 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.0 -159.4 9.14 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.55 136.91 48.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -1.186 . . . . 0.0 109.308 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.615 HD13 ' HG2' ' A' ' 36' ' ' LYS . 34.8 mm -105.37 131.13 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.253 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.947 HG12 ' CA ' ' A' ' 65' ' ' LYS . 1.4 m -131.8 158.04 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.344 -0.848 . . . . 0.0 109.469 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.04 136.36 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.137 -0.977 . . . . 0.0 109.007 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 31' ' ' LYS . . . -57.39 117.13 3.81 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 109.631 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.037 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 26.0 mt -90.39 -28.49 18.64 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -136.52 139.41 29.37 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 37.4 Cg_endo -59.73 141.25 96.58 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.925 2.416 . . . . 0.0 111.888 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.599 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 29.7 t80 -131.79 122.82 26.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.0 109.384 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 2.4 m-20 -102.57 110.92 23.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.116 -0.99 . . . . 0.0 108.858 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.97 89.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.3 mt -93.42 -14.98 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -1.131 . . . . 0.0 108.482 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -112.82 174.15 2.47 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 51.0 Cg_endo -70.65 -34.34 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.402 2.068 . . . . 0.0 112.022 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -111.41 -9.61 14.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.118 -0.989 . . . . 0.0 110.361 -179.43 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -60.29 120.62 10.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.975 -1.078 . . . . 0.0 109.772 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.113 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -84.54 135.64 34.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.999 -1.063 . . . . 0.0 108.336 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.113 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -84.3 136.51 33.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.584 -178.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 19' ' ' TYR . 13.9 p90 -140.29 149.1 42.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 108.754 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.535 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -107.68 136.78 46.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.909 -1.119 . . . . 0.0 109.392 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -38.87 154.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 72.5 -15.76 1.99 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.9 OUTLIER -80.17 156.42 26.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.825 -1.397 . . . . 0.0 108.926 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -107.08 144.37 33.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 110.355 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.641 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -140.48 154.79 46.73 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.444 0.64 . . . . 0.0 109.298 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.615 ' HG2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -122.24 139.86 53.28 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.66 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 1.3 t -99.87 119.22 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.015 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -90.23 -21.27 22.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.409 -0.807 . . . . 0.0 110.073 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 48.2 tt0 -144.51 138.12 27.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.932 -1.105 . . . . 0.0 109.787 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.37 133.27 52.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.329 -0.857 . . . . 0.0 109.0 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.522 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 77.9 m-70 -121.6 34.15 5.28 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.216 -0.928 . . . . 0.0 109.361 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.48 -110.53 4.04 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.36 -7.49 58.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -1.137 . . . . 0.0 109.892 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.572 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 m95 -130.65 142.55 50.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.985 -1.072 . . . . 0.0 109.908 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.66 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.85 168.16 20.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.287 -0.883 . . . . 0.0 109.766 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.628 ' O ' HD12 ' A' ' 38' ' ' LEU . 7.9 tttm -110.88 117.38 33.23 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.03 -172.03 2.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 110.354 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 6.8 ttpm? -139.88 149.0 42.86 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -88.44 125.97 35.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.084 -1.01 . . . . 0.0 109.508 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.5 mt -69.98 -13.49 62.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.017 -1.052 . . . . 0.0 109.288 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.8 tp -82.92 -55.62 4.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.798 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.468 ' OG1' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.96 10.61 26.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.386 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.5 OUTLIER 49.72 25.43 1.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.88 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.577 ' HB3' HD23 ' A' ' 27' ' ' LEU . 13.4 mttp -79.47 142.54 35.76 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 6.5 pt-20 -120.99 143.4 49.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.074 -1.016 . . . . 0.0 109.391 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.669 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -165.63 -164.74 21.7 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HB3' ' CZ3' ' A' ' 44' ' ' TRP . 1.7 m-85 -96.63 133.54 41.01 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.394 -1.062 . . . . 0.0 109.46 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 58' ' ' ILE . 20.5 pt -125.64 140.31 36.18 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.607 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 54.5 Cg_endo -77.1 161.23 32.75 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 121.663 1.576 . . . . 0.0 110.963 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.593 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 41.8 t -90.88 29.33 1.37 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.677 -1.265 . . . . 0.0 109.872 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 23.5 t-20 -140.65 -0.1 1.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.607 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 9.8 m-85 -102.12 -26.86 13.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.057 -1.027 . . . . 0.0 110.151 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.641 HG11 ' CE ' ' A' ' 35' ' ' MET . 5.1 m -113.76 163.3 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.88 -1.137 . . . . 0.0 110.075 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.037 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -109.69 130.47 55.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 109.379 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.947 ' CA ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.4 130.7 43.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.043 -1.035 . . . . 0.0 109.423 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -132.83 102.94 5.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.892 . . . . 0.0 109.445 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 66' ' ' LEU . 56.8 t30 179.62 151.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.895 . . . . 0.0 109.455 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.462 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.43 119.71 3.45 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.417 ' OD2' ' HE2' ' A' ' 65' ' ' LYS . 1.2 m-20 -146.8 155.48 42.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -1.129 . . . . 0.0 109.381 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.699 HD12 ' HD3' ' A' ' 36' ' ' LYS . 1.8 tp -109.83 134.1 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.845 HG12 ' CA ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -129.4 155.65 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.257 -0.902 . . . . 0.0 109.049 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.764 HG12 ' HB3' ' A' ' 64' ' ' ALA . 9.1 p -113.26 134.28 56.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.087 -1.008 . . . . 0.0 108.958 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -56.14 117.44 3.76 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.465 -0.772 . . . . 0.0 110.107 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 64' ' ' ALA . 32.3 mt -89.1 -29.22 19.55 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -136.58 142.49 39.4 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.1 Cg_endo -60.73 140.03 88.61 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.747 2.298 . . . . 0.0 111.675 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 28.6 t80 -131.76 123.21 27.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 109.371 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -103.23 110.09 21.93 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 108.832 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.58 89.24 0.01 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.6 mt -90.75 -14.99 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.329 -1.101 . . . . 0.0 108.424 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.4 176.21 1.57 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -71.77 -32.94 10.91 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.422 2.081 . . . . 0.0 111.897 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 4.8 m-20 -111.46 -8.82 14.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.163 -0.961 . . . . 0.0 110.216 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.463 ' OD1' ' CZ ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -60.69 122.85 15.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.001 -1.062 . . . . 0.0 109.636 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.108 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -87.45 134.8 33.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.962 -1.086 . . . . 0.0 108.498 179.318 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.108 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -84.21 136.38 33.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.496 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.663 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.6 p90 -139.37 148.1 42.4 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -107.9 137.16 46.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.081 . . . . 0.0 109.437 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 30' ' ' LYS . 9.6 ptmm? -38.81 151.66 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.41 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.11 -16.77 8.38 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.143 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 1.8 mp0 -83.32 153.39 24.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.948 -1.325 . . . . 0.0 109.653 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 8.8 mtpt -105.43 146.33 29.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.413 -0.804 . . . . 0.0 109.958 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.601 ' HE3' HG11 ' A' ' 63' ' ' VAL . 4.9 mtm -138.68 155.18 48.49 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.699 0.761 . . . . 0.0 109.573 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.699 ' HD3' HD12 ' A' ' 12' ' ' ILE . 3.4 tppt? -123.05 138.75 54.6 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.43 ' N ' ' HG3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -104.73 119.25 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.405 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -26.08 17.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.882 . . . . 0.0 109.989 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 68.5 mt-10 -133.04 135.51 45.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 109.155 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.433 ' OE2' ' N ' ' A' ' 42' ' ' GLY . 2.5 tm-20 -109.47 134.8 51.43 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.235 -0.916 . . . . 0.0 109.335 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.596 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 25.8 m80 -119.95 36.02 4.66 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.252 -0.905 . . . . 0.0 108.86 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.433 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 92.63 -106.46 3.41 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -86.59 -8.32 57.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -1.165 . . . . 0.0 110.121 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.607 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 12.2 m95 -131.98 138.74 48.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.919 -1.113 . . . . 0.0 110.375 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.607 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -136.09 167.18 21.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.358 -0.839 . . . . 0.0 109.326 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -109.04 117.51 34.38 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.766 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -113.7 -173.1 2.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.379 -0.826 . . . . 0.0 110.677 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.5 ttmt -139.88 147.49 40.7 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.666 ' O ' ' N ' ' A' ' 53' ' ' LYS . 29.3 t -88.48 129.47 35.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 109.925 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.37 -27.47 66.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.052 . . . . 0.0 109.79 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.13 -41.82 16.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.181 -0.949 . . . . 0.0 109.947 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.495 ' OG1' ' HB3' ' A' ' 49' ' ' SER . 1.3 p -98.94 -18.35 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.354 -0.841 . . . . 0.0 109.371 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 49' ' ' SER . 14.0 mttt 60.65 11.21 2.98 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.334 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -80.21 150.76 29.99 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.597 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 8.6 pt-20 -120.53 143.52 48.53 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.9 -1.125 . . . . 0.0 109.695 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.69 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -167.15 165.6 38.68 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 1.8 m-85 -68.01 134.88 51.43 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.441 -1.035 . . . . 0.0 110.109 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 6.9 pt -125.52 140.85 37.39 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.703 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 52.9 Cg_endo -74.42 157.04 45.52 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 121.62 1.547 . . . . 0.0 111.055 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -89.56 27.98 1.38 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.706 -1.246 . . . . 0.0 109.824 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -140.71 -1.82 1.41 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.841 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.703 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.4 m-85 -102.05 -25.96 13.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.118 -0.989 . . . . 0.0 110.276 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.601 HG11 ' HE3' ' A' ' 35' ' ' MET . 11.5 m -108.79 172.0 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.814 -1.179 . . . . 0.0 109.972 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.807 ' HB2' HD21 ' A' ' 16' ' ' LEU . . . -119.99 126.54 51.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.789 . . . . 0.0 109.595 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.845 ' CA ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -92.08 52.57 2.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.129 -0.982 . . . . 0.0 109.305 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.44 66.63 0.46 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 t30 57.23 167.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.488 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.37 100.68 0.37 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.6 129.75 40.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -1.115 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 3.0 tp -109.4 132.75 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.453 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.75 HG12 ' CA ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -128.38 154.32 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 108.861 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.3 p -113.01 134.02 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.267 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.47 119.36 6.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.603 -0.686 . . . . 0.0 110.303 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.105 HD11 ' HB2' ' A' ' 64' ' ' ALA . 81.1 mt -91.51 -28.1 17.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -137.25 143.48 41.8 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.3 Cg_endo -61.47 140.03 85.3 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.62 2.213 . . . . 0.0 111.331 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.636 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 33.5 t80 -133.67 125.96 29.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.856 . . . . 0.0 110.051 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -103.25 106.76 17.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.016 -1.053 . . . . 0.0 108.371 178.748 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -29.63 92.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.0 mt -78.85 -59.01 3.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.354 -1.086 . . . . 0.0 108.099 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 3.6 m-70 -67.33 172.49 3.67 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 47.3 Cg_endo -68.83 -23.96 34.73 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.555 2.17 . . . . 0.0 112.108 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.544 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.1 m-20 -112.86 -7.48 13.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.151 -0.968 . . . . 0.0 110.284 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.517 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 13.3 m-20 -60.95 118.43 6.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.041 -1.037 . . . . 0.0 109.925 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.122 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -83.8 134.46 34.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.933 -1.104 . . . . 0.0 108.49 179.218 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.122 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.3 m -84.38 137.12 33.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.64 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 19' ' ' TYR . 8.7 p90 -139.56 148.28 42.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.281 -0.887 . . . . 0.0 108.635 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 31' ' ' LYS . 4.6 ttpm? -107.28 139.73 41.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.965 -1.084 . . . . 0.0 109.479 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.66 152.3 0.07 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.73 -16.27 6.86 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -82.84 152.66 25.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.084 -1.244 . . . . 0.0 109.713 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 16.3 mttp -105.95 145.96 30.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.424 -0.798 . . . . 0.0 110.223 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 63' ' ' VAL . 4.5 mtm -139.72 155.78 47.16 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.591 0.71 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.4 ttmm -120.67 137.61 54.37 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.411 ' CG2' ' CB ' ' A' ' 45' ' ' TRP . 1.6 p -104.35 120.12 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.707 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.745 ' N ' HD22 ' A' ' 38' ' ' LEU . 1.6 mm? -88.52 -37.81 15.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.324 -0.86 . . . . 0.0 109.767 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 6.6 tp10 -128.43 136.25 50.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.104 -0.997 . . . . 0.0 109.732 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.627 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -110.83 142.4 42.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.59 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 73.9 m80 -114.96 44.27 1.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.037 -1.039 . . . . 0.0 109.743 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 52.81 27.52 28.76 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.401 -0.904 . . . . 0.0 110.881 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 41' ' ' HIS . 8.2 pt-20 164.04 -40.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.999 -1.295 . . . . 0.0 109.597 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.59 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 39.4 m95 -126.54 121.56 32.63 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.659 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -118.1 166.42 12.58 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.976 -1.077 . . . . 0.0 109.754 -179.51 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -109.45 122.61 47.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -118.69 -174.14 2.62 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 110.944 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 19.3 ttmt -139.09 148.68 43.62 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.3 t -90.45 124.92 35.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.971 -1.081 . . . . 0.0 109.852 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.48 -11.62 60.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.097 -1.002 . . . . 0.0 109.358 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.5 tp -83.87 -55.93 3.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 109.693 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.77 10.0 26.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.298 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' SER . 9.9 mtmt 49.93 25.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.366 -0.834 . . . . 0.0 109.834 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 1.026 ' HG2' HD23 ' A' ' 27' ' ' LEU . 2.9 tttt -80.35 142.52 34.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.089 -1.007 . . . . 0.0 108.317 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 13.2 pt-20 -122.05 142.95 49.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.042 -1.036 . . . . 0.0 109.637 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.685 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -164.14 -163.07 16.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 3.1 m-85 -97.79 133.62 42.05 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.466 -1.02 . . . . 0.0 109.491 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 12.7 pt -125.53 135.95 27.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.624 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 53.1 Cg_endo -75.35 164.21 33.14 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 121.637 1.558 . . . . 0.0 110.905 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.415 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 92.4 p -92.69 28.62 1.98 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.812 -1.18 . . . . 0.0 109.713 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -140.94 -1.71 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 109.915 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.624 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 9.4 m-85 -100.81 -27.89 13.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.044 -1.035 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.541 HG11 ' CE ' ' A' ' 35' ' ' MET . 11.6 m -113.61 163.07 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.029 -1.044 . . . . 0.0 109.534 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.105 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -109.8 129.8 55.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.744 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.75 ' CA ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -105.53 102.14 11.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 109.393 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.94 115.93 22.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 109.456 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.49 41.25 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.955 . . . . 0.0 109.498 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.473 179.985 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.352 0.596 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.44 -114.87 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.94 160.35 2.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -1.148 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.409 ' HA ' HD13 ' A' ' 12' ' ' ILE . 26.8 mm -109.58 133.73 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.57 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -131.35 157.54 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.235 -0.916 . . . . 0.0 109.19 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 7.6 p -115.56 134.06 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.08 -1.013 . . . . 0.0 109.032 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.702 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -53.15 114.22 1.39 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.335 -0.853 . . . . 0.0 109.939 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.918 HD11 ' CB ' ' A' ' 64' ' ' ALA . 27.8 mt -84.76 -30.0 25.03 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -137.49 140.88 31.67 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.638 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 37.6 Cg_endo -59.44 140.16 92.93 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.748 2.299 . . . . 0.0 111.649 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 33.3 t80 -134.27 125.76 28.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.836 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -102.13 107.94 19.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.892 -1.13 . . . . 0.0 108.571 179.003 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.11 89.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' ASP . 76.4 mt -80.94 -57.6 4.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.568 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 8.5 m80 -68.48 171.14 6.43 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 47.5 Cg_endo -68.18 -27.25 35.43 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.655 2.237 . . . . 0.0 112.246 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.575 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 23.6 t0 -111.8 -7.91 14.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.128 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -60.78 123.69 18.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.117 -0.989 . . . . 0.0 109.827 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.112 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -90.16 134.45 34.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.979 -1.075 . . . . 0.0 108.514 179.308 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.112 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -83.31 136.53 34.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.897 . . . . 0.0 110.605 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.3 p90 -138.86 147.07 41.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.339 -0.851 . . . . 0.0 108.721 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -108.87 146.81 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.831 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.638 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -46.51 151.39 0.56 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.918 -1.114 . . . . 0.0 108.545 179.231 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.3 -15.0 7.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -82.68 149.99 27.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.267 . . . . 0.0 109.683 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -105.98 144.94 31.99 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.711 0.767 . . . . 0.0 110.177 -179.307 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.722 ' CE ' HG11 ' A' ' 63' ' ' VAL . 4.7 mtm -137.79 155.23 49.26 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.588 0.708 . . . . 0.0 109.544 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 10.7 ttpp -118.85 136.06 54.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.32 118.77 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.21 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.48 ' H ' HD12 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -88.56 -33.76 17.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -133.52 136.43 45.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 109.525 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.575 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.7 tt0 -111.05 144.92 39.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.549 ' CD2' ' HZ ' ' A' ' 57' ' ' PHE . 1.0 OUTLIER -115.95 43.88 2.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 0.0 109.765 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.86 35.48 12.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 160.56 -45.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -1.161 . . . . 0.0 109.759 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.602 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 11.9 m95 -127.56 122.44 33.24 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.369 -0.832 . . . . 0.0 109.087 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.682 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.37 166.03 12.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.14 -0.975 . . . . 0.0 109.605 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -109.81 123.22 49.17 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.67 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -120.23 -173.63 2.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 110.809 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 ttpt -138.8 148.93 44.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 53' ' ' LYS . 5.2 t -90.07 125.52 35.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.944 -1.097 . . . . 0.0 109.903 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.6 mt -69.5 -13.41 62.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 109.43 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.9 tp -82.64 -55.35 4.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.732 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.22 9.46 25.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 109.286 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.8 OUTLIER 50.67 25.93 2.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.848 . . . . 0.0 109.864 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -80.54 142.38 34.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.177 -0.952 . . . . 0.0 108.435 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -121.98 142.14 50.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.094 -1.004 . . . . 0.0 109.54 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.672 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.65 -164.66 18.17 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -97.42 134.14 41.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.523 -0.987 . . . . 0.0 109.291 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.681 HD12 HG21 ' A' ' 63' ' ' VAL . 13.7 pt -126.49 137.8 31.1 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 52.2 Cg_endo -75.04 163.71 34.71 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 121.683 1.589 . . . . 0.0 110.675 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.7 p -92.21 29.26 1.69 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.72 -1.238 . . . . 0.0 109.906 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -138.92 -0.74 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.887 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.561 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.2 m-85 -106.16 -28.23 10.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 109.259 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.722 HG11 ' CE ' ' A' ' 35' ' ' MET . 22.0 m -122.02 158.05 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.317 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.918 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -155.35 -165.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.657 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -82.45 142.95 31.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.518 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 67' ' ' ASN . 7.8 tt -87.55 147.76 25.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.423 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.706 ' N ' HD23 ' A' ' 66' ' ' LEU . 23.1 m120 -140.7 -89.67 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.451 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.539 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 37' ' ' VAL . . . 99.26 108.09 2.85 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -121.8 152.57 39.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 109.399 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 36' ' ' LYS . 25.0 mm -105.86 129.56 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.972 . . . . 0.0 109.348 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.955 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.5 OUTLIER -129.52 154.85 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.396 -0.815 . . . . 0.0 108.978 -179.649 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 14.3 p -111.55 133.75 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.861 -1.149 . . . . 0.0 108.939 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -57.05 117.09 3.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.436 -0.79 . . . . 0.0 110.164 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.023 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 14.5 mt -89.37 -28.08 20.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.8 140.17 28.79 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 37.6 Cg_endo -59.9 141.28 96.27 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.86 2.373 . . . . 0.0 111.49 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.646 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 34.5 t80 -132.83 123.92 27.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.727 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 22' ' ' ILE . 9.3 t70 -102.71 109.51 21.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.087 -1.008 . . . . 0.0 108.6 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.563 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.98 89.02 0.01 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.592 ' N ' ' O ' ' A' ' 20' ' ' ASP . 17.4 mt -88.36 -14.59 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.185 . . . . 0.0 108.318 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -114.13 176.67 1.4 Allowed Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.1 Cg_endo -72.43 -31.94 10.67 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.489 2.126 . . . . 0.0 112.085 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 17.7 m-20 -112.05 -9.59 13.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.354 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.41 122.24 14.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.918 -1.114 . . . . 0.0 109.778 -179.466 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.12 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -85.43 135.13 33.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.916 -1.115 . . . . 0.0 108.404 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.12 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.2 m -84.56 136.82 33.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.565 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.646 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 10.4 p90 -138.79 147.22 42.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.264 -0.898 . . . . 0.0 108.744 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 15.1 pttt -108.28 146.7 32.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.721 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.614 ' CD ' ' O ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -46.23 152.46 0.41 Allowed 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.868 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.68 -12.67 10.07 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.2 tm-20 -83.8 148.09 27.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.124 -1.221 . . . . 0.0 110.13 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -104.78 147.21 27.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -0.759 . . . . 0.0 109.714 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.565 ' CE ' HG11 ' A' ' 63' ' ' VAL . 8.7 mtm -139.42 155.28 47.72 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.667 0.746 . . . . 0.0 109.931 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -123.59 140.71 52.72 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.596 HG11 ' CB ' ' A' ' 45' ' ' TRP . 2.7 t -102.17 119.58 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.071 -1.018 . . . . 0.0 110.023 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -88.77 -21.64 23.7 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 0.0 109.811 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 4.3 mt-10 -148.33 139.05 22.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.97 -1.082 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.577 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 11.5 tt0 -109.74 135.44 50.66 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.299 -0.876 . . . . 0.0 109.166 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 63.3 m-70 -117.82 36.06 4.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.326 -0.859 . . . . 0.0 108.87 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.49 -110.14 3.95 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -84.74 -6.81 59.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -1.18 . . . . 0.0 109.865 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.572 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 23.4 m95 -130.89 143.16 50.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.058 -1.026 . . . . 0.0 109.97 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.596 ' CB ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -141.31 168.28 20.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.338 -0.851 . . . . 0.0 109.613 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.602 ' O ' HD12 ' A' ' 38' ' ' LEU . 8.7 tttt -110.2 116.36 31.36 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.15 -172.31 2.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.407 -0.808 . . . . 0.0 110.307 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.4 ttpm? -142.33 151.27 41.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 109.305 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -92.23 126.5 37.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.054 -1.029 . . . . 0.0 109.695 -179.376 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 mt -70.19 -13.98 62.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.024 -1.048 . . . . 0.0 109.33 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 51' ' ' LEU . 17.2 tp -75.96 -59.68 2.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -108.69 3.52 22.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 0.0 109.423 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.545 ' CD ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 61.23 25.66 15.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.752 ' HG2' HD23 ' A' ' 27' ' ' LEU . 1.1 tptp -78.51 141.51 38.13 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.153 -0.967 . . . . 0.0 108.521 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 7.2 pt-20 -123.46 146.1 48.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.046 -1.034 . . . . 0.0 109.604 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.723 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -169.75 -164.87 26.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -95.77 134.16 39.04 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.446 -1.031 . . . . 0.0 109.53 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 pt -126.0 141.67 40.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.631 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 54.6 Cg_endo -75.71 156.97 39.97 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.839 1.693 . . . . 0.0 110.921 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.584 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 46.0 t -88.67 28.13 1.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.726 -1.234 . . . . 0.0 110.019 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -139.82 -1.96 1.57 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.138 -0.976 . . . . 0.0 109.819 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.631 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 5.9 m-85 -101.74 -25.38 13.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.385 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.565 HG11 ' CE ' ' A' ' 35' ' ' MET . 24.7 m -113.0 161.42 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.858 -1.151 . . . . 0.0 110.069 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.023 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -108.51 131.7 54.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.444 -0.785 . . . . 0.0 109.62 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.955 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -84.95 101.47 12.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.999 -1.063 . . . . 0.0 109.533 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.21 163.68 3.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 109.439 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -115.76 -179.47 3.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.879 . . . . 0.0 109.415 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.49 -179.943 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.43 36.52 0.12 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.487 ' C ' HD12 ' A' ' 12' ' ' ILE . 10.4 t70 -85.51 141.22 30.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -1.151 . . . . 0.0 109.429 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.7 OUTLIER -104.9 128.65 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.501 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.833 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -130.44 155.51 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.3 p -112.84 133.77 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.943 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -58.48 118.66 5.84 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.476 -0.765 . . . . 0.0 110.385 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.036 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 53.5 mt -92.02 -27.1 18.03 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -137.55 141.39 33.28 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.9 Cg_endo -62.2 141.43 88.11 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.648 2.232 . . . . 0.0 111.56 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.649 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 33.5 t80 -132.84 124.18 27.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.962 . . . . 0.0 109.671 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -103.37 110.32 22.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.069 -1.02 . . . . 0.0 108.796 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.96 89.52 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 20' ' ' ASP . 4.6 mt -90.1 -13.73 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -1.11 . . . . 0.0 108.359 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 1.3 m-70 -114.01 174.56 2.27 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 50.9 Cg_endo -70.78 -32.48 14.26 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.409 2.073 . . . . 0.0 111.916 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.559 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 16.2 m-20 -112.02 -9.64 13.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 110.4 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -59.83 121.62 12.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.891 -1.131 . . . . 0.0 109.745 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.1 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -84.33 136.83 33.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 108.353 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 1.1 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.9 m -86.99 137.5 32.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 0.0 110.629 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.0 p90 -140.28 149.57 42.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -108.85 142.5 39.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 109.731 -179.167 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' LYS . 1.2 pttt -44.79 151.53 0.29 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.112 -0.993 . . . . 0.0 108.423 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.52 -16.43 7.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.575 ' CG ' ' CD2' ' A' ' 51' ' ' LEU . 10.0 tp10 -82.8 151.59 26.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.066 -1.255 . . . . 0.0 109.915 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 3.9 mttt -105.33 146.36 29.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.454 -0.779 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.677 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -138.3 153.8 49.02 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.725 0.774 . . . . 0.0 110.132 -179.423 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG2' HG13 ' A' ' 12' ' ' ILE . 2.8 mtpm? -122.62 138.3 54.63 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 t -88.32 155.38 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 118.48 -1.288 . . . . 0.0 109.292 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.529 ' O ' ' CG ' ' A' ' 39' ' ' GLU . 4.1 mt -122.61 -13.35 7.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.313 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 37.3 mt-10 -159.03 138.94 11.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.381 -0.824 . . . . 0.0 109.054 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 13.0 tt0 -106.18 132.8 51.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 41.6 m-70 -122.2 34.2 5.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.453 -0.779 . . . . 0.0 109.289 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.8 -113.53 4.61 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -83.26 -6.8 59.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -1.165 . . . . 0.0 109.601 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.587 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 32.1 m95 -130.35 148.08 52.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.431 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.587 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -146.69 172.01 14.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 110.072 179.648 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.609 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -111.7 128.41 56.07 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . . . -121.64 -173.29 2.6 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.128 -0.982 . . . . 0.0 110.509 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 26.7 ttpt -136.93 146.69 45.75 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -86.5 124.54 32.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 109.49 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.3 -10.07 52.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.057 -1.027 . . . . 0.0 109.404 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.575 ' CD2' ' CG ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -88.1 -53.16 4.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 109.991 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.543 HG22 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.11 8.84 24.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.922 . . . . 0.0 109.584 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 50.73 26.64 2.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.302 -0.874 . . . . 0.0 109.752 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 11.3 tptt -84.4 142.06 30.4 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 23.4 pt-20 -117.48 139.53 50.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.979 -1.076 . . . . 0.0 109.638 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.664 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -156.58 -166.6 16.56 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.408 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 5.5 m-85 -97.21 132.69 42.73 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 109.541 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.418 HG22 ' CE1' ' A' ' 29' ' ' PHE . 11.5 pt -124.78 141.47 38.2 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.615 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 55.1 Cg_endo -78.71 161.48 27.6 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.66 1.573 . . . . 0.0 111.199 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 32.9 t -90.86 30.01 1.26 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.837 -1.164 . . . . 0.0 109.701 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -141.19 -0.12 1.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.813 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.615 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 7.7 m-85 -102.72 -26.74 13.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 110.122 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.677 HG11 ' CE ' ' A' ' 35' ' ' MET . 6.4 m -114.73 163.92 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.965 -1.084 . . . . 0.0 110.003 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.036 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -109.22 129.49 55.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 109.312 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.833 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -91.18 120.56 32.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.118 -0.989 . . . . 0.0 109.38 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.46 104.73 1.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 0.0 109.516 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -119.96 116.27 25.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.925 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.44 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -105.97 129.72 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.26 154.58 40.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 108.89 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 2.9 p -113.4 133.93 57.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.97 -1.081 . . . . 0.0 108.83 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.655 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -56.32 115.86 2.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.514 -0.741 . . . . 0.0 109.789 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 50.4 mt -88.37 -27.78 21.39 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -136.72 140.32 31.64 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.97 141.47 94.6 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.762 2.308 . . . . 0.0 111.879 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.9 t80 -133.2 124.14 26.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.53 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -102.27 111.33 23.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.97 -1.081 . . . . 0.0 108.958 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -28.15 89.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.7 mt -94.63 -14.14 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.308 -1.113 . . . . 0.0 108.483 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.587 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.5 175.1 1.98 Allowed Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.1 Cg_endo -71.76 -34.34 9.05 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.511 2.14 . . . . 0.0 112.052 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 2.5 m-20 -112.09 -10.73 13.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 0.0 110.574 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 46.1 m-20 -60.34 116.22 4.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.915 -1.115 . . . . 0.0 109.752 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.125 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -78.67 134.96 37.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.907 -1.121 . . . . 0.0 108.45 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.125 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.6 p -83.54 136.6 34.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.354 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.8 p90 -139.41 147.94 42.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.288 -0.882 . . . . 0.0 108.739 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -108.51 140.02 42.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.072 -1.018 . . . . 0.0 109.497 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 30' ' ' LYS . 15.4 ptmt -42.21 152.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.23 -0.988 . . . . 0.0 108.36 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.55 -16.65 7.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -82.66 152.03 26.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.097 -1.237 . . . . 0.0 109.743 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 12.8 mtpt -105.79 145.99 30.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.435 -0.791 . . . . 0.0 109.962 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.617 ' CE ' HG11 ' A' ' 63' ' ' VAL . 5.9 mtm -138.2 154.21 49.13 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.718 0.77 . . . . 0.0 109.834 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 tttp -121.78 136.44 54.94 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.645 HG11 ' CB ' ' A' ' 45' ' ' TRP . 1.5 t -97.96 120.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.005 . . . . 0.0 110.075 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.777 ' N ' HD22 ' A' ' 38' ' ' LEU . 2.2 mm? -86.34 -18.2 32.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 109.923 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -154.24 141.03 19.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.945 -1.097 . . . . 0.0 109.757 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 6.1 tt0 -108.64 135.18 50.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.145 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 74.2 m-70 -121.0 35.01 5.01 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.202 -0.936 . . . . 0.0 109.218 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.85 -110.0 3.94 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -85.76 -7.09 58.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -1.139 . . . . 0.0 109.857 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.577 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 27.3 m95 -129.99 141.86 50.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.071 -1.018 . . . . 0.0 109.786 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.645 ' CB ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.98 167.68 21.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 109.569 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.573 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 13.1 tttp -110.8 118.84 37.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.38 -172.77 2.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 110.473 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 5.4 ttmt -140.83 150.24 43.03 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 53' ' ' LYS . 4.4 t -90.87 125.94 35.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.127 -0.983 . . . . 0.0 109.818 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -12.18 61.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.361 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.09 -55.29 4.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.694 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.71 8.07 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.351 -0.843 . . . . 0.0 109.281 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 49' ' ' SER . 21.4 mtmt 50.93 25.29 2.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.949 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 9.2 tttm -82.07 144.8 30.56 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.128 -0.982 . . . . 0.0 108.386 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 26.9 tt0 -120.84 145.62 47.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.014 -1.054 . . . . 0.0 109.456 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.665 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -164.79 -167.28 25.11 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.93 134.33 40.41 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.317 -1.108 . . . . 0.0 109.461 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 HG21 ' A' ' 63' ' ' VAL . 10.9 pt -126.23 142.47 42.82 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.468 -0.77 . . . . 0.0 109.287 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.527 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 53.7 Cg_endo -75.62 157.55 40.13 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.854 1.703 . . . . 0.0 110.811 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.55 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 47.9 t -89.6 28.96 1.2 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.593 -1.317 . . . . 0.0 110.19 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -137.2 -0.35 2.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.079 -1.013 . . . . 0.0 109.664 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.527 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.7 m-85 -106.61 -25.72 11.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.229 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.7 HG21 HD12 ' A' ' 58' ' ' ILE . 19.5 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.31 -0.869 . . . . 0.0 109.505 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.743 HD13 ' HG3' ' A' ' 36' ' ' LYS . 26.4 mm -109.54 132.87 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.524 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.34 155.6 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 108.957 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 12.7 p -112.79 134.46 55.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.306 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.68 118.83 5.67 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.482 -0.761 . . . . 0.0 110.103 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 82.0 mt -91.51 -28.3 17.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -137.02 142.93 40.19 Favored Pre-proline 0 N--CA 1.486 1.352 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HD3' ' HE3' ' A' ' 31' ' ' LYS . 38.9 Cg_endo -62.13 140.74 85.48 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.785 2.323 . . . . 0.0 111.575 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.633 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 34.2 t80 -132.04 123.6 27.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.576 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' ILE . 13.2 t0 -103.31 109.66 21.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.118 -0.989 . . . . 0.0 108.722 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.76 90.53 0.01 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.9 mt -88.44 -13.62 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -1.135 . . . . 0.0 108.403 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.606 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.63 177.99 1.06 Allowed Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.7 Cg_endo -73.59 -30.83 9.38 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.359 2.039 . . . . 0.0 111.955 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -112.59 -9.56 13.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.338 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.453 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 39.2 m-20 -60.91 116.29 4.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.952 -1.092 . . . . 0.0 109.899 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.112 HD22 ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -80.17 134.24 36.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 108.373 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.112 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.6 p -83.52 137.46 33.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 110.833 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.633 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.5 p90 -139.24 148.55 43.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 108.692 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.12 142.7 37.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.855 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.462 ' HE3' ' HD3' ' A' ' 18' ' ' PRO . 2.8 ptpt -44.19 151.82 0.22 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.29 -16.06 8.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 2.6 tm-20 -83.22 151.33 25.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.238 . . . . 0.0 109.67 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 12.7 mttt -104.97 146.05 29.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.44 -0.787 . . . . 0.0 109.83 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.597 ' CE ' HG11 ' A' ' 63' ' ' VAL . 5.7 mtm -137.73 154.69 49.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.609 0.719 . . . . 0.0 109.662 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.743 ' HG3' HD13 ' A' ' 12' ' ' ILE . 20.2 tttt -118.36 133.73 55.64 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.583 HG21 ' HG3' ' A' ' 40' ' ' GLU . 1.4 p -103.78 119.08 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 109.433 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.796 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -88.53 -40.64 13.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.417 -0.802 . . . . 0.0 109.807 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 7.0 mp0 -129.81 137.08 50.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 109.687 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 4.9 mt-10 -111.11 146.4 36.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 7.8 m-70 -116.86 42.07 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.534 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.89 37.99 16.11 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 160.93 -47.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -1.12 . . . . 0.0 109.412 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.511 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 10.2 m95 -128.87 119.66 24.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.488 -0.757 . . . . 0.0 108.959 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -113.24 167.32 10.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.054 -1.029 . . . . 0.0 109.403 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.796 ' O ' HD12 ' A' ' 38' ' ' LEU . 2.2 tttp -110.44 116.06 30.74 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 36' ' ' LYS . . . -116.45 -172.29 2.16 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.415 -0.803 . . . . 0.0 110.417 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -144.04 154.44 43.24 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -94.55 126.87 40.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 0.0 110.195 -178.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.72 -11.87 60.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.153 -0.967 . . . . 0.0 109.359 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 tp -83.33 -55.73 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 109.728 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.12 10.04 28.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 48.25 24.63 0.71 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.428 -0.795 . . . . 0.0 110.111 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -81.42 144.0 31.72 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt-20 -120.52 149.1 42.95 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 109.392 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.687 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -169.01 -166.35 27.92 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.91 133.8 41.07 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.382 -1.069 . . . . 0.0 109.345 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 58' ' ' ILE . 17.8 pt -125.87 140.31 36.41 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 108.88 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.628 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 53.4 Cg_endo -75.05 159.15 41.51 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 121.694 1.596 . . . . 0.0 110.706 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.447 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 99.5 p -89.73 28.82 1.25 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.684 -1.26 . . . . 0.0 109.705 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -140.48 -1.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 109.999 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.628 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 8.4 m-85 -100.74 -26.6 13.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 0.0 110.07 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.597 HG11 ' CE ' ' A' ' 35' ' ' MET . 14.5 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.041 -1.037 . . . . 0.0 109.644 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.762 HD13 ' HG3' ' A' ' 36' ' ' LYS . 19.4 mm -106.02 129.96 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.162 -0.961 . . . . 0.0 109.561 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.57 156.31 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 8.1 p -114.04 134.45 56.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.027 -1.046 . . . . 0.0 108.807 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.577 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -55.85 115.36 2.34 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.545 -0.722 . . . . 0.0 109.849 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.2 mt -88.02 -28.99 21.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -136.62 139.95 30.76 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.0 Cg_endo -60.76 141.39 94.78 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.857 2.372 . . . . 0.0 111.642 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.3 t80 -133.78 124.92 27.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 109.906 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.564 ' O ' ' C ' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -102.94 110.32 22.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.021 -1.049 . . . . 0.0 108.805 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.83 91.07 0.01 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.56 ' N ' ' O ' ' A' ' 20' ' ' ASP . 14.2 mt -91.76 -14.35 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.282 -1.128 . . . . 0.0 108.524 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.569 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.35 175.78 1.74 Allowed Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 50.7 Cg_endo -71.43 -31.67 13.57 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.4 2.067 . . . . 0.0 111.903 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.517 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.1 m-20 -112.0 -9.34 14.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 110.218 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -60.04 123.37 16.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.948 -1.095 . . . . 0.0 109.713 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.103 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -88.07 135.3 33.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.999 -1.063 . . . . 0.0 108.351 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.103 ' N ' HD22 ' A' ' 27' ' ' LEU . 5.8 p -83.81 136.18 34.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.498 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.5 p90 -139.04 147.93 42.71 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 31' ' ' LYS . 4.5 ttmt -108.69 140.39 42.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.028 . . . . 0.0 109.551 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -42.79 152.01 0.11 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.92 -17.11 7.43 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -82.53 151.75 26.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.057 -1.261 . . . . 0.0 109.728 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -105.56 145.85 30.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.459 -0.776 . . . . 0.0 109.895 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.611 ' CE ' HG11 ' A' ' 63' ' ' VAL . 8.5 mtm -138.26 154.11 49.06 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.649 0.738 . . . . 0.0 109.669 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.762 ' HG3' HD13 ' A' ' 12' ' ' ILE . 4.2 ttpm? -119.72 134.33 55.27 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.63 HG11 ' CB ' ' A' ' 45' ' ' TRP . 1.5 t -96.84 119.9 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 110.14 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 mt -85.31 -20.41 30.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.366 -0.834 . . . . 0.0 110.011 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.24 141.2 20.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.902 -1.124 . . . . 0.0 109.763 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 2.9 tt0 -109.31 137.4 47.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.409 -0.807 . . . . 0.0 108.955 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.609 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 68.7 m-70 -123.43 36.25 4.68 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.208 -0.933 . . . . 0.0 109.197 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.85 -104.11 3.14 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.8 -8.82 48.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -1.088 . . . . 0.0 110.606 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.609 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 17.3 m95 -131.89 124.95 30.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.782 -1.199 . . . . 0.0 110.401 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.632 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.3 168.22 13.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.145 -0.972 . . . . 0.0 109.678 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.17 129.29 56.0 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -124.83 -172.21 2.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 110.537 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.561 ' CG ' ' HB3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -138.77 147.49 42.68 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' LYS . 8.4 t -88.26 124.92 34.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.04 -1.038 . . . . 0.0 109.491 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.2 -13.13 62.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 109.427 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.3 tp -80.65 -57.13 3.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.457 -0.777 . . . . 0.0 109.906 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.4 3.79 23.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 49' ' ' SER . 9.1 mttt 58.42 25.37 12.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.751 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 8.6 mmtp -78.13 142.05 38.31 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.561 ' HB3' ' CG ' ' A' ' 48' ' ' LYS . 10.0 pt-20 -121.59 139.9 52.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.033 -1.042 . . . . 0.0 109.511 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.698 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.11 -163.78 15.66 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.55 135.21 40.42 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.553 -0.969 . . . . 0.0 109.417 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.638 HD12 HG21 ' A' ' 63' ' ' VAL . 18.4 pt -126.22 142.9 44.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.369 -0.832 . . . . 0.0 109.152 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.547 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 53.8 Cg_endo -75.93 157.42 38.87 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.877 1.718 . . . . 0.0 110.746 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 89.1 p -88.92 28.82 1.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.728 -1.232 . . . . 0.0 110.143 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -138.14 0.16 2.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.025 . . . . 0.0 109.741 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.547 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.5 m-85 -105.45 -26.3 11.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.097 -1.002 . . . . 0.0 109.4 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.638 HG21 HD12 ' A' ' 58' ' ' ILE . 18.0 m . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.637 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.582 ' CB ' HG13 ' A' ' 37' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.537 HD11 ' HD3' ' A' ' 36' ' ' LYS . 10.1 mm -107.25 130.39 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 109.356 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.32 153.34 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.274 -0.891 . . . . 0.0 108.928 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 8.7 p -112.41 133.61 57.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 118.841 -1.143 . . . . 0.0 109.168 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -58.18 118.71 5.76 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.494 -0.754 . . . . 0.0 110.285 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.428 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 13.3 mt -91.82 -26.94 18.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -137.34 141.96 35.84 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.0 Cg_endo -62.57 141.49 86.37 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.716 2.277 . . . . 0.0 111.831 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.4 t80 -132.65 123.69 26.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 109.419 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -102.58 110.64 22.65 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.008 -1.058 . . . . 0.0 108.798 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.4 89.69 0.01 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' ASP . 6.2 mt -92.3 -14.27 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -1.163 . . . . 0.0 108.476 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.505 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -113.37 175.24 1.93 Allowed Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 52.9 Cg_endo -72.03 -32.85 10.44 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.414 2.076 . . . . 0.0 112.181 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.537 ' OD2' ' CE ' ' A' ' 46' ' ' LYS . 55.7 t0 -112.77 -10.38 13.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.123 -0.985 . . . . 0.0 110.611 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 44.5 m-20 -60.15 116.41 4.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.951 -1.093 . . . . 0.0 109.797 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.107 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.08 135.85 38.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.934 -1.104 . . . . 0.0 108.286 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.107 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.3 p -85.11 137.08 33.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -0.978 . . . . 0.0 110.423 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.635 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 12.3 p90 -140.4 148.81 41.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.0 108.701 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -108.19 140.62 41.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.027 -1.045 . . . . 0.0 109.428 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.01 152.44 0.11 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.59 -16.74 7.53 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -83.23 151.98 25.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -1.204 . . . . 0.0 109.659 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.697 ' HB2' HD12 ' A' ' 50' ' ' LEU . 13.4 mtmt -105.14 143.86 32.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.816 . . . . 0.0 110.093 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.726 ' CE ' HG11 ' A' ' 63' ' ' VAL . 6.7 mtm -136.91 154.71 50.39 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.619 0.723 . . . . 0.0 109.585 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 10.1 ttpt -121.26 136.12 55.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 ' CB ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -103.12 119.72 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.487 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.822 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -85.64 -31.91 22.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 109.55 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -143.34 139.06 29.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.509 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.635 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tt0 -111.86 145.1 40.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.667 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 14.7 m-70 -114.68 43.25 1.97 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 109.523 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 48.13 40.53 21.34 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.584 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 158.7 -48.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.29 -1.123 . . . . 0.0 109.574 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 8.3 m95 -129.38 120.87 26.28 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.413 -0.804 . . . . 0.0 109.111 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.682 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.17 168.65 9.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.184 -0.948 . . . . 0.0 109.631 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.822 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -110.05 116.12 31.0 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.54 -174.84 2.56 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 110.498 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.5 ttmt -137.55 147.72 45.36 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.655 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -88.56 129.39 35.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.03 -1.044 . . . . 0.0 109.921 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.697 HD12 ' HB2' ' A' ' 34' ' ' LYS . 5.8 mt -68.76 -24.46 64.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.04 . . . . 0.0 109.835 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.6 tp -86.52 -42.36 13.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.966 . . . . 0.0 109.92 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 49' ' ' SER . 1.2 p -99.1 -16.78 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.376 -0.828 . . . . 0.0 109.16 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.655 ' N ' ' O ' ' A' ' 49' ' ' SER . 13.7 mttt 59.56 11.88 2.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.323 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -81.69 151.57 27.48 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 14.2 pt-20 -119.63 146.62 45.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.897 -1.127 . . . . 0.0 109.515 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.659 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -169.85 164.66 38.08 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.591 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -68.05 133.38 48.9 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.492 -1.005 . . . . 0.0 109.962 -179.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.5 pt -124.47 143.04 42.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.0 Cg_endo -73.69 153.57 48.79 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.543 1.495 . . . . 0.0 110.68 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.467 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 91.8 p -87.6 29.37 0.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.616 -1.302 . . . . 0.0 109.954 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -139.81 0.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 109.794 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.649 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 17.2 m-85 -102.06 -25.64 13.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.985 . . . . 0.0 110.198 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.726 HG11 ' CE ' ' A' ' 35' ' ' MET . 14.8 m . . . . . 0 N--CA 1.492 1.657 0 O-C-N 120.997 -1.064 . . . . 0.0 110.061 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.322 0.582 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.874 HD13 ' HG2' ' A' ' 36' ' ' LYS . 10.1 mm -108.0 132.44 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.275 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.49 156.66 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.933 . . . . 0.0 109.185 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 13.0 p -113.47 134.95 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.053 -1.029 . . . . 0.0 109.084 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.66 118.94 5.78 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.483 -0.761 . . . . 0.0 110.302 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 12.6 mt -91.19 -28.56 17.76 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -137.24 142.49 37.99 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.1 Cg_endo -61.13 140.88 91.77 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.783 2.322 . . . . 0.0 111.413 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.5 t80 -133.75 125.74 29.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.998 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -103.38 107.68 18.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.034 -1.041 . . . . 0.0 108.518 179.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 26' ' ' ASP . . . -30.36 92.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.4 mt -79.32 -59.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -66.66 176.1 1.18 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.643 -0.661 . . . . 0.0 109.241 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.5 Cg_endo -71.73 -25.07 20.85 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.528 2.152 . . . . 0.0 111.938 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.2 t70 -112.65 -7.83 13.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.285 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.586 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -60.14 122.78 15.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.968 -1.082 . . . . 0.0 109.763 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.118 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -88.8 135.01 33.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.994 -1.066 . . . . 0.0 108.406 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.118 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.2 m -84.49 136.7 33.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.728 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.653 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.8 p90 -138.91 147.84 42.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 108.586 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.53 140.05 41.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.018 -1.051 . . . . 0.0 109.635 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.83 152.16 0.08 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.88 -15.7 7.85 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -83.34 152.46 25.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.087 -1.243 . . . . 0.0 109.838 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.478 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 30.6 ttmt -105.72 146.08 30.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 109.917 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.695 ' CE ' HG11 ' A' ' 63' ' ' VAL . 3.6 mtm -137.73 154.71 49.59 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.64 0.733 . . . . 0.0 109.919 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.874 ' HG2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -117.86 132.65 56.4 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 p -103.82 119.41 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.961 . . . . 0.0 109.449 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -89.76 -45.87 9.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -0.86 . . . . 0.0 109.953 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 3.7 tt0 -122.97 136.14 54.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.621 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.583 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tt0 -111.74 143.8 42.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.542 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 24.7 m-70 -113.13 44.52 1.52 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.521 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 49.91 36.44 26.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 160.01 -45.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -1.175 . . . . 0.0 109.729 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.542 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 7.5 m95 -128.54 122.58 31.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.014 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -116.7 168.54 10.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.139 -0.976 . . . . 0.0 109.96 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.803 ' O ' HD12 ' A' ' 38' ' ' LEU . 11.3 ttpt -109.41 117.61 34.47 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.32 -173.62 2.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.237 -0.915 . . . . 0.0 110.586 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.7 ttmt -139.01 148.59 43.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 17.3 t -90.05 126.82 35.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.046 -1.034 . . . . 0.0 109.55 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.409 HD13 ' HD2' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -70.32 -11.32 60.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 109.424 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.7 tp -81.99 -57.43 3.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.719 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 54' ' ' LYS . 4.6 t -108.99 7.97 26.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.372 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 49' ' ' SER . 19.2 mttt 53.95 25.76 5.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 109.897 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 1.048 ' HG2' HD23 ' A' ' 27' ' ' LEU . 12.5 tttp -80.29 142.8 34.19 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 21.7 pt-20 -121.36 144.63 48.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.98 -1.075 . . . . 0.0 109.6 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.683 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -165.64 -164.24 20.7 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.49 132.99 41.51 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.374 -1.074 . . . . 0.0 109.633 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 58' ' ' ILE . 11.2 pt -125.99 135.99 27.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.527 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 54.3 Cg_endo -77.95 166.23 25.3 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.591 1.527 . . . . 0.0 111.213 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.511 ' HG ' ' HZ2' ' A' ' 45' ' ' TRP . 35.4 t -91.79 29.17 1.6 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.987 -1.071 . . . . 0.0 109.699 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -140.78 0.09 1.57 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.967 . . . . 0.0 109.719 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.527 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.3 m-85 -100.5 -28.72 12.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.079 -1.013 . . . . 0.0 109.664 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.695 HG11 ' CE ' ' A' ' 35' ' ' MET . 6.1 m . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 109.829 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.692 HD13 ' HG3' ' A' ' 36' ' ' LYS . 17.2 mm -106.74 132.01 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.357 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.82 157.23 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.28 -0.888 . . . . 0.0 109.269 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 6.4 p -113.55 134.63 55.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.077 -1.015 . . . . 0.0 108.552 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.663 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -56.24 115.81 2.68 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.69 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 9.8 mt -88.6 -28.15 20.88 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -136.74 141.02 33.66 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.6 Cg_endo -61.87 141.91 91.49 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.863 2.375 . . . . 0.0 111.82 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.6 t80 -133.55 124.41 26.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.84 . . . . 0.0 109.748 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -102.47 110.91 22.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.987 -1.071 . . . . 0.0 108.727 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.41 90.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.5 mt -93.52 -14.17 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -1.142 . . . . 0.0 108.591 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.66 175.91 1.68 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.2 Cg_endo -72.2 -33.31 9.48 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.46 2.106 . . . . 0.0 112.038 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.491 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 14.0 t0 -112.14 -10.04 13.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 110.366 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 34.1 m-20 -60.58 116.82 4.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.031 -1.043 . . . . 0.0 109.829 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.109 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -79.44 135.79 36.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.941 -1.1 . . . . 0.0 108.509 179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.109 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.3 p -83.73 136.06 34.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 110.493 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.4 p90 -139.49 148.32 42.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.867 . . . . 0.0 108.826 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 31' ' ' LYS . 2.7 ttpt -108.77 140.61 41.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.94 -1.1 . . . . 0.0 109.572 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -42.86 152.7 0.1 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.29 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.19 -16.89 6.74 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.4 tp10 -83.12 152.86 25.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.035 -1.273 . . . . 0.0 109.801 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -105.38 145.42 30.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.473 -0.767 . . . . 0.0 109.662 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.728 ' CE ' HG11 ' A' ' 63' ' ' VAL . 6.6 mtm -137.16 154.17 50.29 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.71 0.767 . . . . 0.0 109.957 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.692 ' HG3' HD13 ' A' ' 12' ' ' ILE . 1.6 ttpm? -118.18 129.01 55.25 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.63 120.03 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 109.344 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.704 ' H ' HD12 ' A' ' 38' ' ' LEU . 1.7 mp -86.65 -37.51 17.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 109.581 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -134.8 136.68 42.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.954 . . . . 0.0 109.653 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.63 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.3 tt0 -110.32 145.07 38.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 21.3 m-70 -111.81 46.23 1.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.122 -0.986 . . . . 0.0 109.584 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 50.57 32.06 23.26 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 161.19 -42.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.058 -1.26 . . . . 0.0 109.869 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.614 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 50.4 m95 -127.2 122.0 32.85 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 108.908 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.648 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -118.82 168.76 10.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.079 -1.013 . . . . 0.0 109.726 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -108.85 121.15 44.48 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -125.7 146.68 49.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 110.983 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 1.7 ptpt -102.44 155.41 18.27 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 4.8 t -98.07 129.88 44.89 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.958 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.82 -12.55 61.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.2 tp -73.27 -62.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 109.714 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.9 -0.28 21.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.407 -0.808 . . . . 0.0 109.349 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 66.93 24.86 9.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -0.894 . . . . 0.0 109.892 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 5.6 mmtt -79.5 140.31 37.32 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 mt-10 -121.81 143.46 49.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.052 -1.03 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.694 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -166.39 -164.72 22.5 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.614 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -96.17 133.04 40.96 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.365 -1.08 . . . . 0.0 109.153 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.818 HD12 HG21 ' A' ' 63' ' ' VAL . 33.2 pt -125.03 141.47 38.51 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.037 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.612 ' HB3' ' CH2' ' A' ' 44' ' ' TRP . 50.6 Cg_endo -72.24 152.56 55.95 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.927 1.751 . . . . 0.0 110.831 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 91.1 p -87.03 28.75 0.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.553 -1.342 . . . . 0.0 109.974 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -137.52 -4.09 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.832 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.575 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 5.2 m-85 -101.67 -24.2 14.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.947 -1.096 . . . . 0.0 109.068 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.818 HG21 HD12 ' A' ' 58' ' ' ILE . 19.7 m . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 109.239 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.255 0.55 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.5 mm -106.2 130.9 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.304 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.76 155.99 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.249 -0.907 . . . . 0.0 109.135 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 12.2 p -113.89 134.88 55.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 120.932 -1.105 . . . . 0.0 108.735 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.49 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -57.83 115.98 3.17 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.527 -0.733 . . . . 0.0 109.951 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.2 mt -89.64 -27.39 20.2 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -137.89 140.98 31.06 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 39.4 Cg_endo -61.98 141.72 90.23 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.629 2.219 . . . . 0.0 111.516 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 38.3 t80 -133.54 124.67 27.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 109.982 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 5.4 m-20 -103.52 109.95 21.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 108.487 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.31 89.14 0.01 OUTLIER Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.3 mt -86.78 -13.46 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.225 -1.162 . . . . 0.0 108.544 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.587 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.91 176.77 1.37 Allowed Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.0 Cg_endo -73.05 -30.18 11.06 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.395 2.064 . . . . 0.0 111.949 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 24.1 t0 -113.2 -9.54 13.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 110.384 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 2.5 m-20 -59.83 122.19 13.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.928 -1.107 . . . . 0.0 109.83 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.104 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -82.9 136.81 34.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.985 -1.072 . . . . 0.0 108.231 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.104 ' N ' HD22 ' A' ' 27' ' ' LEU . 39.5 p -86.41 137.36 32.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.079 -1.013 . . . . 0.0 110.623 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.2 p90 -140.29 149.23 42.54 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -108.77 141.14 41.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.996 -1.065 . . . . 0.0 109.615 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.73 151.83 0.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.083 -1.01 . . . . 0.0 108.386 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.37 -17.21 6.62 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -82.78 152.55 25.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.035 -1.273 . . . . 0.0 109.841 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -105.35 144.58 31.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.692 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.795 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -138.09 153.81 49.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.515 0.674 . . . . 0.0 109.666 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 5.2 ttmt -117.75 130.09 56.1 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.4 p -98.26 120.74 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.113 -0.992 . . . . 0.0 109.625 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.31 -48.82 7.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 0.0 109.827 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 24.8 tt0 -119.03 134.58 55.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.069 -1.019 . . . . 0.0 109.926 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.62 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.8 tt0 -110.54 144.53 39.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 29.7 m-70 -116.74 47.14 1.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 109.756 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.38 34.22 8.85 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.2 OUTLIER 161.08 -43.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -1.103 . . . . 0.0 109.872 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.563 ' CH2' ' HB3' ' A' ' 59' ' ' PRO . 39.2 m95 -127.16 120.78 29.63 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.62 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -117.04 168.29 10.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.029 -1.044 . . . . 0.0 109.555 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -109.53 122.83 48.3 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.7 -174.59 2.51 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 110.812 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -135.93 145.43 46.25 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -85.38 123.87 31.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.0 109.656 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.52 -9.24 53.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.09 -1.007 . . . . 0.0 109.429 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.0 tp -88.97 -53.46 4.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 109.717 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -109.42 7.01 24.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.842 . . . . 0.0 109.412 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 49' ' ' SER . 6.2 mmtp 52.39 26.24 4.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.926 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.12 142.29 32.38 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 6.9 mt-10 -118.65 139.54 51.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.912 -1.118 . . . . 0.0 109.646 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.671 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.79 -162.3 11.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 4.5 m-85 -99.91 133.34 44.42 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.377 -1.073 . . . . 0.0 109.5 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.682 HD12 HG21 ' A' ' 63' ' ' VAL . 18.0 pt -125.0 139.81 34.46 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.563 ' HB3' ' CH2' ' A' ' 44' ' ' TRP . 54.2 Cg_endo -77.42 162.47 30.74 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.712 1.608 . . . . 0.0 111.248 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.582 ' HG ' ' HZ2' ' A' ' 45' ' ' TRP . 41.9 t -91.77 30.06 1.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.797 -1.189 . . . . 0.0 109.794 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -137.81 -0.15 2.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.99 . . . . 0.0 109.743 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.546 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 8.7 m-85 -107.65 -26.91 10.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 108.932 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.795 HG11 ' CE ' ' A' ' 35' ' ' MET . 12.2 m . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.452 -0.78 . . . . 0.0 109.284 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.607 HD12 ' CG ' ' A' ' 36' ' ' LYS . 13.2 mm -105.63 130.94 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.213 -0.929 . . . . 0.0 109.157 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.82 155.96 42.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.299 -0.875 . . . . 0.0 109.332 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 7.6 p -114.26 134.26 57.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.168 -0.957 . . . . 0.0 108.596 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -54.95 113.99 1.56 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.338 -0.851 . . . . 0.0 109.791 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.5 mt -86.5 -29.58 22.63 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -136.35 139.95 31.21 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 38.4 Cg_endo -61.52 141.76 92.76 Favored 'Trans proline' 0 C--O 1.216 -0.584 0 C-N-CA 122.891 2.394 . . . . 0.0 111.82 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.7 t80 -134.02 125.35 27.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.755 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 22' ' ' ILE . 11.0 t70 -102.73 110.71 22.73 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.986 -1.071 . . . . 0.0 108.673 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.55 90.31 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.7 mt -92.72 -14.32 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -1.143 . . . . 0.0 108.662 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.57 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.89 174.95 2.06 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.57 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.4 Cg_endo -71.08 -32.72 12.78 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.425 2.083 . . . . 0.0 111.806 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -111.88 -9.67 14.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 110.284 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.01 123.27 16.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.905 -1.122 . . . . 0.0 109.796 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.114 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -86.38 135.56 33.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.94 -1.1 . . . . 0.0 108.286 179.207 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.114 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -84.35 136.5 33.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 110.422 -178.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 9.4 p90 -139.74 148.39 42.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.922 . . . . 0.0 108.673 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.84 142.54 39.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.026 . . . . 0.0 109.588 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -44.43 152.01 0.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.019 -1.05 . . . . 0.0 108.325 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.4 -16.79 7.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -82.61 152.08 26.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.023 -1.281 . . . . 0.0 109.676 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -106.03 146.04 30.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.421 -0.799 . . . . 0.0 110.005 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.731 ' CE ' HG11 ' A' ' 63' ' ' VAL . 8.0 mtm -137.52 153.77 49.96 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.695 0.76 . . . . 0.0 109.838 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.607 ' CG ' HD12 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -116.41 130.1 56.58 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.628 HG11 ' CB ' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -96.44 119.99 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.936 -1.103 . . . . 0.0 110.113 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.44 -24.02 39.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.505 -0.747 . . . . 0.0 109.738 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -158.68 145.58 17.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.091 -1.006 . . . . 0.0 110.041 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.65 ' HG3' ' CG ' ' A' ' 45' ' ' TRP . 12.2 tt0 -111.42 143.06 42.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 0.0 109.392 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 84.6 m-70 -116.63 42.95 2.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.099 -1.001 . . . . 0.0 109.677 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.603 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.83 41.97 21.08 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.603 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 156.37 -48.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -1.079 . . . . 0.0 109.911 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 59' ' ' PRO . 13.4 m95 -126.65 122.99 36.56 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 109.017 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.65 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.17 166.28 12.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 109.841 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.13 123.45 50.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -122.51 -171.32 2.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.695 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 ttpm? -140.75 150.58 43.58 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -90.11 126.1 35.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.011 -1.055 . . . . 0.0 109.964 -179.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -14.5 63.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.005 . . . . 0.0 109.445 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 tp -85.06 -53.49 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -109.28 13.54 24.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.264 -0.898 . . . . 0.0 109.348 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' SER . 18.7 mttp 44.44 25.38 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.352 -0.843 . . . . 0.0 109.798 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.8 mtpm? -79.45 141.17 37.02 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.13 -0.981 . . . . 0.0 108.355 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 12.5 pt-20 -121.72 144.08 48.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.032 -1.043 . . . . 0.0 109.576 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.697 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -166.69 -163.54 20.64 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.62 134.42 40.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.576 -0.955 . . . . 0.0 109.371 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.621 HD12 HG21 ' A' ' 63' ' ' VAL . 11.9 pt -125.96 142.22 41.75 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.098 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 49.7 Cg_endo -72.4 153.03 55.6 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.811 1.674 . . . . 0.0 110.638 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 80.7 p -86.25 29.45 0.75 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.546 -1.346 . . . . 0.0 109.969 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -138.27 0.61 2.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 0.0 109.736 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.567 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.5 m-85 -105.35 -25.51 12.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.009 . . . . 0.0 109.479 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.731 HG11 ' CE ' ' A' ' 35' ' ' MET . 18.8 m . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 1.6 m-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.288 0.566 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.6 mm -105.85 129.77 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.52 154.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.36 -0.838 . . . . 0.0 108.898 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.524 HG23 ' HG2' ' A' ' 34' ' ' LYS . 9.4 p -114.16 133.93 58.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 120.987 -1.07 . . . . 0.0 108.837 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.685 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -56.61 115.3 2.46 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.471 -0.768 . . . . 0.0 109.682 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.1 mt -88.4 -27.21 21.73 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -137.51 139.96 28.88 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 39.0 Cg_endo -61.87 142.24 92.64 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.652 2.234 . . . . 0.0 111.47 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 39.7 t80 -134.23 125.9 28.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 0.0 109.989 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' C ' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -103.22 110.67 22.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.061 -1.024 . . . . 0.0 108.751 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.573 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.68 91.92 0.01 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.5 mt -93.32 -13.01 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -1.117 . . . . 0.0 108.716 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.532 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -114.65 174.16 2.5 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.532 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 50.8 Cg_endo -71.02 -32.42 13.39 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.388 2.059 . . . . 0.0 112.046 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -112.2 -9.88 13.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.165 -0.96 . . . . 0.0 110.285 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -59.81 126.81 29.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.06 . . . . 0.0 109.857 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.09 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -87.53 137.07 32.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.09 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.0 m -87.48 137.98 31.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 7.7 p90 -141.08 150.14 42.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.85 . . . . 0.0 108.804 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -108.92 138.58 45.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.068 -1.02 . . . . 0.0 109.581 -179.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LYS . 4.1 ptpt -42.16 152.06 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.37 -17.54 7.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -82.1 150.47 27.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.146 -1.208 . . . . 0.0 109.673 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HG2' HG23 ' A' ' 14' ' ' VAL . 12.7 mmtt -105.28 145.03 31.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.435 -0.79 . . . . 0.0 109.799 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.745 ' CE ' HG11 ' A' ' 63' ' ' VAL . 11.7 mtm -137.39 153.67 50.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.519 -0.738 . . . . 0.0 109.743 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.6 tttt -118.38 131.99 56.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.631 HG11 ' CB ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -96.79 121.01 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.986 -1.071 . . . . 0.0 110.366 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.61 -36.49 26.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 109.041 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -128.01 131.56 49.19 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -112.94 98.81 7.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.975 . . . . 0.0 109.802 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 84.1 m-70 -75.86 -157.77 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.352 -1.468 . . . . 0.0 108.954 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . -105.49 43.88 1.58 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 2.2 mt-10 163.51 -40.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.141 -1.211 . . . . 0.0 109.115 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.463 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 7.0 m95 -132.39 123.58 27.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.386 -0.821 . . . . 0.0 109.871 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.647 ' CZ2' ' HB2' ' A' ' 60' ' ' SER . 0.1 OUTLIER -115.54 168.58 9.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.396 -0.815 . . . . 0.0 109.807 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -110.74 121.29 44.96 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -120.17 -170.64 2.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.907 . . . . 0.0 110.631 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -142.04 150.75 41.68 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 53' ' ' LYS . 25.6 t -90.05 125.91 35.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 109.791 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -9.95 57.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 0.0 109.321 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 51' ' ' LEU . 15.6 tp -82.76 -57.53 3.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.314 -0.867 . . . . 0.0 109.812 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -109.32 2.22 20.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 109.378 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' SER . 19.5 mttt 61.99 26.68 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 109.845 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 7.4 mmtp -81.94 140.01 34.28 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.3 pm0 -121.29 144.16 48.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.996 -1.065 . . . . 0.0 109.834 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.721 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -171.49 166.66 39.71 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 10.2 m-85 -66.92 135.09 53.29 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.362 -1.081 . . . . 0.0 109.763 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.472 HG22 ' CE1' ' A' ' 29' ' ' PHE . 2.6 pt -124.92 146.4 53.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.392 -0.818 . . . . 0.0 109.0 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 48.4 Cg_endo -71.95 146.85 48.2 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.98 1.787 . . . . 0.0 110.615 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.647 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 80.6 p -85.09 29.72 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.43 -1.419 . . . . 0.0 110.187 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -137.64 0.43 2.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.119 -0.988 . . . . 0.0 109.737 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.609 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 36.6 m-85 -107.54 -23.84 12.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.092 -1.005 . . . . 0.0 109.467 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.745 HG11 ' CE ' ' A' ' 35' ' ' MET . 29.3 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.0 mm -107.7 131.03 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.419 HG11 ' HZ3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -129.94 154.32 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.24 -0.912 . . . . 0.0 109.107 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.772 ' O ' HD23 ' A' ' 16' ' ' LEU . 12.9 p -116.16 135.17 57.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.075 -1.016 . . . . 0.0 109.001 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -58.95 118.74 6.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.645 -0.659 . . . . 0.0 110.843 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.772 HD23 ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -89.87 -26.4 20.51 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.508 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . 50.6 m-85 -138.26 141.77 32.97 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 40.2 Cg_endo -62.57 141.72 87.22 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.595 2.196 . . . . 0.0 111.474 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 42.8 t80 -133.84 125.39 28.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 0.0 109.8 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' ILE . 6.4 t70 -103.17 110.01 21.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.106 -0.996 . . . . 0.0 108.666 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.04 89.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.4 mp -88.33 -13.42 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.158 -1.201 . . . . 0.0 108.552 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.583 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -114.6 174.91 2.09 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 51.2 Cg_endo -71.38 -31.39 14.11 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.415 2.077 . . . . 0.0 111.906 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 9.4 t70 -112.54 -9.85 13.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.394 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.477 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -59.59 127.27 31.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.941 -1.099 . . . . 0.0 109.806 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.101 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -88.52 136.19 33.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.983 -1.073 . . . . 0.0 108.372 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.101 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.7 m -86.85 137.79 32.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.989 . . . . 0.0 110.452 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.663 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 10.0 p90 -141.37 150.34 42.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 0.0 108.802 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -108.53 137.62 46.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.052 -1.03 . . . . 0.0 109.303 -179.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.25 153.55 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.416 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.87 -17.52 4.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -82.2 154.46 25.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.042 -1.269 . . . . 0.0 109.703 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -106.32 142.93 35.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.768 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -137.67 153.71 49.79 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.497 0.665 . . . . 0.0 109.325 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.2 ptpt -118.34 131.68 56.31 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.381 -0.824 . . . . 0.0 108.818 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -100.65 120.25 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.337 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.56 -37.44 16.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 109.914 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -132.72 136.76 46.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.065 -1.022 . . . . 0.0 109.89 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.625 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.4 tt0 -111.21 146.41 36.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.547 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 36.0 m-70 -116.64 46.34 1.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.692 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 48.61 32.36 10.66 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 162.36 -42.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -1.199 . . . . 0.0 109.831 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.547 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 12.9 m95 -127.5 120.9 29.34 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.44 -0.788 . . . . 0.0 108.875 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.83 166.94 11.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.018 -1.051 . . . . 0.0 109.822 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.469 ' HG2' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -109.66 121.16 44.58 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.12 -173.82 2.43 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 110.644 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -137.21 146.41 44.83 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -85.12 123.58 30.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.675 -179.231 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -8.76 49.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.088 -1.007 . . . . 0.0 109.308 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.95 -54.42 4.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 109.898 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -109.55 1.97 20.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' SER . 21.7 mmtm 59.71 26.66 15.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.227 -0.921 . . . . 0.0 109.744 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HD2' HD23 ' A' ' 27' ' ' LEU . 5.1 ttmm -83.95 141.73 31.03 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 12.8 pt-20 -118.71 137.99 52.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.996 -1.065 . . . . 0.0 109.822 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.661 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -163.37 163.54 35.63 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 18.6 m-85 -65.69 133.93 52.13 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.351 -1.087 . . . . 0.0 109.98 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.627 HD12 HG21 ' A' ' 63' ' ' VAL . 7.7 pt -123.43 144.05 42.99 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.729 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.6 Cg_endo -71.57 148.19 53.15 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.941 1.761 . . . . 0.0 110.786 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 89.3 p -86.14 29.5 0.74 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.481 -1.387 . . . . 0.0 110.241 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -136.99 -1.86 2.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.091 -1.006 . . . . 0.0 109.935 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.729 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 4.8 m-85 -106.64 -23.12 12.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 109.207 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.768 HG11 ' CE ' ' A' ' 35' ' ' MET . 11.0 m . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.375 -0.828 . . . . 0.0 109.32 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 12' ' ' ILE . 19.8 mm -105.42 130.3 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.212 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.07 156.75 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.345 -0.847 . . . . 0.0 109.125 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 p -114.49 134.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.845 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.605 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -57.23 116.67 3.42 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.531 -0.73 . . . . 0.0 109.907 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.4 mt -89.27 -27.74 20.37 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -137.58 141.79 34.65 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.6 Cg_endo -61.83 141.41 89.98 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.731 2.287 . . . . 0.0 111.571 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.649 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 41.2 t80 -134.66 126.25 28.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 110.182 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 22' ' ' ILE . 12.1 t70 -102.0 107.87 19.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.054 -1.029 . . . . 0.0 108.282 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -31.06 90.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.7 mt -79.56 -59.91 2.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.506 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -65.34 173.75 1.73 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.609 -0.682 . . . . 0.0 109.401 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -71.53 -26.59 19.82 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.68 2.253 . . . . 0.0 112.29 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -113.23 -9.87 13.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.532 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.446 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 48.4 m-20 -59.69 121.78 12.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.915 -1.116 . . . . 0.0 109.782 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.12 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -83.39 135.78 34.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.965 -1.084 . . . . 0.0 108.405 179.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.12 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.2 m -85.23 136.41 33.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 110.362 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.5 p90 -139.77 148.71 42.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.302 -0.874 . . . . 0.0 108.709 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.52 141.21 40.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.963 -1.086 . . . . 0.0 109.557 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.63 152.23 0.16 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.37 -17.15 6.67 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 5.4 tp10 -82.45 152.64 26.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.051 -1.264 . . . . 0.0 109.77 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 7.0 mttm -105.88 145.22 31.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.918 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.755 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -138.42 154.11 48.88 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.553 -0.717 . . . . 0.0 109.647 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.691 ' HD3' HD11 ' A' ' 38' ' ' LEU . 5.4 tttp -120.62 136.48 54.8 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.658 HG11 ' CB ' ' A' ' 45' ' ' TRP . 3.3 t -98.4 119.14 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 109.797 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 38' ' ' LEU . 2.3 mm? -88.11 -19.67 26.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.507 -0.746 . . . . 0.0 110.191 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' NE2' ' A' ' 41' ' ' HIS . 12.4 pt-20 -146.91 138.95 24.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.966 -1.084 . . . . 0.0 109.795 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.4 ' OE2' ' N ' ' A' ' 42' ' ' GLY . 2.5 tm-20 -108.65 135.38 49.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.403 -0.81 . . . . 0.0 109.125 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 44.1 m-70 -122.89 36.0 4.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.162 -0.961 . . . . 0.0 109.241 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 93.78 -108.57 3.69 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 60' ' ' SER . 0.4 OUTLIER -87.48 -7.13 57.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 110.01 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.577 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 10.6 m95 -130.21 143.01 50.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.015 -1.053 . . . . 0.0 109.827 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.658 ' CB ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -140.64 167.25 22.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.184 -0.948 . . . . 0.0 109.777 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.94 119.97 40.98 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.57 -172.13 2.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.515 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.1 tttm -138.93 147.86 42.83 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 53' ' ' LYS . 1.4 t -86.14 124.81 32.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 109.588 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -69.51 -10.97 60.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.963 . . . . 0.0 109.394 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.6 tp -86.17 -54.16 4.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -0.855 . . . . 0.0 109.893 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.3 2.0 22.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 109.306 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 49' ' ' SER . 4.8 mttp 57.53 24.73 10.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 110.319 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.5 ttmm -83.23 145.51 29.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 108.253 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -119.46 142.22 48.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.059 -1.025 . . . . 0.0 109.783 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.657 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -167.55 165.12 38.44 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -68.03 135.13 51.8 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.376 -1.073 . . . . 0.0 109.926 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.658 HD12 HG21 ' A' ' 63' ' ' VAL . 10.4 pt -124.43 144.52 46.21 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.64 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.4 Cg_endo -71.95 149.03 52.51 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.028 1.819 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.58 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 46.4 t -86.98 28.76 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.44 -1.413 . . . . 0.0 110.269 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -136.9 -0.98 2.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.956 -1.09 . . . . 0.0 109.818 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.64 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 33.0 m-85 -106.35 -23.81 12.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.003 . . . . 0.0 109.184 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.755 HG11 ' CE ' ' A' ' 35' ' ' MET . 15.6 m . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.298 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.446 HD11 ' HE2' ' A' ' 36' ' ' LYS . 29.7 mm -107.82 132.76 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.839 . . . . 0.0 109.33 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 m -130.31 155.7 41.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.127 -0.983 . . . . 0.0 109.26 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.2 p -113.25 134.6 55.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.107 -0.996 . . . . 0.0 108.775 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.03 117.52 4.07 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 110.131 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 68.7 mt -90.04 -28.21 19.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -137.71 142.93 38.39 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.8 Cg_endo -61.94 140.69 86.29 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.613 2.208 . . . . 0.0 111.419 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.0 t80 -133.78 125.98 29.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 0.0 109.921 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 22' ' ' ILE . 72.5 m-20 -102.86 107.36 18.18 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.954 -1.091 . . . . 0.0 108.385 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.13 90.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 20' ' ' ASP . 16.4 mt -78.77 -59.67 2.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.49 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -66.25 173.34 2.31 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.614 -0.679 . . . . 0.0 109.222 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 50.4 Cg_endo -70.82 -26.07 23.0 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.723 2.282 . . . . 0.0 112.349 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.7 OUTLIER -113.28 -9.4 13.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -0.927 . . . . 0.0 110.762 -178.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.6 OUTLIER -60.69 116.48 4.43 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.799 -1.188 . . . . 0.0 109.882 -179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.113 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.66 135.63 38.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.981 -1.075 . . . . 0.0 108.408 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.113 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.5 m -85.54 137.13 33.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.627 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.8 p90 -139.36 148.04 42.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.289 -0.882 . . . . 0.0 108.718 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.6 141.09 39.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 109.475 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.479 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -43.11 151.21 0.15 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.141 -0.975 . . . . 0.0 108.438 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.36 -16.58 7.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 15' ' ' ALA . 7.5 tm-20 -82.71 151.93 26.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.138 -1.213 . . . . 0.0 109.722 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 37.7 mtpt -105.43 145.89 30.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.522 -0.736 . . . . 0.0 109.866 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.662 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -140.92 155.55 46.25 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.434 0.635 . . . . 0.0 109.427 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.609 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 4.2 tttm -122.55 139.48 53.86 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -104.43 119.7 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.195 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.7 -27.14 18.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 110.09 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -131.45 135.69 47.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.973 -1.079 . . . . 0.0 109.373 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -109.24 136.9 47.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.261 -0.899 . . . . 0.0 109.2 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.583 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 10.6 m-70 -122.47 37.35 4.41 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 108.947 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 -99.57 2.51 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -90.39 -10.39 44.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -1.113 . . . . 0.0 110.372 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.604 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 6.0 m95 -131.33 138.66 49.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.604 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -135.7 165.38 25.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.337 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.598 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 13.2 tttt -109.61 120.99 44.2 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 36' ' ' LYS . . . -115.76 -173.56 2.37 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.389 -0.819 . . . . 0.0 110.697 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.6 ttpt -137.31 146.92 45.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -85.71 125.09 32.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.001 -1.062 . . . . 0.0 109.687 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.91 -10.34 58.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 109.301 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.6 tp -88.4 -53.8 4.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.712 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.69 8.51 26.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 109.42 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' SER . 10.8 mttt 50.2 25.26 1.72 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.991 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.05 143.85 31.25 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -119.02 141.64 48.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 109.453 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.678 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.41 -166.42 21.15 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.439 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -96.63 132.92 41.78 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.416 -1.05 . . . . 0.0 109.419 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 58' ' ' ILE . 17.2 pt -125.14 141.1 37.61 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.644 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 51.9 Cg_endo -74.54 157.54 44.61 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 121.673 1.582 . . . . 0.0 110.942 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.486 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 89.2 p -90.31 29.43 1.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.636 -1.29 . . . . 0.0 109.908 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -140.7 -2.67 1.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.644 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 4.9 m-85 -102.23 -24.39 13.91 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.907 -1.121 . . . . 0.0 110.534 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.662 HG11 ' CE ' ' A' ' 35' ' ' MET . 10.5 m . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 0.0 109.97 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.494 ' C ' HD13 ' A' ' 12' ' ' ILE . 13.0 t70 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.723 HD12 ' CG ' ' A' ' 36' ' ' LYS . 6.7 mm -105.55 130.6 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.77 155.97 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.055 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 p -113.69 135.12 54.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.081 -1.012 . . . . 0.0 108.532 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -57.16 114.38 2.13 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.509 -0.744 . . . . 0.0 109.81 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -88.48 -28.4 20.86 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -136.74 139.15 28.22 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 38.4 Cg_endo -61.62 142.28 94.0 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.758 2.305 . . . . 0.0 111.676 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.3 t80 -133.53 124.45 26.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 109.699 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -102.63 111.1 23.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.002 . . . . 0.0 108.521 179.239 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -25.66 88.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' ASP . 34.5 mt -88.99 -13.97 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -1.184 . . . . 0.0 108.636 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.581 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -115.13 175.85 1.73 Allowed Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.581 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 51.2 Cg_endo -71.93 -32.22 11.53 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.561 2.174 . . . . 0.0 111.697 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -112.34 -10.43 13.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 110.113 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.474 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -60.04 117.54 5.22 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.983 -1.073 . . . . 0.0 109.738 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.117 HD22 ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -81.3 137.18 35.8 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.002 -1.061 . . . . 0.0 108.285 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.117 ' N ' HD22 ' A' ' 27' ' ' LEU . 6.2 p -84.96 137.34 33.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.975 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.1 p90 -139.37 148.77 43.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 2.3 ttmt -108.96 140.26 42.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.977 -1.077 . . . . 0.0 109.697 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' LYS . 1.5 ptmt -43.65 152.66 0.14 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.3 -17.93 5.88 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 6.0 tm-20 -82.23 153.15 26.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.031 -1.276 . . . . 0.0 109.643 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 144.63 32.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.437 -0.79 . . . . 0.0 109.78 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.684 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.1 mpp? -137.64 153.29 49.88 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.52 -0.737 . . . . 0.0 109.624 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.723 ' CG ' HD12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -118.99 132.76 56.09 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.72 HG11 ' HB2' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -97.15 119.91 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.037 . . . . 0.0 109.794 -179.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mt -88.04 -22.38 24.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.462 -0.774 . . . . 0.0 110.317 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -146.4 138.81 25.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.798 -1.189 . . . . 0.0 109.771 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -108.76 137.0 47.41 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.412 -0.805 . . . . 0.0 109.13 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.546 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 16.0 m-70 -121.56 37.79 4.26 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.23 -0.919 . . . . 0.0 109.058 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.11 -106.08 3.34 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.78 -7.77 55.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -1.074 . . . . 0.0 110.008 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.595 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 29.6 m95 -129.25 139.48 51.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.0 109.777 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.72 ' HB2' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.72 167.34 22.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 109.759 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.561 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 12.2 tttt -110.66 123.51 50.14 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -118.78 -170.88 1.99 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 110.5 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 15.8 ttpt -140.87 150.28 43.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.2 t -88.6 125.51 34.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.058 -1.026 . . . . 0.0 109.783 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -10.75 59.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.184 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.2 tp -85.9 -54.34 4.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 109.847 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.68 8.39 24.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 49' ' ' SER . 53.5 mttp 51.99 26.74 3.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.733 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.0 OUTLIER -84.77 142.86 29.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 4.6 pt-20 -117.98 148.69 41.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.64 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -166.05 -167.4 26.63 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.94 132.91 42.24 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.354 -1.086 . . . . 0.0 109.151 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.787 HD12 HG21 ' A' ' 63' ' ' VAL . 40.0 pt -124.92 140.99 37.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.556 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 51.5 Cg_endo -75.15 157.08 42.34 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.753 1.635 . . . . 0.0 110.837 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.539 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 48.1 t -88.6 29.85 0.96 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.609 -1.307 . . . . 0.0 109.836 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.492 ' OD1' ' C ' ' A' ' 60' ' ' SER . 6.0 m-20 -137.42 0.92 2.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 0.0 109.652 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.556 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 3.0 m-85 -108.19 -26.25 10.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.018 . . . . 0.0 109.286 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.787 HG21 HD12 ' A' ' 58' ' ' ILE . 15.3 m . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 12' ' ' ILE . 18.4 mm -107.3 131.04 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.554 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.56 156.75 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.28 -0.887 . . . . 0.0 108.994 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 p -112.47 134.32 55.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.939 -1.1 . . . . 0.0 109.001 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.35 118.2 4.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.443 -0.785 . . . . 0.0 110.281 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 62' ' ' TYR . 25.5 mt -90.94 -29.11 17.63 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -137.16 143.05 40.27 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.5 Cg_endo -61.72 140.09 84.19 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.752 2.301 . . . . 0.0 111.552 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 39.2 t80 -134.05 126.37 30.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.957 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 22' ' ' ILE . 3.0 m-20 -103.22 107.39 18.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.942 -1.099 . . . . 0.0 108.516 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.04 91.42 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' ASP . 13.4 mm -79.29 -58.75 3.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.588 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -67.26 175.4 1.55 Allowed Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.4 Cg_endo -71.74 -25.47 20.38 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.637 2.225 . . . . 0.0 112.045 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 35.8 m-20 -112.65 -8.33 13.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.33 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.49 121.05 11.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.026 -1.046 . . . . 0.0 109.754 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.116 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -85.5 134.64 34.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.921 -1.112 . . . . 0.0 108.363 179.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.116 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.7 p -84.27 136.93 33.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.955 . . . . 0.0 110.635 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.6 p90 -139.01 147.34 42.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 11.6 mtpp -107.25 140.98 39.29 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.081 -1.012 . . . . 0.0 109.499 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -42.6 151.47 0.12 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.153 -0.967 . . . . 0.0 108.397 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.97 -16.03 7.59 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.9 tp10 -83.33 151.63 25.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.032 -1.275 . . . . 0.0 109.542 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 4.1 mttt -105.77 146.49 29.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.425 -0.797 . . . . 0.0 110.166 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.555 ' HE3' HG11 ' A' ' 63' ' ' VAL . 3.1 mtm -138.2 155.35 48.76 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.663 0.744 . . . . 0.0 109.557 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -123.0 138.86 54.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.0 119.07 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 109.288 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.62 -26.91 16.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.998 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -132.0 135.82 46.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.002 -1.062 . . . . 0.0 109.294 -179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.88 134.78 51.09 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.176 -0.952 . . . . 0.0 109.251 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.608 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 56.5 m-70 -120.61 34.85 5.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.309 -0.869 . . . . 0.0 109.009 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 -108.33 3.66 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 75.3 tt0 -85.15 -7.53 59.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -1.136 . . . . 0.0 109.987 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.611 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 21.4 m95 -132.28 140.13 48.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.948 -1.095 . . . . 0.0 110.315 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.611 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -136.54 166.53 23.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.463 -0.773 . . . . 0.0 109.186 179.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -108.73 117.36 33.97 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -112.03 -175.08 2.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.363 -0.836 . . . . 0.0 110.47 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 32.2 ttpt -139.13 148.17 42.88 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.9 t -88.89 124.94 34.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 0.0 109.672 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -69.2 -11.77 61.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.058 -1.026 . . . . 0.0 109.281 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 tp -87.43 -53.57 4.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 0.0 109.769 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.533 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 1.8 t -108.99 14.63 23.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.355 -0.841 . . . . 0.0 109.351 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER 42.43 25.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -80.99 142.67 33.19 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.033 -1.042 . . . . 0.0 108.416 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 18.9 tt0 -121.44 141.09 51.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.092 -1.005 . . . . 0.0 109.6 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.699 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -168.65 166.94 39.98 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -67.76 134.41 50.97 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.431 -1.041 . . . . 0.0 109.913 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.64 142.28 40.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.678 ' CG ' ' CD1' ' A' ' 62' ' ' TYR . 50.1 Cg_endo -72.02 151.26 55.78 Favored 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 121.7 1.6 . . . . 0.0 110.918 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.503 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 98.9 p -87.67 28.09 1.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.55 -1.344 . . . . 0.0 109.983 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -140.27 -4.23 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.086 -1.009 . . . . 0.0 110.032 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.678 ' CD1' ' CG ' ' A' ' 59' ' ' PRO . 7.6 m-85 -98.7 -23.36 15.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.058 -1.026 . . . . 0.0 110.388 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.555 HG11 ' HE3' ' A' ' 35' ' ' MET . 17.5 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.179 . . . . 0.0 109.737 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.615 HD13 ' HG2' ' A' ' 36' ' ' LYS . 34.8 mm -105.37 131.13 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.253 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.8 158.04 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.344 -0.848 . . . . 0.0 109.469 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.04 136.36 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.137 -0.977 . . . . 0.0 109.007 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 31' ' ' LYS . . . -57.39 117.13 3.81 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 109.631 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 mt -90.39 -28.49 18.64 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -136.52 139.41 29.37 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 37.4 Cg_endo -59.73 141.25 96.58 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.925 2.416 . . . . 0.0 111.888 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.599 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 29.7 t80 -131.79 122.82 26.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.0 109.384 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 2.4 m-20 -102.57 110.92 23.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.116 -0.99 . . . . 0.0 108.858 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.97 89.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.3 mt -93.42 -14.98 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -1.131 . . . . 0.0 108.482 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -112.82 174.15 2.47 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 51.0 Cg_endo -70.65 -34.34 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.402 2.068 . . . . 0.0 112.022 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -111.41 -9.61 14.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.118 -0.989 . . . . 0.0 110.361 -179.43 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -60.29 120.62 10.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.975 -1.078 . . . . 0.0 109.772 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.113 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -84.54 135.64 34.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.999 -1.063 . . . . 0.0 108.336 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.113 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -84.3 136.51 33.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.584 -178.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 19' ' ' TYR . 13.9 p90 -140.29 149.1 42.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 108.754 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.535 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -107.68 136.78 46.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.909 -1.119 . . . . 0.0 109.392 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -38.87 154.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 72.5 -15.76 1.99 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.9 OUTLIER -80.17 156.42 26.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.825 -1.397 . . . . 0.0 108.926 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -107.08 144.37 33.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 110.355 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.641 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -140.48 154.79 46.73 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.444 0.64 . . . . 0.0 109.298 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.615 ' HG2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -122.24 139.86 53.28 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.66 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 1.3 t -99.87 119.22 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.015 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -90.23 -21.27 22.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.409 -0.807 . . . . 0.0 110.073 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 48.2 tt0 -144.51 138.12 27.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.932 -1.105 . . . . 0.0 109.787 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.37 133.27 52.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.329 -0.857 . . . . 0.0 109.0 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.522 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 77.9 m-70 -121.6 34.15 5.28 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.216 -0.928 . . . . 0.0 109.361 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.48 -110.53 4.04 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.36 -7.49 58.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -1.137 . . . . 0.0 109.892 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.572 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 m95 -130.65 142.55 50.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.985 -1.072 . . . . 0.0 109.908 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.66 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.85 168.16 20.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.287 -0.883 . . . . 0.0 109.766 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.628 ' O ' HD12 ' A' ' 38' ' ' LEU . 7.9 tttm -110.88 117.38 33.23 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.03 -172.03 2.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 110.354 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 6.8 ttpm? -139.88 149.0 42.86 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -88.44 125.97 35.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.084 -1.01 . . . . 0.0 109.508 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.5 mt -69.98 -13.49 62.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.017 -1.052 . . . . 0.0 109.288 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.8 tp -82.92 -55.62 4.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.798 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.468 ' OG1' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.96 10.61 26.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.386 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.5 OUTLIER 49.72 25.43 1.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.88 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.577 ' HB3' HD23 ' A' ' 27' ' ' LEU . 13.4 mttp -79.47 142.54 35.76 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 6.5 pt-20 -120.99 143.4 49.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.074 -1.016 . . . . 0.0 109.391 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.669 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -165.63 -164.74 21.7 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HB3' ' CZ3' ' A' ' 44' ' ' TRP . 1.7 m-85 -96.63 133.54 41.01 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.394 -1.062 . . . . 0.0 109.46 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 58' ' ' ILE . 20.5 pt -125.64 140.31 36.18 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.607 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 54.5 Cg_endo -77.1 161.23 32.75 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 121.663 1.576 . . . . 0.0 110.963 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.593 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 41.8 t -90.88 29.33 1.37 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.677 -1.265 . . . . 0.0 109.872 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 23.5 t-20 -140.65 -0.1 1.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.607 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 9.8 m-85 -102.12 -26.86 13.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.057 -1.027 . . . . 0.0 110.151 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.641 HG11 ' CE ' ' A' ' 35' ' ' MET . 5.1 m . . . . . 0 N--CA 1.492 1.666 0 O-C-N 120.88 -1.137 . . . . 0.0 110.075 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.699 HD12 ' HD3' ' A' ' 36' ' ' LYS . 1.8 tp -109.83 134.1 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.4 155.65 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.257 -0.902 . . . . 0.0 109.049 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 9.1 p -113.26 134.28 56.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.087 -1.008 . . . . 0.0 108.958 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -56.14 117.44 3.76 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.465 -0.772 . . . . 0.0 110.107 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 63' ' ' VAL . 32.3 mt -89.1 -29.22 19.55 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -136.58 142.49 39.4 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.1 Cg_endo -60.73 140.03 88.61 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.747 2.298 . . . . 0.0 111.675 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 28.6 t80 -131.76 123.21 27.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 109.371 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -103.23 110.09 21.93 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 108.832 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.58 89.24 0.01 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.6 mt -90.75 -14.99 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.329 -1.101 . . . . 0.0 108.424 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.4 176.21 1.57 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -71.77 -32.94 10.91 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.422 2.081 . . . . 0.0 111.897 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 4.8 m-20 -111.46 -8.82 14.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.163 -0.961 . . . . 0.0 110.216 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.463 ' OD1' ' CZ ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -60.69 122.85 15.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.001 -1.062 . . . . 0.0 109.636 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.108 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -87.45 134.8 33.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.962 -1.086 . . . . 0.0 108.498 179.318 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.108 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -84.21 136.38 33.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.496 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.663 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.6 p90 -139.37 148.1 42.4 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -107.9 137.16 46.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.081 . . . . 0.0 109.437 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 30' ' ' LYS . 9.6 ptmm? -38.81 151.66 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.41 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.11 -16.77 8.38 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.143 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 1.8 mp0 -83.32 153.39 24.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.948 -1.325 . . . . 0.0 109.653 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 8.8 mtpt -105.43 146.33 29.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.413 -0.804 . . . . 0.0 109.958 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.601 ' HE3' HG11 ' A' ' 63' ' ' VAL . 4.9 mtm -138.68 155.18 48.49 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.699 0.761 . . . . 0.0 109.573 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.699 ' HD3' HD12 ' A' ' 12' ' ' ILE . 3.4 tppt? -123.05 138.75 54.6 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.43 ' N ' ' HG3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -104.73 119.25 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.405 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -26.08 17.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.882 . . . . 0.0 109.989 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 68.5 mt-10 -133.04 135.51 45.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 109.155 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.433 ' OE2' ' N ' ' A' ' 42' ' ' GLY . 2.5 tm-20 -109.47 134.8 51.43 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.235 -0.916 . . . . 0.0 109.335 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.596 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 22.3 m-70 -119.95 36.02 4.66 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.252 -0.905 . . . . 0.0 108.86 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.433 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 92.63 -106.46 3.41 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -86.59 -8.32 57.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -1.165 . . . . 0.0 110.121 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.607 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 12.2 m95 -131.98 138.74 48.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.919 -1.113 . . . . 0.0 110.375 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.607 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -136.09 167.18 21.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.358 -0.839 . . . . 0.0 109.326 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -109.04 117.51 34.38 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -113.7 -173.1 2.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.379 -0.826 . . . . 0.0 110.677 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.5 ttmt -139.88 147.49 40.7 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.666 ' O ' ' N ' ' A' ' 53' ' ' LYS . 29.3 t -88.48 129.47 35.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 109.925 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.37 -27.47 66.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.052 . . . . 0.0 109.79 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.13 -41.82 16.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.181 -0.949 . . . . 0.0 109.947 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.495 ' OG1' ' HB3' ' A' ' 49' ' ' SER . 1.3 p -98.94 -18.35 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.354 -0.841 . . . . 0.0 109.371 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 49' ' ' SER . 14.0 mttt 60.65 11.21 2.98 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.334 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -80.21 150.76 29.99 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 8.6 pt-20 -120.53 143.52 48.53 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.9 -1.125 . . . . 0.0 109.695 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.69 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -167.15 165.6 38.68 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 1.8 m-85 -68.01 134.88 51.43 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.441 -1.035 . . . . 0.0 110.109 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 6.9 pt -125.52 140.85 37.39 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.703 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 52.9 Cg_endo -74.42 157.04 45.52 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 121.62 1.547 . . . . 0.0 111.055 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -89.56 27.98 1.38 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.706 -1.246 . . . . 0.0 109.824 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -140.71 -1.82 1.41 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.841 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.703 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.4 m-85 -102.05 -25.96 13.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.118 -0.989 . . . . 0.0 110.276 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.601 HG11 ' HE3' ' A' ' 35' ' ' MET . 11.5 m . . . . . 0 N--CA 1.492 1.65 0 O-C-N 120.814 -1.179 . . . . 0.0 109.972 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 3.0 tp -109.4 132.75 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.453 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.521 HG11 ' HZ3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -128.38 154.32 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 108.861 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.3 p -113.01 134.02 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.267 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.47 119.36 6.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.603 -0.686 . . . . 0.0 110.303 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.1 mt -91.51 -28.1 17.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -137.25 143.48 41.8 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.3 Cg_endo -61.47 140.03 85.3 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.62 2.213 . . . . 0.0 111.331 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.636 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 33.5 t80 -133.67 125.96 29.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.856 . . . . 0.0 110.051 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -103.25 106.76 17.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.016 -1.053 . . . . 0.0 108.371 178.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -29.63 92.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.0 mt -78.85 -59.01 3.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.354 -1.086 . . . . 0.0 108.099 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 3.6 m-70 -67.33 172.49 3.67 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 47.3 Cg_endo -68.83 -23.96 34.73 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.555 2.17 . . . . 0.0 112.108 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.544 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.1 m-20 -112.86 -7.48 13.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.151 -0.968 . . . . 0.0 110.284 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.517 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 13.3 m-20 -60.95 118.43 6.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.041 -1.037 . . . . 0.0 109.925 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.122 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -83.8 134.46 34.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.933 -1.104 . . . . 0.0 108.49 179.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.122 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.3 m -84.38 137.12 33.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.64 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 19' ' ' TYR . 8.7 p90 -139.56 148.28 42.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.281 -0.887 . . . . 0.0 108.635 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 31' ' ' LYS . 4.6 ttpm? -107.28 139.73 41.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.965 -1.084 . . . . 0.0 109.479 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.66 152.3 0.07 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.73 -16.27 6.86 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -82.84 152.66 25.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.084 -1.244 . . . . 0.0 109.713 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 16.3 mttp -105.95 145.96 30.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.424 -0.798 . . . . 0.0 110.223 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 63' ' ' VAL . 4.5 mtm -139.72 155.78 47.16 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.591 0.71 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.4 ttmm -120.67 137.61 54.37 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.411 ' CG2' ' CB ' ' A' ' 45' ' ' TRP . 1.6 p -104.35 120.12 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.707 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.745 ' N ' HD22 ' A' ' 38' ' ' LEU . 1.6 mm? -88.52 -37.81 15.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.324 -0.86 . . . . 0.0 109.767 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 6.6 tp10 -128.43 136.25 50.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.104 -0.997 . . . . 0.0 109.732 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.627 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -110.83 142.4 42.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.59 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 68.2 m-70 -114.96 44.27 1.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.037 -1.039 . . . . 0.0 109.743 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 52.81 27.52 28.76 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.401 -0.904 . . . . 0.0 110.881 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 41' ' ' HIS . 8.2 pt-20 164.04 -40.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.999 -1.295 . . . . 0.0 109.597 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.59 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 39.4 m95 -126.54 121.56 32.63 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.659 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -118.1 166.42 12.58 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.976 -1.077 . . . . 0.0 109.754 -179.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -109.45 122.61 47.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -118.69 -174.14 2.62 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 110.944 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 19.3 ttmt -139.09 148.68 43.62 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.3 t -90.45 124.92 35.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.971 -1.081 . . . . 0.0 109.852 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.48 -11.62 60.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.097 -1.002 . . . . 0.0 109.358 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.5 tp -83.87 -55.93 3.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 109.693 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.77 10.0 26.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.298 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' SER . 9.9 mtmt 49.93 25.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.366 -0.834 . . . . 0.0 109.834 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 1.026 ' HG2' HD23 ' A' ' 27' ' ' LEU . 2.9 tttt -80.35 142.52 34.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.089 -1.007 . . . . 0.0 108.317 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 13.2 pt-20 -122.05 142.95 49.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.042 -1.036 . . . . 0.0 109.637 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.685 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -164.14 -163.07 16.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 3.1 m-85 -97.79 133.62 42.05 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.466 -1.02 . . . . 0.0 109.491 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 12.7 pt -125.53 135.95 27.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.624 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 53.1 Cg_endo -75.35 164.21 33.14 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 121.637 1.558 . . . . 0.0 110.905 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.415 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 92.4 p -92.69 28.62 1.98 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.812 -1.18 . . . . 0.0 109.713 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -140.94 -1.71 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 109.915 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.624 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 9.4 m-85 -100.81 -27.89 13.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.044 -1.035 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.541 HG11 ' CE ' ' A' ' 35' ' ' MET . 11.6 m . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.029 -1.044 . . . . 0.0 109.534 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.409 ' HA ' HD13 ' A' ' 12' ' ' ILE . 26.8 mm -109.58 133.73 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.57 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.35 157.54 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.235 -0.916 . . . . 0.0 109.19 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 7.6 p -115.56 134.06 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.08 -1.013 . . . . 0.0 109.032 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.702 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -53.15 114.22 1.39 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.335 -0.853 . . . . 0.0 109.939 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.543 ' O ' ' CD ' ' A' ' 31' ' ' LYS . 27.8 mt -84.76 -30.0 25.03 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -137.49 140.88 31.67 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.638 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 37.6 Cg_endo -59.44 140.16 92.93 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.748 2.299 . . . . 0.0 111.649 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 33.3 t80 -134.27 125.76 28.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.836 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -102.13 107.94 19.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.892 -1.13 . . . . 0.0 108.571 179.003 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.11 89.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' ASP . 76.4 mt -80.94 -57.6 4.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.568 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 8.5 m80 -68.48 171.14 6.43 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 47.5 Cg_endo -68.18 -27.25 35.43 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.655 2.237 . . . . 0.0 112.246 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.575 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 23.6 t0 -111.8 -7.91 14.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.128 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -60.78 123.69 18.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.117 -0.989 . . . . 0.0 109.827 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.112 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -90.16 134.45 34.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.979 -1.075 . . . . 0.0 108.514 179.308 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.112 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -83.31 136.53 34.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.897 . . . . 0.0 110.605 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.3 p90 -138.86 147.07 41.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.339 -0.851 . . . . 0.0 108.721 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -108.87 146.81 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.831 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.638 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -46.51 151.39 0.56 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.918 -1.114 . . . . 0.0 108.545 179.231 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.3 -15.0 7.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -82.68 149.99 27.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.267 . . . . 0.0 109.683 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -105.98 144.94 31.99 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.711 0.767 . . . . 0.0 110.177 -179.307 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.722 ' CE ' HG11 ' A' ' 63' ' ' VAL . 4.7 mtm -137.79 155.23 49.26 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.588 0.708 . . . . 0.0 109.544 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 10.7 ttpp -118.85 136.06 54.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.32 118.77 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.21 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.48 ' H ' HD12 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -88.56 -33.76 17.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -133.52 136.43 45.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 109.525 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.575 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.7 tt0 -111.05 144.92 39.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 44' ' ' TRP . 4.5 m-70 -115.95 43.88 2.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 0.0 109.765 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.86 35.48 12.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 160.56 -45.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -1.161 . . . . 0.0 109.759 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.602 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 11.9 m95 -127.56 122.44 33.24 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.369 -0.832 . . . . 0.0 109.087 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.682 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.37 166.03 12.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.14 -0.975 . . . . 0.0 109.605 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -109.81 123.22 49.17 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -120.23 -173.63 2.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 110.809 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 ttpt -138.8 148.93 44.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 53' ' ' LYS . 5.2 t -90.07 125.52 35.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.944 -1.097 . . . . 0.0 109.903 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.6 mt -69.5 -13.41 62.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 109.43 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.9 tp -82.64 -55.35 4.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.732 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.22 9.46 25.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 109.286 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.8 OUTLIER 50.67 25.93 2.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.848 . . . . 0.0 109.864 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -80.54 142.38 34.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.177 -0.952 . . . . 0.0 108.435 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -121.98 142.14 50.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.094 -1.004 . . . . 0.0 109.54 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.672 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.65 -164.66 18.17 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -97.42 134.14 41.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.523 -0.987 . . . . 0.0 109.291 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.681 HD12 HG21 ' A' ' 63' ' ' VAL . 13.7 pt -126.49 137.8 31.1 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 52.2 Cg_endo -75.04 163.71 34.71 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 121.683 1.589 . . . . 0.0 110.675 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.7 p -92.21 29.26 1.69 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.72 -1.238 . . . . 0.0 109.906 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -138.92 -0.74 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.887 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.561 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.2 m-85 -106.16 -28.23 10.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 109.259 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.722 HG11 ' CE ' ' A' ' 35' ' ' MET . 22.0 m . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.317 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 36' ' ' LYS . 25.0 mm -105.86 129.56 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.972 . . . . 0.0 109.348 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.52 154.85 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.396 -0.815 . . . . 0.0 108.978 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 14.3 p -111.55 133.75 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.861 -1.149 . . . . 0.0 108.939 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -57.05 117.09 3.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.436 -0.79 . . . . 0.0 110.164 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.614 ' O ' ' CD ' ' A' ' 31' ' ' LYS . 14.5 mt -89.37 -28.08 20.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.8 140.17 28.79 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 37.6 Cg_endo -59.9 141.28 96.27 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.86 2.373 . . . . 0.0 111.49 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.646 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 34.5 t80 -132.83 123.92 27.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.727 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 22' ' ' ILE . 9.3 t70 -102.71 109.51 21.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.087 -1.008 . . . . 0.0 108.6 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.563 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.98 89.02 0.01 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.592 ' N ' ' O ' ' A' ' 20' ' ' ASP . 17.4 mt -88.36 -14.59 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.185 . . . . 0.0 108.318 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -114.13 176.67 1.4 Allowed Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.1 Cg_endo -72.43 -31.94 10.67 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.489 2.126 . . . . 0.0 112.085 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 17.7 m-20 -112.05 -9.59 13.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.354 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.41 122.24 14.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.918 -1.114 . . . . 0.0 109.778 -179.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.12 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -85.43 135.13 33.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.916 -1.115 . . . . 0.0 108.404 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.12 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.2 m -84.56 136.82 33.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.565 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.646 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 10.4 p90 -138.79 147.22 42.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.264 -0.898 . . . . 0.0 108.744 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 15.1 pttt -108.28 146.7 32.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.721 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.614 ' CD ' ' O ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -46.23 152.46 0.41 Allowed 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.868 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.68 -12.67 10.07 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.2 tm-20 -83.8 148.09 27.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.124 -1.221 . . . . 0.0 110.13 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -104.78 147.21 27.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -0.759 . . . . 0.0 109.714 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.565 ' CE ' HG11 ' A' ' 63' ' ' VAL . 8.7 mtm -139.42 155.28 47.72 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.667 0.746 . . . . 0.0 109.931 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -123.59 140.71 52.72 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.596 HG11 ' CB ' ' A' ' 45' ' ' TRP . 2.7 t -102.17 119.58 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.071 -1.018 . . . . 0.0 110.023 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -88.77 -21.64 23.7 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 0.0 109.811 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 4.3 mt-10 -148.33 139.05 22.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.97 -1.082 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.577 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 11.5 tt0 -109.74 135.44 50.66 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.299 -0.876 . . . . 0.0 109.166 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 63.3 m-70 -117.82 36.06 4.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.326 -0.859 . . . . 0.0 108.87 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.49 -110.14 3.95 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -84.74 -6.81 59.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -1.18 . . . . 0.0 109.865 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.572 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 23.4 m95 -130.89 143.16 50.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.058 -1.026 . . . . 0.0 109.97 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.596 ' CB ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -141.31 168.28 20.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.338 -0.851 . . . . 0.0 109.613 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.602 ' O ' HD12 ' A' ' 38' ' ' LEU . 8.7 tttt -110.2 116.36 31.36 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.15 -172.31 2.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.407 -0.808 . . . . 0.0 110.307 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.4 ttpm? -142.33 151.27 41.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 109.305 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -92.23 126.5 37.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.054 -1.029 . . . . 0.0 109.695 -179.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 mt -70.19 -13.98 62.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.024 -1.048 . . . . 0.0 109.33 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 51' ' ' LEU . 17.2 tp -75.96 -59.68 2.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -108.69 3.52 22.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 0.0 109.423 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.545 ' CD ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 61.23 25.66 15.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.752 ' HG2' HD23 ' A' ' 27' ' ' LEU . 1.1 tptp -78.51 141.51 38.13 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.153 -0.967 . . . . 0.0 108.521 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 7.2 pt-20 -123.46 146.1 48.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.046 -1.034 . . . . 0.0 109.604 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.723 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -169.75 -164.87 26.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -95.77 134.16 39.04 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.446 -1.031 . . . . 0.0 109.53 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 pt -126.0 141.67 40.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.631 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 54.6 Cg_endo -75.71 156.97 39.97 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.839 1.693 . . . . 0.0 110.921 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.584 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 46.0 t -88.67 28.13 1.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.726 -1.234 . . . . 0.0 110.019 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -139.82 -1.96 1.57 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.138 -0.976 . . . . 0.0 109.819 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.631 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 5.9 m-85 -101.74 -25.38 13.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.385 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.565 HG11 ' CE ' ' A' ' 35' ' ' MET . 24.7 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.858 -1.151 . . . . 0.0 110.069 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.487 ' C ' HD12 ' A' ' 12' ' ' ILE . 10.4 t70 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.7 OUTLIER -104.9 128.65 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.501 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.44 155.51 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.3 p -112.84 133.77 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.943 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -58.48 118.66 5.84 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.476 -0.765 . . . . 0.0 110.385 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.5 mt -92.02 -27.1 18.03 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -137.55 141.39 33.28 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.9 Cg_endo -62.2 141.43 88.11 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.648 2.232 . . . . 0.0 111.56 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.649 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 33.5 t80 -132.84 124.18 27.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.962 . . . . 0.0 109.671 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -103.37 110.32 22.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.069 -1.02 . . . . 0.0 108.796 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.96 89.52 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 20' ' ' ASP . 4.6 mt -90.1 -13.73 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -1.11 . . . . 0.0 108.359 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.559 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -114.01 174.56 2.27 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 50.9 Cg_endo -70.78 -32.48 14.26 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.409 2.073 . . . . 0.0 111.916 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.559 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 16.2 m-20 -112.02 -9.64 13.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 110.4 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -59.83 121.62 12.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.891 -1.131 . . . . 0.0 109.745 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.1 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -84.33 136.83 33.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 108.353 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 1.1 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.9 m -86.99 137.5 32.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 0.0 110.629 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.0 p90 -140.28 149.57 42.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -108.85 142.5 39.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 109.731 -179.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' LYS . 1.2 pttt -44.79 151.53 0.29 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.112 -0.993 . . . . 0.0 108.423 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.52 -16.43 7.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.575 ' CG ' ' CD2' ' A' ' 51' ' ' LEU . 10.0 tp10 -82.8 151.59 26.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.066 -1.255 . . . . 0.0 109.915 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 3.9 mttt -105.33 146.36 29.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.454 -0.779 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.677 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -138.3 153.8 49.02 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.725 0.774 . . . . 0.0 110.132 -179.423 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG2' HG13 ' A' ' 12' ' ' ILE . 2.8 mtpm? -122.62 138.3 54.63 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 t -88.32 155.38 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 118.48 -1.288 . . . . 0.0 109.292 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.529 ' O ' ' CG ' ' A' ' 39' ' ' GLU . 4.1 mt -122.61 -13.35 7.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.313 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 37.3 mt-10 -159.03 138.94 11.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.381 -0.824 . . . . 0.0 109.054 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 13.0 tt0 -106.18 132.8 51.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 41.6 m-70 -122.2 34.2 5.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.453 -0.779 . . . . 0.0 109.289 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.8 -113.53 4.61 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -83.26 -6.8 59.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -1.165 . . . . 0.0 109.601 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.587 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 32.1 m95 -130.35 148.08 52.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.431 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.587 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -146.69 172.01 14.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 110.072 179.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.609 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -111.7 128.41 56.07 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . . . -121.64 -173.29 2.6 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.128 -0.982 . . . . 0.0 110.509 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 26.7 ttpt -136.93 146.69 45.75 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -86.5 124.54 32.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 109.49 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.3 -10.07 52.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.057 -1.027 . . . . 0.0 109.404 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.575 ' CD2' ' CG ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -88.1 -53.16 4.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 109.991 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.543 HG22 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.11 8.84 24.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.922 . . . . 0.0 109.584 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 50.73 26.64 2.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.302 -0.874 . . . . 0.0 109.752 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 11.3 tptt -84.4 142.06 30.4 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 23.4 pt-20 -117.48 139.53 50.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.979 -1.076 . . . . 0.0 109.638 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.664 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -156.58 -166.6 16.56 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.408 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 5.5 m-85 -97.21 132.69 42.73 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 109.541 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.418 HG22 ' CE1' ' A' ' 29' ' ' PHE . 11.5 pt -124.78 141.47 38.2 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.615 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 55.1 Cg_endo -78.71 161.48 27.6 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.66 1.573 . . . . 0.0 111.199 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 32.9 t -90.86 30.01 1.26 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.837 -1.164 . . . . 0.0 109.701 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 60' ' ' SER . 6.8 m120 -141.19 -0.12 1.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.813 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.615 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 7.7 m-85 -102.72 -26.74 13.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 110.122 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.677 HG11 ' CE ' ' A' ' 35' ' ' MET . 6.4 m . . . . . 0 N--CA 1.491 1.618 0 O-C-N 120.965 -1.084 . . . . 0.0 110.003 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.303 0.573 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.21 114.83 3.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -102.93 151.02 22.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -1.127 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -105.97 129.72 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -129.26 154.58 40.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 108.89 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 2.9 p -113.4 133.93 57.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.97 -1.081 . . . . 0.0 108.83 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.655 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -56.32 115.86 2.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.514 -0.741 . . . . 0.0 109.789 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.899 HD11 ' HB3' ' A' ' 64' ' ' ALA . 50.4 mt -88.37 -27.78 21.39 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -136.72 140.32 31.64 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.97 141.47 94.6 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.762 2.308 . . . . 0.0 111.879 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.9 t80 -133.2 124.14 26.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.53 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -102.27 111.33 23.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.97 -1.081 . . . . 0.0 108.958 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -28.15 89.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.7 mt -94.63 -14.14 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.308 -1.113 . . . . 0.0 108.483 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.587 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.5 175.1 1.98 Allowed Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.1 Cg_endo -71.76 -34.34 9.05 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.511 2.14 . . . . 0.0 112.052 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 2.5 m-20 -112.09 -10.73 13.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 0.0 110.574 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 46.1 m-20 -60.34 116.22 4.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.915 -1.115 . . . . 0.0 109.752 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.125 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -78.67 134.96 37.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.907 -1.121 . . . . 0.0 108.45 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.125 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.6 p -83.54 136.6 34.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.354 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.8 p90 -139.41 147.94 42.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.288 -0.882 . . . . 0.0 108.739 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -108.51 140.02 42.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.072 -1.018 . . . . 0.0 109.497 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 30' ' ' LYS . 15.4 ptmt -42.21 152.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.23 -0.988 . . . . 0.0 108.36 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.55 -16.65 7.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -82.66 152.03 26.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.097 -1.237 . . . . 0.0 109.743 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 12.8 mtpt -105.79 145.99 30.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.435 -0.791 . . . . 0.0 109.962 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.617 ' CE ' HG11 ' A' ' 63' ' ' VAL . 5.9 mtm -138.2 154.21 49.13 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.718 0.77 . . . . 0.0 109.834 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 tttp -121.78 136.44 54.94 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.645 HG11 ' CB ' ' A' ' 45' ' ' TRP . 1.5 t -97.96 120.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.005 . . . . 0.0 110.075 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.777 ' N ' HD22 ' A' ' 38' ' ' LEU . 2.2 mm? -86.34 -18.2 32.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 109.923 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -154.24 141.03 19.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.945 -1.097 . . . . 0.0 109.757 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 6.1 tt0 -108.64 135.18 50.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.145 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 74.2 m-70 -121.0 35.01 5.01 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.202 -0.936 . . . . 0.0 109.218 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.85 -110.0 3.94 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -85.76 -7.09 58.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -1.139 . . . . 0.0 109.857 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.577 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 27.3 m95 -129.99 141.86 50.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.071 -1.018 . . . . 0.0 109.786 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.645 ' CB ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.98 167.68 21.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 109.569 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.573 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 13.1 tttp -110.8 118.84 37.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.38 -172.77 2.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 110.473 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 5.4 ttmt -140.83 150.24 43.03 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 53' ' ' LYS . 4.4 t -90.87 125.94 35.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.127 -0.983 . . . . 0.0 109.818 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -12.18 61.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.361 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.09 -55.29 4.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.694 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.71 8.07 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.351 -0.843 . . . . 0.0 109.281 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 49' ' ' SER . 21.4 mtmt 50.93 25.29 2.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.949 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 9.2 tttm -82.07 144.8 30.56 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.128 -0.982 . . . . 0.0 108.386 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 26.9 tt0 -120.84 145.62 47.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.014 -1.054 . . . . 0.0 109.456 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.665 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -164.79 -167.28 25.11 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.93 134.33 40.41 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.317 -1.108 . . . . 0.0 109.461 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 HG21 ' A' ' 63' ' ' VAL . 10.9 pt -126.23 142.47 42.82 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.468 -0.77 . . . . 0.0 109.287 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.527 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 53.7 Cg_endo -75.62 157.55 40.13 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.854 1.703 . . . . 0.0 110.811 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.55 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 47.9 t -89.6 28.96 1.2 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.593 -1.317 . . . . 0.0 110.19 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -137.2 -0.35 2.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.079 -1.013 . . . . 0.0 109.664 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.527 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.7 m-85 -106.61 -25.72 11.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.229 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.7 HG21 HD12 ' A' ' 58' ' ' ILE . 19.5 m -123.53 164.68 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -0.869 . . . . 0.0 109.505 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.899 ' HB3' HD11 ' A' ' 16' ' ' LEU . . . -160.66 -165.47 1.41 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.088 -1.008 . . . . 0.0 109.752 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 66' ' ' LEU . 70.7 mttt -89.73 129.42 36.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.408 -0.808 . . . . 0.0 109.619 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.509 ' C ' HG11 ' A' ' 14' ' ' VAL . 2.7 tp 45.39 -171.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.55 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.719 ' ND2' HD23 ' A' ' 16' ' ' LEU . 28.5 t-20 172.12 -87.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.477 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.5 m . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.477 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.06 -140.74 1.59 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.54 146.76 52.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -1.158 . . . . 0.0 109.481 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.743 HD13 ' HG3' ' A' ' 36' ' ' LYS . 26.4 mm -109.54 132.87 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.524 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.888 HG12 ' CA ' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -129.34 155.6 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 108.957 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 12.7 p -112.79 134.46 55.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.306 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.68 118.83 5.67 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.482 -0.761 . . . . 0.0 110.103 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 64' ' ' ALA . 82.0 mt -91.51 -28.3 17.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -137.02 142.93 40.19 Favored Pre-proline 0 N--CA 1.486 1.352 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HD3' ' HE3' ' A' ' 31' ' ' LYS . 38.9 Cg_endo -62.13 140.74 85.48 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.785 2.323 . . . . 0.0 111.575 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.633 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 34.2 t80 -132.04 123.6 27.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.576 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' ILE . 13.2 t0 -103.31 109.66 21.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.118 -0.989 . . . . 0.0 108.722 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.76 90.53 0.01 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' ASP . 5.9 mt -88.44 -13.62 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -1.135 . . . . 0.0 108.403 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.606 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.63 177.99 1.06 Allowed Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.7 Cg_endo -73.59 -30.83 9.38 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.359 2.039 . . . . 0.0 111.955 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -112.59 -9.56 13.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.338 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.453 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 39.2 m-20 -60.91 116.29 4.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.952 -1.092 . . . . 0.0 109.899 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.112 HD22 ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -80.17 134.24 36.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 108.373 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.112 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.6 p -83.52 137.46 33.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 110.833 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.633 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.5 p90 -139.24 148.55 43.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 108.692 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.12 142.7 37.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.855 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.462 ' HE3' ' HD3' ' A' ' 18' ' ' PRO . 2.8 ptpt -44.19 151.82 0.22 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.29 -16.06 8.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 2.6 tm-20 -83.22 151.33 25.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.238 . . . . 0.0 109.67 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 12.7 mttt -104.97 146.05 29.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.44 -0.787 . . . . 0.0 109.83 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.597 ' CE ' HG11 ' A' ' 63' ' ' VAL . 5.7 mtm -137.73 154.69 49.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.609 0.719 . . . . 0.0 109.662 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.743 ' HG3' HD13 ' A' ' 12' ' ' ILE . 20.2 tttt -118.36 133.73 55.64 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.583 HG21 ' HG3' ' A' ' 40' ' ' GLU . 1.4 p -103.78 119.08 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 109.433 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.796 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -88.53 -40.64 13.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.417 -0.802 . . . . 0.0 109.807 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 7.0 mp0 -129.81 137.08 50.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 109.687 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 4.9 mt-10 -111.11 146.4 36.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 7.8 m-70 -116.86 42.07 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.534 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.89 37.99 16.11 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 160.93 -47.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -1.12 . . . . 0.0 109.412 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.511 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 10.2 m95 -128.87 119.66 24.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.488 -0.757 . . . . 0.0 108.959 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -113.24 167.32 10.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.054 -1.029 . . . . 0.0 109.403 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.796 ' O ' HD12 ' A' ' 38' ' ' LEU . 2.2 tttp -110.44 116.06 30.74 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 36' ' ' LYS . . . -116.45 -172.29 2.16 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.415 -0.803 . . . . 0.0 110.417 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -144.04 154.44 43.24 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -94.55 126.87 40.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 0.0 110.195 -178.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.72 -11.87 60.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.153 -0.967 . . . . 0.0 109.359 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 tp -83.33 -55.73 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 109.728 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.12 10.04 28.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 48.25 24.63 0.71 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.428 -0.795 . . . . 0.0 110.111 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -81.42 144.0 31.72 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt-20 -120.52 149.1 42.95 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 109.392 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.687 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -169.01 -166.35 27.92 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.91 133.8 41.07 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.382 -1.069 . . . . 0.0 109.345 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 58' ' ' ILE . 17.8 pt -125.87 140.31 36.41 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 108.88 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.628 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 53.4 Cg_endo -75.05 159.15 41.51 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 121.694 1.596 . . . . 0.0 110.706 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.447 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 99.5 p -89.73 28.82 1.25 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.684 -1.26 . . . . 0.0 109.705 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -140.48 -1.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 109.999 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.628 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 8.4 m-85 -100.74 -26.6 13.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 0.0 110.07 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.597 HG11 ' CE ' ' A' ' 35' ' ' MET . 14.5 m -113.97 159.47 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.041 -1.037 . . . . 0.0 109.644 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -106.23 130.2 54.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.639 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.888 ' CA ' HG12 ' A' ' 13' ' ' VAL . 1.5 tmtt? -99.59 75.2 1.92 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.245 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.78 165.02 23.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.623 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -137.46 -163.16 1.39 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.273 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.452 ' O ' ' OG1' ' A' ' 68' ' ' THR . 5.0 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.514 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.9 85.27 0.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -134.26 154.41 51.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.326 -1.102 . . . . 0.0 109.207 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.762 HD13 ' HG3' ' A' ' 36' ' ' LYS . 19.4 mm -106.02 129.96 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.162 -0.961 . . . . 0.0 109.561 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.57 156.31 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 8.1 p -114.04 134.45 56.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.027 -1.046 . . . . 0.0 108.807 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.577 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -55.85 115.36 2.34 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.545 -0.722 . . . . 0.0 109.849 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.935 HD11 ' CB ' ' A' ' 64' ' ' ALA . 36.2 mt -88.02 -28.99 21.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -136.62 139.95 30.76 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.0 Cg_endo -60.76 141.39 94.78 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.857 2.372 . . . . 0.0 111.642 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.3 t80 -133.78 124.92 27.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 109.906 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.564 ' O ' ' C ' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -102.94 110.32 22.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.021 -1.049 . . . . 0.0 108.805 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.83 91.07 0.01 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.56 ' N ' ' O ' ' A' ' 20' ' ' ASP . 14.2 mt -91.76 -14.35 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.282 -1.128 . . . . 0.0 108.524 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.569 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.35 175.78 1.74 Allowed Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 50.7 Cg_endo -71.43 -31.67 13.57 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.4 2.067 . . . . 0.0 111.903 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.517 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.1 m-20 -112.0 -9.34 14.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 110.218 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -60.04 123.37 16.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.948 -1.095 . . . . 0.0 109.713 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.103 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -88.07 135.3 33.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.999 -1.063 . . . . 0.0 108.351 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.103 ' N ' HD22 ' A' ' 27' ' ' LEU . 5.8 p -83.81 136.18 34.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.498 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.5 p90 -139.04 147.93 42.71 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 31' ' ' LYS . 4.5 ttmt -108.69 140.39 42.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.028 . . . . 0.0 109.551 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -42.79 152.01 0.11 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.92 -17.11 7.43 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -82.53 151.75 26.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.057 -1.261 . . . . 0.0 109.728 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -105.56 145.85 30.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.459 -0.776 . . . . 0.0 109.895 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.611 ' CE ' HG11 ' A' ' 63' ' ' VAL . 8.5 mtm -138.26 154.11 49.06 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.649 0.738 . . . . 0.0 109.669 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.762 ' HG3' HD13 ' A' ' 12' ' ' ILE . 4.2 ttpm? -119.72 134.33 55.27 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.63 HG11 ' CB ' ' A' ' 45' ' ' TRP . 1.5 t -96.84 119.9 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 110.14 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 mt -85.31 -20.41 30.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.366 -0.834 . . . . 0.0 110.011 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.24 141.2 20.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.902 -1.124 . . . . 0.0 109.763 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 2.9 tt0 -109.31 137.4 47.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.409 -0.807 . . . . 0.0 108.955 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.609 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 68.7 m-70 -123.43 36.25 4.68 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.208 -0.933 . . . . 0.0 109.197 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.85 -104.11 3.14 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.8 -8.82 48.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -1.088 . . . . 0.0 110.606 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.609 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 17.3 m95 -131.89 124.95 30.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.782 -1.199 . . . . 0.0 110.401 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.632 ' CZ2' ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.3 168.22 13.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.145 -0.972 . . . . 0.0 109.678 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.17 129.29 56.0 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -124.83 -172.21 2.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 110.537 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.561 ' CG ' ' HB3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -138.77 147.49 42.68 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' LYS . 8.4 t -88.26 124.92 34.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.04 -1.038 . . . . 0.0 109.491 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.2 -13.13 62.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 109.427 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.3 tp -80.65 -57.13 3.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.457 -0.777 . . . . 0.0 109.906 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.4 3.79 23.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 49' ' ' SER . 9.1 mttt 58.42 25.37 12.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.751 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 8.6 mmtp -78.13 142.05 38.31 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.561 ' HB3' ' CG ' ' A' ' 48' ' ' LYS . 10.0 pt-20 -121.59 139.9 52.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.033 -1.042 . . . . 0.0 109.511 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.698 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.11 -163.78 15.66 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.55 135.21 40.42 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.553 -0.969 . . . . 0.0 109.417 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.638 HD12 HG21 ' A' ' 63' ' ' VAL . 18.4 pt -126.22 142.9 44.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.369 -0.832 . . . . 0.0 109.152 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.547 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 53.8 Cg_endo -75.93 157.42 38.87 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.877 1.718 . . . . 0.0 110.746 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 89.1 p -88.92 28.82 1.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.728 -1.232 . . . . 0.0 110.143 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -138.14 0.16 2.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.025 . . . . 0.0 109.741 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.547 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.5 m-85 -105.45 -26.3 11.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.097 -1.002 . . . . 0.0 109.4 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.638 HG21 HD12 ' A' ' 58' ' ' ILE . 18.0 m -122.58 164.77 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.637 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.935 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -160.38 -166.03 1.57 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.89 119.31 35.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.385 -0.822 . . . . 0.0 109.574 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 67' ' ' ASN . 8.6 tt -53.59 138.63 33.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.422 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.697 ' N ' HD23 ' A' ' 66' ' ' LEU . 1.1 m-80 -134.41 178.45 6.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 0.0 109.635 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.44 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.13 7.63 10.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.582 ' CB ' HG13 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -74.78 119.4 18.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -1.159 . . . . 0.0 109.463 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.537 HD11 ' HD3' ' A' ' 36' ' ' LYS . 10.1 mm -107.25 130.39 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 109.356 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.942 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -128.32 153.34 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.274 -0.891 . . . . 0.0 108.928 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 8.7 p -112.41 133.61 57.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 118.841 -1.143 . . . . 0.0 109.168 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -58.18 118.71 5.76 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.494 -0.754 . . . . 0.0 110.285 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.098 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 13.3 mt -91.82 -26.94 18.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -137.34 141.96 35.84 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 40.0 Cg_endo -62.57 141.49 86.37 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.716 2.277 . . . . 0.0 111.831 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.4 t80 -132.65 123.69 26.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 109.419 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -102.58 110.64 22.65 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.008 -1.058 . . . . 0.0 108.798 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.4 89.69 0.01 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' ASP . 6.2 mt -92.3 -14.27 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -1.163 . . . . 0.0 108.476 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.505 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -113.37 175.24 1.93 Allowed Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 52.9 Cg_endo -72.03 -32.85 10.44 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.414 2.076 . . . . 0.0 112.181 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.537 ' OD2' ' CE ' ' A' ' 46' ' ' LYS . 55.7 t0 -112.77 -10.38 13.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.123 -0.985 . . . . 0.0 110.611 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 44.5 m-20 -60.15 116.41 4.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.951 -1.093 . . . . 0.0 109.797 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.107 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.08 135.85 38.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.934 -1.104 . . . . 0.0 108.286 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.107 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.3 p -85.11 137.08 33.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -0.978 . . . . 0.0 110.423 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.635 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 12.3 p90 -140.4 148.81 41.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.0 108.701 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -108.19 140.62 41.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.027 -1.045 . . . . 0.0 109.428 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.01 152.44 0.11 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.59 -16.74 7.53 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -83.23 151.98 25.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -1.204 . . . . 0.0 109.659 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.697 ' HB2' HD12 ' A' ' 50' ' ' LEU . 13.4 mtmt -105.14 143.86 32.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.816 . . . . 0.0 110.093 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.726 ' CE ' HG11 ' A' ' 63' ' ' VAL . 6.7 mtm -136.91 154.71 50.39 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.619 0.723 . . . . 0.0 109.585 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 10.1 ttpt -121.26 136.12 55.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 ' CB ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -103.12 119.72 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.487 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.822 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -85.64 -31.91 22.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 109.55 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -143.34 139.06 29.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.509 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.635 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tt0 -111.86 145.1 40.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.667 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 14.7 m-70 -114.68 43.25 1.97 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 109.523 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 48.13 40.53 21.34 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.584 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 158.7 -48.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.29 -1.123 . . . . 0.0 109.574 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 8.3 m95 -129.38 120.87 26.28 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.413 -0.804 . . . . 0.0 109.111 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.682 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.17 168.65 9.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.184 -0.948 . . . . 0.0 109.631 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.822 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -110.05 116.12 31.0 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.54 -174.84 2.56 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 110.498 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.5 ttmt -137.55 147.72 45.36 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.655 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -88.56 129.39 35.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.03 -1.044 . . . . 0.0 109.921 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.697 HD12 ' HB2' ' A' ' 34' ' ' LYS . 5.8 mt -68.76 -24.46 64.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.04 . . . . 0.0 109.835 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.6 tp -86.52 -42.36 13.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.966 . . . . 0.0 109.92 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 49' ' ' SER . 1.2 p -99.1 -16.78 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.376 -0.828 . . . . 0.0 109.16 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.655 ' N ' ' O ' ' A' ' 49' ' ' SER . 13.7 mttt 59.56 11.88 2.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.323 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -81.69 151.57 27.48 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 14.2 pt-20 -119.63 146.62 45.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.897 -1.127 . . . . 0.0 109.515 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.659 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -169.85 164.66 38.08 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.591 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -68.05 133.38 48.9 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.492 -1.005 . . . . 0.0 109.962 -179.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.5 pt -124.47 143.04 42.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.0 Cg_endo -73.69 153.57 48.79 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.543 1.495 . . . . 0.0 110.68 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.467 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 91.8 p -87.6 29.37 0.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.616 -1.302 . . . . 0.0 109.954 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -139.81 0.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 109.794 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.649 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 17.2 m-85 -102.06 -25.64 13.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.985 . . . . 0.0 110.198 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.726 HG11 ' CE ' ' A' ' 35' ' ' MET . 14.8 m -117.03 162.66 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.997 -1.064 . . . . 0.0 110.061 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.098 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -108.59 133.73 52.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.749 . . . . 0.0 109.412 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.942 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -95.25 90.35 5.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.903 -1.123 . . . . 0.0 109.328 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 tp -67.02 80.95 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.321 -0.862 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.87 22.6 6.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.409 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.477 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.7 144.98 10.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 175.75 153.47 0.16 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 109.475 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.874 HD13 ' HG2' ' A' ' 36' ' ' LYS . 10.1 mm -108.0 132.44 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.275 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.835 HG12 ' CA ' ' A' ' 65' ' ' LYS . 0.9 OUTLIER -130.49 156.66 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.933 . . . . 0.0 109.185 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 13.0 p -113.47 134.95 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.053 -1.029 . . . . 0.0 109.084 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.66 118.94 5.78 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.483 -0.761 . . . . 0.0 110.302 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.054 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 12.6 mt -91.19 -28.56 17.76 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -137.24 142.49 37.99 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.1 Cg_endo -61.13 140.88 91.77 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.783 2.322 . . . . 0.0 111.413 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 35.5 t80 -133.75 125.74 29.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.998 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -103.38 107.68 18.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.034 -1.041 . . . . 0.0 108.518 179.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 26' ' ' ASP . . . -30.36 92.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.4 mt -79.32 -59.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -66.66 176.1 1.18 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.643 -0.661 . . . . 0.0 109.241 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.5 Cg_endo -71.73 -25.07 20.85 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.528 2.152 . . . . 0.0 111.938 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.2 t70 -112.65 -7.83 13.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.285 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.586 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -60.14 122.78 15.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.968 -1.082 . . . . 0.0 109.763 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.118 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -88.8 135.01 33.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.994 -1.066 . . . . 0.0 108.406 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.118 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.2 m -84.49 136.7 33.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.728 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.653 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.8 p90 -138.91 147.84 42.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 108.586 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.53 140.05 41.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.018 -1.051 . . . . 0.0 109.635 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.83 152.16 0.08 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.88 -15.7 7.85 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -83.34 152.46 25.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.087 -1.243 . . . . 0.0 109.838 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.478 ' O ' ' OE2' ' A' ' 33' ' ' GLU . 30.6 ttmt -105.72 146.08 30.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 109.917 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.695 ' CE ' HG11 ' A' ' 63' ' ' VAL . 3.6 mtm -137.73 154.71 49.59 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.64 0.733 . . . . 0.0 109.919 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.874 ' HG2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -117.86 132.65 56.4 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 p -103.82 119.41 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.961 . . . . 0.0 109.449 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -89.76 -45.87 9.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -0.86 . . . . 0.0 109.953 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 3.7 tt0 -122.97 136.14 54.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.621 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.583 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 tt0 -111.74 143.8 42.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.542 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 24.7 m-70 -113.13 44.52 1.52 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.521 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 49.91 36.44 26.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 160.01 -45.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -1.175 . . . . 0.0 109.729 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.542 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 7.5 m95 -128.54 122.58 31.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.014 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -116.7 168.54 10.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.139 -0.976 . . . . 0.0 109.96 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.803 ' O ' HD12 ' A' ' 38' ' ' LEU . 11.3 ttpt -109.41 117.61 34.47 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.32 -173.62 2.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.237 -0.915 . . . . 0.0 110.586 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.7 ttmt -139.01 148.59 43.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 17.3 t -90.05 126.82 35.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.046 -1.034 . . . . 0.0 109.55 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.409 HD13 ' HD2' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -70.32 -11.32 60.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 109.424 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.7 tp -81.99 -57.43 3.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.719 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 54' ' ' LYS . 4.6 t -108.99 7.97 26.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.372 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 49' ' ' SER . 19.2 mttt 53.95 25.76 5.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 109.897 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 1.048 ' HG2' HD23 ' A' ' 27' ' ' LEU . 12.5 tttp -80.29 142.8 34.19 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 21.7 pt-20 -121.36 144.63 48.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.98 -1.075 . . . . 0.0 109.6 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.683 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -165.64 -164.24 20.7 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.49 132.99 41.51 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.374 -1.074 . . . . 0.0 109.633 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 58' ' ' ILE . 11.2 pt -125.99 135.99 27.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.527 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 54.3 Cg_endo -77.95 166.23 25.3 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.591 1.527 . . . . 0.0 111.213 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.511 ' HG ' ' HZ2' ' A' ' 45' ' ' TRP . 35.4 t -91.79 29.17 1.6 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.987 -1.071 . . . . 0.0 109.699 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -140.78 0.09 1.57 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.967 . . . . 0.0 109.719 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.527 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.3 m-85 -100.5 -28.72 12.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.079 -1.013 . . . . 0.0 109.664 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.695 HG11 ' CE ' ' A' ' 35' ' ' MET . 6.1 m -115.39 160.1 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 109.829 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.054 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -106.36 130.22 54.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.507 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.835 ' CA ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -97.47 85.84 3.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.086 -1.009 . . . . 0.0 109.435 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.33 133.24 56.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.643 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -87.76 175.5 7.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.92 . . . . 0.0 109.426 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.335 0.588 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.75 -174.14 17.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.1 152.36 36.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -1.162 . . . . 0.0 109.504 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.692 HD13 ' HG3' ' A' ' 36' ' ' LYS . 17.2 mm -106.74 132.01 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.357 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.548 HG12 ' C ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -131.82 157.23 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.28 -0.888 . . . . 0.0 109.269 -179.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 66' ' ' LEU . 6.4 p -113.55 134.63 55.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.077 -1.015 . . . . 0.0 108.552 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.663 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -56.24 115.81 2.68 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.69 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 64' ' ' ALA . 9.8 mt -88.6 -28.15 20.88 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -136.74 141.02 33.66 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.6 Cg_endo -61.87 141.91 91.49 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.863 2.375 . . . . 0.0 111.82 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 36.6 t80 -133.55 124.41 26.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.84 . . . . 0.0 109.748 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -102.47 110.91 22.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.987 -1.071 . . . . 0.0 108.727 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.41 90.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.5 mt -93.52 -14.17 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -1.142 . . . . 0.0 108.591 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.66 175.91 1.68 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.2 Cg_endo -72.2 -33.31 9.48 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.46 2.106 . . . . 0.0 112.038 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.491 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 14.0 t0 -112.14 -10.04 13.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 110.366 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 34.1 m-20 -60.58 116.82 4.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.031 -1.043 . . . . 0.0 109.829 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.109 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -79.44 135.79 36.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.941 -1.1 . . . . 0.0 108.509 179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.109 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.3 p -83.73 136.06 34.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 110.493 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.4 p90 -139.49 148.32 42.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.867 . . . . 0.0 108.826 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 31' ' ' LYS . 2.7 ttpt -108.77 140.61 41.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.94 -1.1 . . . . 0.0 109.572 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -42.86 152.7 0.1 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.29 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.19 -16.89 6.74 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.4 tp10 -83.12 152.86 25.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.035 -1.273 . . . . 0.0 109.801 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -105.38 145.42 30.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.473 -0.767 . . . . 0.0 109.662 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.728 ' CE ' HG11 ' A' ' 63' ' ' VAL . 6.6 mtm -137.16 154.17 50.29 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.71 0.767 . . . . 0.0 109.957 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.692 ' HG3' HD13 ' A' ' 12' ' ' ILE . 1.6 ttpm? -118.18 129.01 55.25 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.63 120.03 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 109.344 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.704 ' H ' HD12 ' A' ' 38' ' ' LEU . 1.7 mp -86.65 -37.51 17.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 109.581 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -134.8 136.68 42.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.954 . . . . 0.0 109.653 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.63 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.3 tt0 -110.32 145.07 38.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 21.3 m-70 -111.81 46.23 1.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.122 -0.986 . . . . 0.0 109.584 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 50.57 32.06 23.26 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 161.19 -42.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.058 -1.26 . . . . 0.0 109.869 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.614 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 50.4 m95 -127.2 122.0 32.85 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 108.908 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.648 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -118.82 168.76 10.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.079 -1.013 . . . . 0.0 109.726 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -108.85 121.15 44.48 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -125.7 146.68 49.64 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 110.983 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 1.7 ptpt -102.44 155.41 18.27 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 4.8 t -98.07 129.88 44.89 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.958 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.82 -12.55 61.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.2 tp -73.27 -62.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 109.714 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.9 -0.28 21.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.407 -0.808 . . . . 0.0 109.349 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 66.93 24.86 9.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -0.894 . . . . 0.0 109.892 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 5.6 mmtt -79.5 140.31 37.32 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 mt-10 -121.81 143.46 49.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.052 -1.03 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.694 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -166.39 -164.72 22.5 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.614 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -96.17 133.04 40.96 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.365 -1.08 . . . . 0.0 109.153 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.818 HD12 HG21 ' A' ' 63' ' ' VAL . 33.2 pt -125.03 141.47 38.51 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.037 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.612 ' HB3' ' CH2' ' A' ' 44' ' ' TRP . 50.6 Cg_endo -72.24 152.56 55.95 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.927 1.751 . . . . 0.0 110.831 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 91.1 p -87.03 28.75 0.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.553 -1.342 . . . . 0.0 109.974 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -137.52 -4.09 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.832 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.575 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 5.2 m-85 -101.67 -24.2 14.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.947 -1.096 . . . . 0.0 109.068 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.818 HG21 HD12 ' A' ' 58' ' ' ILE . 19.7 m -124.25 157.3 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 109.239 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.616 ' HB3' HD11 ' A' ' 16' ' ' LEU . . . -151.57 -166.58 2.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.997 . . . . 0.0 109.543 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -98.3 64.47 1.61 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.458 -0.776 . . . . 0.0 109.415 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.761 ' H ' HG12 ' A' ' 14' ' ' VAL . 0.9 OUTLIER 41.46 85.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.349 -0.844 . . . . 0.0 109.488 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -51.71 151.44 3.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.553 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 11' ' ' ASP . . . -155.65 -159.78 9.56 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER 163.84 137.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -1.179 . . . . 0.0 109.57 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.5 mm -106.2 130.9 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.304 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -130.76 155.99 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.249 -0.907 . . . . 0.0 109.135 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.432 HG11 ' HG ' ' A' ' 66' ' ' LEU . 12.2 p -113.89 134.88 55.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 120.932 -1.105 . . . . 0.0 108.735 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.49 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -57.83 115.98 3.17 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.527 -0.733 . . . . 0.0 109.951 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' ' 64' ' ' ALA . 52.2 mt -89.64 -27.39 20.2 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -137.89 140.98 31.06 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 39.4 Cg_endo -61.98 141.72 90.23 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.629 2.219 . . . . 0.0 111.516 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 38.3 t80 -133.54 124.67 27.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 109.982 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 5.4 m-20 -103.52 109.95 21.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 108.487 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.31 89.14 0.01 OUTLIER Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.3 mt -86.78 -13.46 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.225 -1.162 . . . . 0.0 108.544 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.587 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -114.91 176.77 1.37 Allowed Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.0 Cg_endo -73.05 -30.18 11.06 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.395 2.064 . . . . 0.0 111.949 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 24.1 t0 -113.2 -9.54 13.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 110.384 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 2.5 m-20 -59.83 122.19 13.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.928 -1.107 . . . . 0.0 109.83 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.104 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -82.9 136.81 34.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.985 -1.072 . . . . 0.0 108.231 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.104 ' N ' HD22 ' A' ' 27' ' ' LEU . 39.5 p -86.41 137.36 32.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.079 -1.013 . . . . 0.0 110.623 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.2 p90 -140.29 149.23 42.54 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -108.77 141.14 41.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.996 -1.065 . . . . 0.0 109.615 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.73 151.83 0.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.083 -1.01 . . . . 0.0 108.386 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.37 -17.21 6.62 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -82.78 152.55 25.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.035 -1.273 . . . . 0.0 109.841 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -105.35 144.58 31.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.692 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.795 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -138.09 153.81 49.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.515 0.674 . . . . 0.0 109.666 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 5.2 ttmt -117.75 130.09 56.1 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.4 p -98.26 120.74 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.113 -0.992 . . . . 0.0 109.625 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.31 -48.82 7.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 0.0 109.827 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 24.8 tt0 -119.03 134.58 55.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.069 -1.019 . . . . 0.0 109.926 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.62 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.8 tt0 -110.54 144.53 39.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 29.7 m-70 -116.74 47.14 1.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 109.756 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.38 34.22 8.85 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.2 OUTLIER 161.08 -43.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -1.103 . . . . 0.0 109.872 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.563 ' CH2' ' HB3' ' A' ' 59' ' ' PRO . 39.2 m95 -127.16 120.78 29.63 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.62 ' CD1' ' CG ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -117.04 168.29 10.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.029 -1.044 . . . . 0.0 109.555 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -109.53 122.83 48.3 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.7 -174.59 2.51 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 110.812 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -135.93 145.43 46.25 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -85.38 123.87 31.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.0 109.656 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.52 -9.24 53.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.09 -1.007 . . . . 0.0 109.429 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.0 tp -88.97 -53.46 4.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 109.717 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -109.42 7.01 24.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.842 . . . . 0.0 109.412 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 49' ' ' SER . 6.2 mmtp 52.39 26.24 4.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.926 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.12 142.29 32.38 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 6.9 mt-10 -118.65 139.54 51.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.912 -1.118 . . . . 0.0 109.646 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.671 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -158.79 -162.3 11.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 4.5 m-85 -99.91 133.34 44.42 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.377 -1.073 . . . . 0.0 109.5 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.682 HD12 HG21 ' A' ' 63' ' ' VAL . 18.0 pt -125.0 139.81 34.46 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.563 ' HB3' ' CH2' ' A' ' 44' ' ' TRP . 54.2 Cg_endo -77.42 162.47 30.74 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.712 1.608 . . . . 0.0 111.248 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.582 ' HG ' ' HZ2' ' A' ' 45' ' ' TRP . 41.9 t -91.77 30.06 1.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.797 -1.189 . . . . 0.0 109.794 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -137.81 -0.15 2.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.99 . . . . 0.0 109.743 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.546 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 8.7 m-85 -107.65 -26.91 10.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 108.932 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.795 HG11 ' CE ' ' A' ' 35' ' ' MET . 12.2 m -123.98 161.12 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.452 -0.78 . . . . 0.0 109.284 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 16' ' ' LEU . . . -156.07 -166.25 2.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.993 . . . . 0.0 109.798 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -99.48 113.99 26.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.471 -0.768 . . . . 0.0 109.525 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HG ' HG11 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -63.45 102.17 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.466 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 m120 55.38 -172.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.93 . . . . 0.0 109.473 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 68' ' ' THR . 2.7 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.428 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.357 0.598 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.41 -96.64 0.16 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.91 159.64 26.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -1.127 . . . . 0.0 109.375 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.607 HD12 ' CG ' ' A' ' 36' ' ' LYS . 13.2 mm -105.63 130.94 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.213 -0.929 . . . . 0.0 109.157 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -130.82 155.96 42.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.299 -0.875 . . . . 0.0 109.332 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.687 HG21 HD12 ' A' ' 66' ' ' LEU . 7.6 p -114.26 134.26 57.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.168 -0.957 . . . . 0.0 108.596 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -54.95 113.99 1.56 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.338 -0.851 . . . . 0.0 109.791 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.025 HD11 ' HB3' ' A' ' 64' ' ' ALA . 47.5 mt -86.5 -29.58 22.63 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -136.35 139.95 31.21 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 38.4 Cg_endo -61.52 141.76 92.76 Favored 'Trans proline' 0 C--O 1.216 -0.584 0 C-N-CA 122.891 2.394 . . . . 0.0 111.82 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.7 t80 -134.02 125.35 27.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.755 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 22' ' ' ILE . 11.0 t70 -102.73 110.71 22.73 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.986 -1.071 . . . . 0.0 108.673 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.55 90.31 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.7 mt -92.72 -14.32 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -1.143 . . . . 0.0 108.662 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.57 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.89 174.95 2.06 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.57 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 51.4 Cg_endo -71.08 -32.72 12.78 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.425 2.083 . . . . 0.0 111.806 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -111.88 -9.67 14.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 110.284 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.01 123.27 16.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.905 -1.122 . . . . 0.0 109.796 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.114 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -86.38 135.56 33.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.94 -1.1 . . . . 0.0 108.286 179.207 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.114 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -84.35 136.5 33.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 110.422 -178.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 9.4 p90 -139.74 148.39 42.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.922 . . . . 0.0 108.673 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.84 142.54 39.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.026 . . . . 0.0 109.588 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -44.43 152.01 0.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.019 -1.05 . . . . 0.0 108.325 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.4 -16.79 7.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -82.61 152.08 26.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.023 -1.281 . . . . 0.0 109.676 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -106.03 146.04 30.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.421 -0.799 . . . . 0.0 110.005 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.731 ' CE ' HG11 ' A' ' 63' ' ' VAL . 8.0 mtm -137.52 153.77 49.96 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.695 0.76 . . . . 0.0 109.838 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.607 ' CG ' HD12 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -116.41 130.1 56.58 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.628 HG11 ' CB ' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -96.44 119.99 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.936 -1.103 . . . . 0.0 110.113 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.44 -24.02 39.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.505 -0.747 . . . . 0.0 109.738 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -158.68 145.58 17.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.091 -1.006 . . . . 0.0 110.041 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.65 ' HG3' ' CG ' ' A' ' 45' ' ' TRP . 12.2 tt0 -111.42 143.06 42.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 0.0 109.392 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 84.6 m-70 -116.63 42.95 2.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.099 -1.001 . . . . 0.0 109.677 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.603 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.83 41.97 21.08 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.603 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 156.37 -48.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -1.079 . . . . 0.0 109.911 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 59' ' ' PRO . 13.4 m95 -126.65 122.99 36.56 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 109.017 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.65 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.17 166.28 12.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 109.841 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.13 123.45 50.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -122.51 -171.32 2.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.695 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 ttpm? -140.75 150.58 43.58 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -90.11 126.1 35.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.011 -1.055 . . . . 0.0 109.964 -179.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -14.5 63.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.005 . . . . 0.0 109.445 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 tp -85.06 -53.49 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -109.28 13.54 24.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.264 -0.898 . . . . 0.0 109.348 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' SER . 18.7 mttp 44.44 25.38 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.352 -0.843 . . . . 0.0 109.798 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.8 mtpm? -79.45 141.17 37.02 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.13 -0.981 . . . . 0.0 108.355 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 12.5 pt-20 -121.72 144.08 48.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.032 -1.043 . . . . 0.0 109.576 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.697 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -166.69 -163.54 20.64 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.62 134.42 40.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.576 -0.955 . . . . 0.0 109.371 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.621 HD12 HG21 ' A' ' 63' ' ' VAL . 11.9 pt -125.96 142.22 41.75 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.098 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 49.7 Cg_endo -72.4 153.03 55.6 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.811 1.674 . . . . 0.0 110.638 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 80.7 p -86.25 29.45 0.75 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.546 -1.346 . . . . 0.0 109.969 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -138.27 0.61 2.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 0.0 109.736 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.567 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 6.5 m-85 -105.35 -25.51 12.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.009 . . . . 0.0 109.479 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.731 HG11 ' CE ' ' A' ' 35' ' ' MET . 18.8 m -123.16 160.68 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.025 ' HB3' HD11 ' A' ' 16' ' ' LEU . . . -157.25 -165.3 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 109.587 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -79.88 135.55 36.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -0.797 . . . . 0.0 109.512 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.687 HD12 HG21 ' A' ' 14' ' ' VAL . 1.2 tp -73.64 116.03 13.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.44 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -134.05 6.36 3.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.3 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.47 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 10' ' ' GLY . 25.7 mt-30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 9' ' ' GLN . . . 57.75 110.68 0.01 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 1.6 m-20 -111.98 155.4 23.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -1.129 . . . . 0.0 109.491 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.6 mm -105.85 129.77 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.6 OUTLIER -129.52 154.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.36 -0.838 . . . . 0.0 108.898 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 66' ' ' LEU . 9.4 p -114.16 133.93 58.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 120.987 -1.07 . . . . 0.0 108.837 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.685 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -56.61 115.3 2.46 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.471 -0.768 . . . . 0.0 109.682 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.862 HD11 ' HB3' ' A' ' 64' ' ' ALA . 56.1 mt -88.4 -27.21 21.73 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -137.51 139.96 28.88 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 39.0 Cg_endo -61.87 142.24 92.64 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.652 2.234 . . . . 0.0 111.47 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 39.7 t80 -134.23 125.9 28.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 0.0 109.989 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' C ' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -103.22 110.67 22.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.061 -1.024 . . . . 0.0 108.751 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.573 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.68 91.92 0.01 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 20' ' ' ASP . 7.5 mt -93.32 -13.01 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -1.117 . . . . 0.0 108.716 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.532 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -114.65 174.16 2.5 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.532 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 50.8 Cg_endo -71.02 -32.42 13.39 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.388 2.059 . . . . 0.0 112.046 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -112.2 -9.88 13.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.165 -0.96 . . . . 0.0 110.285 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -59.81 126.81 29.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.06 . . . . 0.0 109.857 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.09 HD22 ' N ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -87.53 137.07 32.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.09 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.0 m -87.48 137.98 31.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 7.7 p90 -141.08 150.14 42.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.85 . . . . 0.0 108.804 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -108.92 138.58 45.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.068 -1.02 . . . . 0.0 109.581 -179.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LYS . 4.1 ptpt -42.16 152.06 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.37 -17.54 7.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -82.1 150.47 27.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.146 -1.208 . . . . 0.0 109.673 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HG2' HG23 ' A' ' 14' ' ' VAL . 12.7 mmtt -105.28 145.03 31.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.435 -0.79 . . . . 0.0 109.799 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.745 ' CE ' HG11 ' A' ' 63' ' ' VAL . 11.7 mtm -137.39 153.67 50.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.519 -0.738 . . . . 0.0 109.743 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.6 tttt -118.38 131.99 56.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.631 HG11 ' CB ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -96.79 121.01 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.986 -1.071 . . . . 0.0 110.366 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.61 -36.49 26.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 109.041 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -128.01 131.56 49.19 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -112.94 98.81 7.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.975 . . . . 0.0 109.802 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 84.1 m-70 -75.86 -157.77 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.352 -1.468 . . . . 0.0 108.954 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . -105.49 43.88 1.58 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 2.2 mt-10 163.51 -40.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.141 -1.211 . . . . 0.0 109.115 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.463 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 7.0 m95 -132.39 123.58 27.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.386 -0.821 . . . . 0.0 109.871 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.647 ' CZ2' ' HB2' ' A' ' 60' ' ' SER . 0.1 OUTLIER -115.54 168.58 9.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.396 -0.815 . . . . 0.0 109.807 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -110.74 121.29 44.96 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -120.17 -170.64 2.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.907 . . . . 0.0 110.631 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -142.04 150.75 41.68 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 53' ' ' LYS . 25.6 t -90.05 125.91 35.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 109.791 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -9.95 57.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 0.0 109.321 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 51' ' ' LEU . 15.6 tp -82.76 -57.53 3.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.314 -0.867 . . . . 0.0 109.812 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -109.32 2.22 20.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 109.378 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' SER . 19.5 mttt 61.99 26.68 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 109.845 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 7.4 mmtp -81.94 140.01 34.28 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.3 pm0 -121.29 144.16 48.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.996 -1.065 . . . . 0.0 109.834 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.721 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -171.49 166.66 39.71 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 10.2 m-85 -66.92 135.09 53.29 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.362 -1.081 . . . . 0.0 109.763 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.472 HG22 ' CE1' ' A' ' 29' ' ' PHE . 2.6 pt -124.92 146.4 53.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.392 -0.818 . . . . 0.0 109.0 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 48.4 Cg_endo -71.95 146.85 48.2 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.98 1.787 . . . . 0.0 110.615 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.647 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 80.6 p -85.09 29.72 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.43 -1.419 . . . . 0.0 110.187 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -137.64 0.43 2.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.119 -0.988 . . . . 0.0 109.737 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.609 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 36.6 m-85 -107.54 -23.84 12.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.092 -1.005 . . . . 0.0 109.467 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.745 HG11 ' CE ' ' A' ' 35' ' ' MET . 29.3 m -124.7 159.31 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.862 ' HB3' HD11 ' A' ' 16' ' ' LEU . . . -154.33 -166.31 2.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.633 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -102.49 127.75 49.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.428 -0.795 . . . . 0.0 109.556 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.555 ' HB2' HG11 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -127.88 96.71 4.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.481 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -95.61 -168.73 1.83 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.507 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.411 ' OXT' HG22 ' A' ' 68' ' ' THR . 4.9 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.515 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 9' ' ' GLN . . . -60.31 -117.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.96 141.02 0.09 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -1.182 . . . . 0.0 109.445 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.0 mm -107.7 131.03 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -129.94 154.32 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.24 -0.912 . . . . 0.0 109.107 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.772 ' O ' HD23 ' A' ' 16' ' ' LEU . 12.9 p -116.16 135.17 57.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.075 -1.016 . . . . 0.0 109.001 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HB2' ' SD ' ' A' ' 35' ' ' MET . . . -58.95 118.74 6.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.645 -0.659 . . . . 0.0 110.843 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.772 HD23 ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -89.87 -26.4 20.51 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.508 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . 50.6 m-85 -138.26 141.77 32.97 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 40.2 Cg_endo -62.57 141.72 87.22 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.595 2.196 . . . . 0.0 111.474 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 42.8 t80 -133.84 125.39 28.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 0.0 109.8 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' ILE . 6.4 t70 -103.17 110.01 21.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.106 -0.996 . . . . 0.0 108.666 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.04 89.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' ASP . 2.4 mp -88.33 -13.42 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.158 -1.201 . . . . 0.0 108.552 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.583 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -114.6 174.91 2.09 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 51.2 Cg_endo -71.38 -31.39 14.11 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.415 2.077 . . . . 0.0 111.906 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 9.4 t70 -112.54 -9.85 13.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.394 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -59.59 127.27 31.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.941 -1.099 . . . . 0.0 109.806 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.101 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -88.52 136.19 33.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.983 -1.073 . . . . 0.0 108.372 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.101 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.7 m -86.85 137.79 32.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.989 . . . . 0.0 110.452 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.663 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 10.0 p90 -141.37 150.34 42.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 0.0 108.802 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -108.53 137.62 46.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.052 -1.03 . . . . 0.0 109.303 -179.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.25 153.55 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.416 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.87 -17.52 4.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -82.2 154.46 25.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.042 -1.269 . . . . 0.0 109.703 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -106.32 142.93 35.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.768 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -137.67 153.71 49.79 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.497 0.665 . . . . 0.0 109.325 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.2 ptpt -118.34 131.68 56.31 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.381 -0.824 . . . . 0.0 108.818 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -100.65 120.25 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.337 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.56 -37.44 16.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 109.914 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -132.72 136.76 46.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.065 -1.022 . . . . 0.0 109.89 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.625 ' CG ' ' CD1' ' A' ' 45' ' ' TRP . 1.4 tt0 -111.21 146.41 36.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.547 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 36.0 m-70 -116.64 46.34 1.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.692 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 48.61 32.36 10.66 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 162.36 -42.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -1.199 . . . . 0.0 109.831 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.547 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 12.9 m95 -127.5 120.9 29.34 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.44 -0.788 . . . . 0.0 108.875 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.83 166.94 11.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.018 -1.051 . . . . 0.0 109.822 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.469 ' HG2' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -109.66 121.16 44.58 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -116.12 -173.82 2.43 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 110.644 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -137.21 146.41 44.83 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -85.12 123.58 30.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.675 -179.231 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -8.76 49.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.088 -1.007 . . . . 0.0 109.308 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.95 -54.42 4.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 109.898 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -109.55 1.97 20.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' SER . 21.7 mmtm 59.71 26.66 15.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.227 -0.921 . . . . 0.0 109.744 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HD2' HD23 ' A' ' 27' ' ' LEU . 5.1 ttmm -83.95 141.73 31.03 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 12.8 pt-20 -118.71 137.99 52.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.996 -1.065 . . . . 0.0 109.822 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.661 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -163.37 163.54 35.63 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 18.6 m-85 -65.69 133.93 52.13 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.351 -1.087 . . . . 0.0 109.98 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.627 HD12 HG21 ' A' ' 63' ' ' VAL . 7.7 pt -123.43 144.05 42.99 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.729 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.6 Cg_endo -71.57 148.19 53.15 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.941 1.761 . . . . 0.0 110.786 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 89.3 p -86.14 29.5 0.74 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.481 -1.387 . . . . 0.0 110.241 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -136.99 -1.86 2.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.091 -1.006 . . . . 0.0 109.935 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.729 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 4.8 m-85 -106.64 -23.12 12.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 109.207 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.768 HG11 ' CE ' ' A' ' 35' ' ' MET . 11.0 m -123.75 157.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.375 -0.828 . . . . 0.0 109.32 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 13' ' ' VAL . . . -153.36 -166.13 2.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.982 . . . . 0.0 109.532 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.83 111.53 24.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.377 -0.827 . . . . 0.0 109.556 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 66' ' ' LEU . 3.5 mm? 46.66 -166.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.462 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -178.98 153.13 0.61 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 0.0 109.515 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.64 146.46 18.76 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -136.09 163.94 29.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -1.163 . . . . 0.0 109.425 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 12' ' ' ILE . 19.8 mm -105.42 130.3 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.212 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 1.1 m -131.07 156.75 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.345 -0.847 . . . . 0.0 109.125 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.543 HG11 ' HB2' ' A' ' 66' ' ' LEU . 6.6 p -114.49 134.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.845 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.605 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -57.23 116.67 3.42 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.531 -0.73 . . . . 0.0 109.907 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.723 HD11 ' CB ' ' A' ' 64' ' ' ALA . 20.4 mt -89.27 -27.74 20.37 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -137.58 141.79 34.65 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.6 Cg_endo -61.83 141.41 89.98 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.731 2.287 . . . . 0.0 111.571 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.649 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 41.2 t80 -134.66 126.25 28.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 110.182 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 22' ' ' ILE . 12.1 t70 -102.0 107.87 19.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.054 -1.029 . . . . 0.0 108.282 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -31.06 90.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.7 mt -79.56 -59.91 2.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.506 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -65.34 173.75 1.73 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.609 -0.682 . . . . 0.0 109.401 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -71.53 -26.59 19.82 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.68 2.253 . . . . 0.0 112.29 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -113.23 -9.87 13.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.532 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.446 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 48.4 m-20 -59.69 121.78 12.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.915 -1.116 . . . . 0.0 109.782 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.12 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -83.39 135.78 34.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.965 -1.084 . . . . 0.0 108.405 179.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.12 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.2 m -85.23 136.41 33.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 110.362 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.5 p90 -139.77 148.71 42.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.302 -0.874 . . . . 0.0 108.709 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -108.52 141.21 40.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.963 -1.086 . . . . 0.0 109.557 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -43.63 152.23 0.16 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.37 -17.15 6.67 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 5.4 tp10 -82.45 152.64 26.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.051 -1.264 . . . . 0.0 109.77 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 7.0 mttm -105.88 145.22 31.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.918 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.755 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -138.42 154.11 48.88 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.553 -0.717 . . . . 0.0 109.647 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.691 ' HD3' HD11 ' A' ' 38' ' ' LEU . 5.4 tttp -120.62 136.48 54.8 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.658 HG11 ' CB ' ' A' ' 45' ' ' TRP . 3.3 t -98.4 119.14 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 109.797 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 38' ' ' LEU . 2.3 mm? -88.11 -19.67 26.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.507 -0.746 . . . . 0.0 110.191 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' NE2' ' A' ' 41' ' ' HIS . 12.4 pt-20 -146.91 138.95 24.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.966 -1.084 . . . . 0.0 109.795 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.4 ' OE2' ' N ' ' A' ' 42' ' ' GLY . 2.5 tm-20 -108.65 135.38 49.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.403 -0.81 . . . . 0.0 109.125 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 44.1 m-70 -122.89 36.0 4.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.162 -0.961 . . . . 0.0 109.241 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 93.78 -108.57 3.69 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 60' ' ' SER . 0.4 OUTLIER -87.48 -7.13 57.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 110.01 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.577 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 10.6 m95 -130.21 143.01 50.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.015 -1.053 . . . . 0.0 109.827 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.658 ' CB ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -140.64 167.25 22.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.184 -0.948 . . . . 0.0 109.777 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.94 119.97 40.98 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.57 -172.13 2.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.515 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 1.1 tttm -138.93 147.86 42.83 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 53' ' ' LYS . 1.4 t -86.14 124.81 32.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 0.0 109.588 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -69.51 -10.97 60.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.963 . . . . 0.0 109.394 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.6 tp -86.17 -54.16 4.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -0.855 . . . . 0.0 109.893 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.3 2.0 22.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 109.306 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 49' ' ' SER . 4.8 mttp 57.53 24.73 10.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 110.319 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.5 ttmm -83.23 145.51 29.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 108.253 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -119.46 142.22 48.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.059 -1.025 . . . . 0.0 109.783 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.657 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -167.55 165.12 38.44 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -68.03 135.13 51.8 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.376 -1.073 . . . . 0.0 109.926 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.658 HD12 HG21 ' A' ' 63' ' ' VAL . 10.4 pt -124.43 144.52 46.21 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.64 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 50.4 Cg_endo -71.95 149.03 52.51 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.028 1.819 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.58 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 46.4 t -86.98 28.76 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.44 -1.413 . . . . 0.0 110.269 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -136.9 -0.98 2.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.956 -1.09 . . . . 0.0 109.818 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.64 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 33.0 m-85 -106.35 -23.81 12.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.003 . . . . 0.0 109.184 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.755 HG11 ' CE ' ' A' ' 35' ' ' MET . 15.6 m -123.91 157.13 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.298 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.723 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -151.77 -166.96 2.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.701 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -98.93 135.2 40.7 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.774 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.617 HD23 HG23 ' A' ' 68' ' ' THR . 0.5 OUTLIER -107.98 125.7 51.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -0.845 . . . . 0.0 109.318 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 66' ' ' LEU . 15.0 t30 -42.71 115.91 0.79 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.568 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.617 HG23 HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.469 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.35 151.1 20.04 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.58 155.72 20.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.214 -1.168 . . . . 0.0 109.496 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.446 HD11 ' HE2' ' A' ' 36' ' ' LYS . 29.7 mm -107.82 132.76 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.839 . . . . 0.0 109.33 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.877 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.6 m -130.31 155.7 41.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.127 -0.983 . . . . 0.0 109.26 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.532 ' CG1' ' HB3' ' A' ' 64' ' ' ALA . 11.2 p -113.25 134.6 55.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.107 -0.996 . . . . 0.0 108.775 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.03 117.52 4.07 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 110.131 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.935 HD11 ' HB2' ' A' ' 64' ' ' ALA . 68.7 mt -90.04 -28.21 19.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -137.71 142.93 38.39 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.8 Cg_endo -61.94 140.69 86.29 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.613 2.208 . . . . 0.0 111.419 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.0 t80 -133.78 125.98 29.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 0.0 109.921 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 22' ' ' ILE . 72.5 m-20 -102.86 107.36 18.18 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.954 -1.091 . . . . 0.0 108.385 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.13 90.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 20' ' ' ASP . 16.4 mt -78.77 -59.67 2.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.49 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -66.25 173.34 2.31 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.614 -0.679 . . . . 0.0 109.222 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 50.4 Cg_endo -70.82 -26.07 23.0 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.723 2.282 . . . . 0.0 112.349 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.7 OUTLIER -113.28 -9.4 13.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -0.927 . . . . 0.0 110.762 -178.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.6 OUTLIER -60.69 116.48 4.43 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.799 -1.188 . . . . 0.0 109.882 -179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.113 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -77.66 135.63 38.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.981 -1.075 . . . . 0.0 108.408 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.113 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.5 m -85.54 137.13 33.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.627 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 17.8 p90 -139.36 148.04 42.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.289 -0.882 . . . . 0.0 108.718 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.6 141.09 39.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 109.475 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.479 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -43.11 151.21 0.15 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.141 -0.975 . . . . 0.0 108.438 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.36 -16.58 7.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 15' ' ' ALA . 7.5 tm-20 -82.71 151.93 26.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.138 -1.213 . . . . 0.0 109.722 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 37.7 mtpt -105.43 145.89 30.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.522 -0.736 . . . . 0.0 109.866 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.662 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -140.92 155.55 46.25 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.434 0.635 . . . . 0.0 109.427 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.609 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 4.2 tttm -122.55 139.48 53.86 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -104.43 119.7 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.195 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.7 -27.14 18.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 110.09 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -131.45 135.69 47.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.973 -1.079 . . . . 0.0 109.373 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -109.24 136.9 47.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.261 -0.899 . . . . 0.0 109.2 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.583 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 10.6 m-70 -122.47 37.35 4.41 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 108.947 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 -99.57 2.51 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -90.39 -10.39 44.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -1.113 . . . . 0.0 110.372 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.604 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 6.0 m95 -131.33 138.66 49.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.604 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -135.7 165.38 25.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.337 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.598 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 13.2 tttt -109.61 120.99 44.2 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 36' ' ' LYS . . . -115.76 -173.56 2.37 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.389 -0.819 . . . . 0.0 110.697 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.6 ttpt -137.31 146.92 45.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -85.71 125.09 32.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.001 -1.062 . . . . 0.0 109.687 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.91 -10.34 58.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 109.301 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.6 tp -88.4 -53.8 4.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.712 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.69 8.51 26.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 109.42 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' SER . 10.8 mttt 50.2 25.26 1.72 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.991 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.05 143.85 31.25 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -119.02 141.64 48.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 109.453 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.678 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.41 -166.42 21.15 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.439 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -96.63 132.92 41.78 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.416 -1.05 . . . . 0.0 109.419 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 58' ' ' ILE . 17.2 pt -125.14 141.1 37.61 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.644 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 51.9 Cg_endo -74.54 157.54 44.61 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 121.673 1.582 . . . . 0.0 110.942 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.486 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 89.2 p -90.31 29.43 1.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.636 -1.29 . . . . 0.0 109.908 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -140.7 -2.67 1.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.644 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 4.9 m-85 -102.23 -24.39 13.91 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.907 -1.121 . . . . 0.0 110.534 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.662 HG11 ' CE ' ' A' ' 35' ' ' MET . 10.5 m -111.16 155.5 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 0.0 109.97 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.935 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -102.78 129.44 49.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.452 -0.78 . . . . 0.0 109.561 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.877 ' HA ' HG12 ' A' ' 13' ' ' VAL . 13.9 ptpt -80.03 134.48 36.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.967 -1.083 . . . . 0.0 109.391 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mp 63.33 -91.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.49 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 174.17 110.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.431 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.494 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.296 0.57 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.63 81.14 0.23 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.494 ' C ' HD13 ' A' ' 12' ' ' ILE . 13.0 t70 -127.21 122.32 33.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.338 -1.095 . . . . 0.0 109.28 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.723 HD12 ' CG ' ' A' ' 36' ' ' LYS . 6.7 mm -105.55 130.6 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -130.77 155.97 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.055 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.446 HG11 ' HB3' ' A' ' 66' ' ' LEU . 14.3 p -113.69 135.12 54.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.081 -1.012 . . . . 0.0 108.532 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -57.16 114.38 2.13 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.509 -0.744 . . . . 0.0 109.81 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.869 HD11 ' CB ' ' A' ' 64' ' ' ALA . 49.9 mt -88.48 -28.4 20.86 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -136.74 139.15 28.22 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 38.4 Cg_endo -61.62 142.28 94.0 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.758 2.305 . . . . 0.0 111.676 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 37.3 t80 -133.53 124.45 26.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 109.699 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -102.63 111.1 23.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.002 . . . . 0.0 108.521 179.239 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -25.66 88.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' ASP . 34.5 mt -88.99 -13.97 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -1.184 . . . . 0.0 108.636 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.581 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -115.13 175.85 1.73 Allowed Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.581 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 51.2 Cg_endo -71.93 -32.22 11.53 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.561 2.174 . . . . 0.0 111.697 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -112.34 -10.43 13.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 110.113 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.474 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -60.04 117.54 5.22 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.983 -1.073 . . . . 0.0 109.738 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.117 HD22 ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -81.3 137.18 35.8 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.002 -1.061 . . . . 0.0 108.285 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.117 ' N ' HD22 ' A' ' 27' ' ' LEU . 6.2 p -84.96 137.34 33.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.975 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.1 p90 -139.37 148.77 43.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 2.3 ttmt -108.96 140.26 42.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.977 -1.077 . . . . 0.0 109.697 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' LYS . 1.5 ptmt -43.65 152.66 0.14 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.3 -17.93 5.88 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 6.0 tm-20 -82.23 153.15 26.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.031 -1.276 . . . . 0.0 109.643 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 144.63 32.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.437 -0.79 . . . . 0.0 109.78 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.684 ' CE ' HG11 ' A' ' 63' ' ' VAL . 1.1 mpp? -137.64 153.29 49.88 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.52 -0.737 . . . . 0.0 109.624 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.723 ' CG ' HD12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -118.99 132.76 56.09 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.72 HG11 ' HB2' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -97.15 119.91 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.037 . . . . 0.0 109.794 -179.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mt -88.04 -22.38 24.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.462 -0.774 . . . . 0.0 110.317 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -146.4 138.81 25.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.798 -1.189 . . . . 0.0 109.771 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -108.76 137.0 47.41 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.412 -0.805 . . . . 0.0 109.13 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.546 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 16.0 m-70 -121.56 37.79 4.26 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.23 -0.919 . . . . 0.0 109.058 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.11 -106.08 3.34 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.78 -7.77 55.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -1.074 . . . . 0.0 110.008 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.595 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 29.6 m95 -129.25 139.48 51.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.0 109.777 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.72 ' HB2' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.72 167.34 22.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 109.759 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.561 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 12.2 tttt -110.66 123.51 50.14 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -118.78 -170.88 1.99 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 110.5 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 15.8 ttpt -140.87 150.28 43.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.2 t -88.6 125.51 34.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.058 -1.026 . . . . 0.0 109.783 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -10.75 59.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.184 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.2 tp -85.9 -54.34 4.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 109.847 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.68 8.39 24.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 49' ' ' SER . 53.5 mttp 51.99 26.74 3.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.733 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 1.0 OUTLIER -84.77 142.86 29.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 4.6 pt-20 -117.98 148.69 41.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.64 ' HA3' ' CB ' ' A' ' 27' ' ' LEU . . . -166.05 -167.4 26.63 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.94 132.91 42.24 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.354 -1.086 . . . . 0.0 109.151 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.787 HD12 HG21 ' A' ' 63' ' ' VAL . 40.0 pt -124.92 140.99 37.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.556 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 51.5 Cg_endo -75.15 157.08 42.34 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.753 1.635 . . . . 0.0 110.837 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.539 ' OG ' ' CZ2' ' A' ' 45' ' ' TRP . 48.1 t -88.6 29.85 0.96 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.609 -1.307 . . . . 0.0 109.836 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.492 ' OD1' ' C ' ' A' ' 60' ' ' SER . 6.0 m-20 -137.42 0.92 2.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 0.0 109.652 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.556 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 3.0 m-85 -108.19 -26.25 10.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.018 . . . . 0.0 109.286 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.787 HG21 HD12 ' A' ' 58' ' ' ILE . 15.3 m -124.22 161.06 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.869 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -155.41 -166.59 2.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 109.776 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.36 87.95 2.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.522 -0.736 . . . . 0.0 109.484 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HA ' HD12 ' A' ' 66' ' ' LEU . 12.6 tp -137.83 119.93 15.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.42 41.68 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.452 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.335 0.588 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 11' ' ' ASP . . . -105.03 177.17 23.14 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -158.32 158.9 35.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -1.101 . . . . 0.0 109.395 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 12' ' ' ILE . 18.4 mm -107.3 131.04 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.554 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.867 HG12 ' HA ' ' A' ' 65' ' ' LYS . 1.0 OUTLIER -130.56 156.75 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.28 -0.887 . . . . 0.0 108.994 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 p -112.47 134.32 55.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.939 -1.1 . . . . 0.0 109.001 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.35 118.2 4.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.443 -0.785 . . . . 0.0 110.281 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.081 HD11 ' HB2' ' A' ' 64' ' ' ALA . 25.5 mt -90.94 -29.11 17.63 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -137.16 143.05 40.27 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.5 Cg_endo -61.72 140.09 84.19 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.752 2.301 . . . . 0.0 111.552 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 39.2 t80 -134.05 126.37 30.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.957 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 22' ' ' ILE . 3.0 m-20 -103.22 107.39 18.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.942 -1.099 . . . . 0.0 108.516 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.04 91.42 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' ASP . 13.4 mm -79.29 -58.75 3.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.588 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -67.26 175.4 1.55 Allowed Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.4 Cg_endo -71.74 -25.47 20.38 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.637 2.225 . . . . 0.0 112.045 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 35.8 m-20 -112.65 -8.33 13.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.33 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.49 121.05 11.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.026 -1.046 . . . . 0.0 109.754 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.116 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -85.5 134.64 34.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.921 -1.112 . . . . 0.0 108.363 179.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.116 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.7 p -84.27 136.93 33.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.955 . . . . 0.0 110.635 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 15.6 p90 -139.01 147.34 42.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 11.6 mtpp -107.25 140.98 39.29 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.081 -1.012 . . . . 0.0 109.499 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -42.6 151.47 0.12 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.153 -0.967 . . . . 0.0 108.397 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.97 -16.03 7.59 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.9 tp10 -83.33 151.63 25.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.032 -1.275 . . . . 0.0 109.542 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 4.1 mttt -105.77 146.49 29.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.425 -0.797 . . . . 0.0 110.166 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.555 ' HE3' HG11 ' A' ' 63' ' ' VAL . 3.1 mtm -138.2 155.35 48.76 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.663 0.744 . . . . 0.0 109.557 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -123.0 138.86 54.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.0 119.07 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 109.288 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.62 -26.91 16.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.998 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -132.0 135.82 46.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.002 -1.062 . . . . 0.0 109.294 -179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.88 134.78 51.09 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.176 -0.952 . . . . 0.0 109.251 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.608 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 56.5 m-70 -120.61 34.85 5.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.309 -0.869 . . . . 0.0 109.009 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 -108.33 3.66 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 75.3 tt0 -85.15 -7.53 59.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -1.136 . . . . 0.0 109.987 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.611 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 21.4 m95 -132.28 140.13 48.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.948 -1.095 . . . . 0.0 110.315 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.611 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -136.54 166.53 23.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.463 -0.773 . . . . 0.0 109.186 179.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -108.73 117.36 33.97 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -112.03 -175.08 2.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.363 -0.836 . . . . 0.0 110.47 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 32.2 ttpt -139.13 148.17 42.88 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.9 t -88.89 124.94 34.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 0.0 109.672 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -69.2 -11.77 61.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.058 -1.026 . . . . 0.0 109.281 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 tp -87.43 -53.57 4.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 0.0 109.769 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.533 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 1.8 t -108.99 14.63 23.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.355 -0.841 . . . . 0.0 109.351 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER 42.43 25.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -80.99 142.67 33.19 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.033 -1.042 . . . . 0.0 108.416 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 18.9 tt0 -121.44 141.09 51.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.092 -1.005 . . . . 0.0 109.6 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.699 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -168.65 166.94 39.98 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -67.76 134.41 50.97 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.431 -1.041 . . . . 0.0 109.913 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.64 142.28 40.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.678 ' CG ' ' CD1' ' A' ' 62' ' ' TYR . 50.1 Cg_endo -72.02 151.26 55.78 Favored 'Trans proline' 0 C--O 1.216 -0.586 0 C-N-CA 121.7 1.6 . . . . 0.0 110.918 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.503 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 98.9 p -87.67 28.09 1.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.55 -1.344 . . . . 0.0 109.983 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -140.27 -4.23 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.086 -1.009 . . . . 0.0 110.032 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.678 ' CD1' ' CG ' ' A' ' 59' ' ' PRO . 7.6 m-85 -98.7 -23.36 15.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.058 -1.026 . . . . 0.0 110.388 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.555 HG11 ' HE3' ' A' ' 35' ' ' MET . 17.5 m -110.42 156.69 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.179 . . . . 0.0 109.737 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.081 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -104.6 128.21 52.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 109.734 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.867 ' HA ' HG12 ' A' ' 13' ' ' VAL . 2.7 mtpt -82.47 79.42 8.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -0.978 . . . . 0.0 109.254 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.672 HD12 ' ND2' ' A' ' 67' ' ' ASN . 1.1 tm? 77.99 -71.99 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.361 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.672 ' ND2' HD12 ' A' ' 66' ' ' LEU . 6.5 p30 -145.8 -39.4 0.23 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.562 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 68' ' ' THR . 6.7 t . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.481 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.33 0.586 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.0 -159.4 9.14 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.55 136.91 48.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -1.186 . . . . 0.0 109.308 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.615 HD13 ' HG2' ' A' ' 36' ' ' LYS . 34.8 mm -105.37 131.13 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.253 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.947 HG12 ' CA ' ' A' ' 65' ' ' LYS . 1.4 m -131.8 158.04 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.344 -0.848 . . . . 0.0 109.469 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.04 136.36 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.137 -0.977 . . . . 0.0 109.007 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 31' ' ' LYS . . . -57.39 117.13 3.81 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 109.631 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.037 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 26.0 mt -90.39 -28.49 18.64 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -136.52 139.41 29.37 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 37.4 Cg_endo -59.73 141.25 96.58 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.925 2.416 . . . . 0.0 111.888 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.599 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 29.7 t80 -131.79 122.82 26.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.0 109.384 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 2.4 m-20 -102.57 110.92 23.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.116 -0.99 . . . . 0.0 108.858 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.97 89.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.3 mt -93.42 -14.98 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -1.131 . . . . 0.0 108.482 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -112.82 174.15 2.47 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 23' ' ' HIS . 51.0 Cg_endo -70.65 -34.34 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.402 2.068 . . . . 0.0 112.022 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -111.41 -9.61 14.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.118 -0.989 . . . . 0.0 110.361 -179.43 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -60.29 120.62 10.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.975 -1.078 . . . . 0.0 109.772 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.113 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -84.54 135.64 34.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.999 -1.063 . . . . 0.0 108.336 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.113 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -84.3 136.51 33.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.584 -178.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 19' ' ' TYR . 13.9 p90 -140.29 149.1 42.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 108.754 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.535 ' O ' ' C ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -107.68 136.78 46.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.909 -1.119 . . . . 0.0 109.392 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -38.87 154.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . 72.5 -15.76 1.99 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 0.9 OUTLIER -80.17 156.42 26.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.825 -1.397 . . . . 0.0 108.926 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -107.08 144.37 33.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 110.355 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.641 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -140.48 154.79 46.73 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.444 0.64 . . . . 0.0 109.298 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.615 ' HG2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -122.24 139.86 53.28 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.66 ' CG1' ' HB2' ' A' ' 45' ' ' TRP . 1.3 t -99.87 119.22 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.015 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -90.23 -21.27 22.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.409 -0.807 . . . . 0.0 110.073 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 48.2 tt0 -144.51 138.12 27.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.932 -1.105 . . . . 0.0 109.787 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.37 133.27 52.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.329 -0.857 . . . . 0.0 109.0 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.522 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 77.9 m-70 -121.6 34.15 5.28 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.216 -0.928 . . . . 0.0 109.361 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.48 -110.53 4.04 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.36 -7.49 58.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -1.137 . . . . 0.0 109.892 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.572 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 1.6 m95 -130.65 142.55 50.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.985 -1.072 . . . . 0.0 109.908 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.66 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.85 168.16 20.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.287 -0.883 . . . . 0.0 109.766 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.628 ' O ' HD12 ' A' ' 38' ' ' LEU . 7.9 tttm -110.88 117.38 33.23 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -115.03 -172.03 2.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 110.354 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 6.8 ttpm? -139.88 149.0 42.86 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -88.44 125.97 35.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.084 -1.01 . . . . 0.0 109.508 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.5 mt -69.98 -13.49 62.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.017 -1.052 . . . . 0.0 109.288 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.8 tp -82.92 -55.62 4.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.798 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.468 ' OG1' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -108.96 10.61 26.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.386 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.5 OUTLIER 49.72 25.43 1.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.88 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.577 ' HB3' HD23 ' A' ' 27' ' ' LEU . 13.4 mttp -79.47 142.54 35.76 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 6.5 pt-20 -120.99 143.4 49.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.074 -1.016 . . . . 0.0 109.391 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.669 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -165.63 -164.74 21.7 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HB3' ' CZ3' ' A' ' 44' ' ' TRP . 1.7 m-85 -96.63 133.54 41.01 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.394 -1.062 . . . . 0.0 109.46 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 58' ' ' ILE . 20.5 pt -125.64 140.31 36.18 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.607 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 54.5 Cg_endo -77.1 161.23 32.75 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 121.663 1.576 . . . . 0.0 110.963 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.593 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 41.8 t -90.88 29.33 1.37 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.677 -1.265 . . . . 0.0 109.872 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 23.5 t-20 -140.65 -0.1 1.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.607 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 9.8 m-85 -102.12 -26.86 13.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.057 -1.027 . . . . 0.0 110.151 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.641 HG11 ' CE ' ' A' ' 35' ' ' MET . 5.1 m -113.76 163.3 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.88 -1.137 . . . . 0.0 110.075 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.037 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -109.69 130.47 55.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 109.379 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.947 ' CA ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.4 130.7 43.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.043 -1.035 . . . . 0.0 109.423 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -132.83 102.94 5.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.892 . . . . 0.0 109.445 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 66' ' ' LEU . 7.0 t-20 179.62 151.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.895 . . . . 0.0 109.455 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.462 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.43 119.71 3.45 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.417 ' OD2' ' HE2' ' A' ' 65' ' ' LYS . 1.2 m-20 -146.8 155.48 42.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -1.129 . . . . 0.0 109.381 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.699 HD12 ' HD3' ' A' ' 36' ' ' LYS . 1.8 tp -109.83 134.1 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.845 HG12 ' CA ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -129.4 155.65 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.257 -0.902 . . . . 0.0 109.049 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.764 HG12 ' HB3' ' A' ' 64' ' ' ALA . 9.1 p -113.26 134.28 56.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.087 -1.008 . . . . 0.0 108.958 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -56.14 117.44 3.76 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.465 -0.772 . . . . 0.0 110.107 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 64' ' ' ALA . 32.3 mt -89.1 -29.22 19.55 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -136.58 142.49 39.4 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.1 Cg_endo -60.73 140.03 88.61 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.747 2.298 . . . . 0.0 111.675 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 28.6 t80 -131.76 123.21 27.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 109.371 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -103.23 110.09 21.93 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 108.832 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.58 89.24 0.01 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.6 mt -90.75 -14.99 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.329 -1.101 . . . . 0.0 108.424 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -113.4 176.21 1.57 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 52.2 Cg_endo -71.77 -32.94 10.91 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.422 2.081 . . . . 0.0 111.897 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 4.8 m-20 -111.46 -8.82 14.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.163 -0.961 . . . . 0.0 110.216 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.463 ' OD1' ' CZ ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -60.69 122.85 15.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.001 -1.062 . . . . 0.0 109.636 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.108 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -87.45 134.8 33.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.962 -1.086 . . . . 0.0 108.498 179.318 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.108 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -84.21 136.38 33.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.496 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.663 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.6 p90 -139.37 148.1 42.4 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -107.9 137.16 46.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.081 . . . . 0.0 109.437 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 30' ' ' LYS . 9.6 ptmm? -38.81 151.66 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.41 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.11 -16.77 8.38 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.143 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 1.8 mp0 -83.32 153.39 24.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.948 -1.325 . . . . 0.0 109.653 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 8.8 mtpt -105.43 146.33 29.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.413 -0.804 . . . . 0.0 109.958 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.601 ' HE3' HG11 ' A' ' 63' ' ' VAL . 4.9 mtm -138.68 155.18 48.49 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.699 0.761 . . . . 0.0 109.573 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.699 ' HD3' HD12 ' A' ' 12' ' ' ILE . 3.4 tppt? -123.05 138.75 54.6 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.43 ' N ' ' HG3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -104.73 119.25 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.405 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -26.08 17.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.882 . . . . 0.0 109.989 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 68.5 mt-10 -133.04 135.51 45.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 109.155 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.433 ' OE2' ' N ' ' A' ' 42' ' ' GLY . 2.5 tm-20 -109.47 134.8 51.43 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.235 -0.916 . . . . 0.0 109.335 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.596 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 22.3 m-70 -119.95 36.02 4.66 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.252 -0.905 . . . . 0.0 108.86 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.433 ' N ' ' OE2' ' A' ' 40' ' ' GLU . . . 92.63 -106.46 3.41 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -86.59 -8.32 57.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -1.165 . . . . 0.0 110.121 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.607 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 12.2 m95 -131.98 138.74 48.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.919 -1.113 . . . . 0.0 110.375 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.607 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -136.09 167.18 21.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.358 -0.839 . . . . 0.0 109.326 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -109.04 117.51 34.38 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -113.7 -173.1 2.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.379 -0.826 . . . . 0.0 110.677 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.5 ttmt -139.88 147.49 40.7 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.666 ' O ' ' N ' ' A' ' 53' ' ' LYS . 29.3 t -88.48 129.47 35.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 109.925 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.37 -27.47 66.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.052 . . . . 0.0 109.79 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.13 -41.82 16.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.181 -0.949 . . . . 0.0 109.947 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.495 ' OG1' ' HB3' ' A' ' 49' ' ' SER . 1.3 p -98.94 -18.35 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.354 -0.841 . . . . 0.0 109.371 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 49' ' ' SER . 14.0 mttt 60.65 11.21 2.98 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.334 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -80.21 150.76 29.99 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 8.6 pt-20 -120.53 143.52 48.53 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.9 -1.125 . . . . 0.0 109.695 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.69 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -167.15 165.6 38.68 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 1.8 m-85 -68.01 134.88 51.43 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.441 -1.035 . . . . 0.0 110.109 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 6.9 pt -125.52 140.85 37.39 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.703 ' HG2' ' HB2' ' A' ' 62' ' ' TYR . 52.9 Cg_endo -74.42 157.04 45.52 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 121.62 1.547 . . . . 0.0 111.055 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -89.56 27.98 1.38 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.706 -1.246 . . . . 0.0 109.824 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -140.71 -1.82 1.41 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.841 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.703 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.4 m-85 -102.05 -25.96 13.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.118 -0.989 . . . . 0.0 110.276 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.601 HG11 ' HE3' ' A' ' 35' ' ' MET . 11.5 m -108.79 172.0 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.814 -1.179 . . . . 0.0 109.972 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.807 ' HB2' HD21 ' A' ' 16' ' ' LEU . . . -119.99 126.54 51.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.789 . . . . 0.0 109.595 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.845 ' CA ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -92.08 52.57 2.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.129 -0.982 . . . . 0.0 109.305 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.44 66.63 0.46 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 t30 57.23 167.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.488 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.37 100.68 0.37 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.6 129.75 40.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -1.115 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 3.0 tp -109.4 132.75 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.453 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.75 HG12 ' CA ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -128.38 154.32 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 108.861 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.3 p -113.01 134.02 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.267 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -57.47 119.36 6.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.603 -0.686 . . . . 0.0 110.303 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.105 HD11 ' HB2' ' A' ' 64' ' ' ALA . 81.1 mt -91.51 -28.1 17.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -137.25 143.48 41.8 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 38.3 Cg_endo -61.47 140.03 85.3 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.62 2.213 . . . . 0.0 111.331 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.636 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 33.5 t80 -133.67 125.96 29.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.856 . . . . 0.0 110.051 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -103.25 106.76 17.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.016 -1.053 . . . . 0.0 108.371 178.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -29.63 92.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 20' ' ' ASP . 3.0 mt -78.85 -59.01 3.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.354 -1.086 . . . . 0.0 108.099 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 3.6 m-70 -67.33 172.49 3.67 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 47.3 Cg_endo -68.83 -23.96 34.73 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.555 2.17 . . . . 0.0 112.108 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.544 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.1 m-20 -112.86 -7.48 13.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.151 -0.968 . . . . 0.0 110.284 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.517 ' HB3' ' HE1' ' A' ' 19' ' ' TYR . 13.3 m-20 -60.95 118.43 6.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.041 -1.037 . . . . 0.0 109.925 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.122 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -83.8 134.46 34.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.933 -1.104 . . . . 0.0 108.49 179.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.122 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.3 m -84.38 137.12 33.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.64 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 19' ' ' TYR . 8.7 p90 -139.56 148.28 42.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.281 -0.887 . . . . 0.0 108.635 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 31' ' ' LYS . 4.6 ttpm? -107.28 139.73 41.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.965 -1.084 . . . . 0.0 109.479 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -41.66 152.3 0.07 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.73 -16.27 6.86 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -82.84 152.66 25.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.084 -1.244 . . . . 0.0 109.713 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 16.3 mttp -105.95 145.96 30.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.424 -0.798 . . . . 0.0 110.223 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 63' ' ' VAL . 4.5 mtm -139.72 155.78 47.16 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.591 0.71 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 3.4 ttmm -120.67 137.61 54.37 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.411 ' CG2' ' CB ' ' A' ' 45' ' ' TRP . 1.6 p -104.35 120.12 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.707 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.745 ' N ' HD22 ' A' ' 38' ' ' LEU . 1.6 mm? -88.52 -37.81 15.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.324 -0.86 . . . . 0.0 109.767 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 6.6 tp10 -128.43 136.25 50.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.104 -0.997 . . . . 0.0 109.732 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.627 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -110.83 142.4 42.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.59 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 68.2 m-70 -114.96 44.27 1.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.037 -1.039 . . . . 0.0 109.743 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 52.81 27.52 28.76 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.401 -0.904 . . . . 0.0 110.881 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 41' ' ' HIS . 8.2 pt-20 164.04 -40.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.999 -1.295 . . . . 0.0 109.597 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.59 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 39.4 m95 -126.54 121.56 32.63 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.659 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -118.1 166.42 12.58 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.976 -1.077 . . . . 0.0 109.754 -179.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -109.45 122.61 47.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -118.69 -174.14 2.62 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 110.944 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 19.3 ttmt -139.09 148.68 43.62 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 53' ' ' LYS . 2.3 t -90.45 124.92 35.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.971 -1.081 . . . . 0.0 109.852 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.48 -11.62 60.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.097 -1.002 . . . . 0.0 109.358 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.5 tp -83.87 -55.93 3.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 109.693 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.77 10.0 26.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.298 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' SER . 9.9 mtmt 49.93 25.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.366 -0.834 . . . . 0.0 109.834 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 1.026 ' HG2' HD23 ' A' ' 27' ' ' LEU . 2.9 tttt -80.35 142.52 34.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.089 -1.007 . . . . 0.0 108.317 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 13.2 pt-20 -122.05 142.95 49.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.042 -1.036 . . . . 0.0 109.637 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.685 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -164.14 -163.07 16.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 3.1 m-85 -97.79 133.62 42.05 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.466 -1.02 . . . . 0.0 109.491 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 12.7 pt -125.53 135.95 27.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.624 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 53.1 Cg_endo -75.35 164.21 33.14 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 121.637 1.558 . . . . 0.0 110.905 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.415 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 92.4 p -92.69 28.62 1.98 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.812 -1.18 . . . . 0.0 109.713 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -140.94 -1.71 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 109.915 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.624 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 9.4 m-85 -100.81 -27.89 13.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.044 -1.035 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.541 HG11 ' CE ' ' A' ' 35' ' ' MET . 11.6 m -113.61 163.07 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.029 -1.044 . . . . 0.0 109.534 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.105 ' HB2' HD11 ' A' ' 16' ' ' LEU . . . -109.8 129.8 55.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.744 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.75 ' CA ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -105.53 102.14 11.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 109.393 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.94 115.93 22.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 109.456 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.49 41.25 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.955 . . . . 0.0 109.498 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.473 179.985 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.352 0.596 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.44 -114.87 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.94 160.35 2.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -1.148 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.409 ' HA ' HD13 ' A' ' 12' ' ' ILE . 26.8 mm -109.58 133.73 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.57 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -131.35 157.54 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.235 -0.916 . . . . 0.0 109.19 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 7.6 p -115.56 134.06 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.08 -1.013 . . . . 0.0 109.032 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.702 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -53.15 114.22 1.39 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.335 -0.853 . . . . 0.0 109.939 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.918 HD11 ' CB ' ' A' ' 64' ' ' ALA . 27.8 mt -84.76 -30.0 25.03 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -137.49 140.88 31.67 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.638 ' HD3' ' HG3' ' A' ' 31' ' ' LYS . 37.6 Cg_endo -59.44 140.16 92.93 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.748 2.299 . . . . 0.0 111.649 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 33.3 t80 -134.27 125.76 28.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.836 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -102.13 107.94 19.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.892 -1.13 . . . . 0.0 108.571 179.003 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -30.11 89.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 20' ' ' ASP . 76.4 mt -80.94 -57.6 4.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.568 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 8.5 m80 -68.48 171.14 6.43 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 23' ' ' HIS . 47.5 Cg_endo -68.18 -27.25 35.43 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.655 2.237 . . . . 0.0 112.246 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.575 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 23.6 t0 -111.8 -7.91 14.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.128 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -60.78 123.69 18.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.117 -0.989 . . . . 0.0 109.827 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.112 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -90.16 134.45 34.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.979 -1.075 . . . . 0.0 108.514 179.308 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.112 ' N ' HD22 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -83.31 136.53 34.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.897 . . . . 0.0 110.605 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 8.3 p90 -138.86 147.07 41.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.339 -0.851 . . . . 0.0 108.721 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -108.87 146.81 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.831 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.638 ' HG3' ' HD3' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -46.51 151.39 0.56 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.918 -1.114 . . . . 0.0 108.545 179.231 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.3 -15.0 7.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -82.68 149.99 27.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.267 . . . . 0.0 109.683 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -105.98 144.94 31.99 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.711 0.767 . . . . 0.0 110.177 -179.307 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.722 ' CE ' HG11 ' A' ' 63' ' ' VAL . 4.7 mtm -137.79 155.23 49.26 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.588 0.708 . . . . 0.0 109.544 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 10.7 ttpp -118.85 136.06 54.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.32 118.77 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.21 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.48 ' H ' HD12 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -88.56 -33.76 17.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -133.52 136.43 45.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 109.525 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.575 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 1.7 tt0 -111.05 144.92 39.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 44' ' ' TRP . 4.5 m-70 -115.95 43.88 2.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 0.0 109.765 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 43' ' ' GLU . . . 47.86 35.48 12.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 160.56 -45.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -1.161 . . . . 0.0 109.759 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.602 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 11.9 m95 -127.56 122.44 33.24 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.369 -0.832 . . . . 0.0 109.087 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.682 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.37 166.03 12.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.14 -0.975 . . . . 0.0 109.605 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -109.81 123.22 49.17 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -120.23 -173.63 2.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 110.809 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.9 ttpt -138.8 148.93 44.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 53' ' ' LYS . 5.2 t -90.07 125.52 35.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.944 -1.097 . . . . 0.0 109.903 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.6 mt -69.5 -13.41 62.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 109.43 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.9 tp -82.64 -55.35 4.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.732 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.22 9.46 25.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 109.286 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.8 OUTLIER 50.67 25.93 2.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.848 . . . . 0.0 109.864 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -80.54 142.38 34.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.177 -0.952 . . . . 0.0 108.435 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -121.98 142.14 50.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.094 -1.004 . . . . 0.0 109.54 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.672 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -162.65 -164.66 18.17 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' A' ' 44' ' ' TRP . 0.1 OUTLIER -97.42 134.14 41.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.523 -0.987 . . . . 0.0 109.291 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.681 HD12 HG21 ' A' ' 63' ' ' VAL . 13.7 pt -126.49 137.8 31.1 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 52.2 Cg_endo -75.04 163.71 34.71 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 121.683 1.589 . . . . 0.0 110.675 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.7 p -92.21 29.26 1.69 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.72 -1.238 . . . . 0.0 109.906 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -138.92 -0.74 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.887 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.561 ' HB2' ' HG2' ' A' ' 59' ' ' PRO . 9.2 m-85 -106.16 -28.23 10.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 109.259 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.722 HG11 ' CE ' ' A' ' 35' ' ' MET . 22.0 m -122.02 158.05 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.317 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.918 ' CB ' HD11 ' A' ' 16' ' ' LEU . . . -155.35 -165.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.657 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -82.45 142.95 31.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.518 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 67' ' ' ASN . 7.8 tt -87.55 147.76 25.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.423 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.706 ' N ' HD23 ' A' ' 66' ' ' LEU . 23.1 m120 -140.7 -89.67 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.451 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.539 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 37' ' ' VAL . . . 99.26 108.09 2.85 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -121.8 152.57 39.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 109.399 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 36' ' ' LYS . 25.0 mm -105.86 129.56 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.972 . . . . 0.0 109.348 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.955 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.5 OUTLIER -129.52 154.85 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.396 -0.815 . . . . 0.0 108.978 -179.649 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 14.3 p -111.55 133.75 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.861 -1.149 . . . . 0.0 108.939 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 63' ' ' VAL . . . -57.05 117.09 3.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.436 -0.79 . . . . 0.0 110.164 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.023 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 14.5 mt -89.37 -28.08 20.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.8 140.17 28.79 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 37.6 Cg_endo -59.9 141.28 96.27 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.86 2.373 . . . . 0.0 111.49 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.646 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 34.5 t80 -132.83 123.92 27.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.727 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 22' ' ' ILE . 9.3 t70 -102.71 109.51 21.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.087 -1.008 . . . . 0.0 108.6 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.563 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -26.98 89.02 0.01 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.592 ' N ' ' O ' ' A' ' 20' ' ' ASP . 17.4 mt -88.36 -14.59 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.185 . . . . 0.0 108.318 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -114.13 176.67 1.4 Allowed Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 53.1 Cg_endo -72.43 -31.94 10.67 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.489 2.126 . . . . 0.0 112.085 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 17.7 m-20 -112.05 -9.59 13.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.354 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -60.41 122.24 14.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.918 -1.114 . . . . 0.0 109.778 -179.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.12 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -85.43 135.13 33.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.916 -1.115 . . . . 0.0 108.404 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.12 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.2 m -84.56 136.82 33.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.565 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.646 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 10.4 p90 -138.79 147.22 42.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.264 -0.898 . . . . 0.0 108.744 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 15.1 pttt -108.28 146.7 32.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.721 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.614 ' CD ' ' O ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -46.23 152.46 0.41 Allowed 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.868 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.68 -12.67 10.07 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 3.2 tm-20 -83.8 148.09 27.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.124 -1.221 . . . . 0.0 110.13 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -104.78 147.21 27.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -0.759 . . . . 0.0 109.714 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.565 ' CE ' HG11 ' A' ' 63' ' ' VAL . 8.7 mtm -139.42 155.28 47.72 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.667 0.746 . . . . 0.0 109.931 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -123.59 140.71 52.72 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.596 HG11 ' CB ' ' A' ' 45' ' ' TRP . 2.7 t -102.17 119.58 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.071 -1.018 . . . . 0.0 110.023 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -88.77 -21.64 23.7 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 0.0 109.811 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 4.3 mt-10 -148.33 139.05 22.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.97 -1.082 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.577 ' HG3' ' CD1' ' A' ' 45' ' ' TRP . 11.5 tt0 -109.74 135.44 50.66 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.299 -0.876 . . . . 0.0 109.166 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 63.3 m-70 -117.82 36.06 4.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.326 -0.859 . . . . 0.0 108.87 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.49 -110.14 3.95 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -84.74 -6.81 59.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -1.18 . . . . 0.0 109.865 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.572 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 23.4 m95 -130.89 143.16 50.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.058 -1.026 . . . . 0.0 109.97 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.596 ' CB ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -141.31 168.28 20.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.338 -0.851 . . . . 0.0 109.613 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.602 ' O ' HD12 ' A' ' 38' ' ' LEU . 8.7 tttt -110.2 116.36 31.36 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -114.15 -172.31 2.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.407 -0.808 . . . . 0.0 110.307 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.4 ttpm? -142.33 151.27 41.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 109.305 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -92.23 126.5 37.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.054 -1.029 . . . . 0.0 109.695 -179.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 mt -70.19 -13.98 62.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.024 -1.048 . . . . 0.0 109.33 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 51' ' ' LEU . 17.2 tp -75.96 -59.68 2.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -108.69 3.52 22.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 0.0 109.423 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.545 ' CD ' ' N ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 61.23 25.66 15.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.752 ' HG2' HD23 ' A' ' 27' ' ' LEU . 1.1 tptp -78.51 141.51 38.13 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.153 -0.967 . . . . 0.0 108.521 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 7.2 pt-20 -123.46 146.1 48.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.046 -1.034 . . . . 0.0 109.604 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.723 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -169.75 -164.87 26.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -95.77 134.16 39.04 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.446 -1.031 . . . . 0.0 109.53 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 pt -126.0 141.67 40.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.631 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 54.6 Cg_endo -75.71 156.97 39.97 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.839 1.693 . . . . 0.0 110.921 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.584 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . 46.0 t -88.67 28.13 1.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.726 -1.234 . . . . 0.0 110.019 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -139.82 -1.96 1.57 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.138 -0.976 . . . . 0.0 109.819 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.631 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 5.9 m-85 -101.74 -25.38 13.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.385 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.565 HG11 ' CE ' ' A' ' 35' ' ' MET . 24.7 m -113.0 161.42 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.858 -1.151 . . . . 0.0 110.069 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.023 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -108.51 131.7 54.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.444 -0.785 . . . . 0.0 109.62 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.955 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -84.95 101.47 12.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.999 -1.063 . . . . 0.0 109.533 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.21 163.68 3.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 109.439 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -115.76 -179.47 3.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.879 . . . . 0.0 109.415 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.49 -179.943 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.43 36.52 0.12 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.487 ' C ' HD12 ' A' ' 12' ' ' ILE . 10.4 t70 -85.51 141.22 30.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -1.151 . . . . 0.0 109.429 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.7 OUTLIER -104.9 128.65 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.501 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.833 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -130.44 155.51 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 11.3 p -112.84 133.77 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.943 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -58.48 118.66 5.84 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.476 -0.765 . . . . 0.0 110.385 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.036 ' CD1' ' HB2' ' A' ' 64' ' ' ALA . 53.5 mt -92.02 -27.1 18.03 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -137.55 141.39 33.28 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 30' ' ' LYS . 38.9 Cg_endo -62.2 141.43 88.11 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.648 2.232 . . . . 0.0 111.56 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.649 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 33.5 t80 -132.84 124.18 27.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.962 . . . . 0.0 109.671 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -103.37 110.32 22.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.069 -1.02 . . . . 0.0 108.796 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 20' ' ' ASP . . . -27.96 89.52 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 20' ' ' ASP . 4.6 mt -90.1 -13.73 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -1.11 . . . . 0.0 108.359 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.559 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -114.01 174.56 2.27 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HD2' ' CD2' ' A' ' 23' ' ' HIS . 50.9 Cg_endo -70.78 -32.48 14.26 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.409 2.073 . . . . 0.0 111.916 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.559 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 16.2 m-20 -112.02 -9.64 13.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 110.4 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -59.83 121.62 12.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.891 -1.131 . . . . 0.0 109.745 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.1 HD22 ' N ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -84.33 136.83 33.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 108.353 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 1.1 ' N ' HD22 ' A' ' 27' ' ' LEU . 2.9 m -86.99 137.5 32.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 0.0 110.629 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 19' ' ' TYR . 11.0 p90 -140.28 149.57 42.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -108.85 142.5 39.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.051 -1.031 . . . . 0.0 109.731 -179.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' LYS . 1.2 pttt -44.79 151.53 0.29 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.112 -0.993 . . . . 0.0 108.423 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.52 -16.43 7.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.575 ' CG ' ' CD2' ' A' ' 51' ' ' LEU . 10.0 tp10 -82.8 151.59 26.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.066 -1.255 . . . . 0.0 109.915 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 3.9 mttt -105.33 146.36 29.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.454 -0.779 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.677 ' CE ' HG11 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -138.3 153.8 49.02 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.725 0.774 . . . . 0.0 110.132 -179.423 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG2' HG13 ' A' ' 12' ' ' ILE . 2.8 mtpm? -122.62 138.3 54.63 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 2.2 t -88.32 155.38 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 118.48 -1.288 . . . . 0.0 109.292 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.529 ' O ' ' CG ' ' A' ' 39' ' ' GLU . 4.1 mt -122.61 -13.35 7.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.313 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 45' ' ' TRP . 37.3 mt-10 -159.03 138.94 11.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.381 -0.824 . . . . 0.0 109.054 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 45' ' ' TRP . 13.0 tt0 -106.18 132.8 51.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 44' ' ' TRP . 41.6 m-70 -122.2 34.2 5.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.453 -0.779 . . . . 0.0 109.289 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.8 -113.53 4.61 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -83.26 -6.8 59.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -1.165 . . . . 0.0 109.601 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.587 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 32.1 m95 -130.35 148.08 52.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.431 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.587 ' CD1' ' C ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -146.69 172.01 14.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 110.072 179.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.609 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -111.7 128.41 56.07 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . . . -121.64 -173.29 2.6 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.128 -0.982 . . . . 0.0 110.509 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 26.7 ttpt -136.93 146.69 45.75 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -86.5 124.54 32.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 109.49 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.3 -10.07 52.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.057 -1.027 . . . . 0.0 109.404 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.575 ' CD2' ' CG ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -88.1 -53.16 4.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 109.991 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.543 HG22 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.11 8.84 24.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.922 . . . . 0.0 109.584 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER 50.73 26.64 2.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.302 -0.874 . . . . 0.0 109.752 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 11.3 tptt -84.4 142.06 30.4 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 23.4 pt-20 -117.48 139.53 50.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.979 -1.076 . . . . 0.0 109.638 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.664 ' N ' ' HB2' ' A' ' 27' ' ' LEU . . . -156.58 -166.6 16.56 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.408 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 5.5 m-85 -97.21 132.69 42.73 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 109.541 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.418 HG22 ' CE1' ' A' ' 29' ' ' PHE . 11.5 pt -124.78 141.47 38.2 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.615 ' HG2' ' CD1' ' A' ' 62' ' ' TYR . 55.1 Cg_endo -78.71 161.48 27.6 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.66 1.573 . . . . 0.0 111.199 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . 32.9 t -90.86 30.01 1.26 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.837 -1.164 . . . . 0.0 109.701 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 60' ' ' SER . 6.8 m120 -141.19 -0.12 1.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.813 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.615 ' CD1' ' HG2' ' A' ' 59' ' ' PRO . 7.7 m-85 -102.72 -26.74 13.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 110.122 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.677 HG11 ' CE ' ' A' ' 35' ' ' MET . 6.4 m -114.73 163.92 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.965 -1.084 . . . . 0.0 110.003 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.036 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -109.22 129.49 55.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 109.312 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.833 ' HA ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -91.18 120.56 32.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.118 -0.989 . . . . 0.0 109.38 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.46 104.73 1.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 0.0 109.516 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -119.96 116.27 25.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.925 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.44 -179.878 . . . . . . . . 0 0 . 1 stop_ save_